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SUMMARY
In contrast to the increasingly sophisticated 
knowledge of herpes simplex virus type 1 (HSV-1), our
understanding of varicella-zoster virus (VZV) gene 
regulation is at an early stage. VZV gene 62 is one of a 
number of VZV genes which, on the basis of homology with 
known HSV-1 regulatory genes, are predicted to encode gene 
regulatory polypeptides. The work presented in this 
thesis investigated the properties and functions of the 
product of VZV gene 62.
VZV gene 62 encodes a polypeptide with a predicted 
molecular weight of 140,000 (VZV 140k) which shares 
considerable predicted amino acid sequence homology with
the HSV-1 polypeptide, Vmwl75 (or ICP4), encoded by IE gene
3. Vmwl75 is an essential viral polypeptide with a pivotal 
role in the activation of early and late viral gene 
expression, and also repression of immediate early gene 
expression. There is compelling evidence that VZV 140k is a 
functional counterpart of Vmwl75, and as such may have a
critical role in the regulation of VZV gene expression.
This hypothesis was tested by inserting VZV gene 62 coding 
sequences (expressed from the HSV-1 IE-3 promoter) into 
both IE-3 gene loci in the short region repeats of the HSV- 
1 genome. The parent virus used for this manipulation was 
D30EBA, which is a variant of HSV-1 from which the majority 
of the Vmwl75 coding sequences have been deleted. Like 
other HSV-1 viruses lacking Vmwl75 function, D30EBA is able 
to grow only in cell lines which express Vmwl75 
constitutively. Significantly, the resulting recombinant 
virus, HSV-140, is able to propagate (but unable to form 
obvious plaques) on normal cell lines. The properties of 
HSV-140 were studied in comparison to HSV-1 by monitoring 
the time-course of polypeptide expression and DNA 
replication during normal infection. It was found that 
HSV-140 synthesises apparently normal amounts of many viral 
polypeptides during a high multiplicity infection, although 
the expression of certain late polypeptides (for example, 
Vmw65, and the major capsid protein) is reduced; this 
slight defect may be related to the decreased efficiency of
HSV-140 DNA replication. At low multiplicity HSV-140 
expressed viral polypeptides inefficiently. Surprisingly, 
the VZV 140K polypeptide was produced in large amounts at 
later times of a normal infection, indicating that VZV 140k 
fails to repress the IE-3 promoter. Finally, infection of 
cells in the presence of actinomycin-D revealed that HSV- 
140 is much less efficient than wild type virus in the 
shut-off of host protein synthesis, suggesting that HSV-140 
presents reduced amounts of the virion-associated host 
shut-off factor (encoded by gene UL41). These results 
indicate that VZV 140K is able to perform most of the 
functions of Vmwl75 during growth of HSV-1, but that 
differences in detail lead to less efficient virus growth.
The properties of VZV 140k have also been studied 
in transient transfection assays. It was of particular 
interest to determine whether VZV 140k was able to repress 
expression from its own promoter (that of gene 62). To 
this end plasmid pl40CAT was constructed in which VZV gene 
62 upstream sequences from -1146 to +57 (which include the 
complete promoter) were linked to the coding sequences of 
the chloramphenicol acetyl transferase (CAT) gene. 
Co-transfection experiments utilizing pl40CAT demonstrated 
that VZV 140k strongly represses expression from its own 
promoter, thus establishing further functional homology 
between the polypeptides. Interestingly, Vmwl75 is 
competent in repression of the VZV gene 62 promoter whereas 
VZV 140k was unable to repress the HSV-1 IE-3 promoter in 
the reciprocal experiment. The failure of VZV 140k to 
repress the IE-3 promoter is consistent with observations 
made with HSV-140 (see above). Plasmids expressing mutant 
forms of Vmwl75 which have small, in-frame insertions into 
region 2 of the polypeptide (e.g. pI13) are defective in
repression of the IE-3 promoter. Similarly, co-transfection 
of pI13 fails to repress expression of pl40CAT. The 
sequences comprising region 2 of Vmwl75 and VZV 140k are 
among the most highly conserved between the polypeptides. 
Notably, an analogous plasmid to pI13 which expresses a 
mutant form of VZV 140k containing an in-frame insertion 
into homology region 2 (pC34) is likewise impaired in its 
ability to repress expression of pl40CAT. These results
strongly suggest that repression of the VZV gene 62 
promoter by VZV 140k and Vmwl75 involves a similar 
mechanism to that of repression of the HSV-1 IE-3 promoter 
by Vmwl75. That is, both polypeptides may effect repression 
of gene 62 by binding to specific sequences at or near the 
gene 62 capsite. Furthermore, pC34, like pI13 and other 
region 2 insertion mutants of Vmv/175, is severely impaired 
in its ability to trans-activate the HSV-1 glycoprotein D 
promoter in transfection assays. Thus the mechanism of 
trans-activation might also be conserved between the 
polypeptides.
Vmwl7 5 binds to DNA sequences containing the 
consensus, ATCGTC, present in some, but not all HSV-1 
promoters. The transfection experiments described above 
suggest that VZV 140k may bind to specific sequences in the 
vicinity of the VZV gene 62 capsite, and thus it was of 
interest to investigate the DNA binding properties of the 
polypeptide. VZV 140k was found to bind non-specifically 
to calf-thymus DNA. In order to determine whether VZV 140k 
is able to bind to specific sequences in DNA, gel 
retardation assays were performed with nuclear extracts 
prepared from cells transfected with a plasmid expressing
VZV 140k, or from cells infected with VZV or HSV-140, and a
panel of probes representing the entire VZV gene 62
promoter-leader region. These analyses did not detect 
sequence-specific DNA binding by VZV 140k. This is
discussed in relation to the mechanism whereby VZV 140k 
might represses VZV gene 62.
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11. INTRODUCTION
VZV gene 62 encodes a polypeptide with a predicted 
molecular weight of 140,000 (VZV 140k) which shares
extensive predicted amino acid sequence homology with the 
immediate early gene regulatory polypeptide, Vmwl75, of 
HSV-1. The research presented in this thesis investigated 
the properties and functions of VZV 140k with a view to
obtaining a better understanding of its role in the VZV
life cycle. This introduction, therefore, includes an 
overview of the biology and molecular biology of VZV, and 
aims to review the current knowledge of gene regulation in 
the alphaherpesvirinae (of which VZV is a member) , with 
particular emphasis on HSV-1 and the role and functions of 
Vmwl75. In addition, since viral immediate early
polypeptides regulate gene expression through interactions 
with the eukaryotic transcriptional machinery, relevant 
aspects of eukaryotic gene expression will be discussed.
1A. THE BIOLOGY OF VZV
1A.1. Definition and Classification of the Herpesviridae
The family herpesviridae is comprised of more than 
80 distinct members which infect a wide range of higher 
eukaryotic hosts (Roizman and Batterson, 1985). Members of 
the herpesviridae are characterized by the inclusion of a 
linear double-stranded DNA genome in an enveloped virion 
particle 150-200nm in diameter. The herpesvirion is 
composed of four distinct structural elements:
i) The core is an electron dense structure within the
capsid which contains the genomic DNA (Epstein, 1962; 
Furlong et al., 1972; Nazerian, 1974).
ii) The capsid is icosahedral in structure, 100-110nm
in diameter, and is composed of 150 hexameric and 12 
pentameric capsomeres (Wildy et al.r 1960).
iii) The tegument is an ill-defined proteinaceous
structure located between the capsid and the envelope 
(Roizman and Furlong, 1974).
iv) The envelope surrounding the capsid and tegument is
2a tri laminar membrane containing numerous virus-encoded 
protein spikes approximately 8nm in length (Wildy et al., 
1960; Wildy and Watson, 1963; Spear and Roizman, 1972).
Asher et al. (1969) proposed that the envelope was derived 
from budding through the host cells nuclear membrane, but 
recent electron microscopic data suggests that the mature 
virus particle acquires its envelope by budding into 
cytoplasmic vesicles (Roffman et al., 1990).
The herpesviruses as a family exhibit a diverse
range of biological properties. However, common to all 
herpesviruses is the capacity to persist in a latent state 
in the infected host.
Herpesviridae have been classified into three 
subfamilies (alphaherpesvirinae, betaherpesvirinae, and 
gammaherpesvirinae) on the basis of their biological 
properties including host range, length of reproductive 
cycle, cytopathology, and characteristics of latent 
infection (Matthews, 1982; Roizman, 1982). The 
herpesviruses have also been classified into five groups (A 
through E) based on the arrangement of the characteristic 
reiterated DNA sequences within their genomes (Roizman et
al. , 1981) .
Members of the alphaherpesvirinae are characterized 
by a short reproductive cycle, typically less than 24h in 
tissue culture, and capacity to establish latency, 
primarily in ganglia. This subfamily contains herpes 
simplex virus types 1 and 2 (HSV-1 and HSV-2), pseudorabies 
virus (PRV), varice11a-zoster virus (VZV), and equine 
herpes virus type 1 (EHV-1).
Betaherpesvirinae have a restricted host range, 
long reproductive cycles, and infection progresses slowly 
in tissue culture resulting in enlargement of infected 
cells (cytomegalia). Latency can be established in a number 
of tissues. This subfamily contains the cytomegaloviruses, 
including human cytomegalovirus (HCMV).
The gammaherpesvirinae, of which Epstein-Barr virus 
(EBV) is a member, have a restricted host range and
3replicate in lymphoblastoid cell lines in tissue culture. 
Some members undergo lytic infections in epithelial and 
fibroblastic cells. Latent infections are frequently 
established in lymphoid tissues.
It should be noted that classification on the basis 
of biological properties alone may not always accurately 
reflect phylogenetic relationships. Human herpesvirus 6 
(HHV-6), for example, was provisionally classified as a 
gammaherpesvirus since its tissue tropism closely mirrors 
that of gammaherpesviruses, and it shares some reiterated 
sequences with Marek's disease virus (Kishi et al., 1988; 
Lopez et al.r 1988). Recently, however, more extensive 
sequence analysis of HHV-6 has revealed that it is in fact 
more closely related to HCMV than to EBV, HSV, or VZV, 
which suggests that it is a representative of a novel 
subgroup of the betaherpesvirus subfamily (Lawrence et al., 
1990; Martin et al., and Dambaugh et al., XVth
International Herpesvirus workshop). It is clearly possible
that a virus genetically related to one subfamily might,
through having lost or gained non-homologous functions,
have acquired a similar phenotype to viruses of another
subfamily. Thus, there is no necessary contradiction in a 
virus (such as HHV-6) that may be a valid member of the 
biologically defined gammaherpesvirinae, having a 
betaherpesvirus as its closest relative in a molecular 
phylogeny.
Finally, Frenkel et al. (1990) have reported the 
isolation of a seventh human herpesvirus from CD4+ T-cells 
of a healthy individual. Hybridization studies indicate 
limited homology of the new virus, designated HHV-7, with 
HHV-6 and HCMV. Analysis of the DNA sequence of HHV-7 will 
be required to determine the precise relationship of this 
new virus to previously defined human herpesviruses.
1A.2. Human Herpesviruses and Disease
The human herpesviruses are associated with a
number of diseases.
HSV infection is widespread in the human
4population. Following primary infection, which is often 
subclinical, HSV can establish a latent infection in the 
neurons of sensory ganglia or brain tissue (Baringer and 
Swoveland, 1973; Fraser et al., 1981). Periodic
reactivation may give rise to recurrent lesions at the 
primary site of infection or other peripheral sites. 
Infection with HSV-1 is generally not serious, being 
primarily associated with "cold sore" lesions of the lips 
or eyes (herpes keratitis), although in immunocompromised 
hosts it can give rise to the more serious condition herpes 
encephalitis. HSV-2 is generally associated with genital 
lesions (herpes genitalis) (Whitley, 1985).
Primary infection with VZV is usually associated 
with the childhood condition of chicken pox, a widespread 
vesicular rash present normally on the head and trunk, 
though mucous membranes can also be affected. Virus spread 
occurs by the respiratory route or through direct contact. 
VZV can become established in a latent state in dorsal root 
ganglia and the spinal column following primary infection. 
Reactivation from latency can lead to the painful cutaneous 
disease, shingles (herpes zoster) (Hope-Simpson, 1965),
which occurs more commonly with advancing age. In adults
and a small percentage of children, VZV infection can 
spread to the central nervous system (CNS) and cause the 
more serious conditions meningitis and encephalitis
(Kennedy, 1987).
HCMV infects the majority of the human population. 
Although congenital infection is sometimes associated with 
neurological damage and mental retardation (Alford and 
Britt, 1984), infection is generally asymptomatic or causes 
only benign disease. Latent virus can be reactivated as a 
result of immunosuppression, particularly in transplant or 
blood transfusion patients (Ho, 1982). Outbreaks of HCMV 
infection can also occur in patients with acquired 
immunodeficiency syndrome (AIDS).
HHV-6 was first isolated from patients with 
l y m p h o p r o l i f erative disorders. The virus is typically 
acquired in early infancy and can cause the condition
5exanthum subitum in a proportion of infected children 
(Yamanishi et al., 1988).
Primary infection with EBV is often asymptomatic, 
though with increasing age the symptoms become increasingly 
severe resulting in infectious mononucleosis among 
adolescents. EBV is also associated with the development of 
two tumours, Burkitt's lymphoma and Nasopharyngeal 
carcinoma, though its precise role in these conditions is 
not clear (Neiderman et al., 1976; Miller, 1985).
1A.3. BIOLOGY AND PATHOLOGY OF VZV INFECTIONS
As noted above, VZV is associated with two diseases 
in humans, chickenpox or varicella, and herpes zoster. The 
biology and pathology of these two diseases will be 
discussed in more detail.
Almost all persons in industrial society living 
within the temperate climate zone contract varicella, 
usually during childhood, whereas the incidence of herpes 
zoster is generally much lower. Historically, herpes zoster 
was recognized as a distinct clinical entity early in the 
medical literature. Varicella, however, was frequently 
confused with small pox, and it was not until the late 
eighteenth century that Heberden finally distinguished the 
two conditions (Gordon, 1962). That chickenpox and herpes 
zoster were associated with the same infectious agent was 
first proposed in 1888 by von Bokay who reported an 
occurence of chickenpox following exposure to zoster in a 
family setting (Gelb, 1990). Final definitive proof of this 
association was obtained when virus from both chickenpox 
and zoster vesicle fluid was isolated and propagated in 
tissue culture, and the recovered viruses shown to be 
identical (Weller et al., 1958; Weller and Witton, 1958).
3.1. Varicella
Much of the knowledge of varicella pathogenesis is 
derived from comparison with other viral exanthems since 
the clinical disease is quite benign, and no suitable 
experimental models are available (Gelb, 1990) . Fenner
6speculated that the pathogenesis of VZV would follow the 
dual viremic model demonstrated for mousepox (Fenner, 
1948), and clinical and experimental data has subsequently 
confirmed this (Grose, 1981).
The characteristic rash of varicella typically 
develops following an incubation period of 14 or 15 days 
from the primary infection. The virus appears to enter via 
the mucosa of the upper respiratory tract and oropharynx, 
or via the conjuctiva. Viral replication initiates at the 
site of inoculation giving rise to a primary viremia after 
4-5 days. During primary viremia virus disseminates via the 
bloodstream and lymphatic system and is taken up by cells 
of the reticuloendothelial system, where it undergoes 
multiple rounds of replication. The hosts immune response 
limits viral replication in the early stages of infection, 
but is soon inundated whereupon a more extensive secondary 
viremia develops. This results in release of virus into the 
bloodstream in higher tit re} which then rapidly invades 
cutaneous tissue, culminating in the formation of the 
characteristic cutaneous lesions. Lesions continue to 
appear in crops over a period of 2-4 days which probably 
reflects a cyclic viremia. In addition, lesions are also 
found on all mucosal surfaces, including the respiratory 
and gastrointestinal tracts. Termination of the viremic 
phase usually occurs within three days of the appearance of 
lesions as a result of specific humoral and cell-mediated 
responses (in the immunocompetent host) (Asano et al., 
1985; Arvin et al.,1986).
Complications of varicella result from widespread 
dissemination of virus and the failure to limit 
replication. The most common serious complication is 
varicella pneumonia which is generally seen in adults 
(Guess et al., 1986). Neurological complications are most 
often observed in children aged 5—14 (Guess et al., 1986), 
the most common presentation being acute cerebellar ataxia. 
The most severe complications occur in immunosuppressed 
patients, particularly leukemics, but also in patients with 
other malignancies receiving immunosuppressive
7chemotherapy. The persistent viremia in such cases leads to 
extensive invasion of the lungs, liver, and CNS, with fatal 
cases having varicella pneumonia and often encephalitis.
3.2. Herpes zoster
The pathogenesis of herpes zoster is poorly 
understood. The current model, proposed originally by 
Hope-Simpson in 1965, was derived largely from clinical and 
epidemiological data, and by analogy with recurrent HSV-1 
infections. It is thought that following primary infection, 
VZV passes from the skin, via the sensory nerve fibres to 
the sensory ganglia, whereupon a latent infection is
established. Reactivation from this quiescent state is 
considered to be the primary cause of herpes zoster, though 
exposure to exogenous varicella doubtless accounts for a 
minority of cases (particularly in immunosuppressed
individuals) (Berlin and Campbell, 1970). The extensive 
viral replication in the ganglia which follows reactivation
fs/\
is associated with neuronal necrosis and inflamation, often
A
accompanied by neuralgia. These events precede the
development of cutaneous lesions.
The most common complication of herpes zoster is 
postherpetic neuralgia. As with varicella, the most severe 
complications of herpes zoster are associated with patients 
with immune defects, malignancies, and those on immune
suppression therapy. Pneumonia in such patients accounts 
a significant number of mortalities. Persistent infection 
of the CNS also occurs and is associated with two distinct 
forms of encephalitis.
Comparisons between the characteristic distribution 
of zoster lesions and the architecture of the nervous 
system, together with histopathological evidence, 
implicated ganglia as the site of VZV latency (Head and 
Campbell, 1900; Hope-Simpson, 1965). In support of this 
view, both VZV DNA and RNA have been detected in human 
sensory gangliu obtained at autopsy from individuals with 
no recent history or clinical signs of herpes zoster 
(Gilden et al., 1983; Hyman et al., 1983). The site of
latency remains uncertain, however, with both neuronal 
(Gilden et al., 1983; Hyman et al., 1983) and non-neuronal 
cells (Croen et al., 1988) having been suggested. HSV-1
establishes a latent infection in sensory ganglia from 
which it can be recovered by explantation and cultivation 
of the ganglia (Stevens and Cook, 1971); similar attempts 
to recover VZV from ganglia obtained at autopsy have thus 
far failed. However, Straus et al. (1984) employed 
restriction endonuclease analysis to demonstrate that a VZV 
isolate recovered from a patient with zoster was identical 
to that recovered from his primary varicella, thus 
inferring that zoster was a consequence of reactivation of 
virus which had established a latent infection following 
varicella.
The mechanisms underlying the maintenance of, and 
reactivation from latency are unclear. Hope-Simpson (1965) 
speculated that small subclinical reactivations occur 
periodically, but are contained by the immune system, thus 
serving to boost immunity to VZV, as well as marking the 
reactivation event. Asymptomatic rises in tit of 
antibodies to VZV consistent with such reactivations have 
been noted (Luby et al., 1987). In this model, clinical
disease is thought to arise when the hosts immune defences 
deteriorate such that VZV replication is no longer 
contained. The original model considered antibody levels to 
be of prime importance in containment, although more recent 
data suggests that cell mediated immunity is in fact more 
important (Dolin et al., 1978; Burke et al., 1982).
Analysis of transcription during VZV latency has 
revealed that several areas of the latent genome are 
transcriptionally active (Croen et al., 1988). This is in
marked contrast to the situation with HSV-1 where a number 
of groups have detected only one family of transcripts 
during latency, the so called latency associated 
transcripts (or LATS) (Stevens et al., 1987; Croen et al., 
1987; Deatly et al., 1987; Spivack and Fraser, 1987; Rock
et al., 1987; Wagner et al.. 1988).
An animal model would clearly be useful in the
9study of VZV latency. Attempts to develop such a model have 
been hampered by the fact that VZV is highly 
species-specific. Infection of both the guinea pig and 
common marmoset with VZV has been achieved, although the 
resulting clinical disease differs from that in humans, and 
latency has yet to be demonstrated (Myers et al., 1980; 
Provost et al., 1987). A latent simian varicella virus
(SVV, the simian counterpart of VZV) infection has been 
established in african green monkeys in the absence of 
clinical disease (Mahalingam et al.r XVth International 
Herpesvirus Workshop), and although SVV and VZV are clearly 
different viruses, this system may nevertheless be useful 
as an animal model of VZV latency.
1A.4. Growth of VZV in vitro
The inability to isolate stable, high titer stocks 
of cell-free VZV has significantly impaired investigation 
of this important virus.
Weller et al. (1958) first noted that very little, 
if any infectious virus was released into the medium when 
VZV was propagated in tissue culture. In fact, infectious 
virus remains highly cell associated in all the cell types 
which are able to support VZV infection in vitro. 
Consequently, virus has routinely been propagated using 
infected cells as the inoculum. The infectivity of such 
cells is critically dependent upon their continued 
viability (Gold, 1965).
Cell-free virus can be obtained by sonic disruption 
of infected cells, although initially this produced stocks 
of very low titre (Caunt, 1963; Caunt and Taylor-Robinson, 
1964). Schmidt and Lennette (1976) subsequently optimized 
the conditions for isolating cell-free virus and obtained 
yields of up to 106 pfu/ml, although this is at best only 
10-fold greater than the initial inoculum. Furthermore, 
infection with cell—free virus is apparently an inefficient 
process and proceeds much more slowly than if infected 
cells are used as the inoculum (Schmidt and Lennette, 
1976). Hence, the only advantages offered by cell-free VZV
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are its increased stability during storage (relative to 
infected cells) and its ability to produce quantitatively 
controlled, synchronous infections in vitro.
The low infectivity of VZV in tissue culture was 
originally thought to reflect a defect in virions
assembled in vitro (Achong and Meurise, 1968). Cook and 
Stevens (1968, 1970), however, suggested that the lack of 
infectivity was due to lability of the virion coat during 
its transit through the cytoplasm. Gershon et al. (1973) 
reported that VZV virions were packaged into vesicles which 
later coalesced to form larger vacuoles. Interestingly, 
they found acid phosphatase activity, a lysosomal marker, 
associated with these vesicles, which led them to 
speculate that the co-localization of VZV in vacuoles with 
lysosomal enzymes might be responsible for inactivation of 
the virus during egress from the cell. This same group went 
on to study this further with some particularly interesting 
findings (Gabel et al. , 1988). It had previously been
demonstrated that an uncommon oligosaccharide component of 
lysosomal enzymes containing mannose 6-phosphate (Man 6-P) 
specifies their targetting to the lysosomal compartment 
(Kaplan et al., 1977; Ullrich et al., 1978; Von Figura and 
Weber, 1978). Significantly, both the immature and mature 
forms of glycoprotein gp3 (now gpll) were found to contain 
at least one Man 6-P, and may thus target VZV to lysosomes 
in an analogous fashion. These same Man 6-P residues may 
also facilitate entry of VZV into cells via Man 6-P 
receptors in the plasma membrane (Gabel et al., 1988).
1A.5. THE VIRAL GENOME
5.1. Structure
In 1964 two groups reported that the growth of VZV 
in tissue culture was inhibited by 5-iodo-2-deoxyuridine, a 
compound known to inhibit DNA, but not RNA> containing 
viruses (Rapp and Vanderslice, 1964; Rawls et al., 1964). 
Attempts to characterize the VZV genome were initially 
hampered by difficulties associated with isolation and 
purification of viral DNA. Nevertheless, Ludwig et al.
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(1972) succeeded in purifying sufficient viral DNA to 
determine its G+c content as 46%. Dumas et al. (1980) 
subsequently determined the molecular weight of VZV DNA to 
be 80xl06 Daltons by electron microscopy measurements, and 
went on to report the first restriction enzyme maps and 
structure of the genome (Dumas et al., 1981). The linear 
duplex DNA molecule was shown to comprise two covalently 
linked segments, L and S, L consisting of a unique sequence 
(Ul), and S of a unique sequence (Us) bounded by inverted 
repeat sequences (IRs and TRs). VZV virion DNA was found to 
contain equimolar amounts of two arrangements of the genome 
resulting from inversion of S relative to L. A combination 
of restriction mapping, molecular cloning, and electron 
microscopy studies of self annealed single stranded virion 
DNA molecules confirmed and extended this model (Straus et 
al., 1981, 1982; Ecker and Hyman, 1982; Gilden et al. , 
1982; Davison and Scott, 1983; Mishra et al., 1984). It was 
not until the sequence of the genome termini and the L-S 
joint region were determined that a small inverted repeat 
(I R l and T R l ) of 88.5 bp flanking U l was discovered 
(Davison, 1984). This work also established that the VZV 
genome is not terminally redundant (in contrast to HSV-1, 
Davison and Wilkie, 1981), and possesses an unpaired C 
residue at the 3' end of L, and an unpaired G residue at 
the 3' end of S. Furthermore, 2-5% of virions were found to 
have genomes in which L was inverted relative to S. This 
was subsequently confirmed by others (Kinchington et al., 
1985; Ruyechan et a l 1985). This contrasts with HSV, 
where both the L and S segments invert relative to one 
another with equal frequency giving rise to equal amounts 
of the four genome isomers (Roizman, 1979). Hayakawa and 
Hyman (1987) showed that HSV superinfection of VZV infected 
cells did not increase inversion of L relative to S, and 
infrequency of this event has yet to be explained. It 
was also proposed that the genome might occasionally 
circularize, though the significance of this is not clear 
(Straus et al., 1981; Kinchington et al., 1985). The DNA 
sequence of one isolate of varicella-zoster virus has been
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determined (Davison and Scott, 1986). The total genome
contained 124884 bp, with U l containing 104836 bp, TRl and
IRl 88•5 bP each, Us 5232 bp, and TRs and IRs 7319.5 bp 
each.
Restriction enzyme analysis of a number of VZV 
isolates has demonstrated that the genome is relatively 
stable when passaged in vitro (Zweerink et al. , 1981) , 
although small but significant variations exist between 
different isolates (Richards et al., 1979; Martin et al.,
1982; Straus et al., 1983; Hayakawa et al., 1986). Straus 
et al. (1983) mapped regions of the genome exhibiting size 
variability between different virus isolates, and these 
correspond approximately to the locations of reiterated 
sequences (R2, R3, and R4) in the sequence of Davison and 
Scott (1986). More detailed analysis of variations in these 
regions has been performed. Casey et al. (1985) have 
reported variability in the copy number of the 27 bp 
element in the R4 reiteration (within IRs/TRs) between 
virus isolates. Similar variations in the 42 bp element 
of the R2 reiteration within gene 14 have been reported 
(Kinchington et al., 1986). More recently, variations in 
the complex element, Rl, within the gene 11 orf have been 
reported (Kinoshita et al., 1988); the variations were all 
multiples of 3 bp, thus maintaining the translational 
reading frame.
5.2. Molecular Biology
Prior to the determination of the complete VZV DNA 
sequence, studies to identify virus-specific polypeptides 
and functions had adopted two approaches. The first of 
these, analysis of polypeptides in the VZV virion, was 
impeded by difficulties associated with virion 
purification. The second approach, analysis of viral 
polypeptides induced in VZV—infected cells, encountered 
problems of detection due to the high background of host 
cell proteins. Nevertheless, several virus-induced enzyme 
activities were demonstrated: Doberson et al. (1976)
reported pyrimidine deoxyribonucleoside kinase (thymidine
13
kinase) activity in VZV infected cells; DNA polymerase 
activity was identified, purified and characterized (Miller 
and Rapp, 1977; Mar et al. , 1978); Cheng et al. (1979)
confirmed the induction of a thymidine kinase activity, 
and also demonstrated a DNAse activity. Several groups 
reported SDS-PAGE analysis of polypeptides in partially 
purified virions (Wolff, 1978; Shemer et al., 1980; Shiraki 
et al., 1982). The results of these studies were largely in 
agreement and identified between 31 and 33 polypeptides, at 
least five of which were glycoproteins. Asano and Takahashi 
(1979) detected 33 virus induced polypeptides in 
VZV-infected cells by SDS-PAGE, including 13 glycoprotein 
species. The glycoproteins of VZV have been characterized 
by their reactivity with monoclonal antibodies into three 
major families (Davison et al., 1986).
Analysis of the complete VZV DNA sequence (Davison 
and Scott, 1986) identified 71 genes predicted to encode 
polypeptides. Of these, 6!+. are single copy genes present in 
either Ul or Us, and three are diploid genes, one copy 
being present in each of the repeat sequences, IRs and TRs. 
For a summary of the VZV gene layout, see Figure 1. 
Similarities in gene layout between VZV and HSV-1 permitted 
the assignation of functions to a number of the VZV genes. 
Additionally, genes 13 and 66 were predicted to encode a 
thymidylate synthetase and protein kinase^ respectively,on 
the basis of their having homology with polypeptides in the 
NBRF database known to possess these functions. This 
information, together with functions subsequently assigned 
to a further eight genes, is summarized in Table 1. Smith 
and Smith (1989) found a number of sequence motifs 
characteristic of protein kinases in the predicted 
polypeptide product of gene 47. The predicted kinase is 
probably of the serine-threonine type. Genes encoding a 
uracil-DNA glycosylase were recently identified in both 
HSV-1 and HSV-2 (Worrad and Carradona, 1988; Mullaney et 
al., 1989), and significant homology between the HSV-1 
protein and the product of VZV gene 59 was noted (Mullaney 
et al., 1989). Challberg (1986) identified a minimum of
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Figure 1. Summary of the VZV gene layout. The genome is 
represented as in four sections, heavy horizontal lines 
indicating the unique regions (Ul and Us), the two large 
open rectangles depicting the inverted repeats flanking Us 
(TRs and IRs), and the two heavy short vertical lines
d e n o t i n g  the inverted repeats flanking Ul (IRl and TRl).
ORFs 1 to 71 are illustrated as arrows against the 
appropriate strand, and correspond to the protein coding 
sequences shown in Table 1. Light vertical lines indicate 
potential polyadenylation sites in the appropriate strand.
The locations of four reiterations <R1 to R4) are denoted
D1 do R3 are in the codingby filled rectangles; Rl, R<i ana KJ
regions of ORFs 11, 14 and 22 respectively.
Reproduced from Davison and Scott, 1986.
Table 1
Gene1 Codons Mol. wt.2 Function or properties31 108 12103
2 238 25983
3 179 19149
4 452 51540 trans-activator-homologue of 
HSV-1 Vmw63
5 340 38575 possible membrane protein
6 1083 122541 component of DNA helicase- 
primase complex
7 259 28245
8 396 44816 deoxyuridine triphosphatase
9 302 32845
10 410 46573 possible tegument protein
11 819 91825
12 661 74269
13 301 34531 thymidylate synthetase
14 560 61350 predicted membrane 
glycoprotein-(gpV)
15 406 44522
16 408 46087 associated with DNA polymerase
17 455 51365 virion host shut-off protein
18 306 35395 ribonucleotide reductase small 
subunit
19 775 86823 ribonucleotide reductase large 
subunit
20 483 53969 capsid protein
21 1038 115774
22 2763 306325 tegument protein
23 235 24416
24 269 30451 possible virion protein
25 156 17460
26 585 65692 probable virion protein
27 333 38234
28 1194 134041 DNA polymerase
29 1204 132133 single stranded DNA binding 
protein
30 770 86968 probable virion protein
31 868 98062 membrane glycoprotein (gpll)
32 143 15980
required for DNA packaging33 605 66043
34 579 65182 virion protein
35 258 28973 pyrimidine deoxyribonucleoside 
kinase
36 341 37815
37 841 93646 membrane glycoprotein (gpIII)
38 541 60395
39 240 27078 major capsid protein40 1396 154971
41 316 34387 capsid protein
42+45 747 82752
(spliced)
43 676 73905
44 363 40243
46
47
199
510
22544
54347 probable protein kinase
48 551 61268
exonuclease
49 81 8907 myristylated virion protein50 435 48669
51 835 94370 oris-binding protein
52 771 86346 component of DNA helicase-
53 331
primase complex
37417
54 769 86776 virion protein
55 881 98844 component of DNA helicase- 
primase complex
56 244 27166
57 71 8079
58 221 25093
59 305 34375 uracil-DNA glycosylase
60 159 17616
61 467 50913 possible transcriptional 
trans-repressor
62/71 1310 139989 trails-activator-homologue of 
HSV-1 Vmwl7 5
63/70 278 30494 homologue of HSV-1 IE 
polypeptide-Vmw68
64/69 180 19868 virion protein
65 102 11436 tegument protein
66 393 43677 protein kinase
67 354 39362 membrane glycoprotein (gpIV)
68 623 69953 membrane glycoprotein (gpl)
1. Data taken from Davison and Scott, 1986.
2. All predicted molecular weight values, except those of 
the primary translation products of genes 14, 31 and 68, 
were calculated from the amino sequence commencing at the 
first in-frame ATG in the ORF.
3. References to appropriate DNA sequence data which 
confirm the assignment of VZV gene functions are largely 
given in Davison and Scott, 1986. Functions characterized 
since then are referenced in the text or in Davison, 1991.
This Table is adapted from an original Table in Davison 
(1991) , with permission.
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HSV 1 genes which, in combination with DNA polymerase and 
the major DNA binding protein, are sufficient for HSV 
origin directed DNA replication. On the basis of homology 
with these HSV-1 genes, five VZV genes with a potential 
role in VZV DNA replication have been identified. Finally, 
a weak but significant homology between the gene 61 
polypeptide sequence and the HSV-1 IE protein, VmwllO 
(Perry et al., 1986), has been identified. Thus the 
elucidation of the complete VZV DNA sequence has 
significantly increased our knowledge of the potential 
functions of VZV. The products of the relevant genes can 
now be studied in a variety of expression and transfection 
systems largely circumventing the hitherto encountered 
problems of growing VZV in vitro.
5.3. Transcript Mapping
Two groups have reported attempts to map viral 
transcripts isolated from infected cells. Maguire and Hyman
(1986) analysed polyadenylated cytoplasmic transcripts, and 
identified between 41 and 67 transcripts. In a similar
study, VZV-infected total cellular RNA was analysed and a 
total of 77 RNAs identified and mapped (Ostrove et al. , 
1985; Reinhold et al., 1988). Due to a lack of resolution 
in these studies, it was not possible to assign
unequivocally the majority of the transcripts to a specific 
reading frame, although a 4.3 kb transcript was mapped to 
gene 62. In addition, Sawyer et al. (1986) have mapped a
1.8 kb transcript to a region of the genome between 0.52 
and 0.54 map units which contains the thymidine kinase 
gene, gene 36. The unambiguous mapping of remaining
transcripts will require determination of the precise
location of their 5' and 3 ends.
5.4. Mapping of Polypep tides t o S p e c i f i c  Genes
A number of polypeptides have now been mapped to
specific genes. The best characterized in this respect are
the VZV glycoproteins, all of those identified to date
having been mapped. The most abundant of the glycoproteins
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are those of the gpl family. The gpl gene has been mapped 
to gene 68 (Ellis et al., 1985), which has limited sequence 
homology with HSV-1 gE. The gpll gene has been mapped to 
gene 31 in the centre of U l (Keller et al., 1986) which 
has significant homology with HSV-1 gB. However, in 
contrast to gB, the mature gpll glycoproteins appear to be 
disulfide linked dimers (Montalvo and Grose, 1987). The 
9PlH glycoprotein has been purified and its N-terminal 
sequence determined. This information was used to design a 
family of degenerate oligonucleotides which were used to 
map the gpIII gene to gene 37 (Keller et al., 1987). The 
gene for the gpIV (minor) family of glycoproteins has been 
mapped to gene 67 which displays limited homology to the 
HSV-1 Us 7 gene (Davison et al., 1985). The VZV sequence 
contains an additional gene predicted to encode a 
polypeptide product (designated gpV) with homology to HSV-1 
gC, though as yet a fifth serologically distinct
glycoprotein species has not been detected.
That VZV encodes a thymidylate synthetase (TS) was 
confirmed when a plasmid expressing the predicted s gene 
product was shown to complement the growth of a strain of 
E.coli from which the endogenous TS had been deleted 
(Thompson et al., 1987). The only other herpesvirus shown 
to specify a TS to date is herpesvirus saimiri (Honess et 
al., 1986). Another enzyme involved in nucleotide
metabolism, pyrimidine deoxyribonucleoside kinase, has been 
mapped to the viral genome between 0.52 and 0.54, and
presumably corresponds to the predicted TK gene, gene 36 
(Sawyer et al., 1986). A DNA—binding protein has been 
detected in VZV-infected cells (Kinchington et al., 1988).
These workers utilized an antiserU/^ directed against a
synthetic oligopeptide representing 12 amino acids from the 
C-terminus of the predicted product of gene 29, which
encodes a homologue of HSV-1 Vmwl30, the major DNA-binding 
protein. The properties of the VZV protein were similar to 
those of its HSV-1 counterpart. Investigation of the 
potential functions of some of the predicted VZV IE genes 
has begun and is described m  Section IB.4.
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l.B. GENE REGULATION IN THE ALPHAHERPESVIRINAE
This section will review the current knowledge of 
gene regulation in the alphaherpesvirinae, with particular 
emphasis on HSV-1.
-^ ^  *— Regulation of Herpes Simplex Virus Gene Expression: 
An Overview
Analysis of viral polypeptide expression during 
HSV-1 infection of tissue culture cells in the presence of
inhibitors of protein synthesis or DNA replication
identified three broad, coordinately regulated, 
sequentially expressed groups of polypeptides (Honess and 
Roizman, 1974). The first of these, the immediate-early 
(IE) or alpha polypeptides, are detected as early as lh pi, 
and comprise most of the viral gene regulatory functions. 
The second group, the early (E) or beta polypeptides, are 
maximally synthesised from 2-7h pi, and at decreasing rates 
thereafter. Polypeptides involved in viral DNA replication 
are of the E class. Synthesis of the late (L) or gamma 
polypeptides is first detected following the onset of DNA 
replication at around 2h pi, and continues at increasing 
rates late into infection. This group comprises many of the 
virus structural polypeptides.
The IE genes are defined as those which are
transcribed by the unmodified host RNA polymerase in the
absence of de novo protein synthesis (Honess and Roizman,
1974; Clements et al., 1977; Costanzo et al., 1977; Jones
and Roizman, 1979). Functional IE gene products are
absolutely required for the transition to E and L gene 
expression (Preston, 1979a, Watson and Clements, 1980). The 
E genes are those whose expression follows that of the IE 
gene products, but precedes DNA replication. The
expression of both IE and E gene products is a prerequisite 
for L gene expression which, in addition, requires ongoing 
DNA replication for maximum efficiency (Wagner et al . , 
1972; Ward and Stevens, 1975; Jones and Roizman, 1979;
Holland et al., 1980; Pedersden et al., 1981; Conley et 
al 1981) . Two subclasses of L genes have been defined
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according to their sensitivity to inhibitors of viral DNA 
replication. Thus expression of the "leaky" late or 
beta-gamma (gamma 1) genes is reduced, but still clearly 
detectable, when DNA replication is inhibited, whereas 
expression of the "true" late or gamma (gamma 2) genes is 
dramatically reduced under these conditions (Powell et al. , 
1975; Pereira et al., 1977; Pedersden et al. f 1981).
. Control of HSV Gene Expression Involves Both
Transcriptional and Post-Transcriptional Mechanisms
Synthesis of viral transcripts is also temporally 
regulated, and IE, E and L RNA species have been defined 
(Clements et al., 1977; Jones and Roizman, 1979). Several 
groups have analysed the accumulation of specific 
transcripts and their protein products (Zhang and Wagner, 
1987; Smith and Sandri-Goldin, 1988), from which they
concluded that transcription is the major control mechanism 
in the temporal regulation of viral genes. 
Post-transcriptional mechanisms have also been implicated 
(Weinheimer and McKnight, 1987). Intriguingly, when DNA 
synthesis was inhibited, the rate of transcription of the 
gC gene (a true L gene) was indistinguishable from that of 
E genes. However, under these conditions E transcripts 
accumulated, whereas, in marked contrast, little or no 
accumulation of L mRNA was observed (Weinheimer and 
McKnight, 1987). It would then appear that the interplay of 
several regulatory mechanisms controls herpesvirus gene 
expression.
Finally, Silver and Roizman (1985) reported that a 
true late promoter (that of the UL42 gene) was regulated as 
an early promoter when incorporated into the cellular 
genome, suggesting that the environment of the viral genome 
may also influence gene regulation.
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IB.. 3. REGULATI0N__0F IMEDIATE-EARLY . EARLY AND I,ATE GENE
EXPRESSION
This section will describe the cis-acting sequences 
and trans-acting factors involved in the regulation of the 
various classes of HSV genes.
3 • 1 ♦— Immediate-Early (IE) Gene Regulation
(a) Cis-Acting Elements
A number of functionally distinct elements have 
been defined within IE promoters. A minimal promoter region 
of low constitutive activity contains the TATA element 
which is required for both basal and induced levels of 
transcription, and which ensures the fidelity of 
transcription initiation. Upstream of this minimal promoter 
is a regulatory region which comprises multiple 
cis-acting elements involved in both constitutive activity 
and IE gene specific induction.
Post et al. (1981) were the first group to
demonstrate that IE gene regulation was determined by 
specific promoter sequences. They replaced the TK gene (an 
E gene) promoter with the IE gene 3 promoter, and showed 
that the resulting chimeric gene was regulated as an IE 
gene when present in either the viral or cellular genome. 
All HSV-1 IE genes have since been shown to contain an
upstream regulatory region capable of conferring IE 
regulation on heterologous genes (Mackem and Roizman, 1982 
a ,b ,c ; Cordingley et al., 1983; Kristie and Roizman, 1984 ; 
Preston et al., 1984; Mosca et al., 1985). Sequence
comparisons between the upstream regions of the IE genes
revealed that they all contain at least one copy of an A+T 
sequence element of consensus, TAATGARAT (where R is a 
purine) , and it was proposed that this element might
mediate the coordinate induction of IE promoters during
virus infection. Gaffney et al. (1985) subsequently
established that the TAATGARAT element was of itself
sufficient for IE gene activation. The viral function
responsible for IE gene induction was mapped to a genome 
fragment encoding Vmw65, a component of the virion tegument
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(Campbell et al., 1984). The functions of Vmw65 and its 
role in IE gene regulation are discussed in detail in 
Section 3.1.(b).
The IE gene 3 upstream promoter region, as well as 
conferring IE regulation, was shown to have many of the 
properties of an enhancer. It functioned in either
orientation, exhibited cell-type specificity, and retained
function when moved over lOOObp upstream of the TATA box
(Lang et al., 1984; Preston and Tannahill, 1984). However,
it did not function well when located downstream of the 
TATA box. The sequences mediating induction by Vmw65 are 
distinct from those containing enhancer activity (Bzik and 
Preston, 1986).
A detailed analysis of the IE gene 3 upstream
regulatory region identified multiple distinct cis-acting 
sequence elements. Enhancer activity was found to reside in 
three separable motifs; two of these contained GC boxes
(Spl binding sites) , and the third a GA element (Bzik and 
Preston, 1986). The three elements were able to function
independently, and their effects in combination were
approximately additive. Spl, a cellular transcription 
factor, has been shown to bind the GC boxes in the IE3
promoter and activate IE3 gene expression in vitro (Jones 
and Tjian, 1985). Further functional complexity has been
revealed in this region. Thus although the TAATGARAT 
element alone is sufficient to mediate induction by Vmw65, 
the GA element upstream of IE genes 2, 3 and 4/5, which
does not of itself confer responsiveness to Vmw65, appears 
to be necessary for maximum activity of TAATGARAT (Bzik and 
Preston, 1986; Triezenberg et al., 1988b; LaMarco and 
McKnight, 1989). What is more, the GC boxes also appear to 
influence induction by Vmw65 (Preston et al. , 1984).
Therefore, the efficiency with which the TAATGARAT element 
mediates IE gene induction by Vmw65 is apparently modulated
by the elements of the enhancer.
A homology to the octamer motif overlaps many 
TAATGARAT elements (O'Hare and Coding, 1988), and has been 
shown to bind Oct-1 (OTF-1. NFIII) (Pruijn et al., 1986;
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Fletcher et al., 1987; Gerster and Roeder, 1988); the
relevance of this to IE gene regulation is discussed in the 
next section.
(b) Trans-Acting Factors
Following the observation that IE gene induction 
was not dependent on de novo protein synthesis, it was
proposed that induction is mediated by a virion component 
(Post et al., 1981). Studies with a ts mutant, tsBl, which 
was able to penetrate cells but failed to uncoat and 
release viral DNA, led to a similar conclusion (Knipe et
si., 1981; Batterson and Roizman, 1983). The virion
function was subsequently identified as Vmw65, the product 
of gene UL48 (Campbell et al. , 1984) . The sequence of UL48 
has been determined (Dalrymple et al., 1985; Pellet et al.,
1985).
As discussed above, the TAATGARAT sequence element 
mediates induction of IE genes by Vmw65. That Vmw65 has a 
very low intrinsic affinity for DNA (Marsden et al. , 1987), 
suggested that it does not interact directly with the 
TAATGARAT cis-element. It has since been shown that Vmw65 
induces formation of a specific complex (designated
immediate-early complex or IEC) on TAATGARAT elements, but 
only in the presence of host cell factors (McKnight et al., 
1987; O'Hare and Goding, 1988; Preston et al., 1988). 
Competition experiments suggested that the cellular factor, 
Oct-1, might be an essential component of IEC (O'Hare and 
Goding, 1988), and this has been confirmed by Gerster and 
Roeder (1988) using purified Oct-1. There is additional 
evidence that at least one other factor, possibly
interacting with the GARAT portion of TAATGARAT, may be 
required for IEC formation (Gerster and Roeder, 1988;
Kristie et al., 1989).
In a series of elegant experiments, Stern et al.
(1989) demonstrated that the ability of Oct-1 to form IEC 
with Vmw65 is dependent upon the integrity of residues 
within a helix-turn-helix motif of the Oct-1 homeodomam. 
This region of Oct-1 is closely related to a
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helix-turn-helix motif in the bacterial lambda repressor 
which is involved simultaneously in DNA binding and 
protein-protein interactions. Moreover, they present 
evidence that the low efficiency with which Oct-2 forms IEC 
(Gerster and Roeder, 1988) reflects amino acid changes 
(compared to Oct-1) in at most seven of 60 residues in the 
corresponding homeodomain of Oct-2. The Oct-1 protein 
appears to have flexible sequence recognition 
characteristics inasmuch as it can bind both the octamer 
sequence, ATGCTAAT, and TAATGARAT motifs independently 
(ApRhys et al., 1989).
Finally, a cellular polypeptide has been purified
which binds to the GA cis-element of IE genes, and to
related elements in other viral and interferon (IFN)
inducible genes (LaMarco and McKnight, 1989). This is a
particularly interesting finding since IFN treatment has 
been shown to inhibit IE gene expression during HSV-1 
infection (Mittnacht et al., 1988). LaMarco and McKnight 
(1989) present results of transfection experiments which
show that IFN treatment reduces IE promoter activity to a 
similar extent as mutations within the GA element. They 
speculate that a fuller understanding of the function of 
their purified factor, especially its role, if any, in IFN 
induction of gene expression, may lead to a model for 
repression of IE gene expression by IFN.
(c) Immediate-Earlv Complex (IEC) Formation and IE Gene 
Induction
Mutational analysis of both the TAATGARAT element 
and of Vmw65 has defined the role of IEC formation in IE 
gene induction. O'Hare et al. (1988) demonstrated that IEC 
formation is a prerequisite for IE gene induction. They 
found that mutations within the GARAT portion of TAATGARAT 
did not affect Oct-1 binding, but abolished IEC formation 
and induction. Thus Oct-1 binding is not of itself 
sufficient for Vmw65 induction, and it appears that an 
octamer motif (or near relative) with appropriate flanking 
sequences is required. Studies by Kemp and Latchman
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(1988a) support this view. Several mutants of Vmw65 have 
been described which fail to form IEC, and in agreement 
with the above results, they fail to stimulate 
transcription (Ace et al. , 1988). Another class of Vmw65
mutants have been characterized which fail to trans-induce 
IE genes, but are able to form IEC (Triezenberg et al. , 
1988a; Greaves and O'Hare, 1989, 1990). Thus, while IEC
formation is clearly necessary, it is not of itself
sufficient for Vmw65 trans-induction.
(d) Mutational Analysis of Vmw65
An activation domain has been defined in the 
C-terminus of the Vmw65 polypeptide. Deletion mutagenesis 
identified sequences composed of a high proportion of
acidic residues (the so called "acid tail") which were 
dispensable for IEC formation, but absolutely required for 
trans-induction (Triezenberg et al. , 1988a; Greaves and
O'Hare, 1989, 1990). Furthermore, when appended to the 
GAL4 DNA binding domain, the acid tail of Vmw65 strongly 
activates transcription from promoters bearing GAL4 
recognition sequences, and thus represents a separable 
activation domain (Sadowski et al., 1988, Chasman et al., 
1989; Cousens et al., 1989). The acidic nature of the 
Vmw65 activation domain is strikingly reminiscent of the 
activation domains of a number of prokaryotic and 
eukaryotic activators including GAL4 and GCN4 of
Saccharomyces cerevisiae (Ma and Ptashne, 19 87 a,b; Hope
and Struhl, 1986; Hope et al., 1988). This class of
activators are thought to activate transcription through 
interaction with RNA polymerase or the TATA box factor, 
TFIID (Horikoshi et al., 1988a; Ptashne, 1988). Vmw65 might 
then activate transcription by interacting with these same 
components of the transcription machinery. Consistent with 
this view, the acid tail of Vmw65 has now been shown to 
bind directly and specifically to TFIID in vitro (Stringer 
et al., 1990). Significantly, mutations in this region of 
Vmw65 which inactivate the polypeptide in vivo, eliminate 
TFIID binding in vitro. It has been proposed that complex
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formation between Oct 1 and Vmw65 apposes the latters 
acidic tail with PolII or TFIID, resulting in activation 
(Stern et al., 1989).
Thus Vmw65 appears to have two separable functional 
domains, one of which is involved in protein-protein 
interactions with Oct-1 (and possibly other factors) to 
form IEC, while the other is an activation domain which 
interacts with the transcription machinery when Vmw65 is 
present in IEC.
The HSV-2 mutant, ts2203, which has a lesion in 
Vmw65, is impaired in virion assembly, and thus Vmw65 is an 
essential structural polypeptide (Ace et al., 1988). The 
structural requirements of Vmw65 for virion assembly differ 
from those for trane-induction (Ace et al. , 1988).
(e) The Biological Role of Vmw65
The role of Vmw65 in the viral life cycle has been 
investigated by constructing a virus, 2721814 , in which a 
12bp insertion in Vmw65 eliminates its ability to form IEC 
and thus traTis-induce IE gene expression (Ace et al., 
1989) . Although not essential for virus growth in tissue 
culture during infection at high multiplicity, at lower 
multiplicities replication was severely impaired. 
Furthermore, the mutant was avirulent in vivo. Vmw65 
appears then to be required in situations where infection 
involves very few particles per cell. This is reminiscent 
of the phenotype of other HSV-1 mutants which have 
deletions removing both copies of the IE1 gene (encodes 
VmwllO) (Stow and Stow, 1986; Sacks and Schaffer, 1987; 
Everett, 1989). Thus Vmw65 and VmwllO might serve to commit 
the virus to a lytic infection, and perhaps the role of 
Vmw65 is to ensure efficient expression of VmwllO.
3.2. Autoregu]ation of IE Gene Expression
Following the isolation of a number of HSV-1 
mutants with ts lesions in Vmwl75, all of which overproduce 
IE polypeptides at the NPT, it was concluded that Vmwl75 
was involved in repression of IE gene expression (Preston,
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1979, Dixon and Schaffer, 1980; Watson and Clements, 1980). 
The role of Vmwl75 in repression has been investigated in 
transfection assays. Of the IE promoters, only that of IE
gene 3 has unequivocally been shown to be repressed by
Vmwl75 (DeLuca and Schaffer, 1985; O'Hare and Hayward, 
1985b, 1987; Gelman and Silverstein, 1987a,b). The data for 
the other IE genes is less convincing. For example, the IE1 
promoter is activated by low levels of Vmwl75, but 
repressed by higher levels (Gelman and Silverstein, 1986). 
It should be emphasised that during a normal HSV-1 
infection, only IE gene 3 RNA expression is clearly 
repressed at the level of transcription, and significant 
levels of the other IE RNAs persist late into infection 
(Harris-Hamilton and Bachenheimer, 1985; Weinheimer and
McKnight, 1987). Furthermore, at least some of the IE 
polypeptides appear to accumulate as infection proceeds 
(Everett and Orr, 1991). Taken together, the above data
suggest that possibly only IE gene 3 expression is 
effectively repressed during a normal virus infection. The 
overexpression of IE RNA and polypeptides which occurs in 
the absence of functional Vmwl75 might simply result from 
increased availability (relative to a normal infection) of 
a limiting basic transcription factor(s) (such as TFIID)
when E and L promoters are not being utilized. The
functional aspects of repression by Vmwl75 are discussed in 
Section 1C.2.4.
3.3. Early (E) and Late (L) Gene Regulation 
(a) E-Gene Regulation: Cis-Acting—Sequence_s
As discussed earlier (Section 1B.1), E genes are 
those whose expression requires the prior expression of 
functional IE polypeptides, but is not dependant on DNA 
replication. The DNA sequence require’: uts for basal and 
virus induced expression from the gD and TK promoters, both
of the E class, has been studied in detail.
McKnight et al. (1981) created a series of 5’ and 
3 ’ deletion mutations within the promoter region of a 
plasmid-borne TK gene. Analysis of these mutant plasmids by
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microm ject ion into oocytes defined a minimal 
promoter-regulatory region between approximately -100 and 
-40 (relative to the transcription start site). These 
results were extended in the classic "linker scanning" 
mutational analysis of TK regulatory regions (McKnight and 
Kingsbury, 1982). A TATA box was identified which 
influenced the fidelity of transcription initiation, and 
the efficiency of expression was found to be governed by 
distal promoter elements (two GC-rich elements and a CAAT 
box) . These results were duplicated in a HeLa cell derived 
in vitro transcription system, and in addition, the GC-rich 
elements shown to bind Spl (Jones et al., 1985). The
sequence requirements for efficient trans-activation by 
viral IE polypeptides were found to be largely identical 
to those for efficient basal expression (Eisenberg et al., 
1985; ElKareh et al., 1985), although ElKareh et al. 
suggested that virus regulation utilized upstream sequences 
slightly differently. However, analysis of the linker 
scanning TK mutant promoters following their insertion into 
the normal TK locus of the viral genome did not identify 
any sequences specific to virus regulation; all mutations 
that reduced basal level promoter activity in oocytes 
reduced induction during infection (Coen et al. , 1986).
The DNA sequence requirements for basal level and 
regulated expression of the gD gene were defined using a
series of plasmids in which the (i-Glohin gene was
expressed from portions of sequence derived from the gD
promoter region. The plasmids were transfected into cells, 
which were subsequently infected with virus to supply IE 
polypeptides. Sequences located within 83 bp of the
transcription start site were found to be sufficient for 
regulated expression (Everett, 1983). A more detailed 
analysis of this region identified a TATA box and two
G-rich elements (Everett, 1984a). The efficiency of
expression from this promoter region, activated m  cis by
the SV40 ear] y enhancer or m  trans by viral IE gene
,nrnori hv the G-rich elements, and inproducts, was governed by trie
■ anaiVqis of TK promoter elementsagreement with the analysis
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discussed above, no vi m e  cnan-i -i11U virus specific E gene regulatory
elements were identified (Everett, 1984a).
JJlJ— L-Gene—Regulation: Cis-Acting Sequences
The efficient expression of true L genes during 
virus infection requires DNA replication (see Section 
1B.1). The promoter sequence requirements of two true L
genes have been studied in detail.
The regulation of the late US11 gene has been
reproduced in a transient expression system (Johnson and 
Everett, 1986a). The US11 promoter region (linked to a 
promoter-less 3~globin gene) was cloned in a plasmid
containing a functional HSV origin of DNA replication. This
construct was transfected into cells which were then
infected with virus to supply all IE polypeptides and 
functions required for DNA synthesis. Expression of the
USll-ft-globin chimera was activated to high levels
concordant with the onset of DNA replication, mirroring the 
regulation of the US11 gene in the viral genome. Deletion 
analysis demonstrated that a TATA box/capsite region alone 
was sufficient for fully efficient L gene regulation when 
linked to a functional origin of DNA replication (Johnson 
and Everett, 1986b). This finding was supported by an
experiment in which all distal promoter elements were
removed from the gD promoter; when linked to an origin of 
DNA replication, this truncated promoter (with only a TATA 
box) was activated with true late kinetics (Johnson and
Everett, 1986b).
Homa et al. (1986) reported essentially identical
findings following deletion analysis of the gC promoter. In 
the context of the viral genome, sequences within -34 to 
+ 124 conferred late gene regulation on gC and on a
promoter-less TK gene.
(c) The Importance _gf_the__TATA Box
A n a l y s e s  of the promoter s e q u e n c e  r e q u i r e m e n t s  of
1 i c1 anH li aenes for trans—activation by IEseveral viral E and n
t ^ rin infection (discussed above) did not
p o l y p e p t i d e s  during iIueuLi
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identify any sequences which were specific to virus
induction. Since the same sequence elements were involved 
in transcription in uninfected and infected cells, it was 
concluded that trans-activation by viral IE polypeptides is 
mediated via interaction with cellular transcription 
factors. Notably, Coen et al. (1986) found that the TATA
element was quantitatively the most important sequence
element for trans-activation. It has since been shown that 
the precise sequence of the TATA box can affect the 
efficiency of trans-activation, some sequences apparently 
being more responsive than others (Everett, 1988).
Likewise, the TATA box has been implicated in 
trans-actlvation of the adenovirus EIB promoter (which 
consists of only a TATA box and Spl element) by the 
adenovirus Ela polypeptide (Wu et al. , 1987). In addition, 
analysis of trans-activation of the more complex hsp70 gene 
promoter by Ela revealed that activation occurred through 
the basal transcription complex (Simon et al. , 1988;
Williams et al., 1989). Simon et al. demonstrated that only 
certain TATA box sequences were responsive to 
trans-activation by Ela.
Transcription of a limited subset of cellular genes 
is activated during infection (whereas a majority appear to 
be unaffected) , and in at least some cases this requires 
Vmwl75 (Latchman et al., 1987; Kemp and Latchman, 1988b).
The rabbit p-globin gene promoter has been shown to be
trans—activated during infection of transfected cells and 
also of cells with integrated copies of a plasmid 
containing the p-globin gene (Everett and Dunlop, 1984; 
Everett, 1984b, 1985). Furthermore, a number of cellular 
genes (including 3-globin) have been shown to be regulated 
with typical early or late kinetics when resident in the 
viral genome (Smiley et al., 1987; Panning and Smiley,
1989). It is particularly noteworthy that a transduced 
rodent aprtgene, which lacks a TATA box (Dush et al.,
1986; Nalbantoglu et al., 1986), was not transcribed durrng
3 7 1 984). These observationsinfection (Tackney et al., .
that viral trans-activators utilizesupport the proposition that virai
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the cellular transcription machinery, and again highlight 
the importance of the TATA box.
iiU— Trans-Acting Factor Requirements
Expression of IE genes is an absolute requirement 
for E and L gene induction (see Section 1B.1), and this 
section will discuss the role of each of the IE gene 
products in this process. There are five IE genes in HSV-1; 
their approximate locations and orientations on the viral 
genome are shown in Figure 2, and their nomenclature and 
properties are summarized in Table 2.
Vmwl75: The early isolation and characterization of a
number of viruses with ts lesions in Vmwl75 demonstrated 
that functional Vmwl75 was an essential requirement for 
transition from IE to later classes of gene expression 
(Marsden et al., 1976; Watson and Clements, 1978; Preston, 
1979a; Dixon and Schaffer, 1980). What is more, Vmwl75 
function is required continuously rather than transiently 
since upshift to the NPT at later times in infection 
precludes L gene induction (Preston, 1979b; Watson and 
Clements, 1980). Several Vmwl75 ts mutants have since been 
described which express significant amounts of many early 
polypeptides and synthesize near wild-type amounts of viral 
DNA, but underexpress or fail to express many L
polypeptides (DeLuca and Schaffer, 1984; Paterson et al.,
1990) . Vmwl75 is thus directly implicated in the efficient 
expression of L genes. The properties and functions of 
Vmwl75 are discussed in detail in Section 1C.
Vmw63: Vmw63 is an essential viral polypeptide. A ts
mutant with a lesion in Vmw63 over-produces some IE and E 
polypeptides, yet despite synthesizing substantial amounts 
of viral DNA, fails to induce L gene expression (Sacks et 
al., 1985). Mutant viruses with deletions in Vmw63 coding 
sequences have similar phenotypes (McCarthy et al.. 1989). 
Hence Vmw63 appears to be involved in the regulation of L 
genes, as well as some IE and E genes, though the mechanism 
by which this occurs is unclear. Trans-activation and 
trans-repression of viral promoters by Vmw63 in transient
Figure 2. A simplified map of the HSV-1 genome showing the 
positions and orientations of the IE genes. The internal 
and terminal repeat sequences are labelled IR and TR with 
the subscript denoting with which unique segment they are 
associated. The IE genes are labelled 1 to 5. (Not to 
scale.)
Table 2. Nomenclature and properties of the HSV-1 IE genes 
and their products. The Glasgow system of nomenclature for 
the HSV-1 IE genes and their products is shown with the 
sizes of the primary unmodified amino acid sequence deduced 
from the DNA sequence and the sizes of the polypeptides as 
estimated by SDS—polyacrylamide gel electrophoresis.
TRl ul
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IRl IRs us trs
3 4
M ------ ►
5 3
< ►
Gene Product
Size on 
SDS-PAGE
Size From 
Sequence
IE-1
IE-2
IE-3
IE-4
IE-5
Vmwl 10 
Vmw63 
Vmwl 75 
Vmw68 
Vmwl 2
llOkd
63kd
175kd
68kd
12kd
78452
55376
132835
46521
9792
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expression assays has been reported. With one exception 
(Rice and Knipe, 1988), Vmw63 has not been shown to 
trans-activate any viral promoter (IE, E, or L) by itself 
in transient assays (Everett, 1984b; O'Hare and Hayward, 
1985b; Mavromara-Nazos et al., 1986), but is capable of 
modulating the activities of Vmwl75 and VmwllO (Everett, 
1986; Sekulovich et al., 1988). The effects of Vmw63 are 
probably confined to a restricted set of genes.
Q„:. A number of viruses containing insertion and
deletion mutations within IE gene 1 coding sequences have 
been constructed and characterized (Stow and Stow, 1986; 
Sacks and Schaffer, 1987; Everett, 1989). These studies 
established that viruses lacking VmwllO function are able 
to grow in normal cell lines, although in certain cell 
types, they are impaired in plaque formation relative to 
wild type. This defect appears to reflect a reduction in 
the synthesis of viral polypeptides by mutant viruses 
during low multiplicity infections of less permissive cell 
types (Everett, 1989). These defects are overcome during 
infection at high multiplicity. This suggests that VmwllO 
function is required during low multiplicity infections 
(such as those in vivo which, presumably, often initiate at 
low multiplicity) to ensure efficient expression of viral 
genes, thus committing the virus to a lytic infection. As 
such, VmwllO might influence the outcome of infection in 
vivo, that is, whether the virus enters the lytic or latent 
cycle. Interestingly, viruses lacking VmwllO fail to 
stimulate latent viral genomes to reactivate in an in vitio 
latency system (Russell et al., 1987; Harris et al., 1989). 
In accordance with its apparent role in modulating viral 
gene expression, VmwllO activates viral promoters both by 
itself and in combination with Vmwl75 in transient assays 
(Everett, 1984b; O'Hare and Hayward, 1985a,b; Quinlan and 
Knipe, 1985; Gelman and Silverstein, 1985, 1986) .
Vmw68 • A virus containing a deletion m  IE g ene 4 has
been c o n s t r u c t e d  (Post and Roizman, 1981). C h a r a c t e r i z a t i o n  
of t his v i r u s  revealed that Vmw68 is d i s p e n s a b l e  for g r o w t h  
in t i s s u e  culture, although the mutant virus e x h i b i t e d  poor
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growth in certain cell tvoes af lAn ,types, and at least one L gene was
under-expressed (Sears p/- iooc\ ml_.et al" 1985). This suggests that
Vmw68, like Vmw63, miaht havp a ~ .mxyiiL nave a role m  ensuring efficient
L gene expression.
Vmwl2: This is the least characterized of the IE
polypeptides. A number of fortuitous HSV-1 and HSV-2 
deletion mutants which lack IE gene 5 have been isolated. 
These viruses grow efficiently in tissue culture and it was 
concluded that Vmwl2 is a non-essential polypeptide 
(Longnecker and Roizman, 1986; Umene, 1986; Brown and 
Harland, 1987).
13J.— Thfi— Rol.6 of DNA Replication in L Gene Expression
The characterization of viruses containing lesions 
in the IE genes has demonstrated a requirement for Vmwl75 
and Vmw63 (and possibly Vmw68) in the efficient expression 
of L genes (see above). Nonetheless, these experiments have 
not defined the precise role of these IE polypeptides, 
inasmuch as reductions in L gene expression could result 
indirectly from the aberrant expression of other viral 
polypeptides. However, Johnson and Everett (1986a) 
demonstrated that abundant expression of a plasmid-borne 
promoter of a true-late gene during normal virus infection
required DNA replication. Mavromara-Nazos and Roizman
(1987) have also addressed the relative importance of
trans-acting functions versus DNA synthesis in regulation 
of a L gene promoter present in the viral genome. They 
infected cells with a TK~ virus to provide all trans-acting 
functions present during a normal infection. At early and 
late times following this, cells were infected with a 
second virus containing a chimeric TK gene under the 
control of an IE or L promoter, in the presence or absence 
of PAA. The TK gene under L control was not expressed when 
present in a non-replicating genome. Thus cis-activation by 
DNA synthesis, as opposed to trans-acting functions 
specified before and during DNA synthesis, is the principal 
requirement for efficient L gene induction.
The increase in L gene expression which follows the
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onset of DNA replication is believed to be greater than can 
be accounted for by the increased template copy number 
alone (Johnson and Everett, 1986b). Rather, it is envisaged 
that DNA replication has a more direct effect, perhaps 
alleviating some constraint imposed by the secondary 
structure of the DNA. Interestingly, Workman et al. (1988) 
have investigated the effect of DNA structure on 
trans-activation by the PRV IE polypeptide which is closely 
homologous to Vmwl75. Using an in vitro nucleosome assembly 
system, they demonstrated that PRV-IE was able to form a 
potentiated pre—initiation complex prior to, or during 
nucleosome assembly, but that once nucleosomes were 
assembled, the template remained refractory to induction by 
IE polypeptide. They suggested that once in this state, 
activation would require the destabilization of the 
nucleosome structure by, for example, DNA replication. 
Although HSV-1 genomic DNA is not thought to be assembled 
into a chromatin structure, that is not to say that 
occlusion of L promoters by other polypeptides does not 
occur.
IB. 4 VZV GENE REGULATION
The genetic organization of VZV and HSV-1 is 
similar and, moreover, they appear to encode a number of 
closely homologous products. Consequently, it is generally 
assumed that the mechanisms whereby VZV gene expression is 
controlled will be similar to those described above for 
HSV-1. There is as yet little evidence to support this, 
however.
4.1. VZV Immediate-Early Genes
DNA sequence analysis identified four genes in VZV 
which are predicted to encode polypeptides with homology to 
HSV-1 IE polypeptides. The location and orientation of 
these genes is shown in Figure 1, and their known functions 
and properties are summarized below.
Gene 62= The product of VZV gene 62, which has a
p r e d i c t e d  molecular weight of 140,000 ,VZV 140k), shares
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extensive predicted amino acid sequence homology with the 
HSV-1 polypeptide, Vmwl75 (McGeoch et al., 1986), and thus
it was suggested that 140k is the VZV counterpart of
Vmwl7 5. In support of this, expression of VZV 140k in a
transformed cell line (F114), or from a transfected
plasmid, is able to complement the growth of HSV-1 viruses 
with ts and deletion mutations in Vmwl75 (Felser et al., 
1987, 1988). That treatment of F114 cells with
cycloheximide increased accumulation of 140k mRNA indicates 
that 140k may, like Vmwl75, autoregulate its own expression 
(Felser et al., 1988). Consistent with its proposed role 
in VZV gene regulation, VZV 140k has been shown to 
trans-activate both HSV-1 and VZV promoters in transient 
assays (Everett, 1984b; Everett and Dunlop, 1984; Inchauspe 
et al., 1989; Cabirac et al., 1990). A structural 
comparison of VZV 140k and Vmwl75 is shown in Figure 3.
Gene 4: Gene 4 encodes a product of predicted molecular
weight 51,540 whose predicted amino acid sequence displays 
homology to Vmw63, the product of HSV-1 IE gene 2 (Davison
and Scott, 1986; McGeoch et al. , 1988). Accordingly, VZV is 
able to complement the growth of HSV-1 viruses with ts 
lesions in Vmw63, though this is less efficient than 
complementation of Vmwl75 mutant viruses (Felser et al., 
1987). The gene 4 product also activates VZV promoters in 
transfection assays, both alone and in synergy with
VZV 140k (Inchauspe et al., 1989).
Gene 61: The product of gene 61 has limited homology to
the predicted product of HSV-1 IE gene 1, VmwllO (Perry et 
al., 1986). Sequence similarity is confined to a region 
with the potential to form a zinc finger structure (Berg,
1986). Interestingly, an HSV-1 virus (FXE) in which this 
finger region is deleted is as impaired in growth as a 
virus lacking the majority of the VmwllO coding sequences 
(Everett, 1989). To date, the function of VZV gene 61 has 
not been discerned, although Inchauspe et al. (1989) 
reported preliminary results which suggest that the product 
of this gene can repress the VZV TK promoter, and modulate 
its activation by genes 4 and 62.
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Gene _63jL This gene encodes a product with homology to 
Vmw68, the product of HSV-1 IE gene 4. The function of this 
gene product is also unknown.
There is no direct evidence that these genes are 
regulated like HSV-1 IE genes during VZV infection. Two 
attempts to detect IE polypeptides in VZV infected cells in 
classic cycloheximide reversal experiments have been 
reported (Lopetegui et al., 1985; Shiraki and Hyman, 1987). 
There were inconsistencies between the studies, but they 
indicate the presence of at least four VZV IE polypeptides. 
The largest of these, a phosphoprotein of Mr 185,000, was 
proposed to be the product of gene 62.
4.2. Regulation of VZV IE Genes
The cis-acting sequences and trans-acting factors 
regulating expression of VZV gene 62 have been investigated 
(McKee et al., 1990). The VZV promoter exhibited low 
activity compared to the equivalent control sequences of 
HSV-1 or HCMV. It appears, therefore, that unlike these 
other viral IE promoters, the VZV IE promoter does not 
possess an efficient enhancer function, at least in the 
cell types studied. The promoter was strongly activated by 
the HSV-1 polypeptide Vmw65, confirming the earlier results 
of Felser et al. (1988). Within the sequences which 
conferred responsiveness to Vmw65 (-410 to -131), a strong 
homology to the HSV-1 TAATGARAT element was identified. The 
product of VZV gene 10, which shares homology with Vmw65 
(Dalrymple et al., 1985), failed to trans-activate the VZV 
promoter. This is not surprising since the VZV polypeptide 
failed to direct formation of an IEC complex with the 
TAATGARAT element and HeLa cell proteins, and furthermore, 
lacks the C-terminal acidic activation region that is 
essential for the activity of Vmw65 (Sadowski et al., 1988; 
Triezenberg, 1988a; Greaves and O'Hare, 1989, 1990).
Interestingly then, a functional TAATGARAT element 
is conserved in this VZV IE promoter, yet the VZV homologue 
of Vmw65 is inactive. This is reminiscent of PRV which 
apparently does not encode a homologue of Vmw65 (Hampl et
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al,, 1984), but whose sole IE promoter contains a TAATGARAT 
motif and is trans-activated by Vmw65 (Campbell and
Preston, 1987). Ace et al, (1989) found that during 
infection with HSV-1 inl814 (which lacks functional Vmw65) 
under conditions of cycloheximide reversal, the most 
abundantly expressed polypeptides were the IE
polypeptides. They concluded that IE-specific promoter DNA 
sequences, possibly the TAATGARAT element itself, 
distinguish the kinetics of IE gene expression from those 
of E and L genes (rather than activation of IE promoters 
by Vmw65). It may be that within the natural host cells of 
VZV and PRV, binding of a host factor to TAATGARAT is 
sufficient to induce IE gene expression. Alternatively, 
certain cell types may contain a Vmw65 homologue. The
intriguing possibility exists that differences in IE gene 
regulation in these alphaherpesviruses may be related to 
their biological properties.
4.3. Early and Late Genes?
VZV contains genes which are homologous to E and L
genes of HSV-1, although as yet, no formal evidence exists 
that these genes are regulated with E and L kinetics (as
described for HSV-1; Section 1B.1). The finding that at 
least two of the VZV IE polypeptides can trans-activate 
other viral promoters is clearly significant, though 
whether or not VZV contains E and L genes which are 
differentially regulated remains to be determined.
In an attempt to address this question, Asano and 
Takahashi (1979, 1980) analysed viral polypeptide
expression during VZV infection of tissue culture cells in 
the presence and absence of PAA. Under conditions where DNA 
synthesis was inhibited, only a few of the polypeptides 
detected during a normal infection were observed, and it 
was suggested that these might represent E polypeptides. 
However, given the considerable difficulties associated 
with detection of viral polypeptides against the background 
of host cell polypeptides, these results should be viewed 
with caution. The detection of polypeptides which are of
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low abundance in a normal infection might require that 
infection be allowed to spread, thus increasing the 
percentage of infected cells, with a corresponding increase 
in the ratio of viral to host polypeptides. Further 
analysis of gene expression during VZV infections will 
require the use of higher titre cell-free virus stocks 
(with which synchronous infections are possible). Since 
detection of viral polypeptides has previously been a 
limiting factor, it would undoubtedly be better to study 
transcript accumulation using gene specific probes which 
would greatly increase sensitivity. If this approach 
identified VZV genes which were regulated with E or L 
kinetics, their promoters could be analysed in transfection 
assays and in vitro. Studies of HSV-1 gene regulation have 
demonstrated that the results of such assays are largely 
consistent with observations during virus infection.
IB.5. PRV GENE REGULATION
PRV expresses a single IE RNA which is transcribed 
from the inverted repeat sequences of the genome (bounding 
Us), and encodes a multi-functional polypeptide of Mr 
180,000 (Ihara et al., 1983). Molecular hybridization
studies established that the sequences comprising this 
region of the genome are homologous to the corresponding 
repeat sequences of HSV-1, which contain IE gene 3 (Davison 
and Wilkie, 1983; Ben-Porat et al., 1983). Subsequent 
determination of the PRV IE gene sequence has revealed 
extensive predicted amino acid sequence
homology between PRV-IE and both Vmwl75 of HSV-1, and 
VZV 140k (Cheung, 1989; Vlcek et al., 1989).
The regulation of PRV IE polypeptide expression is 
discussed elsewhere (see Section IB.4.2). The functions of 
PRV IE have been studied in some detail. Ihara et al. 
(1983) analysed RNA and protein synthesis during infection 
of cells with a PRV temperature-sensitive mutant tsGi , 
which has a lesion in the IE polypeptide (Ben—Porat et al. ,
1982). During infection of cells at the NPT only IE RNA was 
transcribed. Therefore, as with HSV-1, transcription of
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later classes of PRV genes requires functional IE 
polypeptide, as suggested by earlier studies (Rakusanova et 
al., 1971; Jean et al., 1974; Feldman et al., 1979). The IE 
polypeptide also represses transcription of its own RNA. 
Following infection at the NPT, productive infection 
occurred following shift-down to the PT at 3h p.i., but 
not at 5h p.i., when an abortive infection ensued. This 
aspect of the tsGi phenotype differs from that of HSV-1 
mutants such as tsK, and suggests that overexpression of 
PRV IE may have a deleterious effect on macromolecular 
synthesis (Ihara et al., 1983). It is not known whether any 
of the PRV genes depend for their efficient expression on 
DNA synthesis .
The PRV IE polypeptide stimulates transcription in 
vitro in a cell-free system (Abmayr et al., 1985), 
indicating a direct effect of IE on the hosts transcription 
machinery (rather than an indirect effect by, for example, 
increasing the amount of a limiting transcription factor). 
Further characterization of this system has demonstrated 
that PRV IE apparently activates transcription by 
increasing the rate or extent of recruitment of the general 
transcription factor, TFIID, into a pre-initiation complex 
at the TATA box (Abmayr et al., 1988). This is discussed in 
more detail in Section ID.5. PRV IE has subsequently been 
shown to bind, with differing affinities, to a degenerate 
set of DNA sequences in the adenovirus major late promoter 
(used in the in vitro transcription assay) (Cromlish et 
al., 1989). Moreover, binding to cis-elements appears to be 
required for trans-activation in vitro since 
oligonucleotides homologous to the high affinity sites 
inhibit transcription, and binding of the ts IE polypeptide 
was not observed at the NPT (when IE fails to activate 
transcription)(Cromlish et al., 1989).
IB.6. EHV-1 GENE REGULATION
Caughman et al. (1985) analysed EHV-1 polypeptide 
expression during infection of tissue culture cells in the 
absence and in the presence of metabolic inhibitors. A
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total of thirty polypeptides specific to infected cells 
were identified. Four of these were designated "immediate 
early" polypeptides since they were detected in a 
cycloheximide reversal experiment, but not during a normal 
infection. The synthesis of twelve of the polypeptides was 
reduced in cells infected in the presence of inhibitors of 
viral DNA synthesis. These polypeptides were thus 
classified as "late" polypeptides. These findings indicate 
that EHV-1 polypeptide synthesis is temporally regulated in 
a manner similar to that demonstrated for HSV-1.
Grundy et al. (1989) have since reported the 
sequence of an EHV-1 gene which encodes a polypeptide with 
extensive homology to Vmwl75 and the other alphaherpesvirus 
homologues. This polypeptide is thus implicated in the 
regulation of EHV-1 gene expression.
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1C. THE HSV 1 IE3 GENE AND Vmwl75
This thesis is concerned with the functions and 
properties of the VZV 140k polypeptide which is homologous 
to the HSV-1 IE polypeptide, Vmwl75. Vmwl75 has been 
extensively studied, and its functions and properties are 
discussed in this section.
Vmwl75 is encoded by the diploid IE3 gene, one copy 
of which is present in each of the repeat sequences (Rs)
bounding the short unique region (Us) of the genome (Rixon
et al., 1982) . The Vmwl75 open reading frame is 3894
nucleotides in length and encodes a 1298 amino acid 
polypeptide with a predicted unmodified molecular weight of 
132,835. Translation is predicted to commence at the first
ATG of the transcribed region, at position 131128, and
continues to the termination codon TAA at position 127234 
(McGeoch et al., 1986, 1988). All subsequent references to 
the Vmwl75 orf will assume that the first base of the orf 
is numbered 1, proceeding through to the last base, 3894.
A full description of the cis-acting sequences and 
trans-acting factors involved in IE gene 3 regulation can 
be found in Section IB.3.1.
1C.1. Physical Properties
1.1. Modifications
Vmwl75 is a nuclear-localized phosphoprotein 
(Pereira et al., 1977) which can be purified as a homodimer 
(Metzler and Wilcox, 1985).
The Vmw'175 orf encodes a polypeptide of 1298 amino 
acids with a predicted molecular weight of 133 kDa, 
although migration of the polypeptide in SDS-PAGE indicates 
an Mr of around 175 kDa (McGeoch et al., 1986). Vmwl75 is 
phosphorylated at both serine and threonine residues (Faber 
and Wilcox, 1986a), and can also be poly(ADP-ribosyl)ated 
(Preston and Notarianni, 1983). The conserved serine-rich 
tract in region 1 (see Section 1C.3.4) is likely to be a 
major site of phosphorylation, though other sites have been 
proposed (DeLuca and Schaffer, 1988) . Pereira et al. (1977) 
identified three forms of Vmwl75 with slightly different
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mobilities in SDS PAGE, and these probably represent
differentially modified forms of the polypeptide. The 
relative amounts of these different forms is altered in 
cells infected with the HSV-1 mutant, tsK (which has a
lesion in Vmwl75) at the NPT (Preston, 1979a), and, in 
addition, the tsK polypeptide does not appear to become 
poly(ADP-ribosyl)ated at the NPT (Preston and Notarianni,
1983). Furthermore, there is evidence that phosphate cycles 
on and off two of these forms during a normal infection
(Wilcox et al. , 1980), and that the different forms bind to
consensus and non-consensus Vmwl75 DNA binding sites (see 
below) with different affinities (Michael et al., 1988). 
Interestingly, phosphorylation has been shown to regulate 
the DNA-binding activity of E4F, an inducible cellular 
factor implicated in adenovirus Ela mediated induction of 
the viral E4 promoter (Raychaudhuri et al., 1989). Alkaline 
phosphatase treatment abolished DNA binding activity of 
E4F, which was restored upon incubation of the inactivated 
factor with extract from virus infected cells. It will be 
interesting to determine the precise effect of 
phosphorylation on the DNA binding properties of Vmwl75 and 
its role, if any, in regulation of viral gene expression. 
In this regard, it is interesting that Wu and Wilcox (1990) 
have demonstrated that the unphosphorylated Vmwl75 DNA 
binding domain is competent in sequence-specific DNA
binding. Nevertheless, phosphorylation outwith this domain 
might conceivably regulate DNA binding.
1.2. Nuclear Localization
Within 2-3h p.i., Vmwl75 is localized to the
nucleus of the infected cell, and can be found associated 
with cellular chromatin (Pereira et al., 1977; Hay and Hay, 
1980; Cabral et al., 1980). At the NPT, several ts mutant
forms of Vmwl75 fail to localize to the nucleus, or exhibit
altered intranuclear distribution (Preston, 1979b; Cabral 
et al., 1980; Knipe and Smith, 1986). Surprisingly, the 
nuclear localization of VmwllO and the major DNA binding 
protein (DBP) is apparently blocked by the presence of 
some, but not all t.s alleles of Vmwl75 at the NPT (Preston,
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1979b; Knipe and Smith, 1986).
Immunofluorescence studies have demonstrated that 
Vmwl75 has a diffuse nuclear distribution until the onset 
of DNA replication (when it may be associated with cellular 
chromatin), following which it becomes compartmentalized 
into globular foci (Randall and Dinwoodie, 1986; Knipe et 
al., 1987) . Strikingly, both major DBP and DNA polymerase 
are co-localized with Vmwl75 in these foci or "replication 
compartments" (Quinlan et al., 1984; Randall and Dinwoodie, 
1986; Knipe et al., 1987). It appears, therefore, that
Vmwl75 is recruited into sites of active DNA replication, 
and it is an intriguing possibility that the distribution 
of the polypeptide at early and late times may be related 
to the mechanisms of E and L gene trans-activation.
1.3. DNA Binding
Vmwl75, like other HSV-1 IE polypeptides, is a DNA 
binding protein (Powell and Purifoy, 1976; Hay and Hay, 
1980) . Early reports suggested that Vmwl75 bound indirectly 
to DNA via a host polypeptide (Freeman and Powell, 1982). 
However, Michael et al. (1988) employed the technique of 
south-western blotting to demonstrate that Vmwl75 can bind 
directly to DNA. This has since been confirmed using 
affinity purified Vmwl75 (Kattar-Cooley and Wilcox, 1989).
Vmwl75 is the only Aof the HSV-1 IE polypeptides 
which has been shown to possess a sequence specific DNA 
binding activity. A Vmwl75 DNA binding site of consensus, 
ATCGTCnnnnYCGRC (n=any base; Y=pyrimidine; R=purine), has 
been proposed (Faber and Wilcox, 1986b). Copies of this 
consensus element are distributed throughout the HSV-1 
genome. Notably, the promoters of IE gene 3 and IE gene 1, 
both of which bind Vmwl75 (Kristie and Roizman, 1986a,b; 
Muller, 1987; Faber and Wilcox, 1988; Roberts, 1988; 
Resnick et al., 1989), contain clear homologues of this 
consensus. Conversely, the other IE promoters, which do not 
contain a related sequence, bind Vmwl75 weakly or not at 
all (Faber and Wilcox, 1988). The stoichiometry of binding 
to the IE3 and IE1 sites has been investigated and it was
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found that each consensus (ATCGTC) site bound two monomers 
of Vmwl75 (Michael and Roizman, 1989) . The relationship 
between IE gene regulation and binding of Vmwl75 to these 
sites is discussed in Section 1C.2.4.
The precise DNA sequence requirements for Vmwl75 
consensus binding have been studied in some detail. DNAse 
footprinting and methylation interference assays have 
implicated nucleotides outwith the consensus ATCGTC motif 
in efficient binding (Muller, 1987; Faber and Wilcox,
1988). Indeed, the ATCGTC element is essential, but not of 
itself sufficient, for DNA binding (Roberts et al., 1988). 
Extensive point mutagenesis of the IE3 consensus element 
and flanking nucleotides has been performed. The results 
demonstrate that the ATCGT nucleotides of the consensus 
(ATCGTC) are most important for binding, but that
downstream nucleotides also contribute (Roger Everett, 
pers. comm.). This analysis defined a binding site,
ATCGTnnnnncGG (where the upper case characters are those 
determined to be most important), which is very close to 
the original consensus of Faber and Wilcox (1986b).
Binding of Vmwl75 to a disparate set of 
non-consensus sites has also been described (Kristie and 
Roizman, 1986b; Michael et al., 1988; Sheperd et al., 1989; 
Tedder et al., 1989; Michael and Roizman, 1989; Imbalzano 
et al., 1990).
1C.2. GENE REGULATION BY VMW17 5
2.1. Genetic Analyses of Vmwl75
The isolation and characterization of a number of 
ts mutants in IE gene 3 (discussed in Section IB.3.3 [d]) 
demonstrates that Vmwl75 has a pivotal role in the HSV-1 
transcriptional programme. Two classes of mutants have been 
defined and the sites of their DNA lesions mapped. This 
analysis suggests that Vmwl75 may comprise distinct 
functional domains. At the NPT, the more stringent mutants 
(of which tsK is an example) fail to express E and L 
polypeptides, and overexpress IE polypeptides (Courtney et 
al., 1976; Marsden et al., 1976; Watson and Clements, 1978,
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1980; Preston, 1979a; Dixon and Schaffer, 1980). The
lssions in this class of mutants typically lie in the
central region or toward the amino-terminus of the
polypeptide, that of tsK arising from a single point 
mutation which changes amino acid 475 (Davison et al., 
1984). The second class of mutants exhibit reduced, but 
clearly observable E gene expression and undergo limited 
DNA replication, yet fail to express L polypeptides (DeLuca 
and Schaffer, 1984). The phenotype of these mutants 
suggests that Vmwl75 may possess a distinct function 
required for L gene expression. Consistent with this view, 
the lesions in these E gene "permissive" mutants are
located within the carboxy-third of the polypeptide (DeLuca 
and Schaffer, 1984; Paterson et al., 1990).
2.2. Trans-Activation by Vmwl75
Following genetic studies with mutant viruses which 
demonstrated that functional Vmwl75 was absolutely 
required for induction of E and L gene expression, its role 
in viral gene regulation has been extensively studied. This 
section will not review all of the data on tra^s-activation 
by Vmwl75, but rather will discuss the salient features of 
this work, particularly those pertaining to the possible 
mechanism of action.
In an extension of the original virus studies, 
induction of a plasmid-borne viral E promoter (linked to a 
suitable reporter gene) during virus infection was shown 
to require functional Vmwl75 (Everett, 1983; O'Hare and 
Hayward, 1984) . Subsequently, a variety of approaches have 
been employed in order to study activation by Vmwl75 in the 
absence of other IE polypeptides. Persson et al. (1985) 
constructed a stable transformed cell line which 
constitutively expressed Vmwl75. These cells were infected 
in the absence of de novo protein synthesis and the 
induction of viral genes resident in infecting viral 
genomes analysed. It was found that a number of E genes 
were efficiently induced, whereas the L VPS gene was only 
induced to very low levels, and induction of the L gC gene
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was not detectable. A related study attempted 
co—transformation of cells with Vmwl75 coding sequences and 
certain L genes (Arsenakis et al., 1988). The results
obtained were somewhat complicated, and suggested that 
under some circumstances, Vmwl75 could regulate L gene 
expression both positively and negatively.
Transient transfection assays have been widely 
exploited to study trans-activation using cloned copies of 
the IE genes, both alone and in combination. In this way, 
Vmwl75 has been shown to trans-activate a number of viral 
promoters of both E and L kinetic classes, and in some 
cases, activity was substantially increased in the presence 
of VmwllO (Everett, 1984b; Quinlan and Knipe, 1985; O'Hare 
and Hayward, 1985a,b; Gelman and Silverstein, 1985, 1986). 
There are discrepancies between the various studies 
regarding the actual promoters which are responsive to 
activation, and the response of particular promoters to 
Vmwl75 and VmwllO in combination. This doubtless reflects 
the different cell-types used, and variations in 
experimental detail, as described by Everett (1988). 
Importantly, cloned copies of genes encoding ts forms of 
Vmwl75 have been shown to be temperature-sensitive in their 
ability to activate gene expression in transfection assays 
(DeLuca and Schaffer, 1985).
Active ion of certain promoters by Vmwl75 and 
VmwllO in synergy results in up to 20-fold greater 
activation than occurs with either polypeptide alone. The 
underlying basis of this phenomenon is not known. It may 
reflect a physical interaction or formation of a complex 
between Vmwl75 and VmwllO. Alternatively, the polypeptides 
might act at different stages of the transcription process. 
Whether the phenomenon of synergy in transfection assays 
reflects an important function during infection in vivo 
remains to be determined. Interestingly, viruses which 
lack functional VmwllO exhibit poor growth during infection 
3t' low multiplicity, apparently as a consequence of reduced 
viral gene expression (Everett, 1989). This infers that 
VmwllO augments virus growth at low moi by increasing viral
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gene expression. Perhaps this involves synergistic 
activation in combination with Vmwl75.
Finally, Vmwl75 has been shown to stimulate 
transcription of several viral genes in an in vitro 
transcription system (Beard et al., 1986; Pizer et al.,
1986).
2.3. A Role for DNA-Binding in Trans-Activation?
The studies discussed in Sections IB.3.3.(a) and
lB.3.3.(b) indicate that activation of E and L genes by 
viral IE polypeptides does not involve virus-specific 
sequences. Nevertheless, it is interesting to consider the 
studies on trans-activation of the HSV-1 gD promoter, which 
contains a consensus Vmwl75 DNA binding site located 
upstream of the TATA box. It was found that the consensus 
sequence was dispensable for trans-activation by Vmwl75 in 
transfection assays, although the efficiency of 
trans-activation was increased in its presence (Tedder and 
Pizer, 1988) . In addition, multimerization of binding sites 
upstream of the TATA box increased expression relative to 
the wt promoter (Tedder and Pizer, 1988). In an extension 
of these studies Tedder et al. (1989) identified three
Vmwl75 binding sites within the gD gene: Site II contains a 
consensus ATCGTC motif, site III a near consensus, while 
site I shares no significant homology to either site II or 
III. These sites were found to contribute to 
trans-activation in an in vitro transcription system 
(although low level activation was observed in their 
absence), and it was thus proposed that binding of Vmwl75 
to multiple, non-homologous sites can stimulate 
transcription (Tedder et al., 1989).
The results of Imbalzano et al. (1990) should also 
J30 mentioned. They investigated the functional relevance of 
non—consensus Vmwl75 DNA binding sites in the TK gene 
promoter region (which lacks consensus sites). A mutant 
Vmwl75 polypeptide, which did not detectably bind to 
non-consensus sites in vitro, apparently activated TK 
transcription as efficiently as wild type Vmwl75. This
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suggests that specific DNA binding might not be absolutely 
necessary for activation of all HSV promoters. The 
activities and relative amounts of cellular factors, and 
the number and arrangement of their cognate binding sites 
in viral promoters, may well be important in this regard.
It should be stressed that the precise role of
individual binding sites is difficult to assess in such 
assays since if one site is deleted, the effect might be 
compensated by other weaker Vmwl75 binding sites within the 
promoter or the vector (Tedder et al. , 1989).
2.4. Repression of IE Gene Expression By Vmwl75
Analysis of viral ts mutants and use of metabolic 
inhibitors has implicated Vmwl75 in repression of IE 
polypeptide expression. However, as discussed in Section
IB.3.2, only IE3 RNA expression appears to be repressed 
during a normal virus infection (Harris-Hamilton and
Bachenheimer, 1985; Weinheimer and McKnight, 1987). Thus 
Vmwl75 may be the only IE polypeptide whose expression is 
repressed at early and late times in infection.
Repression of the IE3 promoter has been reproduced 
in transfection assays (O'Hare and Hayward, 1985b). A
direct correlation between the presence of a functional 
ATCGTC motif at the IE3 capsite (capable of binding
Vmwl75) and repression of the IE3 promoter has since been 
demonstrated (Roberts et al., 1988). In agreement with this 
finding, mutation of the IE3 consensus binding site in the 
viral genome increased expression of Vmwl75 during 
infection (DeLuca and Schaffer, 1988). It is thought that 
binding of Vmwl75 to this site represses transcription by 
directly impeding the formation or progress of a
transcription complex.
The IE gene 1 promoter also contains a consensus 
ATCGTC motif located upstream of the TATA box. Resnick et 
al. (1989) have investigated the role of the this consensus
site in IE gene 1 regulation. They determined the effect 
of a point mutation within the consensus motif (which 
abolished Vmwl75 binding) on regulation of the IE1 promoter
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by Vmwl75 (alone or in combination with VmwllO or Vmw65) 
during transfection assays. Their results are somewhat 
complex. In some cases the presence of an intact consensus 
binding site did not affect expression, and in others it 
correlated with reduced activation (rather than 
repression). Notably, mutations within the IE1 consensus 
site in the viral genome do not effect the kinetics or 
efficiency of VmwllO expression during a normal virus 
infection (Everett and Orr, 1991).
It is likely that the ability of Vmwl75 to repress 
gene expression by binding to consensus ATCGTC motifs is 
dependent on the spatial relationship between the binding 
site and TATA box. This might require that the binding site 
be located close to the TATA box and/or that
stereo-alignment of the sites is correct. In this regard, 
it is interesting to consider the results of DiDonato and 
Muller (1989). These workers investigated the binding of 
affinity purified Vmwl75 to consensus sites in the IE1, IE3 
and gD promoters, by high resolution copper footprinting. 
Binding to the IE3 site, which is located approximately 2.5 
helical turns downstream of the TATA box, resulted in 
hypersensitive cleavage in the TATA region, indicative of 
an alteration in the helical geometry of the DNA. Binding 
to the IE1 site, located approximately 3.5 helical turns
upstream of the TATA box, also resulted in TATA
hypersensitivity, though this was less pronounced. In
contrast, binding to the site in the gD promoter, 8 helical 
turns upstream of the TATA box, did not produce TATA 
hypersensitivity. Likewise, increasing the separation 
between the IE3 site and the TATA box to 5 helical turns 
abolished hypersensitivity. There appears then, to be a 
close correlation between TATA hypersensitivity and the 
distance of the binding site from the TATA box.
These observations suggest a model to account for 
the consequences of Vmwl75 binding to consensus sites in 
these promoter regions. The prediction of the model is that 
binding which produces alterations in the DNA structure in 
the TATA box region might disrupt interactions between
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TFIID and the TATA box, thereby reducing (or precluding) 
formation of an initiation complex, and decreasing 
transcription initiation. This could account for repression 
of the IE3 promoter. The lack of repression of the IE1 
promoter by Vmwl75 correlates with reduced TATA 
hypersensitivity induced by binding of Vmwl75 to the IE1 
consensus sequence. In this situation, the alterations in 
TATA box structure only have a moderate effect on TFIID 
binding, and expression is reduced rather than repressed. 
Binding to a site further (upstream) from the TATA box 
(such as that in the gD promoter) , which does not induce 
TATA hypersensitivity, presumably does not diminish TFIID 
binding to TATA, and thus does not repress expression.
Alternatively, repression of the IE3 promoter by 
Vmwl75 might result from direct disruption of the formation 
or passage of the preinitiation complex.
1C.3. Structure of Vmwl75
As a consequence of the G+C content of the Vmwl75 
coding sequence, which is a remarkable 81.5%, alanine, 
proline, glycine, and arginine comprise 54.9% of all amino 
acids in the polypeptide (McGeoch et al., 1986). The G+C 
rich codons specifying these amino acids tend to be located 
in regions of the polypeptide which are less conserved in
the homologous IE polypeptides of other alphaherpesviruses,
and hence which are presumably of less critical functional 
importance. It was suggested that such an extreme base
composition has resulted from an evolutionary force acting
directly on the DNA, rather than indirectly through amino 
acid sequence (and hence functional) requirements (McGeoch
et al., 1986).
The predicted amino acid sequence of Vmwl75 was 
divided into five regions on the basis of homology with the 
corresponding sequence of VZV 140k (Figure 3; McGeoch et 
al. t 1986) . Regions 2 and 4 contain the most highly 
conserved sequences, and within these are blocks of 
nearly-identical sequence. The sequences outwith regions 2 
and 4 display marked divergence, and include insertions and
Figure 3. Sequence alignment of VZV 140k and HSV-1 Vmwl75. 
The coding sequences of VZV 140k and Vmwl75 are divided 
into five regions (1-5) on the basis of sequence homology 
(McGeoch et al., 1986). Portions of the coding sequences 
are represented by blocks, the solid lines being spacers 
introduced to optimize the alignment. The extent of 
homology represented by the different shadings is 
indicated.
HOMOLOGY 
HOMOLOGY 
HOMOLOGY
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deletions relative to VZV 140k. The sequences comprising 
regions 2 and 4 are also highly conserved in the homologous 
PRV and EHV-1 IE polypeptides (Cheung, 1989; Grundy et al., 
1989; Vlcek et al., 1989). Furthermore, it is noteworthy
that of the Vmwl75 ts mutants for which the precise DNA 
lesion has been determined, all alter residues (in region 2 
or 4) conserved in all the known sequences (Paterson et 
al., 1990) . The functional importance of regions 2 and 4 
suggested by the above sequence analyses has been confirmed 
by mutational analyses of Vmwl75 (see below).
1C. 4. Mutational Analysis of Vmwl75
Vmwl75 is a multifunctional polypeptide which 
possesses a DNA-binding activity, and functions during 
virus infection to trans-activate E and L gene expression, 
and in addition, probably represses the expression of IE 
gene 3. In order to determine which parts of the 
polypeptide are involved in the various functions, a number 
of groups have created defined mutations in plasmid-borne 
copies of the Vmwl75 coding sequences. The activities of 
the mutant polypeptides have been determined by expression 
in transfection assays (DeLuca and Schaffer, 1987; Paterson 
and Everett, 1988a,b; Shepard et al., 1989), and in some 
cases during viral infection following recombination of the 
mutations back into the normal Vmwl75 loci of the HSV-1 
genome (DeLuca and Schaffer, 1988; Shepard et al., 1989; 
Paterson and Everett, 1990). Significantly, these analyses 
have shown that regions 2 and 4, which are highly conserved 
in the homologous IE polypeptides of other 
alphaherpesviruses (McGeoch et al., 1986, Cheung, 1989, 
Grundy et al., 1989; Vlcek et al., 1989), are most critical 
for Vmwl75 function. The functional properties of each of 
the 5 domains defined by McGeoch et al. (1986; see above) 
will be considered in turn.
Region 1 (Residues 1~314)_
Insertion mutations within the majority of this 
region have little effect on Vmwl75 function (Paterson and 
Everett. 1988a.br Shepard et al., 1989). The first 90
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residues are dispensable for virus growth (DeLuca and 
Schaffer, 1987, 1988), but may contain sequences involved 
in dimerization of Vmwl75 (Shepard and DeLuca, 1989). A 
striking run of serines centred on residue 193 (13 of 14 
consecutive residues), which is highly conserved in both 
VZV and PRV, probably constitutes a phosphorylation site of 
Vmwl75 (DeLuca and Schaffer, 1988). Surprisingly, deletion
of this region from Vmwl75 does not greatly affect its
function in transfection assays or during lytic infection 
in tissue culture (Paterson and Everett, 1988a,b, 1990).
Residues toward the carboxy end of region 1 appear to
contribute to DNA binding, and this is discussed below. 
Region 2 (Residues 315-484)
This region is clearly the most critical for Vmwl75 
function. Most of the insertion mutations within region 2 
markedly debilitate DNA binding, trans-activation, and 
repression activities (Paterson and Everett, 1988a,b; 
Shepard et al. , 1989). Notably, the DNA lesion in tsK is 
located within this region (Davison et al., 1984). The DNA 
binding function of this region has been analysed further. 
A trpE fusion protein containing residues 262-490 of Vmwl75 
bound specifically to a probe containing a consensus ATCGTC 
motif and, moreover, produced an identical footprint to 
intact Vmwl7 5 (Wu and Wilcox, 1990). A fusion protein 
lacking residues 262-306 (from the distal portion of region 
1) failed to bind DNA. An independent study revealed that 
proteinase K digestion of Vmwl75 liberates a functional DNA 
binding domain (Everett et al. , 1990). Proteinase K
treatment of mutant Vmwl75 polypeptides mapped the 
amino—terminus of the DNA binding domain between residues 
229 and 292 (i.e. within region 1 ), and the
carboxy-terminus between residues 495 and 518. Several 
insertion mutants have intriguing DNA binding properties 
and suggest that further functional complexity exists 
within this domain (Shepard et al., 1989). Thus residues 
445 to 487, which contain a putative helix-turn-helix 
motif, were'critical for DNA binding in general, whereas an 
insertion at residue 338 preferentially affected binding to
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non-consensus sites.
Region 3 (Residues 485-796)
Region 3 exhibits considerable size heterogeneity
between Vmwl75 and its alphaherpesvirus homologues, and is
one of the least conserved regions of the polypeptides.
Region 3 contains a nuclear localization signal (DeLuca
and Schaffer, 1987; Paterson and Everett, 1988a). This
function lies between residues 640 and 773 and is probably
attributable to the sequence
pro-arg-glu-gly-arq-lys-arg-lvs-ser-pro (underlined amino
acids are conserved in VZV 140k) centred on amino acid 728,
which is related to the nuclear localization signal of the
SV40 large T antigen (Kalderon et al. , 1984). No other
tv
functions have been assigned^this region.
Regions 4 and 5 (Residues 797-1224 and 1225-1298)
The function of this part of the polypeptide is 
less well understood, but appears to be more important for 
trans-activation than repression. Intriguingly, small 
insertions into region 4 are apparently more deleterious 
than extensive deletions (Paterson and Everett, 1988a,b). 
Likewise, the amino-terminal 60% of Vmwl75 (residues 
1-7 7 4 ) , which retains considerable activity in transfection 
studies, was more active than the amino-terminal 80% of the 
polypeptide (DeLuca and Schaffer, 1987). The shorter 
polypeptide, however, exhibited reduced trans-activation 
activity and was unable to support virus growth (DeLuca and 
Schaffer, 1988). There is evidence that some mutations 
in this region (including those of several ts mutants) 
affect the conformation of Vmwl75, and it has been proposed 
that region 4 might modulate the activity of functions 
within other regions of the polypeptide (Everett et al., 
1990; Paterson et a l 1990). Thus if regions 2 and 4 are 
closely apposed in the tertiary structure of Vmwl75, such 
conformational alterations could conceivably alter the 
function of region 2. An extension of this hypothesis is 
that interaction with other viral or cellular factors might 
induce similar conformational changes in region 4, and 
modulate the activity of region 2 in an analogous way.
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Since DNA binding is apparently required for 
trans-activation (and is a function of region 2 ), the 
primary consequence of these interactions might be to alter 
the specificity of DNA binding. In this way, the
selectivity and efficiency of promoter activation might be 
modulated.
52
ID. CONTROL OF EUKARYOTIC GENE EXPRESSION
Control of eukaryotic gene expression is 
principally exerted at the level of transcription 
initiation. This section will describe the overall features 
of this process, and will go on to describe in detail those 
aspects most relevant to transcriptional control by viral 
IE polypeptides.
1D.1. RNA Polymerase II
Three distinct RNA polymerase enzymes, which are 
distinguished by their sensitivity to a-amanatin, have been 
isolated from eukaryotic cells. They are complex, 
multi-subunit enzymes with molecular weights in excess of 
500,000. RNA polymerases I and III perform specialized 
roles: polymerase I synthesises the large ribosomal RNAs; 
polymerase III synthesises the small 5S RNA of the 
ribosome, and the transfer RNAs. Further discussion will be 
confined to RNA polymerase II (pol II) which synthesises
all the mRNA precursors for protein biosynthesis.
Eukaryotic Pol II comprises two large,
non-identical subunits (Mr in excess of 100,000 each), and 
7 to 12 smaller polypeptides (Mr <50,000 each)(Lewis and 
Burgess, 1982). The two largest subunits share structural 
homology with the two largest subunits of prokaryotic RNA 
polymerase. However, the largest subunit of the
eukaryotic enzyme has at its C-terminus a unique
heptapeptide tandem repeat of consensus YSPTSPS; the exact 
sequence and number of these repeat units varies between 
species (yeast, 26 copies; Allison et al., 1985;
drosophila, 42 copies; Zehring et al., 1988; mouse, 52
copies; Bartolomei et al., 1988). Deletions which remove
portions of this repeat element are functionally tolerated
in vivo, though the minimal (functional) repeat length
varies between species (Allison et al., 1988; Bartolomei et 
al., 1988; Zehring et al., 1988). Additional in vivo 
studies have shown that the yeast repeat element can be 
replaced with that from hamster, whereas replacement with 
the drosophila element, which is more divergent, results m
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a recessive lethal condition (Allison et al., 1988).
The catalytically active form of pol II is 
phosphorylated, and there is good evidence that the site 
of phosphorylation is the C-terminal repeat element (Cadena 
and Dahmus, 1987). Interestingly, the repeat element is 
dispensable for accurate initiation of transcription in a 
minimal in vitro system, and it has been proposed that it 
may have a regulatory function in vivo (Zehring et al.,
1988). In this regard, it is interesting that mutations in 
GAL4 (a transcriptional regulatory factor of Saccharomyces 
cerevisiae) which reduce its intrinsic trans-activation 
activity can be enhanced or suppressed in vivo by mutations 
in pol II which decrease or increase (respectively) the 
length of the repeat regions (Allison et al. , 1989).
Furthermore, GCN4 (also of Saccharomyces cerevisiae) and 
pol II have been shown to interact directly in vitro 
(Brandi and Struhl, 1989). Clearly such direct interactions 
between pol II and transcription factors bound to promoter 
sites might be important in regulation of transcription in 
vivo. Indirect interactions, mediated for example via TFIID 
bound to the TATA box, are also likely to be important (see 
Section ID.5).
ID.2. Control of RNA Polymerase II Transcription Initiation 
Pol II transcribes three subclasses of genes which 
are defined in terms of the characteristics of their 
expression and the nature of the sequences controlling 
their transcription. The majority of protein coding genes 
contain a TATA element; regulation of this class of genes 
has been extensively studied and is considered below. The 
two remaining subclasses do not possess TATA boxes (see 
Smale and Baltimore, 1989, for review). The so called 
'•housekeeping" genes, which express proteins common to all 
cell types, have G+C rich promoters which exhibit low level
... . ■ .^Hvirv and frequently initiateconstitutive activity, dIlu w
transcription at sites spread over a wide region. The 
second class of TATA-less genes include those whose 
expression is regulated during mammalian
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immunodifferentiation ae*y* tne terminal
deoxynucleotidyltransferase gene (TdT; Landau et al. ,
1984) . Analysis of the TdT gene promoter identified an 
element, the initiator, that contains within itself the 
transcription start site (Smale and Baltimore, 1989). The 
initiator is the simplest functional promoter yet 
identified.
ID.2.1. Regulation of TATA Containing Class II Genes
The promoters of these genes share a common 
architecture which includes a TATA element and various 
upstream regulatory elements (for reviews see Dynan and 
Tjian, 1985; Maniatis et al. , 1987).
The TATA box (consensus TATAA)
The TATA element, which is located 25-30 
nucleotides upstream of the transcription start site in 
mammalian genes, is the most highly conserved cis-acting 
sequence in class II promoters. The effects of mutations in 
this element have been studied in vitro and in vivo. These 
analyses reveal that the TATA element is primarily involved 
in controlling the fidelity of initiation, although in some 
cases dramatic reductions in transcription were observed 
(Grosschedl and Birnstiel, 1980; Wasylyk et al., 1980; 
Benoist and Chambon, 1981; Grosveld et al., 1981; Mathis 
and Chambon, 1981; Grosveld et al., 1982). The TATA box
binds the transcription factor, TFIID (see Section ID.3.3). 
Upstream Promoter Elements (UPEs)
Many promoters contain one or more UPE within 
approximately 100 nucleotides of the TATA box. These 
elements are 10-12 bp in size and interact with cellular 
DNA-binding proteins (transcription factors). They function 
in either orientation, but exhibit reduced activity when 
moved further upstream of TATA. Significantly, alterations 
in spacing which displace an element (relative to TATA) by 
half a helical turn are more deleterious than those
involving a full helical turn. These observations are
consistent with the idea that factors bound to UPEs
influence events at the TATA box, probably by promoting
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formation of an initiation complex containing pol II and
other factors (see Section ID.5). Some UPEs bind
generalized transcription factors which contribute to the 
constitutive activity of a promoter. Other UPEs bind
factors which are regulated by specific stimuli such as 
heat shock, and exposure to heavy metals or steroids; in 
the absence of the appropriate stimuli, these UPEs are not 
occupied by their cognate transcription factors.
Enhancers
The activity of a number of promoters is modulated 
by a cis-linked enhancer. The characteristic features which 
define enhancers are their ability to function over large
distances (1000 bp or more from TATA), both upstream and
downstream of the TATA box. The activity of enhancers often 
displays cell-type specificity. Enhancers are larger and 
more complex than UPEs, comprising sometimes hundreds of 
bases and containing multiple sequence elements. These
elements, like UPEs, bind transcription factors. Indeed,
some elements (e.g. the GC box which binds Spl) function 
both as UPEs and as components of enhancers. Hence it is 
likely that enhancers and UPEs stimulate transcription by 
similar, if not identical mechanisms. The characteristic 
properties of enhancers probably reflect the number and 
arrangement of binding sites for cellular transcription 
factors.
Many of the transcription factors which bind to
UPEs and enhancer elements have been identified. Since
these factors are not directly relevant to the content of 
this thesis, it would be neither worthwhile, nor indeed 
possible, to review them here. Subsequent sections will 
instead focus specifically on events at the TATA box which 
have been the focus of much attention in recent years.
Notably, the TATA box has been shown to be the target for
trans-activation by a number of eukaryotic transcription 
factors, including GAM (Horikoshi et al., 1988a) and ATF 
(Hai et al., 1988 ; Horikoshi et al. , 1988b). Furthermore, 
the TATA box is thought to be a target for a number of
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viral IE trans-activators (Abmayr et al., 1985, 1988; Coen 
et al., 1986; Wu et al, 1987; Simon et al., 1988; Wu and
Berk, 1988).
ID.3. General Factor Requirements for Pol II Initiation
3.1. An Overview
Purified pol II is not competent for transcription 
initiation in vitro. Fractionation of mammalian cell 
extracts combined with reconstitution experiments has 
identified five factors, TFIIA, IIB, IID, H E  and IIF, all 
of which are required in addition to polll for accurate 
transcription of a DNA template in vitro (Matsui et al., 
1980; Samuels et al., 1982; Sawadogo and Roeder, 1985;
Reinberg and Roeder, 1987; Reinberg et al. , 1987). The 
variable requirement for TFIIA in some early experiments 
doubtless reflects contamination of other fractions with 
this factor. Kinetic experiments have established that the 
various factors are involved at different stages of the 
initiation process. In particular, TFIID and TFIIA were 
shown to generate the first stable complex in initiation. 
It was found that preincubation of template DNA with TFIID 
and TFIIA generated a preinitiation complex resistant to 
subsequent challenge with inhibitors of in vitro pol II 
transcription (poly(dl.dC) or sarkosyl; Fire et al., 1984; 
Reinberg et al., 1987). This preinitiation complex is said 
to be "committed" to transcription. Increasingly pure 
preparations of these factors have been obtained, and in 
some cases the genes encoding them cloned, thus permitting 
a more detailed biochemical analysis of their properties. 
This is described in Section ID.3.3.
3.2. Conservation of the Transcription Machinery Between
Yeast and Mammals
There is a high degree of conservation between
yeast and mammalian transcription systems. Thus yeast GAL4
trans-activates transcription in a Hela cell-derived in
vitro transcription system (Lin et al., 1988) and in
mammalian cells (Kakidani and Ptashne, 1988), and fos-LexA
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fusion proteins (in which the LexA DNA binding domain is 
fused to c-fos or v-fos) activate yeast promoters
containing LexA binding sites in vivo (Lech et al., 1988). 
The general transcription factors, TFIID and TFIIA, have 
since been shown to be fully interchangeable between the 
systems (Buratowski et al., 1988; Hahn et al., 1989a).
The purification of mammalian transcription factors 
for biochemical analysis has proved to be an arduous task. 
In this regard, the conservation between yeast and 
mammalian systems has proved to be particularly important. 
Significant advances in our understanding of mammalian 
transcription have stemmed from our ability to readily 
purify the corresponding yeast factors. For example, 
partial amino acid sequencing of yeast TFIID led to several 
groups simultaneously isolating the gene encoding this 
important factor (Cavallini et al., 1989; Hahn et al.,
1989b; Horikoshi et al., 1989; Schmidt et al., 1989). The 
availability of the yeast TFIID gene sequence then quickly 
led to the cloning of the human gene (Kao et al. , 1990; 
Peterson et al., 1990). The power of yeast genetics will 
doubtless lead to the cloning of other yeast genes 
encoding general transcription factors (and hence the 
corresponding mammalian genes) in the near future and, 
furthermore, permit analysis of their function in vivo.
3.3. Functions and Biochemical Properties of the General
Transcription Factors
TFIID
TFIID binds directly to the TATA element (Nakajima 
et al., 1988). This is the first step in formation of a 
preinitiation complex (Davison et al, 1983, Fire et
al., 1984) .
Genes encoding TFIID have now been isolated from 
Saccharomyces cerevisiae (Cavallini et al., 1989, Hahn et 
al., 1989b; Horikoshi et al., 1989; Schmidt et al., 1989), 
Schizosaccharomyces pombe (Hoffman et al., 1990), 
Drosophila melanogaster (Hoey et al., 1990), and humans 
(Kao et al., 1990; P eterson et al., 1990). The existence of
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a spectrum of TATA elements inferred that TFIID might 
comprise a family of proteins with different sequence 
specificity. That a number of groups have isolated the same 
yeast TFIID gene (and two groups the same human gene) 
argues against this. It seems likely, therefore, that a 
single TFIID protein interacts differently with distinct 
TATA sequences (Nakajima et al., 1988).
The yeast TFIID genes encode proteins of predicted 
Mr 27,000, whereas the predicted human and drosophila 
products are significantly larger at 38,000. Comparison of 
the various predicted amino acid sequences reveals a number 
of interesting features. The C-terminal 180 amino acids are
highly conserved in all three species; there is 90%
identity between the human and drosophila sequences, both
of which share 80% identity with the yeast sequence. This 
C-terminal domain contains a region with similarity to the 
bacterial sigma factor (see Section ID.3.4), which is 
required for accurate initiation by bacterial RNA 
polymerase (Horikoshi et al., 1989). In contrast, the
N-termini are considerably divergent and account for the 
size heterogeneity between the various proteins. It has 
been proposed that the N-termini may participate in species 
specific regulatory interactions. Results from mutational 
analyses of the yeast protein are consistent with this 
idea. Thus a truncated protein consisting solely of the 
conserved C-terminal sequences is sufficient for promoter 
recognition and basal level transcription (Horikoshi et 
al., 1990; Peterson et al., 1990), whereas activation of 
transcription by factors bound at UPEs appears to involve 
N-terminal sequences (Peterson et al., 1990) .
Interestingly, Van Dyke and Sawadogo (1990) reported that 
purified TFIID contains a protease-resistant core which 
binds TATA elements and supports basal level transcription. 
Hence it is likely that this core contains C-terminal
sequences.
Finally, analysis of yeast strains with mutations 
in the TFIID gene have demonstrated that TFIID function is 
essential for growth and, moreover, that alterations in
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TFIID can alter transcription initiation in vivo (Eisenmann 
et al., 1989) .
TFIIA
The availability of more highly purified 
preparations of general transcription factors has confirmed 
that TFIIA is essential for accurate initiation of 
transcription in vitro. Kinetic experiments indicate that 
TFIIA, like TFIID, acts at an early stage in transcription 
initiation (Fire et al., 1984). TFIIA does not itself bind 
DNA, but forms a complex with DNA-bound TFIID, resulting in 
an extension of the TFIID DNAse I footprint (Buratowski et 
al. , 1989; Hahn et al. , 1989a). This led Hahn et al. to
speculate that TFIIA functions by altering the conformation 
of TFIID (in such a way as to promote transcription 
initiation) and/or by serving as a bridge between TFIID and 
pol II or other general transcription factors.
TFIIB and TFIIE
Little is known of the function of these factors, 
except that they each bind pol II in solution, and that 
TFIIE appears to be associated with a DNA-dependent ATPase 
activity (Reinberg and Roeder, 1987; Zheng et al., 1987). 
TFIIF
Burton et al. (1986) reported that the 
transcription initiation activity of a HeLa cell extract 
could be abolished by passing it down a column containing 
immobilized pol II. A factor which was eluted from the 
column by 0.5M KC1 was sufficient to reconstitute activity. 
This factor, called RAP30/74 (RAP: RNA polymerase
Associated Protein), comprises two subunits of apparent Mr 
30,000 and 74,000 (Burton et a l 1988; Flores et al. ,
1989). Gel filtration analysis established that native 
RAP30/74 has an Mr of 220 kDa, and is thus probably a 
dimer of the RAP30/74 heterodimer (Flores et a l 1990). 
RAP30/74 is believed to be identical to TFIIF since the 
addition of purified RAP30 and RAP74 subunits to TFIIF 
depleted extracts restores transcription activity (Flores 
et al 1988, 1990). TFIIF functions at a stage following 
template commitment and possibly pol II binding (Flores et
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al. , 1989) .
The gene encoding the RAP30 subunit has been cloned 
(Sopta et al. , 1989). A portion of RAP30 exhibits homology 
to a part of the bacterial sigma factor which is conserved 
among all sigma factors, and is believed to function in 
binding to RNA polymerase. The RAP30/74 complex also has an 
associated DNA helicase activity, probably attributable to 
RAP74 (Sopta et al., 1989). Taken together, these results
suggest that RAP30 may be involved in the correct
positioning (relative to pol II) of the helicase activity 
(RAP74) in the initiation complex. Once appropriately
located, the helicase would melt the DNA at the start site
to facilitate initiation.
3.4. Two Factors Related to Bacterial Sigma?
The predicted amino acid sequences of TFIID and
RAP30 both contain regions which are homologous to the
bacterial sigma factor (Horikoshi et al., 1989; Sopta et
al., 1989). Sigma possesses a spectrum of activities
including RNA polymerase binding, promoter recognition, and 
DNA melting. Strikingly, the homology between TFIID and 
sigma seems to be restricted to a region of sigma 
implicated in binding to the TATA-like sequence in
bacterial promoters (Horikoshi et al., 1989). Moreover, the 
region of sigma which shares homology with the RAP30 
subunit of TFIIF is believed to be responsible for RNA 
polymerase binding (Sopta et al., 1989). It is conceivable, 
therefore, that the activities of sigma are distributed 
among a number of the eukaryotic factors. This would 
clearly increase the number of points at which 
transcription could be regulated in eukaryotes (relative to 
prokaryotes). It will be interesting to see whether the 
sequence of RAP74 (the gene for which has yet to be cloned) 
is homologous to the region of sigma proposed to melt DNA 
during initiation.
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ID ♦4 ♦ A Model For Initiation Complex Assembly
Buratowski et al. (1989) analysed complexes formed 
on the adenovirus major late promoter by general 
transcription factors and pol II. Using a native gel 
retardation DNA binding assay, they were able to determine 
the order with which the components were recruited onto the 
template. They identified a minimum of five intermediate 
complexes leading to a functional initiation complex. 
Furthermore, DNAse I footprint analysis was employed to 
ascertain the relative positions of each of the factors in 
the various complexes. It is apparent from this and other 
studies (Van Dyke et al., 1988) that a preinitiation
complex is formed following the orderly assembly of general 
transcription factors and pol II onto the DNA template, and 
that this involves protein:protein and protein:DNA 
interactions. These results are described below (see also 
Figure 4).
Complex 1: The initial step in preinitiation complex
formation was recognition and binding of the TATA element 
by TFIID. This event was a prerequisite for formation of 
all other complexes. Binding of TFIID alone protected 
residues -37 to -17 from DNAse I digestion, but did not 
produce a complex which was detectable in gel retardation 
assays, indicating that it may be an unstable interaction. 
Complex 2: The addition of TFIIA to complex 1 resulted in
formation of complex 2 with a concomitant increase in DNAse 
1 protection to between -42 and -17, indicating that TFIIA 
is located upstream of TFIID. It was proposed that TFIIA 
functions by increasing the affinity of TFIID for DNA, or 
perhaps by stabilizing TFIID:DNA interactions. However, 
more recent evidence suggests that this is not the case 
(Hahn et al., 1989a). Rather, the increased DNAse I 
footprint may be indicative of a conformational change 
induced in TFIID by TFIIA, possibly reflecting transition 
of TFIID from an "inactive" to an "active" state.
Alternatively, TFIIA may stabilize interactions between 
TFIID and other factors. In this case the increased 
footprint might represent a weak interaction between TFIIA
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and sequences upstream of TFIID, or may simply be due to 
steric effects. This complex probably corresponds to the 
committed1 complex defined in kinetic studies (Davison, 
B.L. et al., 1983; Fire et al., 1984; Reinberg et al., 
1987) .
Complex 3: The next factor to associate with the DNA
template, TFIIB, induced partial protection from DNAse I 
digestion at some sites between -10 and +10. Intriguingly, 
this appeared to be specific for the coding strand. Hence 
TFIIB may associate with the coding strand, and extend from 
the TFIID:TFIIA complex to beyond the initiation site. 
Recruitment of pol II to the preinitiation complex was 
dependent upon the presence of TFIIB, suggesting that TFIIB 
stabilizes interactions between pol II and TFIID (N.B. 
TFIIB binds to pol II in solution; Reinberg and Roeder,
1987) .
Complex 4: Following the addition of TFIIB, Pol II became
stably associated with the preinitiation complex. DNAse I 
protection in complex 4 was extensive; the upstream 
boundary was located at approximately -47, and the 
downstream boundary at around +20. This infers that part of 
pol II is in close proximity to transcription factors bound 
to UPEs. Recall that some factors appear to interact 
directly with a domain of pol II implicated in regulation 
of transcription (see Section 1D.1). Thus, when present in 
a preinitiation complex, pol II may be directly "activated" 
by interactions with transcription factors bound to UPEs. 
Complex 5: The model proposes that TFIIE now binds to
complete formation of the preinitiation complex. However, 
Flores et al. (1989) have since demonstrated that partially 
purified preparations of TFIIE (as used in this study) 
actually contain two factors, TFIIE and TFIIF, thus 
complicating the interpretation of the results. Formation
of complex 5 correlated with the appearance of a novel
DNAse I protected region between +20 and +30, suggesting 
that one or both factors bind downstream of pol II. It 
should be borne in mind that in vivo TFIIE and/or TFIIF may
associate with pol II in solution to form a heteromeric
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complex, which then associates with the developing
preinitiation complex.
TFIIF is associated with a helicase activity and 
presumably interacts with pol II (see Section ID.3.3). 
Earlier results suggested that TFIIE possesses a 
DNA-dependent ATPase activity (Reinberg and Roeder, 1987). 
Whether this was associated with contaminating TFIIF, or 
does in fact reflect a bona fide function of TFIIE is not 
clear. It is possible that the activities are due to 
separate factors which become associated in the final 
preinitiation complex. As noted above (Section ID.3.4), 
such a scheme would enable more subtle regulation than
would be possible with a single, multifunctional
polypeptide. Irrespective of the precise details, it is
clear that the helicase and ATPase activities are recruited 
into a committed complex, whereupon hydrolysis of ATP (or 
dATP) presumably results in unwinding of the DNA, making 
the template strand accessible to pol II.
Finally, it was found that addition of NTPs 
resulted in formation of novel complexes containing 
accurately initiated transcripts. These were of increased 
mobility relative to complex 5, and it was suggested that 
TFIIE (and TFIIF?) might dissociate from the active complex 
following initiation.
ID. 5. TFIID is a Target for Trazzs-Activation
There is now compelling evidence that GAL4, ATF and 
the PRV-IE polypeptide trans-activate transcription through 
interactions with TFIID.
Horikoshi et al. (1988a) reported that GAL4 binding 
to synthetic GAL4 binding sites in the adenovirus E4
promoter qualitatively altered the interaction of TFIID 
with the TATA box region. Similar alterations were detected 
following ATF binding to the E4 promoter (Horikoshi et al., 
1988b). Moreover, the ATF-induced alterations in TFIID:TATA 
interactions were shown to facilitate the subsequent
binding of pol II, TFIIB and TFIIE. In an accompanying
paper, Hai et al. (1988) reported the results of
Figure 4. A model for preinitiation complex assembly. RNA 
polymerase II (polll) and the general transcription 
factors TFIID (D) , TFIIA (A), TFIIB (B), TFIIE (E), and
TFIIF (F), are assembled into a preinitiation complex on 
the DNA template. Buratowski et al. (1989) identified a 
minimum of five intermediate complexes leading to a
functional preinitiation complex in vitro. The order with
which the components were recruited onto the template and 
their relative positions within each complex were 
determined; this information is summarized opposite and 
discussed in Section ID.4. The transcription start site 
(+1 ) is marked by the arrow, the numbering at the top of 
the figure refers to nucleotide positions relative to this. 
This figure is adapted from an original figure in 
Buratowski et al. (1989).
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experiments which investigated trans-activation by ATF 
during in vitro transcription assays. Their results, 
together with those of Horikoshi et al. (1988b), are
consistent with a model whereby ATF functions transiently 
during the template commitment stage of preinitiation
complex formation. It is proposed that ATF, through direct
interaction with TFIID, triggers multiple cooperative 
interactions between general transcription factors leading 
to formation of a functional preinitiation complex.
TFIID is apparently also the target for
trans-activation by the PRV-IE polypeptide. However, in 
contrast to GAL4 and ATF, PRV-IE quantitatively alters 
TFIID:promoter interactions. During in vitro transcription 
assays, maximal activation by PRV-IE is observed at low 
template concentrations, when the rate or extent of 
association of TFIID with template DNA is limiting for 
transcription. PRV-IE is thought to function by increasing 
the rate or extent of association of TFIID with promoter 
sequences, thereby stimulating preinitiation complex 
formation (Abmayr et al., 1988). Workman et al. (1988) 
investigated trans-activation by PRV-IE during in vitro 
nucleosome assembly. It was found that when placed in 
direct competition with nucleosome assembly, the rate or 
extent of TFIID binding was insufficient to overcome 
nucleosome-mediated repression of transcription. Under 
these conditions, PRV-IE apparently stimulated the rate or 
stability of TFIID binding, and transcription was activated 
rather than repressed.
ID.6. Activation by Spl: Evidence for Transcriptional
Adaptors?
Spl stimulates transcription from TATA-containing 
promoters in the presence of general transcription factors. 
Semi-purified TFIID fractions from human or drosophila 
cells are able to support Spl stimulation, whereas 
purified, cloned drosophila or yeast TFIID proteins are not 
(Hoey et al., 1990; Pugh et al., 1990). This suggests that 
interaction between trans-activators and the general
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transcription machinery is mediated via an adaptor protein, 
and that partially purified preparations of TFIID contain 
this moiety. Several other groups have reported indirect 
evidence which supports this hypothesis (Berger et al., 
1990; Kelleher III et al., 1990). Pugh et al. (1990) also 
present evidence of species specificity in
activator-adaptor-TFIID interactions. Thus the drosophila 
adaptor functions with the homologous drosophila TFIID
protein, but not with heterologous yeast TFIID. Likewise, 
the adaptor function from human cells does not interact
with drosophila TFIID. Furthermore, they suggest that 
different types of activation domain may each function 
through distinct adaptor proteins, that is, specific
adaptors exist for acidic activation domains and so on.
This would provide a mechanism whereby the various types of 
activation domain could interact with a single species of 
TFIID. Confirmation of the existence of transcriptional
adaptor proteins awaits their purification and
characterization.
ID.7. Gene Regulation by Viral IE Polypeptides
As discussed in Section lB.3.3.(c), a number of 
viral IE trans-activators activate transcription through
the TATA box. We have seen that formation of an initiation
complex at the TATA box involves the ordered assembly of 
general transcription factors on to the DNA template. In 
theory, any event in this process which is rate limiting 
for transcription is a potential target for 
trans-activators. At least one viral activator, the PRV-IE 
polypeptide, appears to stimulate association of TFIID with 
the TATA box. Given the extensive conservation between the 
IE polypeptides of alphaherpesviruses, it is likely that 
VZV 140k and HSV-1 Vmwl75 function by a similar mechanism. 
This probably accounts for activation of a majority of 
promoters.
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7.1. A Model For Trans-Activation and Repression by Vmwl75
The studies discussed in Section 1C indicate that 
trans-activation of most (though possibly not all)
promoters involves DNA binding by Vmwl75, as does
repression of the IE3 promoter. Since Vmwl75 binds to
consensus and non-consensus sites in viral DNA, the
potential role of each of these activities will be
considered in turn.
Although some viral promoters (such as that of the 
gD gene) contain consensus ATCGTC binding sites, the
majority do not. Thus let us first consider the potential 
role of non-consensus DNA binding in trans-activation. It 
is proposed that Vmwl75 binds to disparate sites in viral 
promoters and brings about trans-activation by directing 
TFIID to bind at the TATA box. This is the rate limiting
step in pre-initiation complex formation during in vitro 
transcription at low template concentrations (which is 
presumably analogous to the situation at the outset of 
viral infections in vivo) (Abmayr et al., 1988). The
requirement for Vmwl75 is probably transient, since once
TFIID is bound at the TATA box, binding of additional
factors stabilizes TFIID:TATA interactions.
Binding of Vmwl75 to the consensus sequence,
ATCGTC, is implicated in both repression and 
trans-activation of transcription. (Thus far, non-consensus 
binding has not been implicated in repression.) As
discussed in Section 1C.2.4., repression probably requires 
a particular spatial relationship between the binding site 
and TATA box (proximity of the binding site to the TATA box 
is probably the key factor). In promoters which satisfy 
these requirements (such as the IE gene 3 promoter),
binding of Vmwl75 reduces binding of TFIID to the TATA box 
and/or preinitiation complex formation, thereby repressing 
transcription. However, the relationship between the 
binding site and TATA box in the majority of promoters 
(such as gD) probably does not meet these requirements, and 
binding of Vmwl75 thus causes trans-activation, presumably 
as described above for non-consensus binding.
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Indirect mechanisms might also operate. Thus an 
activator could function by increasing the level of a 
limiting transcription factor in the infected cell. Indeed, 
this may be important in the SV40 replication cycle. During 
infection of tissue culture cells by SV40, there is a 
10-fold increase in Spl mRNA levels (attributable to an
early viral function), which is accompanied by a
corresponding increase in levels of Spl protein (Saffer et 
al,, 1990). Expression of a number of viral and cellular 
genes is stimulated following this increase in Spl levels. 
The adenovirus Ela protein, in addition to interacting with 
TFIID, probably functions through alternative mechanisms. 
For example, the transcription factor E2F is complexed 
with various cellular factors in uninfected cells. During 
adenovirus infection, Ela apparently dissociates these
complexes liberating free E2F, which then forms a complex
with the adenovirus E4 protein. This new complex has a 
novel promoter specificity, which includes binding to, and 
subsequent activation of the E2F promoter (Bagchi et al 
1990) .
IE. Aims of the Work Presented in This Thesis
There is an accumulating body of evidence which 
suggests that VZV 140k is the functional equivalent of the 
HSV-1 immediate early polypeptide, Vmwl75, and it was thus 
of interest to investigate its properties and functions in 
more detail. A number of approaches were taken. Firstly, a 
recombinant virus, HSV-140, was constructed in which 
VZV 140k coding sequences replace those of Vmwl75 in the 
short region repeats of the HSV-1 genome. The properties of 
this virus were compared to HSV-1 in order to assess the 
degree to which VZV 140k is able to complement for loss of 
Vmwl75 function in HSV-1. Secondly, the trans-activation 
and tr<3/7S-repression properties of wild-type and mutant 
forms of the VZV 140k polypeptide were studied in 
transient transfection assays. Finally, the DNA binding 
properties of VZV 140k were investigated. These studies 
have demonstrated that while VZV 140k and Vmwl75 share many
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properties, they are not indistinguishable. The results of 
these studies are presented.
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2. MATERIALS AND METHODS 
2A. MATERIALS
1. Cells
(i) BHK-21 clone 13 (Macpherson and Stoker, 1962), a 
fibroblastic cell line derived from baby hamster kidney 
cells, was generally used for growth of virus stocks and 
viral gene expression experiments. They were also used for 
transient transfection assays which investigated 
trans-repression, and in nuclear extract experiments.
(ii) W.S.HeLa cells (obtained from Dr. W. Schaffner,
Zurich) were mainly used for transient transfection assays 
which investigated trans-activation.
(iii) Flow HeLa cells (from the ATCC via Flow 
Laboratories) were used for nuclear extract experiments. 
These cells differed significantly in morphology, growth 
conditions and behaviour compared to W.S.HeLa cells.
(iv) Vero cells (also obtained from the ATCC via Flow
Laboratories) were used for transient transfection assays.
(v) HFL cells (Flow Laboratories) were obtained from
Dr. T.A. McKee and used for growth of VZV (and propagation 
of virus as infected cells). They were also used for 
nuclear extract experiments and HSV-140 viral gene 
expression experiments.
(vi) Monkey CV1 cells (obtained from Dr. A. Davison) 
were also used for growth and propagation of VZV and in 
nuclear extract experiments.
2. Tissue Culture Media
(i) BHK cells were grown in Glasgow Modified Eagle's 
Medium (GMEM) supplemented with 100 units/ml penicillin, 
lOOpg/ml streptomycin, 0.2yg/ml amphotericin, 0.02% phenol 
red and 10% newborn calf serum. (=EC10)
(ii) W.S.HeLa cells were grown in Dulbecco's Modified 
Eagle's Medium (DMEM) (supplied by Gibco) supplemented with 
100 units/ml penicillin, lOOpg/ml streptomycin, 0.2pg/ml 
amphotericin, 2.5% foetal calf serum and 2.5% newborn calf
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serum.
(iii) Flow HeLa cells were grown in supplemented GMEM as
for BHK cells but with 10% foetal calf serum replacing the
newborn calf serum. (=EF10)
(iv) Vero cells were grown in EF10.
(v) HFL cells were also grown in EF10.
(vi) CV1 cells were grown in DMEM supplemented as for
W.S.HeLas but with 5% foetal calf serum and no newborn calf 
serum
(vi) HSV-1 viral titrations were overlaid with GMEM
supplemented as above and with 5% human serum (EH5).
3. Viruses
The VZV strain used by Dumas et al. (1981) was used 
in all experiments. Stocks of VZV-infected HFL and CV1
cells were obtained from Dr. T.A. McKee and Dr. A. Davison
respectively.
All other viruses used in this study were
derivatives of the HSV-1 Glasgow strain 17 syn* (Brown et 
al., 1973). Derivative D30EBA (Paterson and Everett, 1990) 
contains a large deletion within IE gene 3 which removes 
codons 83 to 1236.
4. Bacteria
Plasmids based on M13 vectors were propagated in 
the Escherichia coli strain JM101 (supE delta (lac-proAB) ; 
F', traD36 proAB* lacl3 JacZdeltaM15; Messing, 1979). All 
other plasmids used in this study were propagated in 
Escherichia coli. K12 strain HB101 (F- , ramCl, proA2,
galK2, strA, recA; Boyer and Roulland-Dussoix, 1969).
5. Bacterial Culture Media
JM101 strains were grown on 2YT-broth (5g/l NaCl,
16g/l Difco Bactopeptone, 10g/l yeast extract). HB101
strains were grown on L-broth (177mM Nacl, 10g/l Difco 
Bactopeptone, 5g/l yeast extract). Agar plates contained
1.5% (w/v) agar in L-broth and where appropriate the medium
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was supplemented with lOOpg/ml ampicillin.
6. Plasmids
The following plasmids were kindly provided by the 
acknowledged authors.
pl40 (McKee et al., 1990) was provided by Dr. R.D. Everett. 
VZV gene 62 is cloned on a fragment from the Clal site at 
-1146 to the genome terminal site of pVZVSstf (Everett, 
1984) between the AccI and Pstl sites of a pUC9 plasmid 
from which the EcoRI had been removed by cutting and 
filling in.
pl75 (Everett, 1987). The HSV-1 IE-3 gene is cloned on a 
BamEl-Sstl fragment (HSV-1 coordinates 125.1-133.0) under 
the control of the SV40 early promoter and enhancer (SV40 
coordinates 5171-346).
pI13 and pI38 (Paterson and Everett, 1988a). Derivatives of 
pl75 created by insertion of a 12bp EcoRl linker into Smal 
and Nae I sites respectively within the Vmwl75 coding 
sequences.
pill (Everett, 1987). The HSV-1 IE-1 gene is cloned on a
Hpal-Sstl fragment (HSV-1 coordinates 120.4-125.1).
PIE3CAT (Stow et al., 1986). The promoter of the HSV-1 IE-3 
gene is cloned on a Hindlll-BamBl fragment (-331 to +26) 
fused to the CAT reporter gene in a vector derived from 
pBLW2 (Gaffney et al., 1985).
pgDCAT (Everett, 1986). The promoter of the gene encoding
glycoprotein D (gD) (US6) is cloned on a Sstl-Hindlll
fragment (-392 to +11) fused to the CAT gene in a vector
derived from pBLW2 (Gaffney et al., 1985).
pSVEB (Everett, unpublished). The SV40 promoter and
enhancer (coordinates 5171-346) cloned into pBR322. 
pGX161 (Preston and Fisher, 1984) was provided by Dr. C.M. 
Preston. The HSV-1 IE gene 3 promoter is cloned on a
Hindlll-Bamhl fragment (-331 to +26) into a derivative of
pATl53.
pTM14CAT (Dr. T .A . McKee, Ph.D thesis, University of
Glasgow, 1990; see Section 3D.1). Sequences upstream of VZV 
gene 62 from DdeI (-781) to Seal (-22) are fused to the CAT
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gene in a derivative of pFJ3 (Rixon and McLauclan, 1990) in 
which the CAT reporter gene coding sequences replace those 
of the 3~gal gene.
pTM15CAT (Dr. T.A. McKee, Ph.D thesis, University of 
Glasgow, 1990; see Section 3D.1). A double stranded 
oligonucleotide encoding VZV gene 62 sequences from the 
Afllll site (-33) to +20 was inserted between the Afllll 
(-33) and BamUI sites of pTM14CAT (see above) to create 
PTM15CAT (the BamUI site of pTM14 CAT is within polylinker 
sequences located between the VZV insert and the CAT gene). 
pMCl (Campbell et al, 1984) was provided by Dr T.A. McKee. 
Plasmid pMCl contains the HSV-1 UL48 gene encoding Vmw65.
7. Reagents
Oligonucleotides were synthesised in this Institute 
by Dr. John McLauchlan using a Biosearch 8600 DNA 
synthesizer.
In general analytical grade chemicals were 
purchased from BDH Chemicals UK Ltd. or Sigma Chemical Co. 
Ltd.; TEMED (N,N ,N 1,N 'tetramethylethylenediamine) and 
ammonium persulphate were obtained from BIO-RAD
Laboratories; caesium chloride, acrylamide, sodium 
hydroxide and boric acid were obtained from Koch-Light 
Laboratories; nitrocellulose paper from Schleicher and 
Schuell Inc.; 0.25mm silica gel thin-layer chromatography 
(TLC) plates were obtained from Camlab; En3hance 
autoradiography enhancer was supplied by Du Pont UK Ltd.; 
Ampicillin (penbritin) was obtained from Beecham Research 
Labs. Ltd.; tris-[tris(hydroxymethyl-aminomethane)] was 
supplied by Boehringer Mannheim; double-stranded 
polydl:polydC was purchased from Pharmacia; Formamide from 
Fluka; Actinomycin D was from Merck Sharp and Dohme and 
cycloheximide was from Sigma; 2’-deoxyribonucleoside 
5'-triphosphates, unlabelled dNTPs and ultrapure dNTP set, 
ribonucleoside 5'triphosphates, universal sequencing 
primer, and 7-deaza-dGTP were purchased from Pharmacia LKB 
Ltd.
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8. Radiochemicals
Radiolabelled compounds were supplied by Amersham 
International pic at the following specific activities: 
5'[a-32P] dNTPs, 3000 Ci/mmol (lOpCi/yl)
5'[gamma-32P] ATP, 5000Ci/mmol (10 pCi/pl)
L-3ss-Methionine, around 800mCi/mmol
14C Chloramphenicol, 45 mCi/mmol (from NEN DuPont)
9. Enzymes
Restriction enzymes were purchased from Bethesda 
Research Labs, or New England Biolabs., except for Afllll, 
which was obtained from Northumbria Biologicals Ltd. 
Proteinase K, Klenow fragment DNA polymerase (LFP), DNA 
polymerase holoenzyme, T4 polynucleotide kinase, and T4 DNA 
ligase were from Boehringer Mannheim. Bacterial alkaline 
phosphatase (BAP) was obtained from Worthington and 
purified by M. Dunlop. RNAse and lysozyme were supplied by 
Sigma.
10. Solutions
Bradford's Reagent: 0.01% Coomassie brilliant blue G, 
0.003% SDS, 4.75% (v/v) ethanol, 8.5% 
(v/v) phosphoric acid 
CLB (cell lysis buffer): 0.5% SDS, 20mM Tris-HCL
(pH 7.5), 2mM EDTA 
DC buffer: 5% glycerol, ImM p-mercaptoethanol,
(50mM-2M NaCl) in lx TE 
50x Denhardt's: 1% polyvinylpyrrolidone, 1% BSA,
1% Ficoll
20x dNTPs: ImM dATP, dCTP, dGTP and dTTP
5x gel loading buffer: lxTBE, 1% SDS, 50% glycerol
plus bromophenol blue 
Gel soak I: 200mM NaOH, 600mM NaCl
Gel soak II: 1M Tris.HCl (pH 7.5), 600mM NaCl
Gel Elution Buffer: 0.5M Ammonium Acetate, 20mM 
Tris.HCl (pH 7.5), 2mM EDTA 
Giemsa stain: 1.5% suspension of Giemsa in glycerol,
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heated at 56°C for 2h and diluted with 
an equal volume of methanol 
2x HBS: 280mM NaCI, 50mM HEPES, 1.5mM Na2HPCU
pH to 7.12
Hybridization mix: 6x SSC, 5x Denhardt's, 0.1% SDS 
HZ stop: 0.3M NaAcetate (pH 5.5), 0.ImM EDTA,
25pg/ml tRNA 
5x Kinase buffer: 350mM Tris.HCL (pH 7.5), 50mM 
MgCl2> 25mM DTT 
5x Ligase buffer: lOOmM Tris.HCl (pH 7.5), 50mM 
MgCl2 , 50mM DTT, 3mM ATP 
NE buffer A: lOmM HEPES (pH 7.9), 1.5mM MgCl2 ,
lOmM KC1, 0.5mM DTT, 0.5% NonidetP40 
NE buffer C (0.45): 20mM HEPES (pH 7.9), 25%
glycerol, 0.45M NaCl, 1.5mM MgCl2 ,
0.5mM PMSF, 0.5mM DTT 
NE buffer C (0.15): As C (0.45) but containing 0.15M 
NaCl
NT Stop: TE plus 0.1% SDS
PBS-A: 170mM NaCl, 3.4mM KC1, Na2HP04 ,
2mM KH2 P04 (pH 7.2)
PBSc: PBS-A plus CaCl2 .H20 and MgCl2 .6H20 at
lg/1
PEG/NaCl: 20% polyethylene glycol in 2.5M NaCl
BRL REact™ Buffers (lx concentration):
REact 1: 50mM Tris.HCl (pH 8), lOmM MgCl2
REact 2: 50mM Tris.HCl (pH 8), lOmM MgCl2 , 50mM
NaCl
REact 3: 50mM Tris.HCl (pH 8), lOmM MgCl2 ,
lOOmM NaCl
REact 4: 20mM Tris.HCl (pH 8), 5mM MgCl2 ,
50mM KC1
REact 10: lOOmM Tris.HCl (pH 8), lOmM MgCl2 ,
150mM NaCl
RGB (SDS-PAGE resolving gel buffer): 181.5g Tris, 4g 
SDS, 11 H2O pH to 8.9 at RT with 
(HCL)
SDS boiling mix: 1ml SGB, 0.8ml 25% SDS, 0.5ml
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2-mercaptoethanol, bromophenol blue 
SDS tank buffer: 6.32g Tris, 4g glycine, lg SDS,
11 H20
SGB (SDS-PAGE stacking gel buffer): 59g Tris, 4g SDS, 
11 H2O pH to 6.7 at RT 
20x SSC: 174g/l NaCI, 88.2g/l TriSodium Citrate
STET: 8% Sucrose, 5% Triton X-100, 50mM EDTA
(pH 8), 60mM Tris.HCl (pH 8)
5x SUPER buffer: 50mM Tris.HCl, 5mM EDTA, 1.5M NaCI, 
0.5% NP40 pH to 7.5 
TBE: 125mM Tris, 40mM boric acid, 2.7mM
EDTA, not pH'd 
TBS: 25mM Tris.HCl (pH 7.5), 137mM NaCI,
5mM KC1, 0.7mM CaCl2 , 0. 5mM MgCl2 ,
0. 6mM Na2HP04 , pH to 7.4 with HC1 
TE: lOmM Tris.HCl, ImM EDTA (pH 8)
TE/5: 2mM Tris, 0.02 mM EDTA (pH 8)
TEN: 150mM NaCI, 40mM Tris.HCL, ImM EDTA
pH 7.5
TEP: ImM Tris.HCl, 0.ImM EDTA pH 7.5
T4 Pol buffer: 33mM Tris Acetate (pH 7.9), 66mM Na
Acetate, lOmM MgAcetate, lOOmg/ml BSA
0.5mM DTT
Trypsin: 0.25% (w/v) trypsin dissolved in
Tris-saline
Versene: 0.6mM EDTA in PBS-A plus 0.002% (w/v)
phenol red
2B♦ METHODS
1. Tissue Culture
Baby hamster kidney BHK-21 (C13) cells were routinely 
grown in EC10 medium at 37°C, in 175cm2 (Nunclon) flasks, 
in an atmosphere of 95% air, 5% CO2 . Confluent monolayers 
were harvested in 10ml EC10 after two Versene washes and 
brief trypsinization with trypsin:versene (1:4). Cells were 
resuspended by pipetting and remained viable for at least
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five days stored at 4°C. This suspension was used to seed 
further monolayers.
HeLa, Vero, HFL and CV1 cells were routinely passaged 
in 175cm2 (Nunclon) flasks in appropriate medium and 
harvested as described above. Cells did not remain viable 
at 4°C and for long term storage harvested cells were 
pelleted and resuspended in medium plus 5% glycerol and 15% 
foetal calf serum, aliquoted and frozen slowly to -140°C. 
Cells were recovered by rapid thawing and resuspension in 
growth medium.
2. Preparation of Stocks of Infectious Virus
2.1. HSV-1 and HSV-140
An 80% confluent monolayer of BHK cells in an 850cm2 
roller bottle was seeded with HSV-1 at a moi of
0.003pfu/cell or HSV-140 at a moi of 5 particles/cell 
(ppc), and incubated for 2-4 days until the cells exhibited 
obvious cytopathic effect (cpe). The cells were shaken into 
the medium and pelleted at 2K rpm/ 5 min/ 4°C. Cell
associated virus (CAV) was prepared by sonicating the
pellet in 1.5ml EC10. Cell released virus (CRV) was
pelleted from the supernatant at 12K rpm/ 2 hours/ 4°C and 
gently resuspended in 2ml supernatant and sonicated.
Sterility checks were performed by streaking virus 
preparations on blood agar plates and incubating at 31°C
for 5 days. CAV and CRV virus stocks were stored at -70°C.
2.2. VZV
Stocks of VZV-infected HFL cells were produced by
infecting subconfluent HFL monolayers (in a 175cm2 flask) 
with VZV-infected HFL cells. These were incubated until a
cpe of 60-80% had developed (normally 4-5 days). Infected
cells were harvested using trypsin and versene as described 
above (Section 2B.1). Infection was continued in another 
flask of subconfluent cells (as required) by addition of 
1/6 of the product of a 175cm2 flask. The remaining cells 
were pelleted and stored at -140°C as described above 
(Section 2B.1). Stocks of VZV-infected CV1 cells were 
produced in an identical manner.
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3. Titration of HSV-1 Virus Stocks
BHK cells were seeded at 106 cells per 35mm plate in 
2.5ml medium. The following day cells were infected with 
serial 10-fold virus dilutions in 0.3ml medium; after lh 
absorption time (gently mixing every 10 minutes) plates 
were overlaid with 2ml EH5, to prevent secondary plaque 
formation, and incubated for 2-3 days prior to fixing with 
cidex and staining with Giemsa stain. The plates were 
washed after 15 minutes and plaques counted using a 
dissection microscope.
4. Preparation of Total Infected Cell DNA
10mm linbro wells were seeded with around 4xl05 BHK
cells and infected with HSV-1 or HSV-140 the following day.
For preparation of total cellular DNA during construction 
and purification of HSV-140 (for analysis by Southern 
blotting), infections utilized serial dilutions of small 
scale virus preparations as described in the text. In the 
case of viral DNA replication experiments, cells were 
infected with lOpfu/cell HSV-1 or lOOppc HSV-140. When cpe 
became apparent, the supernatant was removed and stored as 
a CRV stock. 0.2ml of cell lysis buffer (CLB) containing
0.25mg/ml proteinase K was added to the cell layer and
incubated at 37°C for 3-5 hours. The glutinous extract was 
transferred to a 1.5ml Eppendorf tube and 15pl of 5M NaCl 
added. Serial 30 minute phenol then chloroform extractions 
were performed, with gentle inversion. DNA was precipitated 
with 2.5 volumes of ethanol, washed with 70% ethanol, 
dessicated briefly, and resuspended in 50ul of TE overnight 
at 4° C .
5. Analysis of Virus Induced Polypeptides
5.1. Immediate-early polypeptides
IE extracts were made from BHK cells infected at 
38.5°C. The best results were obtained when monolayers of 
cells at 50-70% confluence were infected. Thus 10mm linbro 
wells were seeded at 3-4xl05 cells and incubated at 37°C. 
The following day cells were pretreated with 100pg/ml
78
cycloheximide in growth medium (EC10/CHX) for 15-30min 
prior to infection with 20pfu/cell HSV-1 or lOOppc HSV-140, 
also in EC10/CHX (in a total volume of lOOpl). After a lh 
absorption (with frequent mixing) cells were washed and 
overlaid with 0.5ml EC10/CHX. At 5h p.a. cells were washed 
4x with prewarmed PBSc, with the final wash containing
2. 5ug/]il Actinomycin D. 200yl of PBSc containing 2.5 ug/ml 
Actinomycin D and 50pCi [33S]methionine was added to each 
well and cells incubated at 38.5°C. Finally, after a lh 
labelling period, cells were washed 3x with PBSc and lOOpl 
of SDS boiling mix added. Samples were transferred to 
Eppendorf tubes and stored at -20°C.
5.2. Pulse Labelling of Polypeptides
10mm linbro wells were seeded with around 5xl03 BHK 
or HFL cells and infected the following day with HSV-1 or 
HSV-140 at the required multiplicity. Following a lh
absorption period (mixing every 10 minutes) medium was
replaced and the infection allowed to proceed at 37°C. At
the appropriate time p.a. (as specified in the text), 
medium was removed and cells washed with prewarmed PBSc, 
and 200jj1 of PBSc containing 50pCi [3 3 S]methionine added to 
each well and cells incubated for a further 2h at 37°C. 
Finally, cells were washed and harvested as described
above.
5.3. SDS Polyacrylamide Gel Electrophoresis
Based on the procedure of Marsden et. al., (1978).
[33S]methionine labelled polypeptides were resolved on 0.75 
mm thick 7.5% single concentration polyacrylamide gels 
using a Bio-Rad Mini Protean™ II electrophoresis kit, 
following the manufacturers instructions. Gel plates were 
carefully washed with Decon then ethanol, and allowed to
dry. The resolving and stacking gels were made up as
follows:
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For two gels:
Resolving gel Stacking gel 
30% (a+b) stock 2.5ml 0.4ml
(2.5% bis acrylamide)
RGB 2.5ml
SGB 0.6ml
distilled water 5ml 1.4ml
10% APS 80]il 20pl
TEMED 8]il 3pl
The resolving gel was overlaid with butan-2-ol and allowed 
to set. After washing, the resolving gel was overlaid with 
the stacking gel, and wells created with a teflon comb.
Protein samples were boiled for 2min prior to 
loading around 2x10s cell equivalents per cm of gel. Gels 
were run at a constant voltage of 200V in freshly prepared 
SDS tank buffer until the dye front was approximately 0.5cm 
from the bottom of the gel. Gels were fixed for 10 minutes 
in ethanol/ acetic acid/ H20 (1:4:35) before drying down
under vacuum at 80°C onto a sheet of Whatman 3MM paper and 
exposing to Kodak X-Omat S XS-1 film for 18-72h.
6. Transfection of Cells With DNA
6.1. Transfection of HeLa, Vero and BHK Cells for CAT 
Assays
Cells were seeded at a density of 106 cells per 
50mm petri dish and the following day the rapidly dividing, 
subconfluent monolayers were transfected by the calcium 
phosphate precipitation method (Corsalo and Pearson, 1981). 
The amounts of CAT reporter plasmids and test plasmids used 
in experiments are given in the relevant Sections of the 
Results. The amount of DNA in each of the transfection 
mixes within an experiment was equalized by the addition of 
pUC9 where appropriate. TEP buffer was added to the plasmid 
DNA to a final volume of 140ul, then 20pl of 2M CaCl2 added 
to the solution whilst vortexing. This was then added 
dropwise to 160ul of 2xHBS (vortexing), and the resulting 
mixture left to stand at RT for 30 minutes. The
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precipitate thus formed was added dropwise to the media in 
the culture dishes, mixed thoroughly to ensure an even 
distribution, and the cells incubated at 38.5°C. The cells 
were washed 2x with TBS after 24h and fresh medium 
replaced, and after a further 24h at 37°C extracts were 
prepared by washing the cells in PBS-A then scraping into 
3ml TEN. The cells were pelleted at 2K rpm/ 4°C/ lmin, then 
resuspended in 0.25M Tris pH 7.8 and sonicated. The 
sonicates were cleared by a 2min microfuge spin and stored 
at -20° C .
6.2. Transfection of F.HeLa Cells for Protein Extracts
Transfections were carried out as described above 
(6.1) but the volumes increased 3-fold for 90mm plates and 
7-fold for 135mm plates. 30 or 60yg of plasmid pl40 were 
used, with 15 or 30pg pUC9 as carrier.
6.3. Transfection of Cells with Viral DNA for Marker Rescue
BHK cells seeded at a density of 2xl06 cells per
50mm dish were transfected by the method of Stow and 
Wilkie, (1976). A mixture of approximately lug of
linearized pGD140, 3pg of intact D30EBA viral DNA (kindly 
provided by Dr. T. Paterson) and 5yg of calf thymus carrier 
DNA were precipitated as described above (6.1). After 30 
minutes medium was removed from the cells and the
precipitate added, the cells were then incubated at 38.5°C 
for 4h, being overlaid with 2ml medium after 40 min. The 
cells were then washed once with growth medium and overlaid 
with 25% DMSO in HBS for 4min. The cells were then washed a 
final time and overlaid with growth medium. After 2-4 days 
at 37°C the monolayers developed extensive cpe, and the 
cells were scraped into the medium and sonicated to release 
infectious virus for further analysis.
7. CAT Assays
Cell sonicates prepared as described above (6.1) 
were analysed for chloramphenicol acetyl transferase (CAT) 
activity essentially as described by Gorman et al. (1982).
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Assay mixtures contained lyl 50mM acetyl-CoA, 0.5ul of 
stock t14C]chloramphenicol and 14yl distilled H20 together 
with 25ul neat or diluted sonicate. After incubation for 30 
minutes at 37°C the products were extracted with 200pl 
ethyl acetate, dried down and resuspended in 20yl ethyl 
acetate to spot onto thin layer chromatography (TLC) 
plates. TLCs were run in 95% chloroform/ 5% methanol (A/R), 
air dried and autoradiographed at room temperature. The 
percentage conversion was determined by cutting out
non-acetylated substrate and 3'-monoacetylated product from 
the TLC plate and quantitating radioactivity in the 
resulting strips of TLC plate by scintillation counting in 
2ml Ecoscint. The protein concentration of the extract was 
determined by the method of Bradford (1976; see Section 8 
below) and the percentage conversion from substrate to
product per ug protein calculated.
8. Determination of Protein Concentrations in Cell Extracts
The protein concentration of CAT extracts, whole 
cell extracts and nuclear protein extracts was determined 
by the method of Bradford et al. (1976). 5-10pl of extract 
was made up to lOOul in 0.25M Tris.HCl pH 7.8 and 1ml of
Bradford's reagent added and mixed. After a 15min
incubation the OD at 595nm was measured in disposable
plastic cuvettes by spectrophotometry. The protein 
concentration of extracts were determined by constructing a 
standard curve using standard concentrations of BSA 
(5-80yg) assayed as above, and OD plotted against
concentration mg/ml.
9. Preparation of Whole Cell and Nuclear Extracts for DNA 
Binding Studies and Purification
9.1. Standard Protocol
Nuclear extracts were prepared from infected or 
transfected cells by a procedure modified from that of 
Dignam et al. (1983). Cells scraped from 90mm or 135mm
culture dishes were washed in PBSc, pelleted and
resuspended in 2 volumes NE buffer A without NP40. NP40 was
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added to a final concentration of 0.5% and the cells lysed 
on ice for 10 minutes. Nuclei were then pelleted by 
successive 2K/10min and 12K/20min spins in the Sorval/SS34. 
Nuclei were resuspended in 1.5 volumes NE buffer C (0.45) 
and nuclear proteins eluted by incubating for 30 minutes 
on ice before clearing with a 30 minute 15K rpm spin 
(Sorval/SS34). The supernatants were flash frozen and 
stored at -140°C.
Whole cell extracts containing both nuclear and 
cytoplasmic proteins were prepared by lysing cells directly 
in NE buffer C containing 0.5% NP40 then proceeding as 
above.
9.2. Modified Protocol
Cells were lysed in NE buffer A and nuclei isolated 
as above. Nuclei were resuspended in 1.5 volumes NE buffer 
C (0.15) (rather than buffer C (0.45)) and incubated on ice 
for 15 minutes prior to pelleting nuclei with a 15K/15min 
spin. This procedure was repeated twice more and nuclei 
then resuspended in NE buffer C (0.45) and a high salt 
extract isolated and stored as above.
10. Gel Retardation Assay
Probes for gel retardation assays were prepared by 
end labelling appropriate DNA fragments (see Section 3E) by 
filling in (see Section 18.2) and purification on 5-8% 
polyacrylamide gels and a Sephadex G-50 "nick" column 
(Pharmacia)(Section 2B.15). Standard binding reactions were 
performed at 0°C or 20°C for 20 minutes in a 20-30pl mix 
containing l-5pg poly(dl):poly (dC) , approximately O.lng 
probe (2000cpm) and l-4yl nuclear extract (2-16pg protein). 
Samples were resolved on 4% native polyacrylamide gels 
(3.3% cross linker) run in 0.5x TBE, and dried down before 
autoradiography. The specific details of alterations to 
this protocol are given in the text.
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11. Large Scale Plasmid Preparation
Isolated single bacterial colonies on plates
selective for a plasmid-borne resistance marker (generally 
ampr) were inoculated into 5ml L-broth and grown overnight. 
These cultures were added to 300ml L-broth in a 21 flask 
and grown shaking at 37°C until the cells reached an ODebo 
of approximately 0.8. Then chloramphenicol was added to a 
final concentration of lOOpg/ml and the cultures left 
shaking overnight to amplify the plasmids.
Plasmid DNA was prepared by the "maxi-boiling"
technique of Holmes and Quigley (1981). Cells were pelleted 
at 5K rpm/ 6min (Sorvall GS3 rotor) and resuspended in 17ml 
STET per 300ml culture. 2ml of lOmg/ml lysozyme in STET was 
added for 1 minute prior to bringing the suspension to the
boil for 40 seconds. The lysate was cleared with a 45min/
18K rpm/ 4°C spin (Sorvall SS34 rotor) and DNA precipitated 
from the supernatant by addition of 0.9vol isopropanol. The 
DNA was pelleted at 3K rpm/ 4min/ RT (MSE Coolspin) and the 
pellets drained well before resuspending in TE and adding 
CsCl to give a final density of 1.6g/ml and EtBr to
0.5mg/ml. The solution was incubated on ice for 15 minutes
and then cleared with a 3K rpm/ lOmin/ 4°C spin (MSE 
Coolspin). The DNA was banded by spinning at 40K rpm/ 15°C/ 
16 hours in the vertical TV865 rotor. The DNA was
visualized by daylight or long-wave UV illumination and the 
lower, supercoiled plasmid DNA band collected with a large 
bore needle and syringe (after removal of the upper,
. chromosomal DNA band if necessary). EtBr was
extracted from the DNA with 2x 2.5 volumes of Butan-l-ol 
(TE saturated), the DNA dialysed against TE at RT for 2h, 
treated with lOpg/ml RNAse (lh/65°C), then proteinase K 
(lug/ml) plus 0.1% SDS (lh/37°C), before extraction with 
phenol/chloroform then chloroform and precipitation with 
ethanol. The pellet was resuspended in 400ul 0.3M NaAcetate 
and DNA again ethanol precipitated, washed with 70% 
ethanol, lyophilized and resuspended in 300pl TE overnight. 
The concentration of the DNA was determined by 
spectrophotometry (OD260 1.0=50yg DNA/ml).
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12. Miniprep Plasmid DNA Preparation
Single plasmid-transformed bacterial colonies were 
grown overnight in 3ml L-broth at 37°C with shaking. 1.5ml 
stationary phase culture was aliquoted into a 1.5ml
Eppendorf tube and cells pelleted at 12K rpm/ 15sec 
(benchtop minicentrifuge). Cells were resuspended in 200ul 
STET, 5pl of lysozyme (lOmg/ml) added, and the suspension
immediately placed in a 100°C water bath for 45 seconds, 
then centrifuged at 12K rpm/ lOmin. The glutinous pellet 
was removed and DNA precipitated from the supernatant by 
addition of 0.9vol isopropanol and a 12K rpm/ 5min spin. 
The pellet was washed with 70% ethanol, dried and
resuspended in 20jj1 TE. Miniprep DNA was stored at -20 or 
4°C and 2-5pl used for restriction enzyme analysis (0.2pl 
lmg/ml RNAse was added to digestions of miniprep DNA).
13. Restriction Enzyme Digests
Restriction enzyme (RE) digests were generally 
carried out in the recommended BRL REact™ buffer, using 
0.5pg DNA and 1 unit of enzyme for lh at the appropriate
temperature. Preparative rather than diagnostic RE 
digestions used increased amounts of DNA and RE under 
similar conditions, in 20-50ul volumes.
14. Separation and Preparation of Purified DNA Restriction 
Fragments
14.1. Non-denaturing agarose gels
Slab gels of 0.5-2.0% agarose in lxTBE (or lx 
L-buffer for southern transfers) were run submerged at up 
to 12v/cm. Gels were run for l-3h until the dye was around 
0.5cm from the end, and then stained for lOmin in lug/ml 
EtBr and examined and photographed with short-wave UV 
illumination (long-wave UV was used to reduce DNA damage 
when preparative gels were being analysed).
Following resolution, DNA fragments were isolated 
as- follows. A strip of DE-81 paper (presoaked in 2.5M NaCl 
overnight, then stored in ImM EDTA at 4°C) was inserted in 
front of the band of interest, the gel reassembled and the
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fragment electrophoresed onto the paper (15-30mins). The 
paper was then pulverized and the fragment eluted by 
shaking overnight in 1.5M NaCl/ lx TE, following which the 
solution was filtered through siliconized glass wool, 
clarified and the fragment ethanol precipitated.
14.2. Non-denaturing polyacrylamide gels
Fragments of 40-400bp in size were resolved in 4-8% 
polyacrylamide (acrylamide:bis-acrylamide, 19:1) gels run
in lx TBE. Gels were prepared in 1.5mm thick vertical glass 
plate sandwiches, and cross-linked with 0.001 vol TEMED
catalysed with O.Olvol 10% APS. Samples were loaded and 
electrophoresed at a maximum voltage of 16V/cm, and DNA 
visualized by autoradiography or EtBr staining.
32P-labelled DNA fragments were cut out of the gel after 
detection by autoradiography and purified in one of two 
ways. Fragments for sequencing were recovered from 
polyacrylamide strips by extrusion through a pierced 0.4ml 
vial into a 1.5ml tube (benchtop minicentrifuge/ 12K rpm/ 
5mins). The DNA was eluted by shaking overnight in TE at 
37°C, the slurry filtered through siliconized glass wool
and DNA precipitated. Probes for gel retardation assays 
were eluted into gel elution buffer (2x 3h/45°C
incubations) after dicing the polyacrylamide strips. The 
supernatant was then purified on a Sephadex G-50 column 
(Section 2B.15).
14.3. Denaturing polyacrylamide gels
The products of DNA sequencing reactions were 
resolved in 0.35mm thick gels prepared to a final 
concentration of 8-20% acrylamide
(acrylamide:bis-acrylamide, 19:1) in lx TBE containing 7M 
urea. The acrylamide was filtered through a 0.45 micron
filter and degassed prior to polymerization, and the 
completed gel pre-run at 40W for 30min. Sequencing reaction 
samples were denatured at 90° C. for 2min, and loaded onto 
the gel and run at 40W for 2-5h. Gels were covered with 
cling-film and autoradiographed at -70°C with screens.
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15. Sephadex G-50 Columns (gel exclusion chromatography)
Sephadex G-50 "nick" columns obtained from 
Pharmacia were used to purify 32P-labelled fragments for 
use as probes in gel retardation assays, and also to purify 
nick-translated plasmid probes used in southern blotting. 
Columns for purifying gel retardation probes were run in 
distilled H2O, whereas all other columns were run in TE 
plus 0.1% SDS. 100-800ul of sample were loaded onto the 
column and the fastest eluting fractions (detected by 
scintillation counting) taken as purified DNA. 
Nick-translated probes were used directly. Gel retardation 
probe fractions were pooled, ethanol precipitated in the 
presence of lug of poly(dl):poly(dC), and resuspended in a 
suitable volume (usually lOOpl) and stored at -20°C prior 
to use.
16. DNA Ligations
DNA ligations were performed in 10pl lx ligase 
buffer (which contains 0.6mM ATP) with 50-500ng DNA and 1 
unit of T4 DNA ligase, for l-2h at RT or overnight at 16°C.
11. Preparation and Transformation of Competent E.coli 
strain HB101
A sample of overnight culture of bacteria was 
streaked out onto a nutrient agar plate, and incubated 
overnight at 37°C. The following day a single colony was 
diluted into fresh L-broth plus lOmM MgCl2 / lOmM MgS04 and 
and aerated vigorously at 37°C until reaching an ODs40 of 
0.3. Using sterile, ice cold procedures throughout, cells 
were pelleted (5K rpm/ 2°C/ lOmin), resuspended in 1/4 vol 
0.1M MgCl2 and immediately pelleted again (5K rpm/ 2°C/ 
lOmin). Cells were resuspended in 1/20 vol 0.1M CaCl2 and 
left on ice for 45min before again pelleting cells (5K/ 
2°C/ lOmin. Cells were resuspended in the same volume of 
0.1M MOPS/ 50mM CaCl2/20% glycerol and left on ice for 20 
min prior to dispensing 50-200)jl aliquots into sterile 
Eppendorf reaction vials, snap freezing and storing at 
-70° C .
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Transformations generally utilized stored, frozen 
competent cells. 100-200]il of competent cells (as required) 
were thawed on ice, 100-500ng of plasmid DNA (either 
ligation mix or purified plasmid) added, and the mixture 
left on ice for 20 minutes. Then cells were heat-shocked 
at 37°C for lmin, 500pl of prewarmed L-broth added and the 
mixture incubated at 37°C for 30mins prior to plating the 
mixture out onto antibiotic (usually ampicillin) containing 
nutrient agar plates. Plates were incubated at 37°C 
overnight following which they could be stored for several 
months at 4°C .
18. Radioactive Labelling of DNA
18.1. 5'-end labelling
This approach was used to label DNA fragments from 
insertion mutant plasmids prior to chemical sequencing. In 
order to label DNA fragments at the 5'-end the 5'-phosphate 
was first removed by treatment with bacterial alkaline 
phosphatase (BAP) for lh at 65°C in TE pH 8.0 (or in react 
1, 2 or 3). The sample was diluted to lOOyl and extensively 
extracted with phenol then chloroform to remove BAP, and 
ethanol precipitated to concentrate. The precipitated DNA 
was resuspended in 10-20yl lx kinase buffer containing 
10-50pCi [gamma-32P]dATP and 1 unit of T4 polynucleotide 
kinase (37°C/lh). The labelled DNA was purified from 
unincorporated label by gel electrophoresis, ethanol 
precipitation in the presence of lug carrier tRNA, or by 
running on a Sephadex G-50 column.
Oligonucleotides were phosphorylated in a similar 
fashion. For use as probes in plaque hybridization assays, 
oligonucleotides were phosphorylated by addition of 
oligonucleotide, 5x kinase buffer and enzyme direct to 
[gamma-32P]dATP to ensure labelling to high specific 
activity. 0.5mM cold ATP replaced label in the reaction 
mixture when oligonucleotides were to be phosphorylated for 
cloning purposes. The reaction was stopped at 70°C.
18.2. 3 1-end labelling
3'-ends were labelled by filling in 5'-overhangs 
with either klenow polymerase or T4 DNA polymerase. Digests 
of l-2yg of plasmid DNA were filled in after
heat-inactivating the restriction enzymes at 65°C/10min. 
Klenow reactions were carried out in REact™ 2 buffer, and 
used 1 unit of enzyme incubated at RT for 20min with
appropriate hot 5'-[a-32P]- and cold dNTPs followed by a 
20min chase with all four cold dNTPs. T4 DNA polymerase 
reactions differed in that they were performed in T4 DNA 
polymerase buffer at 37°C for lh. Both enzymes were 
inactivated at 65°C/10min prior to second enzyme
digestions. The labelled DNA fragments were finally
purified by gel electrophoresis.
18.3. Internal labelling by nick translation
Plasmid DNA was radiolabelled by the method of 
Rigby et al. (1977). Labelling reactions were performed in 
lx REact™ 1 buffer and included lOOng of plasmid DNA, 
lOpCi of all 5'-[a-32P]dNTPs, 1 unit E.coli DNA polymerase 
holoenzyme and 5xl0~7 yg/ml DNAse I in a final volume of 
20pl. Following incubation for lh at RT the reaction was 
stopped by addition of lOOyl of NT stop and labelled DNA 
purified on a Sephadex G-50 column (Section 2B,15).
19. Chemical Sequencing of DNA
The nucleotide sequence of 5' or 3'-end labelled 
DNA fragments derived from insertion mutant plasmids 
(pVIl-pVI8) was determined by the chemical methodology of 
Maxam and Gilbert (1977, 1980). Uniquely end-labelled DNA
restriction fragments were prepared by filling in or 
phosphorylating a cut RE site (see Sections 18.1 and 18.2 
above) then cutting with a second enzyme to yield fragments 
50-500bp in length labelled solely on one strand. These 
were then purified as described (Section 14.2) and 
20—50,000 cpm aliquots reacted to modify either purines or 
cytosine bases. For the purine reaction the DNA was 
resuspended in 2% Diphenylamine/ ImM EDTA/ 66% formic acid
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for 2min at 25°C. The DNA was then ether extracted and 
lyophilized. Cytosine residues were modified by treatment 
with hydrazine in the presence of 1.5M NaCl (2min/25°C), 
stopped by addition of 0.3M NaCl and 0.1M EDTA and ethanol 
precipitated. The partially modified DNA was then 
resuspended in fresh 1M piperidine at 90°C for 30min to 
cleave the DNA at the modified bases. The products were 
lyophilized three times, reconstituted in 5pl of formamide 
dyes mix, and 2yl resolved on a denaturing polyacrylamide 
gel of appropriate concentration (Section 14.3).
20. Transformation of E.coli Strain JM101
Ligation mix containing 50-500ng of M13 replicative 
form (RF) DNA was added to lOOul of competent E.coli JM101 
cells and the mixture left on ice for 20min before 
heat-shock at 42°C/ 40 seconds. Half of this transformation 
mix was added to a prewarmed tube (42°C) containing 3ml top 
agar, 50pl of a fresh overnight culture of JM101, 25pl of 
X-gal and 10pl of IPTG. The contents were mixed and poured 
onto an L-broth agar plate which was gently swirled to
ensure an even distribution of bacteria and top agar. The
top agar was left to set for lOmin, the plate inverted and 
incubated at 37°C overnight. Blue plaques and clear plaques 
developed. The clear plaques harboured bacteriophage 
containing insertions into the vector cloning sites within 
lacZ coding sequences.
21. Small-Scale Preparation of Replicative-form and 
Template DNAs from JM101 Bacteria Transformed with M13 
Vectors
20yl of a fresh overnight culture of E.coli JM101 
bacteria was added to 100ml of 2YT broth. Single, isolated 
plaques, freshly picked with a sterile pasteur pipette, 
were added to 1.5ml aliquots of this suspension in sterile 
universals. The cultures were incubated with shaking at 
37°C/5-6h. 1ml of the final infected culture was 
transferred to a 1.5ml Eppendorf vial and centrifuged twice 
at 12K rpm/2min, turning the tube through 180° between
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spins. (The residual culture was retained as a stock of 
bacteriophage.) Single-stranded template DNA and 
replicative form (RF) DNA were then prepared as follows:
Template DNA
800jil of the supernatant were transferred to a 
fresh tube containing 200pl of 20% PEG/ 2.5M NaCl, mixed 
and left for 30min at RT. Precipitated bacteriophage were 
recovered by centrifugation at 12K rpm/ lOmin in a 
minicentrifuge. All of the supernatant was carefully 
removed using a sterile disposable pipette tip and the 
pellet of bacteriophage resuspended in lOOul of TE. lOOyl 
of phenol (equilibrated with TE) was added, the contents of 
the tube mixed well and then centrifuged at 12K rpm/ lOmin. 
The upper aqueous phase was transferred to a fresh tube, 
lOpl of 4M NaAcetate and 250pl of ethanol added, the 
mixture vortexed and again centrifuged at 12K rpm/ lOmin. 
The pellet of single-stranded bacteriophage DNA was washed 
with 70% ethanol, dried and resuspended in 50yl TE/5.
RF DNA
The pellet of infected bacteria from above was 
resuspended in 200yl STET/ lysozyme and RF DNA prepared by 
the method described in Section 12.
22. Dideoxy Sequencing of DNA
The products of site-directed mutagenesis 
experiments were sequenced by the dideoxynucleotide chain 
termination method of Sanger et al. (1977). Single-stranded 
template DNA was prepared from a 1.5ml culture in 2YT broth 
(as described in 21 above) and dissolved in 50yl TE/5. 2yl 
of this template DNA was annealed to 2. 5ng of the M13 
single-stranded universal primer in a final volume of lOpl 
lx M13 sequencing buffer (lOmM Tris.HCl pH 8.5, lOmM MgCl2 ) 
at 37° C/ 30min. 2 units of Klenow DNA polymerase were
added to the annealed DNA and 2pl aliquots of the mixture 
dispensed into four corresponding T, C, G and A wells of a 
U-bottomed 96-well microwell plate (Nunclon). To each well
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was added 2pl of the appropriate sequencing mix containing 
dNTPs and specific ddNTPs (see Table below), 0.09pm dATP
and 4pCi [a-32P]dATP. The tray was spun briefly and the
reaction allowed to proceed for 15min at 31°C. 2pl of chase 
mix (4x cold dNTPs each at 0.25mM) were added to each well 
and the incubation continued for a further 30min at 31°C.
The reaction was stopped by addition of 2pl formyl dyes 
mixture (0.1% bromophenol blue (w/v), 0.1% xylene cyanol
(w/v) in deionised formamide). The plate was heated at 
100°C for lmin and 2-3pl of each reaction resolved on a
denaturing polyacrylamide sequencing gel (Section 14.3).
Sequencing Solutions
dA-0 dT-0 dC-0 dG-0
5mM dTTP 20 1 20 20
5mM dCTP 20 20 1 20
5mM 7-deaza dGTP 20 20 20 1
lOx TE(seq) 50 50 50 50
H20 540 370 370 370
TE(seq): lOmM Tris-HCl pH8, 0.lmM EDTA
Nucleotide Concentrations in Sequencing Mixes
dN-0 mix ddNTP H2O
T seq 500 500 (600pMddTTP) 0
C seq 500 105 (140pMddCTP) 395
G seq 500 155 (200pMddGTP) 345
A seq 500 250 (140pMddATP) 250
(ddNTPs sold in solution at 5mM)
23. Oligonucleotide-Mediated M13 Site Directed Mutagenesis 
Mutagenesis of VZV gene 62 DNA fragments was 
performed by the standard double-primer method (Norris et 
al., 1983; Zoller and Smith, 1987). A suitable fragment 
containing the region to be mutagenised was cloned into
M13mpl8 (Norrander et al., 1983). Ligation mix was
transformed into competent E.coli JM101 (Section 20), 
recombinant bacteriophage plaques isolated and
single-stranded template DNA prepared (Section 21). In
order to check the specificity of hybridization of the
mutagenic oligonucleotide to the DNA template, a set of DNA
sequencing reactions were carried out in which the
mutagenic oligonucleotide replaced the M13 universal
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primer. Provided this generated the expected sequence the 
oligonucleotide was used in the mutagenesis protocol 
described below.
Hybridization of oligonucleotides to template DNA and
primer extension
The M13 universal primer and mutagenic 
oligonucleotides were phosphorylated as described in 
Section 18.1. 4yl of template DNA and 2pl of each
phosphorylated oligonucleotide were diluted to a final 
volume of 20yl in lx M13 sequencing buffer (lOmM Tris.HCl 
pH 8.5, lOmM MgCl2 ). The mixture was incubated at 37°C for 
30min to allow the oligonucleotides to anneal to the 
template. Then lyl each of T4 DNA ligase, Klenow DNA 
polymerase, 20x dNTPs and lOmM ATP were added and primer 
extension and ligation allowed to proceed at 15°C
overnight, resulting in formation of double-stranded 
heteroduplex DNA.
Transformation of JM101 and screening for mutants
2pl of the above material were transformed into 
competent E.coli JM101 as described (Section 20). (In some 
cases it was necessary to dilute the ligation mix prior to 
transformation in order to obtain well separated plaques.) 
The plaques obtained were screened in a plaque 
hybridization assay (Section 24) using 32P-labelled 
mutagenic oligonucleotide as a probe. Plaques identified as 
harbouring recombinant bacteriophage containing the desired 
mutation probably contained a mixture of mutant and wild 
type phage at this stage. Thus in order to purify the 
desired phage, candidate plaques were picked and plated out 
as follows. Plaques of interest were picked into lOOul of 
2YT broth, vortexed and a ten-fold dilution series prepared 
in 2YT. 50pl of each dilution were then added to prewarmed 
(42°C) tubes containing 3ml top agar and 50yl of a fresh 
overnight culture of JM101 and plated onto LB-agar plates. 
Following incubation at 37°C/ overnight, a plate containing 
30-100 plaques was selected for further analysis.
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Confirmation of the presence of the mutation
Plaques from above were picked and RF and template 
DNAs prepared as described in Section 21. RF DNAs were 
analysed by RE digestion for the presence of a novel 
restriction site or a deletion in order to identify phage 
containing the desired mutation. The presence of the 
mutation was confirmed by dideoxy sequencing (Section 22) 
of the corresponding template.
Large scale preparation of RF DNA containing the mutation
Residual culture corresponding to the RF and 
template DNA preparations which contained the mutation (see 
above) was used as a stock of bacteriophage to infect 
cultures of JM101 for large scale preparation of mutant RF 
DNA. 5jil of residual culture was inoculated into 200ml 2YT 
broth containing lOOul of a fresh overnight culture of 
JM101. Following incubation at 37°C for 5h with vigorous 
aeration, infected cells were isolated and by 
centrifugation at 5K rpm/ 6min (GS3/Sorvall), resuspended 
in 17ml STET and RF DNA prepared by the method described in 
Section 11.
24. M13 Plaque Hybridization Assay
Following the primer extension/ligation reaction an 
aliquot of the resulting double-stranded DNA was 
transformed into JM101 and plated out as described (Section 
23). Plates were incubated at 37°C overnight and then 
placed at 4°C for 15min. A nitrocellulose filter was then 
carefully placed onto the surface of the plate and the 
orientation marked. The filter was removed after 5min and 
air dried for 5min/RT before baking at 80°C in a vacuum 
oven for 2h. Filters were prehybridized at 37°C/lh in 
prehybridization buffer (6x SSC/ 0.2% SDS/ 0.5% dried 
skimmed milk) . Following prehybridization, mutagenic 
oligonucleotide which had been labelled by phosphorylation 
wi'th [gamma-3 2 P] dATP and T4 kinase (Section 18.1) was 
diluted to lOOpl with TE and added to the prehybridization 
mixture in the bag. Hybridization was performed overnight
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under the same conditions as prehybridization. The 
following day the filter was washed twice in 6x SSC/ 5min/ 
RT and then once in 6x SSC/ 5min/ 37° C, and 
autoradiographed at -70°C with a screen (30-60min). The 
filter was then washed at increasing temperatures in 6x
SSC/ 15min, beginning 10 degrees below the calculated T m 
(Tm= 4x[G+C] + 2x[A+T]) for the oligonucleotide and
increasing in 2 degree intervals near the Tm . The filter 
was monitored at each stage with a Geiger counter to
determine the point at which counts decreased. At this
stage the oligonucleotide was hybridizing selectively to 
DNA from plaques harbouring mutant phage, and the filter 
was again autoradiographed at -70°C to allow location of 
plaques containing mutant phage on the plate.
25. Southern Transfer of DNA to Nitrocellulose
Restricted DNAs for Southern transfer (Southern,
1975) were resolved on agarose gels of the appropriate
concentration run in L-buffer. Following electrophoresis 
the gel was washed in Gel Soak I for 45min then in Gel Soak 
II for 45min. The DNA was blotted overnight onto presoaked 
Nitrocellulose paper using lOx SSC, a wick of Whatman 3MM 
paper and a weighted capillary stack of absorbent paper 
towelling. The filter was air dried and baked at 80°C for 
2h in a vacuum oven prior to hybridization.
26. Immobilization of DNA on Nitrocellulose by Slot-Blot
A Schleicher and Schuell slot-blot apparatus was 
used to immobilize equivalent quantities of viral infected 
total cell DNA onto nitrocellulose. DNA was extracted as 
described above (Section 4) and digested with RNAse. DNA 
was denatured by addition of 1 vol 1M NaOH (lOmin/RT) then 
neutralized with 2 vols of 2M ammonium acetate. The 
denatured sample was then applied to a presoaked (2x SSC) 
membrane under vacuum using the slot-blot apparatus, and 
washed through with 1M ammonium acetate. The filter was 
then air dried and baked at 80°C in a vacuum oven prior to 
hybridization.
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27. DNA-DNA Hybridization
Nitrocellulose filters were prehybridized in fresh 
hybridization mix for 2-4h at 65-70°C. 107-108 cpm of nick 
translated plasmid probe DNA was denatured by addition of 
0.04vol 5M NaOH then neutralized with 5M HC1 prior to 
adding to the filter bag and hybridizing overnight under 
the same conditions used for prehybridization. The filter 
was then washed twice at RT in 2x SSC for lOmin and twice 
at the hybridization temperature in 2x SSC plus 0.1% SDS 
for lh each before autoradiography at -70°C with screens.
28. FPLC Gel Filtration Chromatography
Gel filtration chromatography was performed on an 
automated Pharmacia FPLC system using a Superose 12 column 
under the conditions outlined in Section 3F.
29. Computing
Computer analyses of DNA and protein sequences were 
performed on the MicroVAX 11 computer in this department 
using the University of Wisconsin Genetics Computer Group 
software package.
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3. RESULTS
3A. VZV GENE 62 AND PLASMID p!40
Much of the work described in this thesis has utilized 
either plasmid pl40 (which contains VZV gene 62 sequences) 
or derivatives of pl40. Therefore, before entering the main 
results section I will describe in detail the structure of 
VZV gene 62 and plasmid pl40.
3A.1. Gene and Transcript Structure
The VZV 140k polypeptide is encoded by a diploid 
gene (designated genes 62 and 71), a copy of which is 
located within each of the repeat sequences bounding the Us 
region of the genome (Davison and Scott, 1986). A 4.3kb 
transcript has been mapped to within these repeats (Ostrove 
et al., 1985; Reinhold et al., 1988), and its capsite
determined to lie 73 nucleotides upstream of the ATG codon 
(McKee et al., 1990). Gene 62 is located within the
internal repeat and is transcribed from the capsite at
109206 towards U l and the polyadenylation signal at 105147. 
Translation of the polypeptide is predicted to begin at the 
ATG codon at position 109133 and to continue to the
termination codon at 105204 (Davison and Scott, 1986). The 
corresponding gene 71 is located within the terminal repeat 
and is transcribed from the capsite at 120691 towards the 
genome terminus and polyadenylation signal at 124750. The 
open reading frame begins at 120764 and terminates at 
124693 (Davison and Scott, 1986). The 1310 amino acid 
residue polypeptide encoded by these open reading frames 
has a predicted unmodified molecular weight of 140,000 
(140k) .
3A.2. Plasmid p!40
Within this thesis gene 62 nucleotide sequences 
will be numbered according to the following conventions. 
Nucleotides within the reading frame will be numbered
sequentially from the first base, 1, through to the last 
base, 3930. Sequences upstream of the reading frame will be
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numbered relative to the capsite, which is designated +1, 
positions upstream of the capsite having negative values, 
while the positions of nucleotides located between the 
capsite and the reading frame have positive values.
Plasmid pl40 contains VZV gene 62* in a fragment
from the Clal site at -1146 to the genome terminal PstI
site of pVZVSstf (Everett, 1984) inserted between the AccI 
and PstI sites of a pUC9 plasmid from which the EcoRI site 
had been removed by cutting and filling in (McKee et al., 
1990;. see figure 5). Gene 62 sequences in this plasmid are 
expressed from the authentic gene 62 promoter which has 
been determined to lie within the region -410 to +57 (McKee 
et al., 1990). Within pl40 there are two BamlII sites which 
will frequently be referred to when describing cloning
procedures in later sections. The first of these is located
in the pUC9 polylinker sequences, 5' to the VZV insert, the 
second being located within the gene 62 coding sequences at 
position 2198.
&
N.B. Gene 71 sequences (which are assumed to be identical 
to those of gene 62) were actually cloned.
Figure 5. Structure of Plasmid pl40. Plasmid pl40 (8019 bp) 
contains VZV gene 62 on a Clal-PstI fragment (-1146 to the 
genome terminus) derived from pVZVSstf (Everett, 1984) 
cloned between the AccI and PstI sites of a pUC9 plasmid 
from which the EcoRI site had been removed (McKee et al., 
1990). VZV 140k coding sequences are represented by the 
hatched region. The sequences controlling expression of 
VZV 140k (which are located between Sail (-410) and the 
orf) are indicated. The pUC9 vector sequences are marked by 
the arrow, and the location of the ampicillin resistance 
gene (amp) within the vector sequences is shown. The 
locations of some restriction enzyme recognition sites a(e 
marked. Plasmid pl40 contains two BamHI sites, one of which 
is located in pUC9 polylinker sequences immediately 
adjacent (upstream) to the VZV insert, the other within the 
VZV 140k orf. The Tthllll site is located just 2 bp beyond 
the 3' end of the VZV 140k orf.
A loose copy of this Figure can be found inside the rear 
cover
Hindlll
PstI
Tthllll
Xhol
Xhol
Hindlll
BamHI
BamHI
Clal
EcoRV Sail
I Xhol 
capsite
Hindlll Xhol
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3B. CONSTRUCTION AND CHARACTERIZATION OF THE RECOMBINANT 
VIRUS HSV-140
The overall aim of the work presented in this 
thesis was to investigate the biochemical and functional 
properties of the VZV 140k polypeptide. This section 
describes the construction and characterization of an HSV-1 
recombinant (HSV-140) in which VZV 140K coding sequences 
replace both copies of the Vmwl75 coding sequences in the 
repeat sequences bounding the short unique region of the 
HSV-1 genome.
The primary aim of this work was to characterize 
the phenotype of the recombinant virus in order to 
determine the extent to which 140k and Vmwl75 are 
functionally interchangeable. Additionally, it was 
envisaged that HSV-140 might be a useful vector with which 
to express 140k in tissue culture cells, thus permitting a 
biochemical analysis of the polypeptide. Analysis of DNA 
replication and the expression of viral polypeptides during 
HSV-140 infection of tissue culture cells (in the absence 
and presence of metabolic inhibitors) has provided more 
detailed information on the functional relationship 
between 140k and Vmwl75 than was afforded by the earlier 
complementation studies of Felser et al. (1987, 1988). The 
results demonstrate that 140k can perform many of the 
functions of Vmwl75 during growth of HSV-1, but that slight 
differences in the detail of gene expression might lead to 
less efficient virus growth.
3B.1. CONSTRUCTION
1.1. Strategy
The objective was to introduce VZV gene 62 coding 
sequences into the normal Vmwl75 loci in the HSV-1 genome 
by the process of homologous recombination. To this end 
plasmid pGD140 was constructed in which gene 62 coding 
sequences are contained in an IE gene 3 transcription unit 
comprising both 5' promoter sequences and 3' transcription 
termination signals, and also the HSV-1 "a" sequence. The 
parent virus for the recombination was D30EBA in which the
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majority of the Vmwl75 coding sequences have been deleted 
from both copies of the IE3 gene. Like other HSV-1 viruses 
lacking Vmwl75 function, D30EBA is unable to grow on normal 
cell lines. Since D30EBA lacks endogenous Vmwl75 coding 
sequences, its use rvuAifwises problems which might be 
encountered due to intragenic recombination between
homologous regions of Vmwl75 and VZV 140k. In addition, its
use provides a powerful selection for progeny virus which, 
unlike D30EBA, should be competent for growth on normal 
cell lines. Thus plasmid pGD140 was linearized at a unique 
PstI site (within vector sequences) and
cotransfected into BHK cells with D30EBA viral DNA, progeny 
virus isolated, and screened for the presence of the 
desired recombinant.
1.2. Virus D30EBA
D30EBA (Paterson and Everett, 1990) is a mutant of 
HSV-1 in which nucleotides 248-3806 of the Vmwl75 orf 
(amino acid residues 83-1269) are deleted from both copies 
of the IE3 gene (a description of the location and
structure of the IE3 gene can be found in Section 1C).
D30EBA was constructed from the HSV-1 strain inl411 
(Russell et al., 1987) which has an oligonucleotide 
encoding a translation termination codon introduced into 
the Pvull site at position 248 of the IE3 reading frame,
and thus expresses a truncated form of Vmwl75. A marker
rescue experiment was performed in which linearized pdellll 
DNA was cotransfected into M64A cells (see below) with 
inl411 DNA; D30EBA was isolated and purified from progeny 
virus by plaque picking on M64A cells. Plasmid pdellll 
carries a copy of the Vmwl75 coding sequences from which 
nucleotides 248-3806 have been deleted. Both D30EBA and 
inl411 are unable to grow on normal cell lines and were 
propagated on M64A cells which express functional Vmwl75.
M64A cells (which are equivalent to M65 cells as described 
by'Davidson and Stow, 1985) are a biochemically transformed 
cell line derived by transfection of the Xhol-Hindlll 
fragment spanning IRs in HSV-1 (and containing the tk gene
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and the linked IE3 gene ) into tk~ BHK cells.
1.3. Construction of Plasmid pGD140
The construction of plasmid pGD140, which contains 
the VZV 140k coding sequences in an HSV-1 IE-3 
transcription unit (Figure 6), first required construction 
of a plasmid (pl40BTE) from which the intact VZV 140k 
coding sequences (lacking flanking 5* and 3' VZV 
sequences) could be conveniently isolated. Before 
describing the construction of pGD140 in detail, the 
construction of pl40BTE will be outlined.
Plasmid pl40BTE is a derivative of pl40 (see 
Section 3A.2 and Figure 5) which has a unique Bglll site at 
+57 (relative to the transcription start site at +1), 16 
nucleotides upstream of the ATG initiation codon, and a 
unique EcoRl site 4 nucleotides beyond the 3' end of the 
reading frame. The first step was the production of a 
plasmid containing the Bglll site (pl40BT). M13
oligonucleotide directed mutagenesis was employed to mutate 
nucleotide +57 of gene 62 from A to G, changing the 
sequence from AAATTC to GAATTC. To facilitate mutagenesis, 
a BamHl-EcoRI fragment representing VZV gene 62 sequences 
from -1146 (ClaI) to nucleotide 1412 of the reading frame 
was isolated from pVI8 (a derivative of pl40 created by 
insertion of an 8 base E’coRI linker into the Sau3A site at 
nucleotide 1412; see section 3C.1.1), and inserted between 
the BamHI and E’coRI sites of M13 mpl8. Following 
mutagenesis, miniprep DNAs were screened for the presence 
of a new EcoRl site, a clone (pM13E13) selected, and its 
DNA sequence in the region of the mutation confirmed by 
dideoxy sequencing. A BamWI-EcoRV fragment representing 
sequences from -1146 to nucleotide 1245 (EcoRV) , and 
containing the single A to G mutation, was isolated from 
M13E13 and used to replace the wild type BamRI-EcoRV 
fragment in pl40 to create pl40ET. Plasmid pl40ET was 
cleaved at the unique FcoRI site, the 5' overhangs filled 
in with Klenow polymerase, and ligated directly to the 8 
base Bglll oligonucleotide linker 5’GAGATCTC3’ to create
Sst I
PSt I
pGD140
\  Bam HI 
Bgl IIEcoRl
EcoRl 
TGA
K—  ' X
a IE3 Vmw175
mRNA carboxy
stop terminus
(-331)
H ind lll
140K orf
ATG
Bgl II BamHI
+57 +27
IE3
promoter
Figure 6. The structure of plasmid pGD140. Plasmid pGD140 
contains VZV gene 62 coding sequences flanked by HSV-1 IE3 
transcriptional control sequences. The vector sequences 
extend from the PvizII site of pBR322 (which had been 
altered to an SstI site as indicated), through the 
ampicillin resistance gene (with its PstI site) to the 
Hindlll site. The Hindlll site is located at the junction 
of HSV-1 and pAT153 sequences and is joined to the Smal 
site at position -331 of the IE3 promoter. The VZV gene 62 
sequences from position +57 to an introduced EcoRl site 
just after the VZV 140K stop codon are shown, with the 
coding sequence in a stippled box. Sequences downstream of 
this include the 3' portion of IE3, the "a” sequence and 
part of TRl as far as the SstI site as shown (not to 
scale). The plasmid was constructed by ligation of the 
Pstl-BamEI fragment of pGX161, the Bglll-EcoRI fragment of 
P140BTE and the EcoRI-SstI fragment of pI38 as detailed in 
the text. Ligation of complementary ends produced by 
enzymes Bglll and BamBI results in a sequence (marked Bglll 
BamKI) which is cut by neither enzyme.
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pl40BT. pl40BT was then linearised by digestion with
Tthllll, which cuts 2 nucleotides beyond the 3' end of the 
gene 62 reading frame, and EcoRl linkers inserted (after 
making the ends blunt) to yield pl40BTE.
Plasmid pGD140 was constructed from fragments
derived from pGX161, pI38, and pl40BTE. Plasmid pGX161
(kindly provided by Dr C M Preston) has been described 
previously (Preston and Fisher, 1984) and contains the 
promoter and upstream regulatory sequences of the HSV-1 IE3 
gene (nucleotides -331 to +27) between the Hindlll and 
BamHI sites of pAT153. Plasmid pI38 is a derivative of 
pl75 (Perry et al, 1986) created by insertion of a 12 base 
EcoRl linker oligonucleotide into a NaeI site within the 
Vmwl75 coding sequences, resulting in an in-frame insertion 
of four amino acids into the proline codon at position 1236 
(Paterson and Everett, 1988a). Plasmid pGD140 was 
constructed in a tri-partite ligation using the Bglll-EcoRI 
fragment from pl40BTE containing the VZV 140K coding 
sequences, the smaller Pstl-BamUI fragment of pGX161
containing the IE3 promoter (and part of the vector
sequences), and the smaller PstI-EcoRl fragment of pI38 
which provides the rest of the vector sequences, the C- 
terminal 62 codons of Vmwl75, the 3' end of the IE3 
transcription unit and subsequent HSV-1 DNA through to the 
SstI site in T R l (figure 6). The C-terminal portion of 
Vmwl75 in this construct follows the TGA stop codon of VZV 
gene 62.
1.4. Marker Rescue of D30EBA
A mixture containing approximately lug of plasmid 
pGD140 DNA (linearised with PstI), 3ug of D30EBA viral DNA 
and 5ug of calf thymus DNA (as carrier) was transfected
into 2xl06 BHK cells by the method of Stow and Wilkie 
(1976). Cells were also transfected with viral or plasmid 
DNA alone as a control. After four days cpe was observed in 
the cells co-transfected with viral and plasmid DNA, 
whereas no cpe was observed in the control transfection 
with viral DNA alone. Cells and medium combined from both
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the control and co-transfected plates were sonicated and 
retained as virus stocks. These stocks were used to infect 
further BHK cells and total infected cell DNA prepared.
This was initially analysed by DNA slot blots using nick 
translated pl40 (McKee et al, 1990) as a probe, which
showed that only DNA prepared from the co-transfected cells 
hybridised to VZV sequences (results not shown).
The recombinant viral DNA was further analysed by 
Southern blotting (Figure 7). The controls show that
neither mock nor wt HSV-1 infected cell DNA samples
hybridized to the pl40 probe. The BamHI restriction map 
for the expected recombinant virus (Figure 8) predicts that 
the probe will hybridize to the following fragments on the 
blot: BamHI [k'] (6.0kb) and BamHI [y'+n] (7.1kb) derived
from IRs ; BamHI [x+y'] (4.1kb) and .BamHI [q1] (3.0kb)
derived from TRS . Fragments corresponding in size to the 
three larger predicted BamHI restriction fragments are 
clearly observed on the blot. However, the BamHI [q'] 
fragment, which represents sequences from the genome 
terminus, was not observed in this experiment. A weakly 
hybridizing fragment of 3kb was once observed during the 
isolation and purification of HSV-140, which probably 
indicates that viral DNA prepared from infected cells is 
highly concatamerised with consequent under-representation 
of the terminal fragment. The simplest interpretation of 
these results is that an intact copy of VZV gene 62 is 
present in both IE3 gene loci in an HSV-1 genome in our 
primary isolate of the recombinant virus, named HSV-140.
The initial isolate was amplified and purification 
by plaqu^ing under agar attempted, but despite several 
attempts no plaques were observed (see below). Virus HSV- 
140 was subsequently purified by limiting dilution in 
linbro wells, such that cpe was observed in 30% or less of
wells. Medium was retained from wells that displayed cpe,
and used to infect cells for total cellular DNA
preparation. Southern blot analysis of the resulting DNAs
showed all eight stocks of virus to be of the predicted 
structure with no evidence of contamination. Recombinant
HSV predicted size
m 140 17 (kb)
h23li —  4  f t  —  Bam (y’+n) 7.10,0 —  Bam k’ 6.04,4 •  ®  Bam (x+y j  4.1
2.3
2.0
Bam q’? 3.0
Figure 7. Southern blot analysis of DNA prepared from HSV- 
140 infected cells. DNA was prepared from infected cells 
when extensive cpe was apparent. The DNA was then digested 
with Banttl and subjected to Southern blot analysis using a 
nick translated plasmid pl40 probe which contains VZV gene 
62 but no HSV-1 sequences. Track 1: mock infected cell 
DNA; tracks 2 and 3: HSV-140 infected cell DNA using two
different virus stocks; track 4: HSV-1 infected cell DNA.
The positions of Lambda Hindlll size markers are shown on 
the left, and the identities of fragments hybridizing to 
the probe were assigned by 'comparison of their estimated 
sizes to those predicted from the maps in Figure 8. The
larger fragments in lane 2 represent partial digestion
products.
Figure 8. Predicted BamHI restriction maps for the short 
regions of the wild type HSV-1 and HSV-140 genomes. The
HSV-1 and HSV-140 genomes are shown. VZV gene 62 coding 
sequences replace both copies of Vmwl75 in the short region 
repeats of the HSV-1 genome in HSV-140; VZV sequences are 
represented by the stippled box, and the limits of the open 
reading frames shown by arrows. The Vmwl75 coding 
sequences in HSV-1 are contained within BamHI q and BamHI 
y, their replacement by the corresponding gene 62 sequences 
in HSV-140 results in restriction fragments designated 
BamHI q' and BamHI y'. BamHI k' represents (q'+ s) derived 
from the IRi/IRs junction. The BamHI site near the capsite 
of the IE-3 gene (present at map units 0.865 and 0.965 
approximately in HSV-1) was destroyed during the 
construction of pGD140 (marked * in HSV-140, see Figure 6). 
Therefore BamHI digestion of HSV-140 DNA.produces fragments 
(y'+ n) and (x+y'). The sizes (kb) of these four novel 
fragments containing portions of the VZV gene 62 sequence 
are shown.
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0.81 
0.82 
0.83 
0.84 
0.85 
0.86 
0.87 
0.88 
0.89 
0.94 
0.95 
0.96 
0.97 
0.98 
0.99
103
viruses carrying only one copy of gene 62 were not detected 
at any stage, suggesting that HSV-140, with two copies of 
gene 62, has a strong growth advantage. One of the small 
scale stocks was used to infect 2X108 BHK cells for 
preparation of a large scale virus stock which was again 
checked by Southern blotting (result not shown). The 
isolation of HSV-140 on normal BHK cells shows that VZV- 
140K can functionally replace Vmwl75.
3B.2. CHARACTERIZATION OF HSV-140
HSV-140 was initially compared to wt virus in a 
standard plaque assay in BHK cells to assess the extent to 
which VZV 140K can complement for loss of Vmwl75 function. 
Cells were infected with increasing dilutions of each virus 
and fixed and stained after two days. At lower dilutions
both viruses produced extensive cpe, although the
appearance of cpe during HSV-140 infections was delayed 
approximately 12h compared to wt virus. At increasing
dilutions single plaques were obtained with wt virus as
normal, but no obvious plaques were produced by HSV-140. 
The assay was repeated several times with independent
stocks of HSV-140 and in no case were distinct plaques 
formed. Similar results were obtained using HFL cells.
The results suggest that while HSV-140 is able to grow in
the absence of Vmwl75 expression, plaque formation is
impaired, at least in the cell types used in these studies.
The numbers of virus particles in the large scale
stocks of cell-associated and supernatant HSV-140 virus
were determined. HSV-140 cell-associated stocks were 
routinely around 3xl010 particles/ml, which was equivalent 
to the corresponding particle counts of stocks of wt virus 
produced in parallel. The supernatant virus particle count 
of HSV-140 was reduced by a factor of ten compared to the 
cell-associated virus (and to the wt supernatant virus 
stock also). If this reflects a slower rate of virus
assembly or release then it may in part explain the lack of 
plaque formation by HSV-140.
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2.1. Titration of HSV-140
As plaque forming unit titres could not be 
determined for HSV-140 virus stocks, viral polypeptide 
synthesis in HSV-140 and wt virus infected cells were 
compared using lOpfu/cell of wt virus, and increasing 
dilutions of HSV-140. Cells were labelled with [35S]- 
methionine from 3-6 hours post-absorption (pa) and proteins 
analysed by SDS-PAGE. Infection with dilutions of HSV-140 
corresponding to multiplicities of 2500, 500, and 100
particles per cell (ppc) resulted in levels of viral gene 
expression that were equivalent to the wt virus infection 
(results not shown). Since an amount of VZV inoculum 
corresponding to 100 ppc gave viral polypeptide expression 
similar to lOpfu wt virus per cell in this single 
experiment, this amount of HSV-140 was used in a subsequent 
time-course experiment.
2.2. Time-Course of HSV-140 Viral Polypeptide Synthesis
Cells were mock-infected or infected with wt and 
HSV-140 viruses and labelled between 0-2, 2-4, 4-6, 6-8, 8- 
10, 10-12, 16-18, and 22-24 hours pa. These results are 
shown in Figure 9. The protein expression profiles of the 
two viruses were similar, but a significant difference was 
the kinetics of expression of a high molecular weight 
protein in HSV-140 infected cells. On the basis of its 
mobility, expression by HSV-140 and Western blotting using 
a polyclonal rabbit antiserum directed against a fusion 
protein including part of VZV 140K (data not shown; D. 
Stevenson and A. Davison, personal communication) the most 
likely interpretation is that this high molecular weight 
band is the VZV 140K polypeptide. It is notable that the 
kinetics of expression of VZV 140K in HSV-140 infected 
cells is very different compared to Vmwl75 in wt virus 
infected cells. Strikingly, VZV 140K was expressed as an 
early protein and was abundant at late times in infection. 
Thus VZV 140K is apparently not subject to autoregulation 
in HSV-140, which suggests that the (apparent) normal 
repression of IE gene expression may be defective in this
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virus. It is not possible to discern from this data 
whether VmwllO, Vmw68, or Vmw63 are also overexpressed
during HSV-140 infection.
Most other clearly visible viral proteins are
expressed in HSV-140 and wt virus infected cells in similar 
amounts and with similar kinetics. However, the expression 
of certain late gene products (for example, Vmw65 and the 
major capsid protein) appears to be lower in HSV-140 
infected cells; this may be the result of less efficient 
replication of viral DNA during HSV-140 infection (see 
below).
2.3. VZV 140k expressed during HSV-140 infection is
localized to the nucleus
In order to determine the cellular location (i.e.
nucleus or cytoplasm) of VZV 140k during HSV-140 infection, 
BHK cells were infected with lOOppc of virus, and labelled 
with [35S]-methionine from 12-14h p.a. Labelled infected 
cells were isolated, and cytoplasmic and nuclear fractions 
prepared (as described in Section 2B.9.1). SDS-PAGE 
analysis of these fractions (Section 3F: Figure 42)
revealed that 140k is exclusively localized to the nucleus 
during HSV-140 infection.
2.4. The Kinetics of 140K Protein Expression
The expression of VZV 140K in HSV-140 is under the 
control of the HSV-1 IE3 promoter, and therefore should be 
expressed as an IE protein. However the time-course 
experiment (Figure 9) indicated that VZV 140K was expressed 
in increasing amounts as infection progressed. To 
investigate this further, the expression of viral proteins 
under IE conditions was examined in a cycloheximide 
reversal experiment. BHK cells were infected with HSV-140 
and wt virus in the presence of cycloheximide. At 5h pa 
the cycloheximide was removed, and [35S]-methionine 
labelling carried out in the presence of actinomycin D. 
The labelled proteins were analysed by SDS gel 
electrophoresis (Figure 10). In the wt virus infection,
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the IE proteins Vmw63, Vmw68, VmwllO, and Vmwl75 were 
prominently labelled as expected. In contrast, in the HSV- 
140 infection Vmw63, Vmw68, and VmwllO were synthesised in 
similar amounts to the wt virus infection, but the VZV 140K 
protein was absent. Despite the fact that VZV 140K is 
expressed from an authentic HSV-1 IE promoter in HSV-140, 
the protein was poorly expressed under IE
conditions. These results also indicate that HSV-140 is 
much less effective in the shutoff of host cell protein 
synthesis compared to wt virus (see also Section 2.7).
2.5. Comparison of Viral DNA Replication During Wild-Type 
and HSV-140 Infections
BHK cells in linbro wells were infected with HSV- 
140 and wt virus and total cellular DNA prepared at 4, 6, 
8, 10, and 16 hours pa. The DNA samples were treated with 
RNase and analysed in a slot blot experiment to compare the 
amounts of viral DNA present in the two infections. Nick 
translated pill (which contains HSV-1 IE gene 1 sequences; 
Everett, 1987) was used as a probe as it contains sequences 
common to both viruses. In cells infected with wt virus, 
DNA accumulation began prior to the earliest time point of 
4h pa, and continued through to 16h pa (Figure 11). The 
onset of HSV-140 DNA replication was delayed 2-4h relative 
to wt virus and the amounts of viral DNA produced were 
generally reduced; no accumulation of DNA was seen at 4h 
pa, and only very low levels were seen at 6h pa (Figure 
11) .
2.6. Viral Gene Expression During Infection With HSV-140 is 
Multiplicity Dependent
Several mutants of HSV-1 containing mutations in 
regulatory functions have been shown to have defects in 
viral gene expression at low multiplicities in certain cell 
types (Stow and Stow, 1986; Sacks and Schaffer, 1987; Ace 
et al, 1989; Everett, 1989). We decided to investigate the 
synthesis of viral polypeptides during high and low 
multiplicity infections of BHK and HFL cells by HSV-140.
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In an attempt to minimize experimental variation, the virus 
stocks used in this study were all prepared in parallel 
from the same batch of cells. BHK or HFL cells in linbro 
wells were infected at 50, 30, 10, and 3 ppc with HSV-140
or wt virus and labelled with [35S]-methionine at 10-12h pa 
(Figure 12). In agreement with the time-course experiment 
(Figure 9) at higher multiplicities both viruses expressed 
similar levels of most viral polypeptides, although the 
expression of certain late proteins (for example Vmw65 and 
the major capsid protein) was again reduced in HSV-140 
infections. At the lower multiplicities of 10 and 3 ppc, 
HSV-140 expressed reduced amounts of all viral polypeptides 
compared to wt virus in both BHK and HFL cells. This 
finding was repeated with several different stocks of HSV- 
140. Therefore HSV-140 exhibits a multiplicity dependent 
gene expression defect which, in the cases examined, is not 
cell type dependent.
2.7. HSV-140 is Defective in Virus-Induced Shut-Off of Host 
Protein Synthesis
The results in Figures 10 and 12, while suggesting 
that the ability of HSV-140 to shutoff host protein 
synthesis is significantly impaired, cannot be considered 
conclusive. The cycloheximide reversal experiment 
(Figure 10) was not performed with equal ppc multiplicities 
of wt and HSV-140 viruses, and in the particle titration 
experiment (Figure 12) labelling at late times means that 
secondary infection by the faster growing wt virus could 
contribute to the observed host shutoff. In order to 
assess whether HSV-140 is defective in shutoff, an 
experiment was performed in which cells were infected with 
1000 particles per cell each of wt virus, HSV-140, and HSV- 
2 strain G (which has a strong shut-off phenotype; Fenwick 
& Clark, 1983) in the presence of actinomycin D (2.5 
ug/ul), and polypeptides labelled with 33S-methionine 
following a 2h infection period. The results show that 
while wt virus and HSV-2 strain G shut-off host protein 
synthesis with a similar efficiency in this experiment
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(strain G is normally more efficient), there is clearly no 
detectable shut-off following HSV-140 infection (Figure 
13). This could be due to inefficient presentation by HSV- 
140 of the virion host shutoff function encoded by gene 
UL41 (Kwong et al, 1988; McGeoch et al, 1988). This might 
simply reflect a reduced amount of the UL41 product in 
virions, although an alternative interpretation might be 
that slight alterations in the composition or structure of 
HSV-140 virus particles reduces their efficiency of 
cellular absorption or penetration.
STRAIN 17
Vmw65
Vmw65
Figure 9. The time-course of viral protein expression in 
BHK cells infected with HSV-140 and wt virus. Linbro wells 
containing 4xl05 cells were infected with 10 pfu/cell wt 
HSV-1 (strain 17) or 100 ppc HSV-140. Proteins were
labelled with [35S]-methionine at the indicated times 
(hours) post-adsorption and analysed by SDS-PAGE. The 
samples in lanes 1 and 10 are from mock infected cells. 
Some of the major viral proteins are indicated: major 
capsid protein, MCP; glycoprotein B, gB; Vmw65; and VZV 
140K (HSV-140 infected cells only). Less intense labelling 
in the later time point samples is due to loss of 
terminally infected cells.
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Figure 10. HSV-140 express^ VZV 140K A in
cycloheximide reversal experiments. Subconfluent BHK cells 
were infected in the presence of cycloheximide. At 5h pa, 
cycloheximide was removed to allow protein labelling with 
[35S]-methionine (in the presence of actinomycin D) and 
their analysis by SDS-PAGE. Tracks 3 and ip contain the 
labelled proteins from wt virus infected cells, and tracks 
5 and 6 the results using HSV-140. Track 2 is a mock 
infected cell extract made under IE conditions, and tracks 
1 and 7 show mock and HSV-140 infected cell extracts made 
under normal conditions. The positions of IE polypeptides 
are indicated.
There is a very slight amount of VZV 140k expressed under 
these conditions (compare lanes 5 and 6 with lane 2).
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Figure 11. Comparison of viral DNA replication in BHK cells 
infected with HSV-140 and wt virus. Cells were infected as 
described in Figure 9, and harvested at 4, 6, 8, 10, and 16 
hours post-absorption for total cellular DNA preparation. 
DNA was also isolated from mock infected cells. The samples 
were treated with RNase prior to slot blot analysis using a 
nick translated pill probe which contains HSV-1 IE gene 1 
sequences common to HSV-140 and wt HSV-1. The control 
contains lOng of pill.
Figure 12. HSV-140 viral gene expression is impaired at
lower multiplicities of infection. BHK or HFL cells in 
linbro wells were infected with HSV-140 or wt virus at 
multiplicities corresponding to 50, 30, 10 and 3 ppc.
Cells were labelled with [35S]-methionine from 10-12 hours 
pa and proteins analysed by SDS-PAGE. Tracks 1 to 5 of 
each gel are samples prepared from BHK cells, tracks 6 to 
10 are samples from HFL cells. Tracks 1 and 6 of each gel 
are mock infected samples. Some major viral proteins are 
indicated, as described in the legend to Figure 9. HSV- 
140 (1) and HSV-140(2) are two separate stocks of virus 
prepared in parallel.
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Figure 13. HSV-140 is defective in virus-induced shut-off 
of host protein synthesis. BHK cells in linbro wells were 
infected with 1000 ppc of wt virus (lanes 2 and 3), HSV-140 
(lanes 4 and 5), or HSV-2 strain G (lane 6) in the presence 
of actinomycin D. Following a 2h infection period 
polypeptides were labelled with [35S]methionine and
analysed by SDS-PAGE. The sample in lane 1 is from mock 
infected cells.
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3C. INVESTIGATION OF THE trans-ACTIVATION PROPERTIES OF
140k
The trans-activation properties of VZV 140k and
Vmwl75 of HSV-1 are markedly different in transfection 
assays. Thus 140k is a much more powerful trans-activator 
of the HSV-1 glycoprotein D (gD) promoter than Vmwl75 (see 
Section 3C.1.2). Furthermore, whereas activation of the gD 
promoter by Vmwl75 and VmwllO exhibits synergy (i.e.
activation by the polypeptides in combination is far 
greater than by either polypeptide alone), 140k and VmwllO 
do not appear to function in synergy (Section 3C.2.3). The 
primary sequence characteristics of 140k responsible for 
these striking differences were investigated. The effects 
of insertion and deletion mutagenesis of sequences in the 
N-terminal third of the protein will be described, as will 
the construction and characterization of plasmids
expressing chimeric 140k/Vmwl75 polypeptides.
3C.1. INSERTION MUTAGENESIS OF VZV 140k
1.1. Construction of insertion mutants
N.B. The construction of the insertion mutants and 
preliminary mapping of their sites of insertion was 
performed by Bridget Harris.
Plasmid pl40 (10yg) was digested with 6u of Sau3K 
for 30 minutes in the presence of 20, 40, 60 or 80yg/ml
ethidium bromide in a final volume of 50yl. Digestion in 
the presence of ethidium bromide maximizes the production 
of singly cut linear molecules. The DNA was loaded onto a 
5-20% sucrose density gradient and centrifuged for 16h at 
28,500 rpm and 15°C in the Sorvall TST41 rotor. Linear DNA 
(which sedimented more slowly than circular forms and was 
easily separated) was isolated, ethanol precipitated 
overnight, and resuspended in a volume of 20yl. 5yl of this 
material was filled in with Klenow polymerase in a volume 
of 20yl. Finally, this blunt ended DNA was ligated to 
phosphory la t ed 8bp F’coRI oligonucleotide linkers
(3 ’ GGAATTCC.3 ’ ) . Plasmids with linker inserts were 
identified by screening small-scale plasmid preparations.
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The site of insertion was initially determined by 
restriction enzyme analysis and their location and 
integrity confirmed by DNA sequencing. The number of 
linkers inserted was determined by restriction analysis 
and, in the case of multiple insertions, reduced to a 
single copy by digestion with EcoRl, followed by 
religation.
The locations of the eight insertion mutants 
obtained is summarized in Table 3. Although there are 
Sau3A sites distributed along the length of the 140k coding 
sequences, all the insertions isolated were located within 
the N-terminal third of the protein. Upon sequencing the 
first of the mutants (pVIl), one nucleotide was found to 
have been deleted from within the filled in Sau3A site 
sequences, 3' to the fi’coRI linker, altering the 
translational reading frame downstream of the insert. Of 
the remaining plasmids, pVI2-pVI7 have insertions within 
homology region 1, whereas the insertion in pVI8 is located 
within region 2.
1.2. Trans-Activation of the HSV-1 gD Promoter by 140k and 
the Insertion Mutants
WS-HeLa cells were seeded at a density of 106 cells 
per 50mm petri dish and transfected by calcium phosphate 
precipitation as described in Section 2B.6.1. Transfections 
included 4yg of the CAT reporter plasmid, pgDCAT, and 4yg 
of pl40 or pVI plasmid. A negative control transfection was 
performed in which 4yg of pUC9 replaced pl40 (or pVI 
derivative). Cells were washed after 24h and replaced in 
fresh medium, and CAT extracts prepared after a further 24h 
(Section 2B.6.1). The CAT activity and protein 
concentrations of the extracts were determined (Sections 
2B.7 & 2B.8), and the percentage conversion from substrate 
to product per microgram of protein calculated.
Cotransfection of cells with pgDCAT and pl40 
resulted in CAT activity being increased around 100-fold 
above that obtained when cells were transfected with pgDCAT 
alone, demonstrating the powerful intrinsic
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trans-activation activity of VZV 140k. This increase was 
used as the assay to test the phenotype of the insertion 
mutants.
The activity of each of the seven in-frame
insertion mutants (pVI2-pVI8) was determined and expressed 
as a percentage of the activity of pl40. These data (Ml shown 
in Table 3. The activities of pVI4-pVI6 were 80-100% of 
that obtained with pl40, and these mutations can be 
considered as having no effect upon activity. Plasmids 
pVI2, pVI3, and pVI7 had activities in the range 30-50% 
and, although reduced relative to pl40, are still strong 
activators. In a similar analysis of Vmwl75 it was likewise 
found that many of the insertion mutations decreased
activity to 40-50% of the wild-type polypeptide^s activity,
indicating that the polypeptide was sensitive to small 
insertions in many regions (Paterson & Everett, 1988a). 
Thus none of the insertions between residues 48 and 418 
(and including the majority of region 1) greatly affected 
the trans-activation function of 140k. In contrast, the 
insertion in pVI8 clearly has a much more deleterious
effect on activity, reducing it to less than 1% of that
observed with pl40. Significantly, this insertion lies 
within homology region 2 which, in the case of Vmwl75, was 
found to be the most critical for trans-activation 
(Paterson and Everett, 1988a; DeLuca and Schaffer, 1988). 
Although only a single region 2 insertion mutant has been
isolated and characterized in 140k, it seems likely,
particularly given the extensive sequence homology between
region 2 of 140k and Vmwl75, that region 2 sequences of the 
two polypeptides fulfil similar roles in
trans-activation.
Table 3. A summary of the positions and activities of the 
insertion mutants. The insertions in plasmids pVIl to pVI8
are all into Sau3A restriction sites within the VZV 140k 
coding sequences of plasmid pl40. The coordinate given for 
each mutant is the position of the first base in the Sau3A 
site at which the insertion occurs, numbering from the 
first base of the reading frame. The insertion in pVI2 lies 
between two codons, whereas the remaining insertions all 
disrupt a codon. The amino acids inserted into or between, 
and their positions in the orf are shown. The 
trans-activation activity of the mutants was determined in 
transfection assays using pgDCAT, which contains the HSV-1 
glycoprotein D (gD) promoter linked to the coding sequences 
of the CAT reporter gene. The activities shown are 
expressed as a percentage of that obtained with pl40 in 
parallel experiments. These results are from a single 
experiment and were consistent with other independent 
experiments. (N.D.= no data.)
Insertion Site Trans-
Plasmid --------------------------------------------- Activation
Nucleotide Amino Acid Activity (%)
pVIl 142 Leu (48) N.D.
pVI2 189 Ile/Val (63/64) 55
pVI3 292 Leu (98) 27
pVI4 538 Gin (180) 100
pVI5 989 Ser (130) 85
pVT6 1088 Ser (363) 83
pVI7 1253 Ser (418) 63
pVI8 1415 Ser (472) 0.7
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3C.2. CONSTRUCTION OF PLASMIDS EXPRESSING CHIMERIC 
POLYPEPTIDES COMPOSED OF SEQUENCES DERIVED FROM VZV 140K 
AND Vmw 17 5
The aim of this work was to construct a series of
plasmids expressing chimeric 140k/Vmwl75 polypeptides. It
was hoped that analysis of such polypeptides might identify
regions of 140k that contribute to its potent
trans-activation phenotype (relative to Vmwl75) and,
furthermore, that such sequences might confer this
phenotype upon portions of Vmwl75. Likewise, Vmwl75 derived
sequences might confer upon portions of 140k the ability to
activate gene expression in synergy with VmwllO. Analysis
of intertypic recombinant viruses generated between HSV-1
and HSV-2 has demonstrated that chimeric proteins composed
of sequences from the type 1 and type 2 Vmwl75 proteins
(which are closely homologous) are fully functional during
virus infection (Smith and Schaffer, 1987a,b), indicating
that chimeric 140k/Vmwl75 polypeptides generated by this
£approach are likely to be functional.
2.1. Strategy
A panel of 39 plasmids (pll to pI39) harbouring a 
single insertion of 12 nucleotides (i.e. in-frame) within 
the Vmwl75 orf have been created by E’coRI oligonucleotide 
linker insertion mutagenesis of plasmid pl75, which 
contains a single copy of the HSV-1 IE3 gene (Paterson and 
Everett, 1988a).
Eight analogous plasmids (pVIl to pVI8) were
derived by insertional mutagenesis of pl40 (Section 3C.1). 
Seven of the insertions isolated were within region 1, and 
one in region 2.
It was proposed to utilize the unique EcoRl sites 
within pairs of insertion mutant plasmids (pVI and pi 
series) to join portions of the VZV 140k and Vmwl75 coding 
sequences.
The results of other "domain swap" experiments are
consistent with this view (see, for example, Ptashne,
1988).
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2.2. Rationale for Selecting Pairs of Plasmids
Pairs of pi and pVI series plasmids were selected 
according to the following criteria:
i) The function of the polypeptides expressed by 
the plasmids should not be significantly affected 
by the insertion mutations (i.e. the insertion 
should not lie within an important functional 
domain).
ii) The insertions should lie within the same 
translational reading frame such that sequences 
downstream of the 140k/Vmwl75 junction in the 
resulting chimeric construct are correctly 
translated.
iii) The insertions in the pair of plasmids should 
have approximately equivalent locations within the 
reading frames.
2.3. Transient Transfection Assay For Characterization of 
Chimeric Plasmids
All of the chimeric plasmids which will be 
described were tested for their ability to trans-activate 
expression from the HSV-1 gD promoter, both alone and in 
synergy with pill (which expresses VmwllO). Transfections 
contained 4pg of plasmid pgDCAT, 4pg of either pl40, pl75, 
or chimeric plasmid, and 4pg of plasmid pill where 
appropriate. The total amount of plasmid DNA in each 
transfection was equalized to 12pg with pUC9. The procedure 
for transfection and determination of CAT activities is 
described in Sections 2B.6.1 and 2B.7.
In a typical assay (Figure 15 and Table 4) 
cotransfection with either plasmid pl75 or pill (which 
express the HSV-1 transcriptional regulators Vmwl75 and 
VmwllO) resulted in CAT activity being increased 3- to 
5-fold above that obtained when cells were transfected with 
pgDCAT alone. However, when both pl75 and pill were 
present in transfections CAT activity was increased 
30-100-fold (reflecting synergistic activation), as
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described previously (Everett, 1987). In contrast, 
cotransfection with pl40 alone increased CAT activity by 
around 100-fold, and inclusion of pill in the transfection 
failed to increase CAT activity further.
2.4. Construction of Plasmids pVHSl and pHVZl
Plasmid pl40 trans-activates the gD promoter 
approximately 20- to 30-fold more efficiently than pl75, 
and it was of interest to determine the molecular basis for 
this striking difference. One possibility was the strength 
of the promoter sequences expressing 140k and Vmwl75 (in 
pl40 and pl75), which may not be equivalent; 140k is 
expressed from the VZV gene 62 promoter, whereas Vmwl75 is 
expressed from the SV40 early promoter/enhancer region.
(SV40 sequences are linked to the IE3 gene at nucleotide 
+27.) Thus if the gene 62 promoter is significantly 
stronger than the SV40 regulatory sequences (thereby
increasing the expression of 140k relative to Vmwl75 in
transfection assays), it could account, at least in part, 
for the efficiency with which pl40 activates gene 
expression. The first pair of chimeric plasmids, pVHSl and 
pHVZl, were constructed with this in mind.
The insertion mutant plasmids chosen for 
construction of this pair of chimeric plasmids were pll,
which has an insertion at nucleotide 33 of the Vmwl75 orf,
and pVI3, which has an insertion at nucleotide 292 of the 
140k orf. Fragments encoding promoter-leader sequences in 
their entirety (and a limited amount of linked N-terminal 
coding sequence) were exchanged between pVI3 and pll to 
create the chimeric plasmids pVHSl and pHVZl, as 
illustrated in Figure 14. Plasmid pVI3, like pl40 and 
other pVI plasmids, contains two Bamhl sites (see Section 
3A.2 and Figure 5). The cloning procedure required that the 
Bamtil-EcoRI fragment representing gene 62 sequences from 
-1146 to nucleotide 292 of the orf was excised, whilst 
leaving the residual coding sequences intact (i.e. avoiding 
cleavage by BamUI at 2198). Thus pVI3 was partially 
digested with BamHI, followed by extensive digestion with
Figure 14. A generalized sheme for construction of the pVHS 
and pHVZ series of chimeric plasmids. The chimeric plasmids 
were constructed using fragments derived from pairs of pVI 
and pi series plasmids. The pVI plasmids each contain a 
single in-frame EcoRI linker insertion within VZV 140k 
coding sequences (represented by the stippled section). 
VZV 140k coding sequences are expressed from the authentic 
VZV gene 62 promoter which is marked VZ. The two BairiHI 
sites in pVI plasmids, one of which is located immediately 
5' to the VZV insert (-1146), the other within the orf, are 
marked. The analogous pi plasmids contain EcoRI linker 
insertions within Vmwl75 coding sequences (represented by 
the open section). Vmwl75 coding sequences are expressed 
from the SV40 early promoter-enhancer region which is 
represented by the solid section and marked SV. The details 
of the cloning procedure are described fully in Section 
3C.2.4. Essentially, BamHI-EcoRI and Kpnl-EcoRI fragments 
(representing promoter sequences linked to N-terminal 
coding sequences) were excised from pVI and pi plasmids 
respectively as shown. The excised pVI BamBI-EcoRI 
fragment was ligated between the Kpnl and E’coRI sites of 
the pi plasmid to generate a pHVZ plasmid. Likewise, 
ligation of the excised Kpnl-EcoRI pi fragment between the 
BamHI and FcoRI sites of the pVI plasmid yielded a pVHS 
plasmid. Thus portions of N-terminal coding sequences and 
linked promoter sequences were exchanged.
pU
C9
 
oa 
PU
C9
ATGATG
vz
svvz
pVI
sv vz
Kpn/Bam
pHVZpVHS
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EcoRI, and both the excised Barriftl-EcoRI fragment (-1146 to 
292), and the appropriate partial digestion product 
isolated. The Kpnl-EcoRI fragment representing the SV40 
promoter-enhancer region linked to IE3 sequences (extending 
to nucleotide 33 of the orf) was excised from pll (and 
isolated), and replaced with the corresponding BamWI-EcoRI 
fragment (-1146 to 292) excised from pVI3, resulting in 
fusion of nucleotides 1-292 of the gene 62 orf to
t b  j  L i n k s /  £  Q-Cf i,{ w e e i )
nucleotides 34-3894 of the IE3 orfA, creating pHVZl. The 
chimeric polypeptide encoded by pHVZl, which consists of 
predominantly Vmwl75 sequences, is thus expressed from gene 
62 promoter sequences. In the reciprocal ligation, the 
KpnI-EcoRI fragment excised from pll (above) , was ligated 
between the BamHI and E’coRI sites of the pVI3 partial
digestion product, resulting in fusion of nucleotides 1-33
(b-1 LmKer soQi^ -encei )
of the IE3 orf to nucleotides 293-3930 of the gene 62 orfA, 
creating pVHSl. The VHS1 chimeric polypeptide, which 
consists predominantly of 140k sequences, is thus expressed 
from SV40 regulatory sequences. Ligation of BamHI 5'
overhanging ends to Kpnl 3' overhanging ends was
facilitated by inclusion of an 8-mer BamBI-Kpnl adaptor 
oligonucleotide, 5’GATCGTAC3’, in the ligations.
2.5. Plasmids pVHSl and pHVZl Activate Gene Expression with 
an Efficiency Similar to That of p!75
Plasmid pHVZl was found to be indistinguishable 
from its parent plasmid (pl75) in transfection assays 
(Figure 15 and Table 4), which indicates that the activity 
of pl75 does not reflect a reduced efficiency of SV40 
promoter sequences relative to gene 62 promoter sequences. 
Somewhat unexpectedly, however, pVHSl (which is composed 
predominantly of pl40 sequences), rather than having a
phenotype like pl40, was found to be equivalent to pl75 
both in the absence, and in the presence of pill (Figure 15 
and Table 4). Alterations in 140k coding sequences in pVHSl 
complicate the interpretation of this result. Either the 
promoter-leader sequences in pl40 and pl75 do indeed 
influence their phenotypes in transfections, or
Figure 15. CAT assays showing the relative trans-activation 
activities of pl40, pl75, and the chimeric plasmids, pVHSl
and pHVZl. The ability of the test plasmids to activate 
expression from pgDCAT, which contains the HSV-1
glycoprotein D (gD) promoter linked to the coding sequences
of the CAT reporter gene, was compared in transfection
assays. The CAT extracts were diluted 1:5 in the assays 
shown (all subsequent Figures show the results of assaying 
neat extract), (a). Activation alone. W.S. HeLa cells were 
transfected with 4ug pgDCAT plus 4ug of either pUC9 
(negative control), pl40, pl75, pVHSl, or pHVZl, as
indicated. The construction and structure of pVHSl and 
pHVZl is described in Section 3C.2.4(a). (b). Activation of
pgDCAT in the presence of VmwllO. The CAT assays in panel 
(b) represent transfection of cells with pgDCAT, test 
plasmid, and in addition, 4ug of plasmid pill, which
expresses VmwllO. The total amount of plasmid DNA in 
transfections was equalized by addition of pUC9 where 
appropriate. These assays graphically demonstrate the 
powerful trans-activation of pgDCAT by pl40 alone (panel 
(a)), and demonstrate synergistic. activation by the 
combination of Vmwl75 and VmwllO (the track in panel (b) 
marked pUC9 shows the low level of activation of pgDCAT by 
pill alone-compare to panel (a)) . The chimeric plasmids 
have phenotypes like that of pl75.

Trans-Activation Activity
Plasmid
Alone + p i l l
pl40 478 (88) 313 (114)
pl75 20 (13) 431 (129)
pVHSl 53 (10) 667 (33)
pHVZl 91 (32) 715 (304)
Table 4. Trans-activation by the chimeric plasmids pVHSl 
and pHVZl. The ability of plasmids pVHSl and pHVZl to 
activate expression from pgDCAT was compared to that of the 
parental plasmids in transfection assays (Section 3C.2.5). 
The CAT assays of a typical experiment are shown in Figure
15. The percentage conversion per microgram protein was 
calculated for each sample as described in Section 2B.7
using appropriate extract dilutions. The results shown are 
the mean of three independant experiments, with the 
standard deviation given in brackets. These results
demonstrate the powerful trans-activation by pl40 alone and 
also synergistic activation by pill in the presence of
pl75. The chimeric plasmids have phenotypes similar to that
of pl75.
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alternatively, the phenotype of pVHSl reflects these coding 
sequence alterations. To distinguish between these 
possibilities, it was necessary to construct two related 
plasmids (pl40SV and pl75VZ) by exchanging fragments 
encoding promoter-leader sequences in isolation. This is 
described in the next section.
It is especially interesting that pVHSl activates 
the gD promoter in synergy with pill. Since only 11 amino 
acids of the VHS1 polypeptide are derived from Vmwl75, the 
most likely interpretation of this result is that the 
ability of VHS1 to function in synergy with VmwllO reflects 
an intrinsic property of 140k. In agreement with this 
view, synergistic activation of both the VZV and HSV-1 tk 
promoters by 140k and VmwllO has been reported (Cabirac et 
al., 1990). The failure to detect this synergy when using
pgDCAT presumably reflects a property of this reporter
plasmid, rather than an inherent functional difference 
between 140k and Vmwl75. Supposing the gD promoter were 
maximally activated by 140k alone, then synergy with VmwllO 
would not be detected as CAT activity would not be 
increased. If, however, the intrinsic activity of 140k were 
reduced (perhaps by small alterations such as those in
pVHSl) and the gD promoter was no longer maximally
activated, then the ability of 140k to function in synergy 
with VmwllO might be revealed.
2.6. Construction of Plasmids p!40SV and p!75VZ
To enable construction of chimeric plasmids in
which only promoter-leader sequences were exchanged between 
pl40 and pl75, it was first necessary to generate
derivatives of these plasmids (pl40ET and pl75ET) with
unique E’coRI sites located just upstream of the 5' ends of 
their respective transcripts. The construction of pl40ET by 
site-directed mutagenesis is described in Section 3B.1.3.
Plasmid pl75 was modified by converting the BstEII 
sife at position +239 of the p!75 leader sequences (65
nucleotides upstream of the ATG codon) to an EcoRI site, to 
yield pl75ET. Plasmid pl75 was partially digested with
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BstEII (as it contains a second BstEli site) and singly 
cut linear plasmid molecules isolated. A partially 
double-stranded oligonucleotide linker was designed in 
which the central region contained an EcoRI site, while the 
5' overhangs were complimentary to those of the BstEII 
site. Thus the oligonucleotide 3’GT(G/C)ACGAATTC3’ was 
synthesised and ligated directly with the BstEII linearized 
pl75 DNA (following phosphorylation of 5' ends), and the 
desired clone isolated.
Plasmids pl40SV and pl75VZ resulted from the 
exchange of BamUI-EcoRI and Kpnl-EcoRI fragments 
(containing promoter-leader sequences) between pl40ET and 
pl75ET. Their construction followed the scheme outlined for 
construction of pVHSl and pHVZl (Figure 14, Section 2.4), 
pl40ET replacing pVI3, and pl75ET replacing pll.
2.7. Promoter-Leader Sequences do not Influence the 
Phenotypes of p!40 and p!75 in Transfection Assays
The effect of promoter-leader sequences on the 
phenotypes of pl40 and pl75 were assessed by determining
the phenotypes of pl40SV and pl75VZ in transfection assays.
The CAT assays from a single experiment are shown 
in Figure 16. The activity of pl40 in this experiment was 
reduced 5- to 10-fold relative to that of earlier 
experiments (Figure 16 and Table 4). Furthermore, inclusion 
of pill in the transfection reduced the activity of pl40 by 
2- to 3-fold. A similar reduction was observed in later 
assays where, in addition, synergistic activation by pill 
in the presence of pl75 was only about 5- to 10-fold, 
values of 30- to 100-fold being more typical (Section
3C.2.3 and Table 4). This is reflected in the results given 
in Table 5. This effect is probably attributable to an 
alteration in the state of the cells (reflecting, for
example, variability in batches of serum). Similar 
variation in transfection data as a result of minor 
alterations in experimental conditions has been reported 
(Everett, 1988). Nevertheless, the assay still clearly 
differentiated between pl75 and pl40, and moreover, between
Figure 16. Promoter-leader sequences do not influence the
phenotypes of pl40 and pl75 in transfection assays. VZV 
gene 62 and SV40 promoter-leader sequences in pl40 and pl75 
respectively, were exchanged to create pl40SV and p!75VZ
(see Section 3C.2.4(c)). Thus VZV 140k and Vmwl75 coding
sequences in these chimeric plasmids are expressed from 
from heterologous promoter-leader sequences. The ability of 
pl40SV and pl75VZ to activate expression from pgDCAT was 
compared with that of the parental plasmids in 
transfection assays, (a). Activation alone. W.S. HeLa cells 
were transfected with 4ug pgDCAT plus 4ug of either pUC9 
(negative control), pl40, pl75, pl40SV, or pl75VZ, as
indicated, (b). Activation of pgDCAT in the presence of 
VmwllO. The CAT assays in panel (b) represent transfection 
of cells with pgDCAT, test plasmid, and in addition, 4ug of 
plasmid pill, which expresses VmwllO. The total amount of 
plasmid DNA in transfections was equalized by addition of 
pUC9 where appropriate. These assays demonstrate that
pl40SV and pl75VZ have phenotypes like that of their 
parental plasmids.

Table 5. Promoter-leader sequences do not influence the 
activities of pl40 and pl75 in transfection assays. The 
ability of plasmids pl40SV and pl75VZ to activate 
expression from pgDCAT was compared with that of the 
parental plasmids in transfection assays (Section 3C.2.4).
The CAT assays of a single experiment are shown in Figure
16. The percentage conversion per microgram protein was 
calculated for each sample as described in Section 2B.7
using appropriate extract dilutions. The results shown give 
the mean and standard deviation (brackets) of at least 
three independent experiments. Note that the activity of 
pl40 is reduced compared to earlier experiments (Table 4), 
with a further reduction of 2- to 3-fold being observed in 
the presence of pill. Furthermore, activation by pill in 
the presence of pl75 was significantly reduced compared to 
earlier experiments (Table 4). Nevertheless, the assay
still clearly differentiates between pl40 and pl75, and 
more importantly between pVHSl (and pHVZl) and pl40, and 
demonstrates that pl40SV and pl75VZ have phenotypes like 
those of their parent plasmids.
Plasmid
Trans-Activation Activity 
Alone +plll
pl40 92 (26) 25 (5)
pl75 9 (3) 30 (11)
pVHSl 6 (1) 42 (10)
pHVZl 12 (4) 24 (8)
pl40SV 84 (18) 26 (8)
p!75VZ 5 (2) 28 (19)
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pVHSl (and pHVZl) and pl40 (Table 5). Plasmids pl40SV and 
pl75VZ activated the gD promoter with comparable efficiency 
to their parent plasmids (pl40 and pl75 respectively), thus 
demonstrating that the promoter-leader sequences in pl40 
and pl75 do not influence their phenotypes in transfection 
assays.
3C. 3. CONSTRUCTION AND CHARACTERIZATION OF PLASMIDS WITH 
DEFINED DELETIONS IN THE N-TERMINAL CODING SEQUENCES OF 
140k
The phenotype of plasmid pVHSl appears, therefore, 
to be a consequence of alterations in coding sequences 
(rather than regulatory sequences). During construction of 
pVHSl, the N-terminal 98 amino acids of 140k were removed, 
and are replaced with the N-terminal 11 amino acids of 
Vmwl75. Thus, either the N-terminal 98 amino acids of 140k 
have a critical role in activation, or alternatively, the 
N-terminal residues derived from Vmwl75 somehow reduce the 
activity of residual 140k sequences. The latter seems 
unlikely as five of these 11 Vmwl75 residues are conserved 
in the N-terminus of 140k (Figure 17). Therefore, defined 
deletions were created within residues 1-98 of 140k in 
order to assess their possible role in trans-activation. 
This is described in the following sections.
3.1. Construction of Plasmid p!40dell
Plasmids pVIl and pVI3 contain single EcoRI linkers 
inserted into the gene 62 orf at nucleotides 142 and 292 
respectively (Section 3C.1.1). Plasmid pl40dell, in which 
an in-frame deletion removes nucleotides 142-292 of the 
orf (codons 48-98), was created from pVIl and pVI3 as 
follows. The BamUI-EcoRI fragment of pVI3, representing 
gene 62 sequences from -1146 to nucleotide 292 of the orf, 
was excised (as described in Section 3C.2.4), and replaced 
by the corresponding fragment from pVIl, which extends to 
only nucleotide 142 of the orf. (The single nucleotide 
deletion in pVIl noted in Section 3C.1.1 is located 3' to 
the EcoRI linker and will not be contained in the fragment
1 MDTPPMQRSTPQRAGS.. 16 VZV 140K
i i i i i
t i i i i
1 MASENKQRPGS.. 11 Vmwl75
Figure 17. Limited N-terminal homology between VZV 140k and
Vmwl75. The N-terminal 16 amino acids of VZV 140k are shown 
aligned with the N-terminal 11 amino acids of Vmwl75. Five 
out of eleven of the Vmwl75 residues are conserved in 
VZV 140k.
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used in this procedure.)
3.2. p!40dell Activates Gene Expression as Efficiently as 
P140
Coding sequences deleted from gene 62 during
construction of pl40dell include a stretch of 19 amino 
acids, nine of which are acidic, a property associated with 
the activation domains of a class of transactivators which 
includes GAL4 of Saccharomyces cerevisiae (Ma and Ptashne, 
1987), and Vmw65 of HSV-1 (Triezenberg et al., 1988;
Sadowski et al., 1988) (see Section IB.3.1. [d]) . However,
activation of gene expression in transfection assays by
ia  th-d. t U x & n c - e  e f  i &
plasmids pl40dell and pl40 is indistinguishable^(Figure 18*v 
and Table 6), thus demonstrating that amino acid residues 
48-98 of 140k are not essential for fully efficient
trans-activation by the polypeptide.
3.3. Construction of p!40delMl and p!40delM2
Two further defined deletions were created within the 
N-terminus of 140k by M13 mutagenesis, one removing
nucleotides 7-57 (codons 3-19), and a second removing
nucleotides 58-117 (codons 20-39). The single-stranded 
template DNA used for mutagenesis was prepared from M13E13 
(described in Section 3B.1.3), which contains gene 62 
sequences from -1146 to nucleotide 1412 of the orf (on a 
BamUl-EcoRI fragment) ligated between the BamUl and EcoRI 
sites of M13 mpl8 (nucleotide +57 of gene 62 having been 
mutated from A to G to create an EcoRI site at +57). The 
procedure for Ml3 deletion mutagenesis is essentially as 
described for point mutagenesis (Section 2B.23), except 
that the mutagenic oligonucleotides contain deletion rather 
than point mutations. Following mutagenesis, mutant phage 
were plaque purified and their sequence confirmed by 
dideoxy sequencing.
The mutations thus created were transferred to 
pl40 by replacing the wt BamHI-EcoRV fragment, which 
encodes gene 62 sequences from -1146 to nucleotide 1245 of 
the orf, with the corresponding BamHI-EcoRV fragments from
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the mutant M13 clones, which contain the deletions. Plasmid 
pl40 was partially digested with BamHI, followed by
complete digestion with EcoRV. The appropriate partial 
digestion product was isolated (from which the above wt
BamUI-EcoRV fragment had been excised), and ligated
directly with the mutant BamHI-EcoRV fragments, yielding 
pl40delMl and pl40delM2.
3.4. The Deletions Contained in p!40delMl and p!40delM2 do 
not Impair Trans-Activation
Plasmids pl40delMl and pl40delM2 were found to 
activate the gD promoter as efficiently as pl40 in
transfection assays (Figure 19), demonstrating that amino 
acid residues 3-19, and 20-39, are also dispensable for 
fully efficient activation. The degree of synergy between 
pl75 and pill was low (2 fold), and activation by pl40 was 
again reduced by cotransfection with pill, as noted in 
Section 3C.2.7). Despite these variations, all previously 
characterised plasmids behaved in a predictable manner.
3C.4. What is the Basis of the Reduced Activity of the VHS1 
Polypeptide?
The importance of residues 1-98 of 140k in
trans-activation was suggested following analysis of pVHSl 
(Section 3C.2.5) and pl40SV (Section 3C.2.7), However, the 
results obtained with pl40dell (Section 3C.3.2), and with 
pl40delMl and pl40delM2 (Section 3C.3.4), argue against the 
importance of these residues. It is possible that the 
deletions in the above constructs, which only remove 
portions of residues 1-98, are insufficient to alter the
activity of 140k. With this in mind, plasmid pl40d@198 was
constructed in which gene 62 sequences from nucleotide +57 
to nucleotide 292 (codon 981 of the orf are deleted. The 
polypeptide expressed by pl40del98 has not been 
characterized, but must be N-terjninally truncated to at 
least amino acid 99. (Codon 99, an ATG codon, way serve as 
a site for initiation of translation, permitting expression 
of a polypeptide lacking amino acids 1-98, although
Figure 18. CAT assays showing that pl40dell activates gene 
expression as efficiently as pl40. Activation of pgDCAT by 
pl40dell and pl40 was compared in transfection assays. 
Plasmid pl40dell contains an in-frame deletion removing 
codons 48-98 of the VZV 140k orf. (a). Activation alone. 
W.S. HeLa cells were transfected with 4ug pgDCAT plus 4ug 
of either pUC9 (negative control), pl40, pl75, pHVZl,
pVHSl, or pl40dell, as indicated, (b). Activation of pgDCAT 
in the presence of VmwllO. The CAT assays in panel (b) 
represent transfection of cells with pgDCAT, test plasmid, 
and in addition, 4ug of plasmid pill, which expresses 
VmwllO. The total amount of plasmid DNA in transfections 
was equalized by addition of pUC9 where appropriate. Note 
that synergistic activation by pl75 in the presence of pill 
is reduced compared to earlier assays in Figures 15 and 16 
(compare the track marked pl75 in panel (b) with that in 
(a)). This is discussed in Section 3C.2.4(d). However, the 
assay still clearly differentiates between pl40 and pl75, 
and shows that pl40dell activates pgDCAT as efficiently as 
does pl40.

Trans-Activation Activity
Plasmid -------------------------
Alone +plll
pl40 132 20
pl75 12 27
pVHSl 7 60
pHVZl 15 20
pl40dell 156 71
Table 6. Plasmid pl40dell activates gene expression as 
efficiently as does pl40. The ability of plasmid pl40dell 
to activate expression from pgDCAT was compared to that of 
pl40 in transfection assays (Section 3C.3.2). The CAT 
assays of a single experiment are shown in Figure 18. The 
percentage conversion per microgram protein was calculated 
for each sample as described in Section 2B.7 using 
appropriate extract dilutions. The results shown are from a 
single experiment. A number of independent experiments were 
performed, and although the transfection efficiency varied 
between experiments, the pattern of results obtained was 
essentially consistent with those shown.
Figure 19. CAT assays showing that pl40delMl and pl40delM2 
activate gene expression as efficiently as pl40. Activation 
of pgDCAT by pl40delMl, pl40delM2, pl40, and other 
previously characterized plasmids was compared in 
transfection assays. Plasmids pl40delMl and pl40delM2 
contain in-frame deletions removing codons 3-19 and 20-39 
respectively of the VZV 140k orf. (a). Activation alone. 
W.S. HeLa cells were transfected with 4ug pgDCAT plus 4ug 
of either pUC9 (negative control), pl75, pl40, pl75VZ,
pl40SV, pHVZl, pVHSl, pl40dell, pl40delMl, or pl40delM2, as 
indicated, (b). Activation of pgDCAT in the presence of 
VmwllO. The CAT assays in panel (b) represent transfection 
of cells with pgDCAT, test plasmid, and in addition, 4ug of 
plasmid pill, which expresses VmwllO. The total amount of 
plasmid DNA in transfections was equalized by addition of 
pUC9 where appropriate. A single experiment was performed 
and the results were not quantitated.
pUC9
pl75
p l 4 0
pl75VZ
p l4 0 S V
pHVZl
pVHSl
p l 4 0 d e l l
p l4 0 d e l M l
p l4 0 d e lM 2
121
initiation could occur further downstream resulting in even 
greater truncation.) The finding that the activity of 
pl40del98 is 50-100% of that obtained with pl40 (results 
not shown) is further evidence that the N-terminal 98 
residues of 140k are non-essential in trans-activation 
transfection assays.
It appears then that the Vmwl75 residues in pVHSl 
are decreasing the activity of residual 140k sequences 
which, in isolation, are fully functional. By analogy, it 
might be predicted that removal of these same sequences 
from the N-terminus of Vmwl75 (as occurs in pHVZl) would
result in the polypeptides activity being increased.
However, pHVZl exhibits an activity that is 
indistinguishable from wt pl75. Thus whatever the mechanism 
by which these sequences mediate their effect in pVHSl, it 
presumably does not reflect a similar role in Vmwl75. That 
is, the low activity of Vmwl75 compared to 140k inferred 
from transfection assays is not attributable to these 
sequences. Their effect in pVHSl is probably highly
dependent on the particular environment in which they are 
located, and thus confined to pVHSl. As such, it is 
unlikely that pVHSl is revealing anything of significance 
regarding the function of 140k or Vmwl75.
3C.5. LIMITATIONS OF TRANSFECTION ASSAYS IN THE STUDY OF 
PROTEIN FUNCTION
When studying the function of a polypeptide by 
determining the effects of small insertion or deletion 
mutations (within the coding sequences) in transfection 
assays (or by analysis of chimeric polypeptides), it is 
assumed that wt and mutant plasmids are expressing 
equivalent amounts of polypeptides, and thus any change in 
activity is attributed to an alteration in the intrinsic 
activity of the polypeptide. In many cases this assumption 
is doubtless correct. Nevertheless, there is clearly the 
potential for such alterations to affect the levels of a 
protein which are expressed. For example, the mRNA might 
become less stable, or might have an altered secondary
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structure which reduces the rate of translation initiation 
or elongation. Alternatively, the protein product may have 
reduced solubility or stability. These complications should 
be borne in mind when interpreting such data. Indeed the 
phenotype of pVHSl may be explained by just such effects 
since the alterations in 140k/Vmwl75 coding sequences are 
in the vicinity of the Vmwl75 ATG start codon (at which 
translation of the VHS1 polypeptide presumably initiates), 
and may thus reduce the stability of the mRNA or the rate 
of initiation or elongation of translation as outlined.
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3D. REPRESSION OF EXPRESSION FROM THE VZV GENE 62 PROMOTER 
BY VZV 140K AND HSV-1 Vmwl75 AND THEIR MUTANT DERIVATIVES
During HSV-1 infection of tissue culture cells, 
expression of IE gene 3 is subject to autoregulation or 
repression by its product, Vmwl75 (see Sections IB.3.2 and 
1C.2.4). Repression of the IE-3 promoter by Vmwl75 has been 
reproduced in transfection assays (O'Hare and Hayward, 
1985a), and it has been demonstrated that region 2
polypeptide sequences have a critical role in the 
autoregulation phenotype (Paterson and Everett, 1988a; 
DeLuca and Schaffer, 1988; Shepard et al., 1989). Since the 
sequences comprising region 2 of Vmwl75 and VZV 140k are 
among the most highly conserved between the two proteins 
(McGeoch et al., 1986), it was of interest to determine 
whether VZV 140k exhibited similar autoregulation of its 
own promoter. To this end plasmid pl40CAT was constructed 
in which the promoter-leader sequences of VZV gene 62 
drive the expression of the CAT gene (Figure 20). The 
following sections describe the results of co-transfection 
experiments utilizing pl40CAT in which the ability of 
VZV 140k to repress gene 62 promoter activity was assessed.
It has been reported that gene 62 promoter activity is
increased about 15-fold by co-transfection of pl40CAT with 
a plasmid expressing Vmw65 (McKee et al., 1990), and
transfection assays were carried out both in the absence 
and in the presence of stimulation by Vmw65. The results 
demonstrate that 140k strongly represses both the basal 
and Vmw65-stimulated levels of expression from the gene 62 
promoter, as does Vmwl75. Moreover, genetic evidence was 
obtained which indicates that the two polypeptides repress 
gene expression by a related mechanism.
3D.1. Plasmids
P l a s m i d  pl40CAT c o n t a i n s  VZV g e n e  62 p r o m o t e r  and
upstream sequences from the Clal site (-1146) to nucleotide 
+57 cloned upstream of the chloramphenicol acetyl
transferase (CAT) gene in the vector pCAT, which was
derived from pBLW2 (Gaffney et al, 1985). A Smal BglII
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fragment representing the above sequences was isolated from 
pl40BT (see Section 3B.1.3), and inserted between the Smal 
and BamUl sites of pCAT to generate pl40CAT (Figure 20).
pl40dellCAT and pl40del2CAT are largely identical 
to pl40CAT, but contain deletions within the gene 62 
capsite~leader region. Fragments containing these 
deletions were isolated from plasmids pTM14CAT and pTM15CAT 
(Tom A. McKee, Ph.D thesis, University of Glasgow, 1990). 
Plasmid pTM14CAT (Figure 21) contains an Xbal-Hindlll
fragment representing sequences upstream of gene 62 from 
DdeI (-781) to Seal (-22) inserted upstream of the CAT gene 
in a derivative of pFJ3 (Rixon and McLauchlan, 1990). The 
Xbal and Hindlll sites are derived from polylinker
sequences flanking the VZV insert in the parent plasmids.
Plasmid pTM14CAT was modified by inserting a double 
stranded oligonucleotide encoding VZV sequences from the 
Afllll site (-33) to +20 to create pTM15CAT (Figure 21). 
The oligonucleotide was designed to have 5'-overhanging 
ends complimentary to those produced by Ajfllll and BanMl. 
pTM14CAT was partially digested with AflIII and then 
cleaved to completion with BanMl (which cleaves a BamHI 
site in the polylinker sequences located between the VZV 
insert and the CAT gene), and the oligonucleotide ligated 
between the Afllll and BanMl sites to produce pTM15CAT. 
Thus in pTM15CAT VZV sequences from -22 to +20 replace the 
polylinker sequences located between the VZV insert and the 
CAT gene in pTM14CAT.
Plasmids pTM14CAT and pTM15CAT lack VZV sequences 
from Clal (-1146) to Dde I (-781) present in pl40CAT, and 
thus cannot be compared directly to pl40CAT in transfection 
assays to determine the effect of the capsite-leader 
deletions. Thus Xhol-EcoRl fragments containing gene 62 
upstream sequences (and including the region harbouring the 
deletions and the 5'-end of the CAT gene) were excised 
from pTMl5CAT and pTM14CAT, and replace the full length 
Xhol-EcoRl fragment of pl40CAT to create pl40dellCAT and 
pl40del2CAT respectively (Figure 21). pl40dellCAT is 
identical to pl40CAT except that it lacks residues +20 to
-1146
Smal
+57
G E N E  6 2  C O N T R O L  S E Q U E N C E S
Bgin
+1
BamHI
CAT
\
\
/
J
Figure 20. Structure of plasmid pl40CAT. A Smal-Bglll 
fragment representing VZV gene 52 sequences from -1146 
{ClaD to +57 (and containing the complete promoter of the 
gene) was isolated from plasmid pl40BT (McKee et al., 1990) 
and inserted between the Smal and BamHI sites of the vector 
pCAT, upstream of the chloramphenicol acetyl transferase 
(CAT) coding sequences, to generate pl40CAT. The 
transcription start site (+1) is indicated. The Smal site 
is derived from pUC9 polylinker sequences located 5' to the 
VZV insert in pl40BT. The Bglll site is the result of a 
two-step mutagenesis protocol in which nucleotide +57 (of 
gene 62) was first mutated, changing the sequence from 
AAATTC to GAATTC, the resulting EcoRl site was subsequently 
modified by linker insertion to create the unique Bglll 
site in pl40BT.
Figure 21. Plasmids containing VZV gene 62 control 
sequences linked to the CAT gene. VZV gene 62 sequences are 
represented by the open boxes, and the solid boxes 
represent N-terminal coding sequences of the CAT reporter 
gene. Some restriction enzyme recognition sites and their 
coordinates (relative to the transcription start site, +1) 
are marked. a) Plasmid pTM14CAT contains VZV gene 62 
sequences from Xbal (-784) to Seal (-22) linked to the CAT 
gene. Polylinker sequences containing the restriction 
enzyme sites Pstl-Hindlll-Pstl-Sail-BamHI are located 
between the VZV insert and the CAT gene in pTM14CAT. 
Plasmid pTM15CAT was created by inserting a double-stranded 
oligonucleotide representing VZV gene 62 sequences from 
Afllll (-33) to +20 between the Afllll and BamHI sites of 
pTM14CAT, thus replacing the polylinker sequences in 
pTM14CAT with VZV sequences from -22 to +20. b) Plasmid 
pl40CAT contains VZV gene 62 sequences from Smal (-1184) to 
+57 (Bglll) linked to the CAT gene (see Section 3D.1). 
Plasmids pl40dellCAT and pl40del2CAT were created by 
replacing the Xhol (-129) to EcoRI (CAT) fragment 
(representing VZV sequences from -129 to +57 linked to the 
CAT gene) with the corresponding Xhol-EcoRI fragments from 
pTMl^CAT and pTM14-CAT respectively (which contain deletions 
in the capsite-leader region).
P stI P stI B a m H I 
H in d l l l  S a il
N  /
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+57 of gene 62; pl40del2CAT lacks residues -22 to +57 and 
thus the bona fide VZV transcription start site.
3D.2. The Assay
BHK cells, at a density of 106 cells per 50mm dish, 
were transfected (as described in Section 2B.6.1) with 4ug 
pl40CAT in the presence or absence of pMCl (which expresses 
Vmw65) and increasing amounts of pl40SV. The total amount 
of plasmid DNA in each transfection was equalised to 14ug
by addition of pUC9. Plasmid pl40SV contains the VZV 140k
transcription unit (without its own promoter) linked to the 
SV40 early promoter and enhancer region (see Section 
3C.2.6), and was used to express VZV 140k. The use of 
pl40SV (rather than a plasmid which expresses VZV 140k from 
the gene 62 promoter) reduces difficulties in the
interpretation of the results which would arise from 
promoter competition effects and through repression of the 
gene 62 promoter in the VZV 140k expression plasmid. CAT 
extracts were prepared 48 hours after transfection and CAT 
activities determined as described in Section 2B.7. The 
protein concentrations of the extracts were determined 
(Section 2B.8) and the percentage conversion from substrate 
to product per microgram protein calculated. The CAT
activities of extracts prepared from cells transfected with 
test plasmid were expressed as a percentage of the control 
value (no test plasmid), and the results depicted
graphically.
3D.3. REPRESSION EXPERIMENTS
3.1. Repression by VZV 140k
The results of a typical repression experiment are 
shown in Figure 22 and are depicted graphically in Figure 
23. Transfection of pl40C.AT alone into cells resulted in 4% 
conversion per microgram protein (which represents a total 
conversion of 36% in the assay), and inclusion of pMCl in 
the transfection increased CAT activity by 30-fold
(determined using suitable extract dilutions). The results 
clearly show that both the basal and Vmw65-stimulated
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levels of CAT activity from pl40CAT were repressed by up to 
50-fold by the addition of increasing amounts of pl40SV. 
The repression is not due to promoter competition effects 
since transfection with equivalent molar amounts of pSVEB 
(which contains the SV40 promoter region present in pl40SV, 
but lacks coding sequences) resulted in levels of 
repression which were insignificant compared to those 
induced by pl40SV. Similar results were obtained using Vero 
cells (data not shown).
It should be noted that repression of the gene 62 
promoter by pl40SV was most clearly observed when the
levels of CAT activity in control transfections were high 
(about 50-200 fold above background). If the cells 
transfected poorly then the degree of repression was
correspondingly reduced (as might be expected). Since 
repression was always most clearly observed with high level 
expression from the gene 62 promoter, most experiments
which will be described included pMCl.
3.2. Vmwl75 Represses the Gene 62 Promoter, But VZV 140k 
Does Not Repress the HSV-1 IE-3 Promoter
The results presented above clearly demonstrate
that co-transfection of pl40SV represses the gene 62 
promoter. Given the functional similarities of VZV 140k and 
Vmwl75 in transactivation transfection assays (Everett, 
1984; Inchauspe et al., 1989; Cabirac et al., 1990), it was 
of interest to determine whether the two proteins were 
functionally interchangeable in repression transfection 
assays. Therefore pl40CAT was co-transfected with 
increasing amounts of pl75 (expression of Vmwl75 in pl75, 
like that of 140k in pl40SV, is driven by the SV40 early 
promoter region). The results show that Vmwl75 also 
represses the gene 62 promoter with an efficiency similar 
to that of VZV 140k (Figure 24). The converse experiment to 
determine whether 140k is able to repress the HSV-1 IE-3 
promoter was performed in Vero cells, the cell-type in 
which repression of the IE-3 promoter by Vmwl75 was first 
demonstrated (O'Hare and Hayward, 1985a). (As noted above,
127
140k efficiently represses the gene 62 promoter in Vero 
cells as well as BHK cells.) Plasmid pIE3CAT (in which the 
HSV-1 IE-3 promoter drives expression of the CAT gene) 
replaced pl40CAT as reporter plasmid in these experiments. 
Figure 25 shows the results of a single experiment in which 
pIE3CAT was cotransfected into cells with pMCl and
increasing amounts of test plasmids. The pMCl stimulated
level of expression from pIE3CAT was of the same order as 
that from pMCl stimulated pl40CAT. IE-3 promoter activity 
showed a small reduction in the presence of pSVEB, a 
maximum of 2-fold being observed at the highest level of 
plasmid. Titration of pl75 led to a greater reduction in 
activity, being 4-fold in the presence of 8ug pl75. 
Although this was less efficient than in previous assays 
(Paterson and Everett, 1988a), it does confirm repression 
of the IE3 promoter by Vmwl75. In marked contrast,
titration of pl40SV resulted in an increase in IE-3 
promoter activity of 2- to 4-fold. In agreement with this, 
it was found that in BHK cells pl40SV strongly 
transactivated the basal level of expression from the IE-3 
promoter (in the absence of pMCl) approximately 40-fold 
(data not shown). Therefore, although both VZV 140k and 
Vmwl75 repress their respective promoters, the mechanisms 
by which this occurs are not entirely interchangeable.
3.3. Repression of the Gene 62 Promoter by VZV 140k and 
Vmwl75 Requires the Integrity of Homology Region 2
The integrity of homology region 2 of Vmwl75 (amino 
acid residues 315-484) has been shown to be of crucial 
importance for repression of the IE-3 promoter (Paterson 
and Everett, 1988a; DeLuca and Schaffer, 1988; Shepard et 
al., 1989). To determine whether region 2 of Vmwl75 was 
also involved in the repression of the gene 62 promoter, 
plasmid pI13 (Paterson and Everett, 1988a) was 
co-transfected in increasing amounts with pl40CAT. Plasmid 
pT13 contains an in-frame insertion of four amino acids 
into the proline codon at position 324 of Vmwl75 (within 
region 2; Paterson and Everett, 1988a). The effect of the
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mutation is to essentially eliminate repression of the IE-3 
promoter by Vmwl75 (Paterson and Everett, 1988a). The same 
effect was observed in co-transfections of pl40CAT and pI13 
(Figure 24). Therefore the same region of Vmwl75 is 
involved in the repression of both the gene 62 and IE-3 
promoters.
Plasmid pVI8 encodes a mutant form of VZV 140k
which is analogous to the protein expressed by pI13. It was 
derived from pl40 (as described in section 3C.1.1) and 
contains a mutation resulting in the insertion of four 
amino acids into the serine codon at position 472 of 140k, 
which lies within region 2 (amino acid residues 467-641). 
Like pI13, pVI8 was unable to repress pl40CAT (Figure 24). 
The interpretation of this result is potentially
complicated since pVI8 uses the gene 62 promoter instead of 
the SV40 early promoter in pl40SV. This raises the
possibility that the lack of repression by pVI8 is not due 
to the mutation in region 2 of VZV 140K but that 
autoregulation of VI8 polypeptide expression from pVI8 
results in insufficient protein to repress the gene 62 
promoter in pl40CAT as well. However, it is difficult to
envisage how the VI8 polypeptide might repress its own 
expression from pVI8 without also reducing gene 62 promoter 
activity in pl40CAT. In addition, in trans-activation 
transfection assays the VI8 mutation, like that of pI13
(Paterson and Everett, 1988a), eliminates the ability of 
plasmid pVI8 to trans-activate the HSV-1 glycoprotein D 
(gD) promoter (which is activated 50-100-fold by 140k; see 
section 3C.1.2). Therefore it is most likely that, as with 
the mutations in region 2 of Vmwl75 (Paterson and Everett, 
1988a; Deluca and Schaffer, 1988; Shepard et al., 1989), 
the VI8 mutation results in an inactive polypeptide. The 
experiment therefore demonstrates that the same homologous 
regions of Vmwl75 and VZV 140k are involved in the
repression of their respective promoters.
Figure 22. CAT assays showing repression of the VZV gene 62 
promoter by VZV 140k. (a). Repression of the cis-activated
level of expression from pl40CAT. BHK cells were 
transfected with 4ug pl40CAT alone (tracks 1 and 6) or with 
in addition increasing amounts of pl40SV (tracks 2-5; 1, 2, 
4 and 8ug respectively) or pSVEB (tracks l-iO; 0.5, 1, 2 and 
4ug respectively). The negative control plasmid, pSVEB, 
lacks coding sequences present in pl40SV and is 
consequently approximately half the size. Hence the actual 
amounts used in transfections were 0.5, 1, 2 and 4ug to
maintain a molar equivalence of common sequences, (b). 
Repression of the Vmw65 trans-activated level of expression 
from pl40CAT. This experiment was performed essentially as 
described in (a), except all transfections contained in 
addition 2ug of plasmid pMCl, which expresses Vmw65. Tracks 
1 and 6 show the strong stimulation of pl40CAT by pMCl. 
Cotransfection of increasing amounts of pl40SV causes 
repression of both the cis- and trans-activated levels of 
expression from pl40CAT not caused by cotransfection of 
pSVEB, which contains only promoter sequences. These 
results are depicted graphically in Figure 23 taking 
account of the protein concentrations in the extracts.
(a)
1 2  3 4 5 6 7 8 9 10
Figure 23. Graph showing repression of the cis- and 
trans-activated levels of expression from VZV gene 62 
promoter-leader sequences (in pl40CAT) by VZV140k. BHK
cells were transfected with 4pg of pl40CAT and increasing 
amounts of pl40SV (which expresses VZV 140k; 1, 2, 4 and
8pg) or pSVEB (0.5, 1, 2 and 4pg), in the presence or 
absence of pMCl (which expresses Vmw65). The negative 
control plasmid, pSVEB, lacks coding sequences present in 
pl40SV and is consequently approximately half the size. 
Hence the actual amounts used in transfections were 0.5, 1, 
2, and 4ug to maintain a molar equivalence of common 
sequences. The relative CAT activities (determined as 
described in the text) from a typical titration experiment, 
the CAT assays of which are shown in Figure 22, are shown 
plotted against the amount of test plasmid DNA added. The 
degree of repression observed in titration experiments was 
variable, and almost certainly reflects the variation in 
levels of expression from the gene 62 promoter noted in the 
text. However, the experiment in the presence of pMCl has 
been repeated many times, and in all cases the pattern of 
results was consistent with those above. The titration in 
the absence of pMCl was performed twice, and in both cases 
the results clearly showed repression.
RE
LA
TI
VE
 
CA
T 
AC
TIV
ITY
 
(%
)
1000
100 -i
1 086420
p 1 4 0 S V  
p S V E B
p 1 4 0 S V + p M C 1
p S V E B + p M C 1
PLASMID DNA (ug)
Figure 24. Graph showing repression of expression from VZV 
gene 62 promoter-leader sequences (in pl40CAT) by VZV140k, 
Vmwl75f and their mutant derivatives. BHK cells were 
transfected with 4pg of pl40CAT and increasing amounts of 
test plasmids (1, 2, 4 and 8ug) or pSVEB (0.5, 1, 2 and 
4pg; see the legend to Figure 23), in the presence of pMCl 
(which expresses Vmw65). The test plasmids used express the 
following polypeptides: VZV 140k (pl40SV); Vmwl75 (pl75); 
Vx<5 and 113, insertion mutant derivatives of 140k and 
Vmwl75 respectively (pVI& and pI13). The relative CAT 
activities (determined as described in the text) are shown 
plotted against the amount of test plasmid DNA added. The 
data shown is derived from a typical titration experiment. 
This experiment has been repeated three times, and in all 
cases the insertion mutants failed to effect significant 
repression of pl40CAT.
Figure 25. Graph showing activation (rather than
repression) of expression from HSV-1 IE gene 3 promoter- 
leader sequences (in pIE3CAT) by VZV 140k. Vero cells were 
transfected with 4yg of pIE3CAT and increasing amounts of 
test plasmids (1, 2, 4 and 8pg) or pSVEB (0.5, 1, 2 and
4pg; see the legend to Figure 23), in the presence of pMCl
(which expresses Vmw65). The test plasmids used express VZV 
140k (pl40SV) and Vmwl75 (pl75). The relative CAT
activities (determined as described in the text) are shown 
plotted against the amount of test plasmid DNA added. The 
data shown is derived from a single titration experiment.
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3.4. Does Repression of the Gene 62 Promoter by VZV 140k 
and Vmwl75 Involve Recognition of a Specific DNA Sequence 
Motif ?
The mechanism of repression of the IE-3 promoter by 
Vmwl75 requires a functional Vmwl75 DNA binding domain 
(Paterson and Everett, 1988b; Shepard et al. , 1989) and the 
presence of a cognate DNA binding site at the cap-site 
(Roberts et al., 1988). This binding site includes a 
consensus sequence (ATCGTC) common to many, but not all, 
sequences with which Vmwl75 can associate (Muller, 1987; 
Faber and Wilcox, 1986b, 1988; Michael et al., 1988). In an 
attempt to determine whether analogous sequences in the 
region of the gene 62 cap site were required for repression 
by VZV 140k and Vmwl75, plasmids pl40dellCAT and 
pl40del2CAT were utilized in repression transfection 
assays. These plasmids are deletion variants of pl40CAT in 
which promoter sequences upstream of the TATA box are 
intact, but leader or capsite-leader sequences are deleted. 
Thus pl40dellCAT and pl40del2CAT are truncated at positions 
+20 and -22 respectively, whereas VZV sequences in pl40CAT 
extend to nucleotide +57.
It was found that the intrinsic activities of the 
deleted promoters in pl40dellCAT and pl40del2CAT were 
consistently reduced by at least 10-fold relative to
pl40CAT (results not shown), which implies that sequences 
in the gene 62 leader region contribute to the efficiency 
of its expression. The activity of both promoters was 
increased by 15- to 30-fold when pMCl was present in 
transfections (as with the intact promoter), but promoter 
activity was still at least 10-fold below that of the pMCl 
activated gene 62 promoter. As noted above, low basal 
levels of promoter activity result in relatively poor 
levels of repression, and it was not possible to draw 
unequivocal conclusions from the results. The reduced
activity of pl40dellCAT might be explained by the absence 
of the bona fide capsite, and that of pl40del2CAT by the
presence of the polylinker sequences located between the
VZV insert and the CAT coding sequences. Therefore, a
130
better approach would probably be to create 
insertions or deletions in pl40CAT.
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3E. VZV 140K DNA BINDING STUDIES
The HSV-1 homologue of VZV 140k, Vmwl75, is a DNA
binding protein which binds to sequences which include the
consensus, ATCGTC (Beard et al., 1986; Faber and Wilcox,
1986b; Kristie and Roizman, 1986b; Tedder et al. , 1989).
Region 2 of Vmwl75 contains sequences that are essential 
for binding to this consensus motif (DeLuca and Schaffer, 
1988; Paterson and Everett, 1988b; Shepard et al., 1989).
Vmwl75 also binds (probably with lower affinity) to other
sites, although these are somewhat diverse and deviate
significantly from the above consensus (Michael et al., 
1988; Michael and Roizman, 1990). Given the extensive
similarities between VZV 140k and Vmwl75, it was of
interest to determine whether 140k binds to specific DNA
sequences, particularly as the sequences comprising region 
2 of Vmwl75 are so highly conserved in VZV 140k.
Repression of the VZV gene 62 promoter by VZV 140k 
has been demonstrated in transfection assays (Section 
3D.3.1). Significantly, genetic evidence obtained in these 
studies suggests that, like repression of the HSV-1 IE3 
promoter by Vmwl75, this involves binding by VZV 140k to 
specific sequences in the gene 62 promoter, presumably in 
the vicinity of the capsite (see Section 3D.3.3). 
Therefore, in an attempt to demonstrate sequence-specific 
binding by 140k, gel retardation studies were undertaken 
using extracts containing VZV 140k and a panel of probes 
representing the entire gene 62 promoter-leader region. In 
addition, the possibility that 140k might be capable of
binding to ATCGTC consensus motifs was investigated.
3E.1. Probes Used in Gel Retardation Assays
The promoter sequences which control expression of 
VZV gene 62 have been defined by deletion analysis (McKee 
et al., 1990). Promoter activity is contained within
residues -410 to +57; constitutive (basal) promoter
activity is associated with residues -131 to +57, while 
residues -410 to -131 (which contain an octamer/TAATGARAT 
element) confer responsiveness to Vmw65 (see Section
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IB.4.2). Therefore, a series of probes representing
sequences between -410 and +57 were prepared.
Plasmid pl40UP6 contains VZV gene 62 sequences 
from Clal (-1146) to nucleotide 142 of the orf on a 
BamHI-EcoRI fragment (derived from pVIl; Section 3C.1.1) 
inserted between the BamHI and EcoRI sites of pUC9. DNA 
fragments representing VZV sequences from Sail (-410) to 
Aval (+43) were derived from pl40UP6 by restriction enzyme
digestion, and end-labelled for use in gel retardation
assays (Section 2B.18.2). A fragment representing gene 62 
sequences from TaqI (-51) to +57 (Bglll) was derived from 
pl40BT (Section 3B.1.3) and similarly end-labelled. The 
locations of these fragments are summarized in Figure 26
and Table 7; a loose copy of these can be found at the back
of the thesis.
For clarity, the VZV gene 62 probes are divided 
into three groups as follows:
Capsite probes
Three partially overlapping probes containing the 
gene 62 capsite were utilized. The largest probe, CAP1, 
contains sequences from -131 to +43, and thus the majority 
of the basal promoter sequences. CAP2 contains sequences 
from -51 to +61 , including the proposed TATA box at -28. 
The smallest probe, CAP3, contains sequences between -23 
and +U-3, and thus does not contain any recognisable 
promoter elements.
Proximal promoter region probe
The UP1 probe (-131 to -23) contains all 
recognisable promoter elements from within the basal 
promoter region, but does not contain any sequences from 
the capsite-leader region.
Far-upstream promoter region probes
The UP2 (-188 to -131) and UP3 (-410 to -188) 
probes represent sequences from the upstream regulatory 
region; UP3 contains the octamer/TAATGARAT motif.
The HSV-1 IE Gene 3 Capsite Probe (IE3 probe)
contains a consensus ATCGTC motif, and was prepared from 
the 45bp BamHI-Aval fragment which spans the IE gene 3
Figure 26. Locations of the VZV gene 62 fragments from 
which were derived the probes used in gel retardation 
assays. VZV gene 62 sequences from -500 to +57 are 
represented by the solid line. The transcription start 
site, +1, is indicated by the arrow. McKee et al. (1990) 
demonstrated that sequences between Xhol (-131) and +57 
constituted a proximal promoter region responsible for 
basal promoter activity, whereas far-upstream sequences 
between Sail (-410) and Xhol (-131) conferred 
responsiveness to Vmw65 of HSV-1. The approximate location 
of an octamer/TAATGARAT motif (centered on nucleotide -255) 
implicated in the response to Vmw65 is shown. The cleavage 
sites of a number of restriction enzymes used to excise 
fragments (from pl40UP6 and pl40BT; see Section 3E.1) for 
the preparation of probes are marked. (The Bglll site in 
pl40BT was created by site-directed mutagenesis of pl40 as 
described in Section 3B.1.3.) The fragments from which 
each of the probes were prepared are indicated by the 
arrows. This information is summarized in the Table below.
Table 7. Summary of the fragments from which VZV gene 62 
promoter-regulatory region probes were derived. The various 
probes were prepared from VZV gene 62 fragments as shown. 
The fragments were end-labelled by "filling in" the 5' 
overhanging ends of the restriction sites shown in bold 
(with Klenow or T4 polymerase and [a-32P]dNTPs).
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capsite (Muller, 1987).
3E.2. GEL RETARDATION ASSAYS WITH VZV INFECTED CELL 
EXTRACTS
2.1. Extract Preparation
Initial experiments utilized extracts prepared from 
either F.HeLa or HFL cells. F.HeLa cells have been used in 
previous studies on Vmwl75 DNA binding, whilst HFL cells 
were selected as they are permissive for VZV infections. 
Later experiments used CV1 cells, which grow better in 
tissue culture and are also permissive for VZV growth. 
Where an experiment was performed in HFL and CV1 cells, the 
results were similar.
HFL or CV1 cells were seeded into 90mm dishes and 
infected (at around 80% confluence) by addition of VZV 
infected cells (HFL or CV1 accordingly) representing 1/16 
of a 175cm2 flask. Where appropriate, infected HFL cells 
were used to infect F.HeLa cells in an analogous fashion. 
Nuclear extracts (NE) or whole cell extracts (WCE) were
generally prepared from cells 48h following infection, as 
described (Section 2B.9). The protein concentration of 
extracts was determined by the method of Bradford (1976; 
Section 2B.8), such that equal amounts of protein from
different extracts were used in each assay.
2.2. Gel Retardation Assays with Extracts Prepared from 
F.HeLa and HFL cells
The following section describes the results
obtained from gel retardation experiments which utilized 
mock and VZV infected extracts prepared from HFL and F.HeLa 
cells. To avoid unnecessary repetition, these results are 
summarized and discussed together at the end of the 
Section.
Binding to the Capsite Region
Figure 27 shows the complexes formed when
increasing amounts of mock or VZV infected F.HeLa WCE were 
incubated with the CAP1 probe (-131 to +43). Incubation
134
with 0.8]ig of mock extract (lane 2) generated three 
complexes, FI, F2, and F3. Incubation with progressively 
more extract resulted in the appearance of a slower
migrating complex, X (lane 6), with a concomitant decrease 
in the intensity of F1-F3, which probably reflects binding 
of multiple factors to each probe molecule. An identical 
profile was obtained when increasing amounts of VZV WCE 
were incubated with CAP1 (lanes 7-11); no complex specific 
to VZV infection of F.HeLa cells was identified.
The above experiment was repeated using extracts 
prepared from HFL cells (Figure 28). The mock infected HFL
extract formed three complexes with the CAP1 probe
designated HI, H2, and H3 (lane 2; H2 and H3 are only
clearly visible in the original autoradiograph). Extract 
prepared from VZV infected cells at 24h p.i. formed these 
same complexes (lane 4). In addition, some minor complexes 
are visible above HI (lane 4); identical complexes are also 
formed in the mock (lane 2; visible in the original 
autoradiograph). However, incubation of CAP1 with extract 
prepared at 48h p.i generated a novel complex designated 
V48 (lane 6).
Binding to Proximal Promoter Sequences
Binding to the UP1 fragment was assayed using mock 
and VZV 48h p.i. HFL extracts (Figure 29). The mock extract 
formed complexes corresponding to HI, H2 and H3 (H3 is 
visible in the original autoradiograph). Addition of 8 and 
16pg of mock extract also formed complexes of lower 
mobility than HI (lanes 5,6). Incubation of UP1 with 48h 
p.i. extract formed an additional weak complex which 
probably corresponds to the V48 complex formed with the 
CAP1 probe (the CAP1 and UP1 probes are in fact partially 
overlapping; see Figure 26).
Binding to Far-Upstream Sequences
Complexes formed with the UP3 probe were analysed 
(Figure 30). Mock extract formed HI and H2 and additional 
complexes of lower mobility (lanes 2-6). Incubation of 
probe with 48h p.i. extract formed reduced amounts of HI 
and H2 (relative to the mock), and several very weak novel
Figure 27. DNA binding assay with whole cell extracts 
(WCE) prepared from mock and VZV infected F.HeLa cells. The 
CAP1 probe was incubated with increasing amounts of mock 
WCE (lanes 2-6) or VZV infected WCE (lanes 7-11). The total 
amount of protein in each incubation was as follows:
Lane Mock Extract (ug) VZV Extract (ug)
1
2
3
4
5
6
7
8
9
10 
11
0.8
1.6
4.0
8.0 
16.0
16.0
0.8
1.6
4.0
8.0
Lane 1 represents probe incubated in the absence of 
extract. The positions of complexes X, FI, F2 and F3 are 
marked.
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Figure 28. DNA binding assay with whole cell extracts 
(WCE) preprared from mock and VZV infected HFL cells. The
CAP1 probe was incubated with mock WCE (lanes 1,2) and with 
VZV infected WCE prepared at 24h post-infection (lanes 3,4) 
or 48h post-infection (lanes 5,6). Incubations contained 
either 3yg (lanes 1,3,5) or 16yg (lanes 2,4,6) of total 
cell protein. The positions of complexes HI, H2, H3 and V48 
are marked.
Figure 29. DNA binding assay with whole cell extracts 
(WCE) prepared from mock and VZV infected HFL cells. The
UP1 probe was incubated with increasing amounts of mock WCE 
(lanes 2-6) or VZV infected WCE (lanes 7-11). The total 
amount of protein in each incubation was as follows:
Lane Mock Extract (ug) VZV Extract (ug)
1
2
3
4
5
6 
7
0.8
1.6
4.0
8.0 
16.0
0.8
1.6
4.0
8.0 
16.0
8
9
10 
11
Lane 1 represents probe incubated in the absence of 
extract. The positions of complexes HI, H2, H3 and V48 are 
marked.
HI
H2
H3
V48
1 2 3 4  5 6 7 8 9  10 11
Figure 30. DNA binding assay with whole cell extracts 
(WCE) prepared from mock and VZV infected HFL cells. The
UP3 probe was incubated with increasing amounts of mock WCE 
(lanes 2-6) or VZV infected WCE (lanes 7-11). The total 
amount of protein in each incubation was as follows:
Lane Mock Extract (ug) VZV Extract (ug)
1
2 0 8
3 1 6
4 4 0
5 8 0
6 16 0
7 0 8
8 1 6
9 4 0
10 8 0
11 16 0
Lane 1 represents probe incubated in the absence of 
extract. The positions of complexes HI and H2 are marked.
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complexes. Experiments in which binding to the UP2 probe 
was assayed yielded similar results (not shown).
Summary of Protein Binding Studies with HFL Extracts
Incubation of probes representing VZV gene 62 
promoter-leader sequences with extract prepared from VZV 
infected HFL cells generated several novel complexes. Of 
these, the V48 complex was the most prominent and 
reproducibly observed. The mobility of the V48 complex is 
indicative of binding by a relatively low molecular weight 
polypeptide, and it is therefore unlikely that V48 contains 
VZV 140k.
2.3. Gel Retardation Assays With Extracts Prepared From CV1 
Cells
Binding to the CAP3 (-23 to +43) and UP1 (-131 to 
-23) probes was assayed using mock and VZV infected 
extracts prepared from CV1 cells (see Figure 31).
Binding to the Capsite Region
Mock CV1 extract formed three complexes, C2-C4,
with the CAP3 probe (lanes 4,5). In addition to these 
complexes, the CV1 48h p.i. extract formed a complex of 
comparable mobility to the V48 complex formed with HFL 
extracts (compare lane 3 with lanes 6,7), as well as a
number of other minor novel complexes. Note that in this 
experiment the V48 complex appears to be a doublet.
Binding to Proximal Promoter Sequences
Incubation of mock CV1 extract with the UP1 probe
formed complexes C2-C4, and, in addition, a slower
migrating complex, Cl (lanes 10,11). A number of novel
complexes were formed when CV1 48h p.i. extract was
incubated with UP1 (lane 12). Most of these novel complexes 
were comparable to those formed with CAP3 (compare lanes 6 
and 7 with lane 12), and included a complex corresponding 
to V48 (compare lane 9 with lane 12) .
That the novel complexes are formed with two
different probes indicates that they represent either
non-specific binding or binding to a common site in both 
probes. As stated in Section 3E.2.2, the mobility of the
Figure 31. DNA binding assay with nuclear extracts (NE) 
prepared from mock and VZV infected HFL and CV1 cells. The
CAP3 probe was incubated without extract (lane 1), or with
mock HFL NE (lane 2), VZV infected HFL NE (lane 3), mock
CV1 NE (lanes 4,5), or VZV infected CV1 NE (lanes 6,7). 
This was repeated using the UP1 probe. Thus UP1 was
incubated with mock HFL NE (lane 8), VZV infected HFL NE 
(lane 9), mock CV1 NE (lanes 10,11), or VZV infected CV1 NE 
(lanes 12,13). The total amount of protein in each
incubation is summarized below:
Lane
1
Extract Amount (uq) Probe
CAP3
2 Mock HFL 3.0 II
3 VZV HFL 3.0 it
4 Mock CV1 1.0 II
5 mock CV1 4.0 it
6 VZV C.V1 1.0 n
7 VZV CV1 4.0 it
8 Mock HFL 3.0 UP1
9 VZV HFL 3.0 it
10 Mock CV1 1.0 II
11 Mock CV1 4.0 ll
12 VZV CV1 1.0 ll
13 VZV CV1 4.0 ll
The positions of complexes Cl, C2, C3, C4 and V48 are
marked.
1 2 3 4 5 6 7 8 9 10 11 12 13
• •
y M
— ¥  
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C l
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C4
V48
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V48 complex is not consistent with it containing VZV 140k. 
However, the possibility that V48 or another novel complex 
contains 140k, or a proteolytic fragment of 140k, cannot be 
excluded. In order to investigate this possibility
further, monoclonal antibodies or antisera reactive against 
a range of VZV 140k epitopes would be required. 
Unfortunately, these were not available during these
studies. In the above experiment (Figure 31), it is 
notable that incubation of either probe with equivalent
amounts of CV1 mock and 48h p.i. extracts did not form 
equivalent amounts of the host derived complexes, C1-C4;
reduced amounts (particularly of C2) were formed with the 
48h p.i. extract (compare lanes 4 and 10 with lanes 6 and 
12). Since reduced formation of C1-C4 was accompanied by 
the appearance of the various novel complexes (including 
V48), it is tempting to speculate that the latter contain 
a proteolytic fragment of one or more of the host factors. 
If so, this suggests that VZV infection of HFL and CV1
cells induces a protease activity.
3E.3. GEL RETARDATION ASSAYS WITH TRANSFECTED CELL EXTRACTS 
Interpretation of the results of gel retardation 
experiments conducted using VZV infected cell extracts is
complicated by the presence of other viral proteins in the
extract. In particular, it is difficult to prove whether or 
not a complex contains VZV 140k. This problem can be 
avoided by using extracts prepared from cells transfected 
with a plasmid expressing only VZV 140k. Therefore, F.HeLa 
cells were transfected with plasmid pl40 and extracts 
prepared for use in gel retardation experiments. (N.B. An 
authentic complex containing Vmwl75 is formed when the HSV- 
1 IE3 probe is incubated with extracts prepared from cells 
transfected with plasmid pl75, which expresses Vmwl75; 
Paterson and Everett, 1988b).
Binding to VZV Gene 62 Promoter-Leader Sequences
The CAP1 (Figure 32), UP1 (Figure 33), UP2 (Figure 
34) and UP3 probes (Figure 35) were incubated with 
increasing amounts of mock (prepared from cells which were
Figure 32. DNA binding assay with nuclear extracts 
prepared from transfected F.HeLa cells. The CAP1 probe was 
incubated with increasing amounts of mock nuclear extract 
(lanes 2-6) or pl40-transfected nuclear extract (lanes 
7-11). The total amount of protein in each incubation was 
as follows:
Lane Mock Extract (ug) p!40 Extract (ug)
1 • *
2 0.3
3 0.6
4 1.4
5 2.8
6 5.6
7 0.3
8 0.6
9 1.4
10 2.8
11 * 5.6
Lane 1 contains probe incubated in the absence of extract.
mmmM»- immm-
1 2 3 4 5 6 7 8 9  10 11
Figure 33. DNA binding assay with nuclear extracts 
prepared from transfected F.HeLa cells. The UP1 probe was 
incubated with increasing amounts of mock nuclear extract 
(lanes 2-6) or pl40-transfected nuclear extract (lanes 
7-11). The total amount of protein in each incubation was 
as follows:
Lane Mock Extract (ug) p!40 Extract (ug)
1
2
3
4
5
6
7
8
9
10 
11
0.3
0.6
1.4
2.8
5.6
0.3
0.6
1.4
2.8
5.6
Lane 1 contains probe incubated in the absence of extract.
1 2 3 4 5  6 7 8  9 10 11
Figure 34. DNA binding assay with nuclear extracts 
prepared from transfected F.HeLa cells. The UP2 probe was 
incubated with increasing amounts of mock nuclear extract 
(lanes 2-6) or pl40-transfected nuclear extract (lanes 
7-11) . The total amount of protein in each incubation was 
as follows:
Lane Mock Extract (ug) p!40 Extract (ug)
1 • •
2 0.3 •
3 0.6 •
4 1.4 •
5 2.8 *
6 5.6 *
7 0.3
8 0.6
9 1.4
10 2.8
11 5.6
Lane 1 contains probe incubated in the absence of extract.
1 2 3 4 5  6 7 8  9 10 11
Figure 35. DNA binding assay with nuclear extracts 
prepared from transfected F.HeLa cells. The UP3 probe was 
incubated with increasing amounts of mock nuclear extract 
(lanes 2-6) or pl40-transfected nuclear extract (lanes 
7-11). The total amount of protein in each incubation was 
as follows:
Lane Mock Extract (ug) p!40 Extract (ug)
1 •
2 0.3 #
3 0.6
4 1.4 #
5 2.8
6 5.6 #
7 # 0.3
8 0.6
9 1.4
10 . 2.8
11 5.6
Lane 1 contains probe incubated in the absence of extract.
1 2 3 4 5  6 7 8  9 10 11
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not transfected) or pl40 transfected F.HeLa extract. In all 
experiments, the complexes formed with mock and 
pl40-transfected F.HeLa extracts were essentially 
identical, though the relative intensities of certain of 
the complexes formed did vary slightly between the two 
extracts (compare, for example, lanes 6 and 11, Figure 34). 
Since similar variations were observed with several probes 
they were not considered to be significant.
3E.4. GEL RETARDATION ASSAYS WITH EXTRACTS PREPARED FROM 
CELLS INFECTED WITH HSV-1 OR HSV-140
The experiments described above using VZV-infected 
and pl40 transfected cell extracts did not demonstrate DNA 
binding by 140k. Amounts of 140k in these extracts 
(relative to host factors) were almost certainly very low 
and, consequently, these results must be considered 
indeterminate since binding would be difficult to detect 
against such a background unless it were of high affinity. 
In order to investigate DNA binding further, extracts 
containing higher amounts of VZV 140k were required. A 
recombinant virus, HSV-140, in which the VZV 140k coding 
sequences replace those of Vmwl75 in an HSV-1 virus genome, 
has been constructed (Section 3B). During HSV-140 infection 
of tissue culture cells, 140k is expressed as an early 
protein, with high levels of expression persisting late 
into infection. Notably, nuclear extracts prepared from 
HSV-140 infected cells contain copious amounts of 140k 
(Section 3F.2).
Hence, BHK cells were infected with HSV-1 
(lOpfu/cell) or HSV-140 (100-200 particles/cell), and
nuclear extracts prepared at 5h p.a. and 12-14h p.a. 
respectively. Extracts were also prepared from uninfected 
cells.
Binding to HSV-1 IE gene 3 Capsite Sequences
The ability of Vmwl75 to bind DNA sequences 
containing the consensus, ATCGTC, is critically dependant 
upon the integrity of region 2 polypeptide sequences. As 
noted in Section 1C.3, there is extensive homology between
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the sequences comprising region 2 of VZV 140k and Vmwl75. 
Therefore, in order to determine whether 140k, like Vmwl75, 
is capable of binding to an ATCGTC consensus motif, 
HSV-140 extracts were incubated with the IE3 probe. When 
the IE3 probe was incubated with mock extract prepared from 
either F.HeLa or BHK cells, two major complexes, Ml and M2, 
and several minor complexes were formed (Figure 36, lanes 1 
and 10). As expected, incubation of the IE3 probe with 
extract prepared from HSV-1 infected F.HeLa cells (kindly 
provided by Dr. T. Paterson) formed the typically strong 
complex which contains Vmwl75 (lane 11). An identical 
complex was formed with the extract prepared from HSV-1 
infected BHK cells (lane 2). In contrast, the HSV-140 
extract did not form any novel complexes with the IE3 probe 
(lane 3), inferring that VZV 140k does not bind to the 
sequence ATCGTC.
Binding to Gene 62 Capsite Sequences
Incubation of the CAP3 probe with mock BHK extract 
formed complexes Ml and M2, and a number of other minor 
complexes (Figure 36, lane 7). The HSV-1 extract formed 
these same complexes, and an additional minor complex of 
lower mobility than Ml (lane 8). However, this complex was 
not formed when different competitor DNA was used (see
Figure 37, lanes 5 and 11), and thus probably does not
reflect sequence specific binding by Vmwl75. The HSV-140 
extract did not form any novel complexes with CAP3 (Figure 
36, lane 9).
A number of experiments were performed in which the 
incubation conditions were varied: NP40 was removed from
the incubation buffer; a number of different competitor 
DNAs were used; incubation was carried out on ice (rather 
than 25° C) . Additionally, gels were run at 4°C . Figure 37 
shows the results of such an experiment. Parallel
incubations were carried out in TEN-P40 and TE (minus NP40) 
buffers, using as competitor DNA polydl:polydC or salmon 
testes DNA (ssDNA). The complexes formed were largely
unaffected by these modifications, although the intensity 
of some of the minor complexes was reduced, indicating that
Figure 36. DNA binding assay with nuclear extracts (NE) 
prepared from mock, HSV-1, and HSV-140 infected BHK cells. 
Each set of three lanes represents incubation of the 
specified probe with extract in the following order: mock 
NE, HSV-1 infected NE, HSV-140 infected NE. The extracts 
assayed in lanes 10 and 11 (kindl y provided by Dr. Trevor 
Paterson), which serve as controls in this experiment, 
were prepared from mock and HSV-1 infected F.HeLa cells. 
The extracts were incubated with the UP1 (lanes 4,5,6) and 
CAP3 (lanes 7,8,9) probes derived from VZV gene 62 
sequences, and a probe which spans the HSV-1 IE-3 capsite 
(lanes 1,2,3,10,11). This is summarized below:
Lane
1
2
3
Probe
IE-3
ll
Extract
Mock
HSV-1
HSV-140
4
5
6
UP1
if
tl
Mock
HSV-1
HSV-140
7 CAP3 Mock
HSV-1
HSV-140
8 tl
9
10
11
IE-3 Mock (TP) 
HSV-1 (TP)
The positions of comlexes Ml and M2 are marked.
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Figure 38. The effect of different competitor DNAs on 
complex formation with the UP3 probe. Each set of three 
lanes represents incubation of the UP3 probe (under the 
specified conditions) with extracts in the following order: 
Mock (M), HSV-1 infected extract, HSV-140 infected extract. 
The experiment used as competitor DNA lug or 4ug of 
polydlrdC (lanes 1,2,3 and 4,5,6 respectively) and lug or 
4ug of salmon testes DNA (ssDNA; lanes 7,8,9 and 10,11,12 
respectively). This is summarized below:
Lane Extract Competitor (ug)
1 M dl:dC (1)
2 HSV-1 19
3 HSV-140 If
4 M dl:dC (4)
5 HSV-1 tl
6 HSV-140 ll
7 M ssDNA (1)
8 HSV-1 If
9 HSV-140 II
10 M ssDNA (4)
11 HSV-1 II
12 HSV-140 It
1 2 3  4  5 6 7 8 9  10 11 12
iHHl •
M
M  HSV HSV 
1 140
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they reflect non-specific binding of host derived proteins. 
A minor complex migrating slightly ahead of the host 
complex Ml was formed with HSV-140 extract; nevertheless, 
an identical complex was also formed with mock extract. 
(The intensity of this minor complex varied between 
extracts and was very weak in the mock in this experiment. 
However, a stronger comparable complex can be seen in the 
mock in Figure 36, lane 1). Identical results were obtained 
from a similar experiment in which adenovirus major late 
promoter sequences were used as competitor (not shown). 
Binding to Proximal Promoter Sequences
Mock, HSV-1 infected and HSV-140 infected extracts 
were incubated with the UP1 probe (Figure 36, lanes 4,5,6). 
The infected cell extracts did not form novel complexes. 
(The increased complex formation with the HSV-1 extract 
probably reflects the addition of slightly more protein.) 
Binding to Far-Upstream Sequences
Binding to the UP3 probe was assayed using 
polydl:polydC or ssDNA as competitor (Figure 38). Complex 
formation was altered depending on the competitor used, 
with polydl:polydC competing non-specific binding less 
efficiently than ssDNA. Thus many of the complexes formed 
in lanes 1-6 are absent from lanes 7-12. Furthermore, 
binding to UP3 was largely abolished in the presence of 4yg 
ssDNA, and no specific complexes were observed. Binding to 
the UP2 probe was not assayed with these extracts, but was 
assayed using partially purified 140k (see Section 3E.6).
4.1. Proteinase K Treatment of HSV-140 Infected-Cell
Nuclear Extract
The results described in preceding sections 
indicate that if the VZV 140k polypeptide binds to DNA, 
then it does so with low affinity. In this situation, it is 
likely that binding of host derived proteins to the probe 
would preclude detection of complexes containing 140k. With 
this in mind, a further experiment was performed following 
a recent report by Everett et al. (1990) . They showed that 
proteinase K (PK) treatment of extract containing Vmwl75
140
(prior to, or following incubation with probe) liberated a 
protease-resistant domain which not only formed a specific 
complex with the IE3 probe, but apparently did so with 
greater affinity than the intact protein. Furthermore, host 
derived binding proteins appeared to be inactivated by 
prior treatment of the extract with PK since, in this case,
mock complexes were not formed. Thus an analogous
experiment was performed in which HSV-140 infected extract 
were pre-treated with PK.
Mock or HSV-140 extract was added to incubation
buffer and treated with PK (by addition of l-6ng) for
lOmin at room temperature. Following this PMSF was added 
to a final concentration of 0.5 mM, then probe (CAP 2)
added, and the sample incubated on ice for 30min. PK
treatment of incubation buffer containing HSV-1 extract (by 
addition of 2ng PK) was performed in parallel, prior to
addition of CAP 2 or IE3 probe. These results are shown in
Figure 39. Pre-treatment of mock extract with PK prevented
formation of complexes Ml and M2 (although several rapidly 
migrating minor complexes were formed; lanes 1,2,3). In 
agreement with the results of Everett et al., PK treated 
HSV-1 extract formed a strong complex with the IE3 probe 
(lane 8). In contrast, the PK treated HSV-140 extract did 
not form any novel complexes with the CAP2 probe (some of 
the minor complexes in lanes 5 and 6 are not visible in 
lanes 2 and 3 in the photograph, but are visible in the 
original autoradiograph). Since it is not known whether or 
not VZV 140k contains a protease resistant domain
comprising similar polypeptide sequences to those contained 
in Vmwl75, no firm conclusions can be drawn from this 
experiment.
3E.5. VZV 14OK BINDS NON-SPECIFICALLY TO DNA
Hay and Hay (1980) employed DNA-cellulose 
chromatography to demonstrate that most of
the HSV-1 IE proteins bind DNA to some extent in vitro. In 
an analogous experiment, the ability of 140k to bind to a 
calf-thymus DNA column was investigated. BHK cells were
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infected with HSV-140 at a multiplicity of lOOppc, labelled 
with [3 5 S]—methionine from 10-12h p.a., and nuclear 
extracts prepared. Nuclear extract was also prepared from 
BHK cells infected with HSV-1 (lOpfu/cell) under 
immediate-early conditions (the infection and labelling 
conditions were exactly as described in Section 3B.2.4 for 
preparation of IE extracts for SDS-PAGE). A suitable 
column was packed with calf-thymus DNA-cellulose (to a 
bed volume-0.3ml) which had been pre-soaked in DC buffer 
for 3h (on ice), and washed extensively with DC buffer. 
5-10yl of nuclear extract (equivalent to 20-40pg protein) 
was diluted to a final volume of 200yl in DC buffer and 
loaded onto the column. The flow through was collected and 
the column washed twice with DC, again collecting the 
eluates. Elution of bound protein was achieved by washing 
the column with DC containing increasing concentrations of 
salt (0.1, 0.2, 0.3, 0.6, and 2M), collecting eluates at
all stages. Finally, approximately 2-3pg total uninfected 
cell protein were added to eluates (as carrier) and 
proteins precipitated by addition of 4 volumes of acetone 
(-20°C/2h). Precipitated proteins were reconstituted in 
20pl boiling mix and analysed by SDS-PAGE (Figure 40). 
Vmwl75 bound to the column (although some protein eluted in 
the washes), and was eluted predominantly between 0.3 and 
2M salt. VmwllO bound more tightly and eluted in the 0.6 
and 2M salt washes. These results are in good agreement 
with those of earlier experiments (Dr. Roger Everett, pers. 
comm.). A protein of identical mobility to that identified 
as VZV 140k in Section 3B.2.2. was retained by the column 
and eluted at higher salt concentrations. The elution 
profile of VZV 140k was essentially like that of Vmwl75, a 
small amount eluting in the wash steps, while the majority 
eluted between 0.3 and 2M salt. Thus 140k, like the IE 
proteins of HSV-1, appears to bind non-specifically to DNA 
in vitro. However, it should be borne in mind that 
retention of VZV 140k on a DNA-cellulose column using crude 
extracts does not prove a direct intraction between 140k
and DNA.
. •
3 4 5 6 7 8
Figure 39. Proteinase K treatment of BHK cell nuclear 
extracts. Mock, HSV-1, or HSV-140 extract was added to 
incubation buffer and treated with proteinase K (PK; 
l-6ng) for 10 mins at room temperature as detailed below:
Lane Extract PK (ng)
1 M 1
2 M 2
3 M 6
4 HSV-140 1
5 HSV-140 2
6 HSV-140 6
7 HSV-1 2
8 HSV-1 2
The PK-treated extracts were incubated with the CAP2 probe 
(lanes 1-7) or a probe spanning the HSV-1 IE-3 capsite 
(lane 8). The position of complex P is marked.
Figure 40. VZV 140k binds to a calf-thymus DNA cellulose 
column. [33S]methionine labelled nuclear extracts (NE) were 
prepared from HSV-140 infected BHK cells, and from BHK 
cells infected with HSV-1 under immediate-early (IE) 
conditions, as described in Section 3E.5. An aliquot of 
each NE extract (containing approximately 20-40ug of
protein) was diluted to 200ul in DC buffer and loaded onto 
a calf-thymus DNA cellulose column. The flow through, which 
contained unbound protein, was collected, and the column 
washed twice with DC buffer, collecting the eluates (Wash 1 
and Wash 2). Bound protein was eluted by washing the column 
with DC buffer containing increasing concentrations of salt 
(0.1M, 0.2M, 0.3M, 0.6M, and 2M), collecting eluates
following each wash. Proteins contained in each of the
eluates were precipitated as described in the text,
reconstituted in boiling mix, and analysed by SDS-PAGE. The 
upper and lower panels show the results of parallel 
experiments with HSV-1 IE NE and HSV-140 NE respectively. 
The outer lanes contain samples of crude nuclear extract 
for comparison; the postions of Vmwl75, VmwllO, and 
VZV 140k are marked.
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3E.J6,— P ART I ALLY—PURIFIED 140K DOES NOT BIND TO GENE 62 
PROMOTER SEQUENCES
As mentioned previously (Section 3E.4.1), it is 
unlikely that low affinity binding of 140k would be 
detected using crude nuclear extracts. It was thus decided 
to attempt the purification of 140k from HSV-140 infected 
cells to facilitate further studies. During this work, it 
was found that 140k in crude nuclear extract became 
insoluble when the salt concentration was reduced to below 
0. 2M (Section 3F.3). Since previous experiments were 
performed at a salt concentration of 0.1M or less, it is 
conceivable that non-specific aggregation of 140k with 
other proteins in the extract might have precluded 
formation of a protein/DNA complex.
Partially purified 140k was obtained by FPLC gel 
filtration chromatography of crude nuclear extract as 
described (Section 3F.3.1). The column was run in Super 
buffer, which is essentially TEN-40 containing 0.3M salt, 
and thus binding activity could be assayed by direct 
addition of polydl:polydC and probe to aliquots of 
appropriate fractions. The experiment described utilized 
the UP1, 2 and 3, and CAP2 probes, which represent the 
entire gene 62 promoter-leader region. The column fractions 
assayed were fraction 9, which contained 140k, and fraction 
15, which did not contain any detectable 140k (as judged by 
SDS-PAGE). Since even partially purified 140k (in fraction 
8) became insoluble when the salt concentration was reduced 
below 0.2M (Section 3F.3.1), binding assays were performed 
at a salt concentration of 0.3M. Fraction 9 did not form a 
complex with any of the probes (Figure 41). However,
fraction 15 formed a strong complex with the UP1 probe (and
also a weak complex with UP3; Figure 41). It has previously 
been suggested that either CCAAT or ATF/CRE binding factors 
form a complex with sequences contained within the UP1 
probe, (T. A. McKee, PhD Thesis, 1990), and thus fraction 
15" may contain one or other of these activities.
An obvious pitfall of this approach is that low
affinity binding may be impaired or abolished at a salt
Figure 41. DNA binding assay with FPLC fractions containing 
partially purified VZV 140k and a set of probes 
representing the entire VZV gene 62 promoter region. 
Nuclear extract was prepared from HSV-140 infected BHK 
cells and polypeptides fractionated by FPLC gel filtration 
chromatography as described in the text. DNA binding assays 
utilized fraction 9, which contained VZV 140k (lanes 
1,2,5,6,9,10,13,14), and fraction 15, which did not contain 
any detectable VZV 140k (lanes 3,4,7,8,11,12). These 
fractions were incubated with the following probes: UP1 
(lanes 1-4) ; UP2 (lanes 5-8); UP3 (lanes 9-12); and CAP2 
(lanes 13,14). Incubations contained 1, 2, 3, or 5pg of
polydl:polydC as competitor as detailed below:
Lane Fraction dI:dC (ug) Probe 
1 9  1 UP1
2 9 3
3 15 1
4 15 3
5 9 1 UP2
6 9 3
7 15 1
8 15 3
9 9 2 UP3
10 9 5 1
11 15 2
12 15 5 »
13 9 1 CAP2
14 9 3 n
1 2 3 4 5 6 7 8 9 10 11 12 13 14
§«
UP1 UP2 UP3 CAP2
14 3
concentration of 0.3M. (The assay was also performed at 
0.2M salt and still binding was not detected; not shown.) 
Purified 140k (which would hopefully remain soluble at 
reduced salt concentrations) will be required for further 
investigation of binding by the intact protein. Such 
material was not available while these studies were in 
progress.
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3F. PARTIAL PURTFTCA T T o m  n o  ___  _
-------------  140K FROM HSV-140 INFECTED
CELLS
The purification of 140k was undertaken to 
facilitate further studies on its DNA binding properties. 
It was envisaged that purified 140k would also permit 
additional biochemical studies to be undertaken, such as 
the development of an in vitro transcription system. A 
partial purification of 140k was achieved, but problems 
were encountered with the solubility of the polypeptide 
which prevented further purification being attempted.
3F.1. Cells and Infection Conditions
BHK cells were used for extract preparation 
throughout. Cells were seeded at a density of 2xl07 per 
140mm dish, infected with HSV-140 (50-200ppc), and labelled 
with [39S]-methionine (2mCi per dish) from 12-14h p.a. 
Nuclear extracts were prepared from labelled cells as 
described below. Since the efficiency of gene expression 
varied somewhat between stocks of virus, the exact moi used 
was determined individually for each stock to optimize 
expression of 140k (whilst avoiding extensive cpe and/or 
nuclear disruption).
3F.2. Modification of the Nuclear Extraction Protocol
The standard nuclear extraction protocol (Section 
2B.9.1) involves first isolating nuclei (at very low salt 
concentration; lOmM), following which DNA binding proteins 
are eluted from the nucleus by resuspending nuclei in high 
salt buffer (0.4iM). This procedure was modified as follows 
(exact details are given in Section 2B.9.2). Nuclei were 
isolated and resuspended in low salt buffer (final 
concentration, 0.09M) and a low salt nuclear extract made. 
This was repeated twice more. Following this residual 
nuclear proteins were eluted by incubating nuclei in high 
salt buffer (final salt concentration, 0.24M). The effect 
of' these alterations was determined by SDS-PAGE analysis of 
equal volumes of each extract (Figure 42). Significant 
amounts of many polypeptides (particularly of lower
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molecular weight) were removed by the low salt extractions, 
whereas 140k was present in the high salt extract, in which 
it was enriched compared to a standard NE. This modified 
procedure was used to generate extract for subsequent 
purification.
3F.3. PURIFICATION BY FPLC
Initially, FPLC ion-exchange (MONO-Q)
chromatography was investigated. The recovery of material 
from the MONO-Q column was found to be only 10-20% 
(determined by liquid scintillation counting of aliquots of 
the fractions). Material appeared to be retained by the 
pre-column filter (rather than being tightly bound to the 
column), suggesting that the low recovery was a consequence 
of aggregation of protein (s) in the extract to form high 
molecular weight complexes unable to pass through the 
filter. The solubility of proteins in the crude extract at 
low salt was thus investigated.
lOOyl aliquots of nuclear extract were dialysed 
overnight at 4°C against modified buffer c containing 0.1 
or 0.2M salt. The dialysed sample was then centrifuged at 
10, OOOrpm for 15 min in the Sorval SS34 rotor. Pelleted 
material was reconstituted in 100pl boiling mix, and 20pl 
of boiling mix added to 5yl of supernatant. These samples 
(20pl of each) were analysed by SDS-PAGE, Figure 43. It is 
assumed that proteins found in the pellet were insoluble 
under the conditions of dialysis. 140k was found to be 
soluble at 0.2M, but insoluble at 0.1M.
3.1. Partial Purification of 140k by— Gel-Filtration
Chromatography
Metzler and Wilcox (1985) noted similar solubility
problems during their purification of Vmwl75. They found, 
however, that following gel-filtration chromatography, the 
partially purified protein was soluble at salt 
concentrations below 0.1M. A similar approach was adopted 
in the purification of 140k in the hope that it too would 
be soluble when partially purified.
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An FPLC Superose 12 column was selected. Since it 
was intended to assay column fractions for DNA binding 
activity, columns were run in Super buffer which is
essentially TEN-P40 (as used in DNA binding assays) to
which had been added 3-mercaptoethanol and salt (to 0.3M). 
Each run generally used 200yl of extract (equivalent to 
6xl07 cells). The column was run at a flow rate of 0.2
ml/min, and 0.5ml fractions collected from 25-75 mins
(elution volume of 6-15ml; the void volume of the column 
was 6ml) These fractions were analysed by SDS-PAGE (7yl of 
3x boiling mix added to 13yl of fraction)(Figure 44). 140k 
eluted in fractions 8-12 (9-llml) and was well separated 
from the majority of lower molecular weight proteins.
Before further purification was attempted, the 
solubility of partially purified 140k contained in 
fractions 8-12 was determined. Fraction 8 was divided into 
two aliquots which were then dialysed against buffer 
containing 50 or lOOmM salt, and analysed as described 
above (Section 3F.3). It was found that 140k was insoluble 
at both salt concentrations (other proteins in the fraction 
displayed partial solubility also.) The addition of 1% NP40 
failed to overcome this lack of solubility (results not 
shown).
That 140k in the FPLC (Superose) fractions is 
insoluble at low salt concentrations presents a 
considerable problem with regard to further purification, 
since many of the steps which might subsequently be 
employed (ion-exchange chromatography, chromatofocussing 
etc.) demand that sample be applied at low salt 
concentrations (i.e. below 0.1M). Thus until 140k can be 
obtained in a form which remains soluble at low salt 
concentrations further purification from HSV—140 infected 
cells will not be possible.
Figure 42. Modified nuclear extraction protocol. BHK cells 
were infected with 50-200 ppc of HSV-140, and labelled with 
[35S]methionine from 12-14h p.a. Cells were isolated and 
lysed in low salt buffer as described, and nuclei pelleted 
by centrifugation. The supernatant from this step, which 
contained cytoplasmic proteins, was retained. Nuclei were 
resuspended in 0.15M salt buffer, incubated on ice for 15 
min, nuclei pelleted, and the 0.15M extract reserved. This 
process was repeated twice more, following which nuclei 
were resuspended in 0.45M salt buffer and a high salt 
extract prepared. Equal volumes of the cytoplasmic fraction 
(C; lanes 1 and 6), each of the sequential 0.15M nuclear 
extracts (lanes 2, 3 and 4), and the final 0.45M nuclear 
extract (lane 5) were analysed by SDS-PAGE. The position of 
VZV 140k in the 0.45M extract is marked. The 0.15M salt 
extractions remove significant amounts of nuclear proteins 
and VZV 140k is thus enriched in the 0.45M extract.
1 2 3 4 5 6
VZV 140k
1 2 3 4 5
P s /n  P s /n  
0.1M 0.2M
VZV 140k
• VZV 140k
C 3 4 5 6 7 8 9  10 11
C 12 13 14 15 16 17 18 19 20
Figure 44. Partial purification of VZV 140k by FPLC gel 
filtration chromatography. [35S]methionine labelled nuclear 
extract was prepared by the modified protocol described in 
the text. This material was fractionated by chromatography 
on an FPLC superose column. Twenty 0.5ml fractions 
representing an elution volume of 5-15ml were collected, 
and equal aliquots of fractions 3-20 (elution volume 
6-15ml) analysed by SDS-PAGE. The sample in the extreme 
left lane of each gel (marked C) is an aliquot of crude 
nuclear extract for comparison. The position of VZV 140k, 
which eluted predominantly in fractions 9 and 10, is 
marked.
147
4. DISCUSSION
The studies described in this thesis sought to 
determine the functions and properties of the VZV 140k 
polypeptide. The results obtained are discussed in relation 
to the properties of Vmwl75, and their implications for VZV 
gene regulation considered. Finally, some areas for further 
study are outlined.
4.1. Functional Homology Between VZV 140k and Vmwl75
Several groups have reported that VZV 140k, like 
Vmwl75, is a powerful trans-activator in transfection 
assays (Everett, 1984; Everett and Dunlop, 1984; Inchauspe 
et al., 1989; Cabirac et al., 1990). Further functional
relatedness between the two polypeptides has been 
demonstrated by Felser et al. (1987, 1988), who showed that 
VZV 140k was able to complement the growth of viruses with 
ts and deletion mutations in Vmwl75. The studies described 
with the HSV-1 recombinant virus, HSV-140, sought to 
analyse this complementation in greater depth. In summary, 
it was found that VZV 140k was able to complement, to a 
large extent, for loss of Vmwl75 function. The phenotype of 
HSV-140, particularly those aspects pertaining to the 
functions of VZV 140k, are discussed in detail below.
HSV-140, unlike wt virus, failed to form clearly 
defined plaques. At first si^ fc , this finding appears to be 
at variance with the results of Felser et al. (1988), who 
described plaque formation by HSV-1 Vmwl75 mutants on 
stably transformed cell lines expressing VZV 140k. However, 
different sequences control the expression of VZV 140k in 
their studies and those reported here, which may explain 
this apparent contradiction. Thus VZV 140k is expressed 
from the HSV-1 IE-3 promoter in HSV-140 and, since this 
promoter is not subject to autoregulation (see below), 
VZV 140k accumulates to high levels as infection proceeds 
(relative to Vmwl75 in a normal wt virus infection). In 
cohtrast, VZV 140k is expressed from the authentic gene 62 
promoter in the cell lines of Felser et al., and hence 
presumably subject to autoregulation. Therefore, levels of
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VZV 140k during their experiments were probably much lower. 
It is conceivable that the presence of significant amounts 
of VZV 140k throughout the later stages of HSV-140 
infections might alter the balance of gene regulation. 
Subtle alterations in gene expression might lead to a 
reduced rate of virus assembly and maturation, which could 
in turn delay the appearance of cpe, and possibly account 
for the lack of plaque formation .
Comparison of viral polypeptide expression during 
HSV-140 and wt virus infections (at high multiplicity) 
demonstrated that a majority of predominant viral 
polypeptides were expressed in similar amounts and with 
similar kinetics. However, it should be stressed that this 
analysis would not detect subtle changes in the expression 
of polypeptides which are of low abundance during a normal 
wt virus infection. Indeed, the defect in DNA synthesis may 
well reflect the aberrant expression of an early function 
involved in DNA replication. It is likely that the reduced 
expression of certain late polypeptides is a consequence of 
less efficient DNA replication.
Intriguingly, gene expression during low 
multiplicity HSV-140 infections is markedly reduced. This 
aspect of the phenotype of HSV-140 is strikingly 
reminiscent of the phenotypes of HSV-1 viruses with 
mutations in Vmw65 and VmwllO (Stow and Stow, 1986; Sacks 
and Schaffer, 1987; Ace et al. , 1989; Everett, 1989). The
deficient growth of viruses lacking VmwllO function is 
apparently a consequence of reduced viral gene expression 
(Everett, 1989). Furthermore, the Vmw65 mutant inl814 
expresses reduced amounts of VmwllO and exhibits partial 
complementation when grown on cells transfected with a 
plasmid expressing VmwllO (Ace et al., 1989). It would thus 
appear that at the outset of low multiplicity infections, 
if VmwllO is absent or underexpressed, then Vmwl75 is not 
of itself able to efficiently induce viral gene expression. 
It' has been proposed that synergistic activation by Vmwl75 
and VmwllO in transfection assays might reflect a mechanism 
whereby VmwllO augments viral gene expression during
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infection. Therefore, is the multiplicity dependence of 
HSV-140 gene expression a consequence of inefficient 
activation of viral promoters by VZV 140k, either alone or 
in combination with VmwllO? This would seem unlikely given 
that VZV 140k has been shown to trans-activate the HSV-1 
glycoprotein D (gD) and thymidine kinase (tk) gene 
promoters much more efficiently than Vmwl75 in transfection 
assays (Section 3C, this thesis; Cabirac et al., 1990), and 
synergistic activation of the tk promoter by VZV 140k and 
VmwllO has been reported (Cabirac et al., 1990). However, 
these observations in transfection assays may not 
accurately reflect the situation at the outset of 
infection, when the relative amounts of the trans-activator 
polypeptides and target promoters is likely to be 
different.
Surprisingly, VZV 140K is p o o r ly  expressed
in a cycloheximide reversal experiment, despite being 
expressed from the HSV-1 IE-3 promoter. IE-3 promoter 
sequences upstream of position +27 (the site used for the 
linkage to VZV gene 62 sequences in HSV-140), have been 
shown to be sufficient to confer IE gene specificity upon 
heterologous sequences (Cordingly et al, 1983), and
therefore it was expected that VZV 140k would be expressed 
as a normal HSV-1 IE gene in HSV-140. (The failure of 
VZV 140k to autoregulate the IE-3 promoter is discussed 
below.) Since much of the IE-3 and VZV gene 62 
untranslated leader sequences are absent from the hybrid 
RNA encoded by HSV-140, a number of explanations for the 
lack of expression of VZV 140k following cycloheximide 
reversal can be envisaged. For example, the gene may not 
be transcribed. Alternatively, the mRNA might be 
intrinsically unstable and fail to accumulate, or may be 
inefficiently translated under these conditions. Whatever 
the reason, these results suggest that the nature of the 
transcribed sequences may play a role in the expression of 
IE" genes after cycloheximide reversal.
The absence of VZV 140K in a cycloheximide reversal 
experiment, which is unphysiological, is probably not
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significant with regard to the growth properties of HSV-140 
in normal infections. The polypeptide profiles at early 
times in HSV-140 and wt virus infections (at high 
multiplicity) were essentially indistinguishable, which 
argues that sufficient amounts of VZV 140K are produced at 
the outset of infection to ensure efficient induction of 
early gene expression.
4.1.1. Trans-Activation and Autoregulation by VZV 140k
The virus studies discussed above demonstrate that 
VZV 140k is able to trans-activate many HSV-1 promoters. 
The trans-activation properties of VZV 140k were analysed 
further in transfection assays. It was found that a small 
in-frame insertion into homology region 2 of the 
polypeptide abolished trans-activation activity.
Significantly, the integrity of region 2 sequences of 
Vmwl75 has been shown to be essential for trans-activation 
(Paterson and Everett, 1988a,* Shepard et al., 1989), which 
suggests that the mechanism of trans-activation by VZV 140k 
is likely to be similar to that of Vmwl75, a model of which 
is discussed in Section ID.7.1.
The results described in Section 3D demonstrate 
repression or autoregulation of the VZV gene 62 promoter by 
VZV140k, thus defining a new function of the polypeptide. 
Interestingly, Vmwl75 is able to repress the VZV gene 62 
promoter with a similar efficiency to VZV 140k, but 
VZV 140k is unable to repress the IE-3 promoter. The 
failure of VZV 140k to repress the IE-3 promoter in 
transfection experiments is consistent with the properties 
of the recombinant virus, HSV-140; infection by HSV-140 
leads to high levels of VZV 140k expression which continues 
late into infection.
The finding that the integrity of homology region 2 
of VZV 140k and Vmwl75 is required for repression of the 
VZV gene 62 promoter is clearly of interest since it 
indicates that both polypeptides repress VZV gene 62 by a 
mechanism similar to that described for repression of the 
HSV-1 IE-3 promoter by Vmwl75 (see Section 1C.2.4). This
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requires a specific DNA recognition sequence at the IE-3 
cap site (Roberts et al., 1988), and a functional Vmwl75 
DNA binding domain (Paterson and Everett, 1988b; Shepard et 
al., 1989). Therefore, in an attempt to identify a 
VZV 140k DNA recognition element, sequences in the gene 62 
capsite-leader region were deleted. These experiments were, 
however, inconclusive. A more productive approach might be 
to direct nucleotide alterations or smaller deletion 
mutations into the otherwise intact capsite-leader in 
P140CAT.
4.1.2. DNA Binding
The immediate-early polypeptides of HSV-1 bind 
non-specifically to DNA in vitro (Powell and Purifoy, 1976; 
Hay and Hay, 1980). A similar approach to that used by Hay 
and Hay was employed to investigate whether or not VZV 140k 
binds DNA. It was found that VZV 140k was retained by a 
DNA-cellulose column and had a similar elution profile to 
Vmwl75. This is indirect evidence that VZV 140k binds to 
DNA, although possible artefacts such as partial 
insolubility of VZV 140k under the conditions used to load 
the column (thus leading to retention) cannot be excluded.
The repression studies discussed above provide 
genetic evidence that both VZV 140k and Vmwl75 bind to 
specific sequences in the VZV gene 62 promoter-leader 
region. Thus gel retardation assays were undertaken with a 
range of probes representing the entire gene 62 
promoter-leader region (-410 to +57) as defined by Mckee et 
al. (1990). These studies did not demonstrate 
sequence-specific binding of either polypeptide to 
sequences in this region. It should be stressed that 
detection of protein-DNA interactions in gel retardation 
assays requires that the interaction be relatively stable 
under the incubation/gel conditions used. It is possible 
that a different approach (e.g. footprinting) may yet 
detect binding of VZV 140k to DNA.
The sequence-specific DNA binding function of 
Vmwl75 resides in a discrete domain of the polypeptide
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comprising predominantly region 2 sequences. This domain, 
either expressed as a fusion protein in bacteria, or 
liberated from the intact polypeptide by proteolytic 
digestion, is able to bind DNA with a similar affinity and 
specificity to the intact polypeptide (Everett et al., 
1990; Wu and Wilcox, 1990). More recent data from Wu and 
Wilcox (XVth International Herpesvirus Workshop; Pers. 
Comm.) has demonstrated binding of region 2 of VZV 140k 
(expressed as a trpE fusion protein in E.coli) to specific 
sequences in the VZV gene 62 promoter-regulatory region; 
their results are discussed in more detail below. The 
failure of the experiments described in this thesis to 
detect such binding probably reflects both the low affinity 
of the binding (as noted by Wu and Wilcox, see below) and 
the solubility problems encountered with the intact 
polypeptide in both crude extracts and in partially 
purified form.
Wu and Wilcox expressed region 2 of VZV 140k, and 
the corresponding sequences from Vmwl75 and the PRV-IE 
polypeptide, as TrpE fusion proteins in E.Coli. These 
fusion proteins were partially purified and utilized in 
DNAse footprinting and gel retardation assays with probes 
representing VZV gene 62 sequences from -410 to +95, 
essentially as investigated by the experiments described in 
this thesis. In addition, binding to probes spanning the 
HSV-1 IE-3 and PRV IE gene capsites was investigated. In 
comparison to the HSV-1 and PRV fusion proteins, the VZV 
140k fusion protein (designated FP617) bound with much 
lower affinity to all sequences analysed. FP617 was found 
to bind to a number of sites in the VZV promoter-leader 
region; the highest affinity binding was to a site located 
between -311 and -282, with binding to a number of weaker 
sites located between -200 and +95 also being detected. 
Interestingly, the sequence specificity of FP617 and the 
Vmwl75 fusion protein, FP449 (and also the PRV fusion 
protein), was found to be similar, the higher affinity 
sites all containing the sequence 3'ATCGT3’. Strikingly, 
these residues are identical to those shown to be most
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important for binding of Vmwl75 to the consensus ATCGTC
motif at the IE-3 capsite (see Section 1C.1.3). However, 
FP449 did not appear to bind to the high affinity site
(-311 to -282) in the VZV promoter (which contains an ATCGT
motif). Thus the fusion proteins appear to have similar
sequence recognition characteristics, though these are not 
indistinguishable.
What are the implications of these results for the 
proposed mechanism of autoregulation of the VZV gene 62 
promoter by VZV 140k and Vmwl75? The genetic evidence 
discussed above suggests that repression involves binding
to specific sequences, presumably at or near the gene 62
capsite. However, the FP617 fusion protein binds most
strongly to a site located between -311 and -282, far
upstream of the experimentally determined capsite, and 
binding to the capsite region itself is very weak. The 
far-upstream site is, however, located immediately 
downstream of what Felser et al. (1988) originally proposed 
(on the basis of sequence analysis alone) to be the gene 62 
TATA box (see Figure 45). Wu and Wilcox propose that gene 
62 may contain two capsites, one as determined by McKee et 
al. (1990), which is designated +1, and a second located
around 300 bp upstream of this at around -300, downstream 
of the proposed "Felser" TATA box at -312. If this 
hypothetical "upstream" capsite were functional and 
constituted a predominant start site (at least early in 
infection), then by analogy with repression of the HSV-1 
IE-3 promoter by Vmwl75, binding of VZV 140k to this site 
might bring about repression of the gene 62 promoter.
There is as yet no experimental evidence for the 
existence of this second capsite, and it is unlikely to be 
important in the expression of gene 62 for the following 
reasons. The sequence elements predicted by Felser et al.
(1988) are located between -664 and -280, whereas McKee et 
al. (1990) demonstrated that basal promoter activity was 
contained in a region between -131 and +57, and that 
sequences upstream of -410 had no effect on either basal or 
Vmw65 induced levels of promoter activity. Furthermore, if
Figure 45. VZV gene 62 control Region. Sequences upstream 
of VZV gene 62 between -599 and +77 are shown. The orf 
begins at the ATG codon at +74. McKee et al. (1990)
analysed the sequences controlling expression of gene 62. 
Basal promoter activity was found to reside between Xhol 
(-131) and +57. The location of the experimentally
determined capsite is indicated by the arrow, and the
location of the presumed TATA box (-30) is shown. Sequences 
between Sail (-410) and Xhol (-131) were found to confer 
responsiveness to Vmw65, and the location of an
octamer/TAATGARAT motif (centered on -255) implicated in 
this response is shown. The TATA box proposed by Felser et 
al. (1988) is indicated (centered on -306).
CCTCCCCATC GGCGGGGTAC CGCGCCCCCT CCCCAT'CGGC GGGGGGTTAC - 5 5 0
GTGAACACCA CAACCCCGTG TGTATTTTAT GGGTTATCGC GGGCTTCGTG -500
CCGCCTGACA TAATCGTTGG GAGGGGTGGT GGT'GT'ATACG CTTGTTGATT -4 50
Sail
GCGCGAACGT AATGACGACG GAGAGGGACC CAAACACACC GTCGACGTGC -4 00
ATTTGATTAA CTAGATGCCG GATGGGTGGA AACAACCCGT GTTATA'TAAG -3 50
Felser "TATA"
ATGTTTTGCA TGTGAGACAA CCCCAATTGT' GTTTATGTAT ATTATATATC -300
Oct/TG
GTCTGTAGAC ACACGATGAT TGGTTGTTAT TTAAAC ATAT GTAA ATGA A A -2 50
TTCACATGTC TGGTATCCCT TGTTATGATG TTGTAAGGTA TGCGGAAATA -200
GACACCGGGC GTACATCGCC AACCAGCGGT CTC-TCCTTAA AC GC AT AC T A -150
Xhol
TGGTCCATGA ACTTCCCGCC TCGAGTCTCG TCCAAT'CACT ACATCGTCTT -100
ATCATTAAGA ATATTTACAC GGTGACGACA CGGGGAGGAA ATATGCGGTC -50
"TATA"
GAGGGGGGGG CACAACACGT TTTAAGTACT GTTGGAACTC CCTCACCAAC +1
CGCAATCGCA ATCCTTTGAA GGCTGCGAGA GCGTTTGGAA AACTCGGGTA +51
CGTCTAAAT'T CACCCCAGTG CGATGG +77
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a mRNA were transcribed from this upstream capsite, its 
untranslated-leader region would contain ten AUG codons 
upstream of the predicted AUG initiation codon, each of 
which is followed by an in-frame termination codon. Even if 
potential splice donor and acceptor sites (located at -212 
and +69 respectively) were utilized, the leader would still 
contain five AUG codons followed by in-frame termination 
codons upstream of the orf. It is likely that translation 
of VZV 140k coding sequences encoded by an mRNA with these 
characteristics would be extremely inefficient. In 
contrast, the untranslated-leader sequence of mRNA 
transcribed from the capsite at +1 contains no AUG codons 
upstream of the orf. Thus, this second "hypothetical" 
capsite, if indeed it exists, is unlikely to be of 
significant importance in the expression of VZV 140k during 
virus infection.
It is informative to also consider repression of 
the VZV gene 62 promoter by Vmwl7 5. Thus although Vmwl75 
represses the gene 62 promoter as efficiently as VZV 140k, 
the FP449 fusion protein, which binds relatively strongly 
to the IE-3 capsite, binds only weakly to sites in the gene 
62 promoter, none of which overlap, or are located close to 
either the experimental or hypothetical capsites. This is 
intriguing since repression of the IE-3 promoter by Vmwl75 
appears to require that the binding site is located at or
close to the capsite. Finally, although FP617 apparently
binds as efficiently to the consensus motif located at the 
HSV-1 IE-3 capsite as it does to sites in the gene 62 
promoter, VZV 140k strongly represses the gene 62 promoter
yet activates the IE-3 promoter.
Genetic evidence suggests that DNA binding is 
central to the mechanism whereby VZV 140k and Vmwl75 
repress expression from the VZV gene 62 promoter. However, 
it is not clear from the DNA binding studies discussed 
above whether this involves binding to the capsite alone, 
or'whether binding to a number of sites might be involved. 
Clearly, further experimentation will be required to 
delineate the mechanism whereby these polypeptides repress
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the VZV gene 62 promoter.
4.2. Gene Regulation and the Biology of VZV
The regulation of expression of one of the 
predicted VZV IE genes, gene 62, has been studied in 
transfection assays. McKee et al. (1990) defined a 
promoter for VZV gene 62 which was shown to respond to the 
HSV-1 virion trans-activator polypeptide, Vmw65. The VZV 
homologue of Vmw65, encoded by VZV gene 10, was found to 
be unable to trans-activate gene 62, and it was concluded 
that a cellular polypeptide might replace Vmw65 function or 
activate VZV IE gene expression directly.
The transfection studies described in this thesis 
demonstrate autoregulation of the VZV gene 62 promoter by 
VZV 140k. Repression of the HSV-1 IE-3 promoter by Vmwl75 
in transfection assays presumably reflects a homeostatic 
mechanism whereby levels of Vmwl75 are stabilized and high 
level expression is prevented as infection proceeds. It is 
proposed that expression of VZV 140k during VZV infection 
will likewise be subject to autoregulation. Autoregulation 
of expression of VZV 140k and Vmwl75 might be important
with respect to the biology of VZV and HSV-1, since
overexpression of these trans-activator polypeptides at 
late times in infection might disrupt gene expression. 
Indeed, this might account for some of the properties of 
HSV-140.
The results presented in this thesis and elsewhere 
provide compelling evidence that VZV 140k has a pivotal 
role in the growth of VZV in vivo. As such, modulation of 
the efficiency of expression of VZV 140k may be important 
in determining the biological properties of VZV. For 
example, differential expression of VZV 140k in different
cell types could have a profound effect on the outcome of
VZV infection. VZV encodes three other polypeptides with 
homology to HSV-1 IE genes. The product of VZV gene 4 is 
able to partially complement HSV-1 mutants with lesions in 
Vmw63, and is thus also likely to be important in the 
growth of VZV. The potential role of the predicted VZV
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equivalent of Vmw68 remains to be determined.
Finally, these studies do not indicate whether or
not VZV genes are regulated with "early" or "late"
kinetics. It will be necessary to analyse gene expression 
during VZV infection to address this question.
4.3. Future Prospects
The work presented in this thesis has increased our 
knowledge of the properties and functions of VZV 140k. A 
number of areas for potential future study will be 
outlined.
VZV 140k is a powerful trans-activator of viral 
promoters, and is also able to repress expression from its 
own promoter, that of gene 62. Homology region 2 of 
VZV 140k, like that of Vmwl75, is important for both of 
these functions. By extension, it is likely that homology 
region 4 of VZV 140k will be functionally important, at
least in trans-activation. It would, therefore, be of
interest to study the properties of regions 2 and 4 in more 
detail. One approach which could be taken would be to 
construct chimeric genes in which region 2 sequences (and 
also the C-terminal end of region 1, which appears to be 
important in the DNA binding properties of Vmwl75), region 
4 sequences, or both were exchanged between VZV 140k and 
Vmwl75. These chimeric genes could then be studied in a 
number of ways:
The trans-activation properties of the polypeptides 
expressed by the chimeric genes could be investigated in 
transfection assays. This would determine whether the 
powerful trans-activation of the HSV-1 gD and VZV tk 
promoters by VZV 140k compared to Vmwl75 (in the absence 
of VmwllO) reflects sequence alterations within or outwith 
the conserved regions of the polypeptides.
Region 2 of VZV 140k and Vmwl75 represent distinct 
DNA binding domains. The DNA binding properties of the 
chdmeric polypeptides (particularly affinity) should, 
therefore, reflect those of the polypeptide from which 
region 2 sequences are derived. Analysis of repression of
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the HSV-1 IE-3 and VZV gene 62 promoters by these chimeric 
polypeptides should help to clarify the relationship 
between the DNA binding and repression properties of 
VZV 140k and Vmwl75, which is at present somewhat opaque.
Finally, these chimeric genes could be recombined 
into D30EBA, and the resulting recombinant viruses 
characterized. Thus it would be possible to determine 
whether the defects in HSV-140 reflect the properties of 
regions 2 and/or 4 of VZV 140k, or whether they reflect 
those of the non-conserved regions. It would hopefully be 
possible to relate the findings of transfection studies to 
the growth properties of the viruses. The effect of
overexpressing VZV 140k on the growth of HSV-140 should 
also be assessed by constructing a virus in which VZV 140k 
is expressed from the gene 62 promoter, rather than the 
HSV-1 IE-3 promoter. If overexpression of VZV 140k were 
found to account for some of the properties of HSV-140, 
then expression of chimeric polypeptides in recombinant 
viruses would utilize a promoter shown to be repressed (in
transfection assays) by the polypeptide in question.
These studies could be extended to include the
corresponding homologous region 2 sequences of the PRV and 
EHV-1 IE polypeptides.
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A herpes simplex virus type 1 recombinant with both copies of the 
Vmwl75 coding sequences replaced by the homologous varicella-zoster 
virus open reading frame
Graham H. Disney and Roger D. Everett*
MRC Virology Unit, Church Street, Glasgow Gil 5JR, U.K.
Varicella-zoster virus (VZV) gene 62 encodes a protein 
with a predicted M r o f 140000 (VZV 140K) that shares 
considerable amino acid hom ology with the immediate 
early (IE) regulatory protein V m w l75 o f herpes 
simplex virus type 1 (H SV-1) and is believed to be its 
functional equivalent. We have tested this hypothesis 
by insertion o f VZV gene 62 (expressed from the H SV- 
1 IE3 promoter) into both IE3 gene loci in the short 
region repeats o f  the HSV-1 genome. The parent virus 
used for this manipulation was D 30EBA , which is a 
variant o f HSV-1 from which the majority o f the 
V m w l75 coding sequences have been deleted. Like 
other HSV-1 viruses lacking V m w l75 function, 
D 30EBA  is able to grow only in cell lines which express 
V m w l75 constitutively. The resulting recombinant 
virus, H SV -140, is able to propagate (but unable to 
form obvious plaques) on normal cell lines. The
properties o f H SV -140 were studied by monitoring the 
time course o f polypeptide expression and D N A  
replication during normal infection. We found that at 
high multiplicity H SV -140 synthesized apparently 
normal amounts o f many viral polypeptides but that 
the expression o f certain late genes was reduced; this 
slight defect may be related to less efficient D N A  
replication by H SV -140. At low multiplicity H SV -140  
expressed viral proteins inefficiently. Surprisingly, 
VZV 140K was produced in large amounts at later 
times o f a normal infection, indicating that the 
polypeptide fails to autoregulate the IE3 promoter. 
The results strongly suggest that VZV 140K is able to 
perform m ost o f  the functions o f  V m w l75 during 
growth o f H SV -1, but that differences in detail lead to 
less efficient virus growth.
Introduction
Varicella-zoster virus (VZV) is a common human 
pathogen which causes chickenpox on initial exposure 
and shingles on subsequent reactivation from latency. It 
is a member of the neurotropic alphaherpesvirinae 
subfamily and is genetically closely related to herpes 
simplex virus type 1 (HSV-1) (Davison & Scott, 1986; 
McGeoch et al., 1988). At present, in contrast to the 
increasingly sophisticated knowledge of the molecular 
biology of HSV, studies on the mechanisms of gene 
regulation during VZV infection are at an early stage. 
This is principally a result of the growth properties of 
VZV in tissue culture, which make the isolation of single 
plaques and establishment of high titre stocks difficult. 
However, the availability of the complete D N A  se­
quence of VZV (Davison & Scott, 1986) and the use of 
transfection and expression systems allow individual 
genes, selected from the 71 predicted major open reading 
frames (ORFs), to be studied. This paper concerns the 
product of VZV gene 62, whose predicted product (VZV
140K) is closely related to the regulatory polypeptide 
Vmwl75 (or ICP4) of HSV-1 (McGeoch et al., 1986).
Gene regulation during HSV-1 infection in tissue 
culture has been extensively studied (for reviews see 
Wagner, 1985; Everett, 1987 a). The viral genes are 
expressed in three broad classes termed immediate early 
(IE), early and late. The IE genes are transcribed by the 
unmodified host R N A  polymerase II at the onset of 
infection (Costanzo et al., 1977). Of the five IE genes, at 
least four can function as transcriptional activators of 
viral (and in some cases cellular) gene expression. The 
product of IE gene 3, Vmwl75, is absolutely required for 
the expression o f early and late genes and is also required 
for the repression or autoregulation of IE gene expression 
(Preston, 1979; Watson & Clements, 1980). HSV-1 
viruses with temperature-sensitive (ts) lesions in 
Vm wl75 are unable to grow at the non-permissive 
temperature.
Homologues of Vm wl75 have been identified from 
D N A  sequence information in all the other alphaherpes- 
viruses so far analysed, including VZV (Davison &
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Wilkie, 1983; McGeoch et al., 1986). The product of 
VZV genes 62 and 71 (the identical gene is present in 
both copies of the short region repeats; Fig. 1 b) has a 
predicted M r of 140K and for several reasons is believed 
to be the VZV equivalent of Vm wl75. The genes are 
located in equivalent positions and there is extensive 
predicted amino acid sequence conservation between 
them (McGeoch et al., 1986). Also, VZV 140K has been 
shown to be a potent activator o f gene expression in 
transient transfection assays (Everett & Dunlop, 1984; 
Everett, 1984; Inchauspe et al., 1989) and the regions of 
the Vm wl75 polypeptide that have been shown to be 
most important for its transactivation and repression 
phenotypes are the most highly conserved in 140K 
(Paterson & Everett, 1988 a; DeLuca & Schaffer, 1988). 
These same regions are also highly conserved in the other 
alphaherpesvirus homologues of Vm wl75 (Grundy etal., 
1989; Cheung, 1989; Vleck etal., 1989). Four IE proteins 
have been identified in VZV-infected cells using 
cycloheximide reversal experiments, the largest o f which 
has an apparent molecular weight of 185000 and has 
been proposed to be the product of gene 62 (Shiraki & 
Hyman, 1987). Perhaps the most compelling evidence 
that VZV 140K and HSV-1 Vm wl75 are functionally 
homologous is that HSV-1 mutants with lesions in 
Vm wl75 can be complemented by either transfected 
plasmids or transformed cell lines which express VZV 
140K (Felser et al., 1987, 1988).
In this paper we have extended such studies by 
construction of a virus (HSV-140) which contains VZV  
140K in place of the coding sequences for Vm wl75 in the 
HSV-1 genome. HSV-140 was constructed from 
D30EBA (Paterson & Everett, 1990), an HSV-1 deriva­
tive that has the majority of the V m wl75 coding 
sequences deleted, and a plasmid in which 140K is 
expressed from the IE3 transcription regulatory signals. 
Unlike D30EBA, HSV-140 is able to grow in normal 
tissue culture cells. We have further investigated the 
properties of VZV 140K and its complementation of 
Vm wl75 by studies on the growth, polypeptide expres­
sion and D N A  replication of HSV-140. We found that 
although VZV 140K is able to complement for the 
absence of Vm wl75, HSV-140 is partially defective in 
comparison to HSV-1.
Methods
Plasmids. P la sm id  p G D 1 4 0 , w h ic h  c o n ta in s  th e  V Z V  140K  co d in g  
seq u en ces  in  a n  H SV -1 IE 3  tra n s c r ip tio n  u n it  (F ig . 1 a) w as c o n s tru c ted  
from  frag m e n ts  d e riv e d  fro m  p G X 1 6 1 , p I3 8  a n d  p l4 0 B T E . P la sm id  
pG X 161  (k in d ly  p ro v id e d  by  D r  C . M . P re s to n )  h as  b e en  d e sc rib e d  
p rev io u sly  (P re s to n  &  F is h e r , 1984) a n d  c o n ta in s  th e  p ro m o te r  a n d  
u p s tre a m  reg u la to ry  seq u en ces  o f  th e  H SV -1 IE 3  gen e  (n u c leo tid e s  
— 331 to  + 2 7 )  b e tw een  th e  Hindlll a n d  BamYll s ites  o f  p A T 153 .
P la sm id  p I3 8  (k in d ly  p ro v id e d  by  D r  T . P a te rso n )  is a  d e riv a tiv e  o f 
p l7 5  (P e rry  et al., 1986) c re a te d  by  in s e r tio n  o f  a  12 b p  E co R I linker 
o lig o n u c le o tid e  in to  a  NaeI s ite  w ith in  th e  V m w l7 5  cod ing  sequences, 
re su ltin g  in  a n  in -f ra m e  in s e r tio n  o f  fo u r  a m in o  ac id s  in to  the  p roline  
c o d o n  a t p o s itio n  1236 (P a te rs o n  &  E v e re tt,  1988a). P lasm id  p l4 0  
c o n ta in s  V Z V  gene  62 in  a  fra g m e n t fro m  th e  Clal s ite  a t  position  
— 1146 to  th e  te rm in a l Pstl s ite  o f  p V Z V S s tf  (E v e re tt,  1984) inserted  
b e tw een  th e  Accl a n d  Pstl s ite s  o f  a  p U C 9  p la sm id  from  w h ich  the 
EcoRl site  h a d  b een  re m o v e d  by  c u tt in g  a n d  filling  in  (M cK ee  et al., 
1990). P la sm id  p l4 0 B T E  is a  d e riv a tiv e  o f  p i 40  w h ich  has a unique 
BglI I  s ite  a t  p o s itio n  +  57 (re la tiv e  to  th e  tra n s c r ip tio n  s ta r t  site  a t + 1 )  
a n d  a  u n iq u e  E co R I s ite  fo u r n u c le o tid e s  b ey o n d  th e  3 ' en d  o f  the  O R F. 
P la sm id  p l4 0  w as su b jec ted  to  s ite -d ire c ted  m u tag en es is  to  create a 
u n iq u e  .EcoRI s ite  a t  + 5 7  (p l4 0 E T ;  M c K e e  et al., 1990), w hich  was 
su b seq u en tly  c o n v e r te d  to  a  Bgll I s ite  by  in s e r tio n  o f  an eight 
n u c leo tid e  Bgll I l in k e r  to  c re a te  p l4 0 B T . P la sm id  p l4 0 B T  was 
lin e a riz ed  by d ig e s tio n  w ith  7761 111, w h ic h  cu ts  tw o  nucleotides 
b e y o n d  th e  e n d  o f  th e  g en e  62 re a d in g  fram e , a n d  E co R I linkers  were 
in se r te d  a f te r  filling  in  th e  e n d s  to  y ie ld  p l4 0 B T E . P la sm id  pG D 140 
w as c o n s tru c ted  in  a  t r ip a r t i te  lig a tio n  u s in g  th e  Bglll-EcoRl fragm ent 
fro m  p l4 0 B T E  c o n ta in in g  th e  V Z V  140K  c o d in g  sequences, the 
sm alle r Pstl-BamHl f ra g m e n t o f  pG X 1 6 1  c o n ta in in g  th e  IE 3  p rom oter 
(a n d  p a r t  o f  th e  v e c to r  seq u e n ces) a n d  th e  sm a lle r P s t l -E c o R I  fragm ent 
o f  p I3 8  w h ic h  p ro v id e s  th e  re s t o f  th e  v e c to r  seq u en ces , th e  C -te rm ina l 
62 c o d o n s  o f  V m w l7 5 , th e  3 ' e n d  o f  th e  IE 3  tra n s c r ip tio n  u n it and  
s u b se q u e n t H SV -1 D N A  th ro u g h  to  th e  Sstl s ite  in  T R L (F ig . la ) .  T he 
C -te rm in a l p o rtio n  o f  V m w l7 5  in  th is  c o n s tru c t fo llow s th e  T G A  stop 
c o d o n  o f  V Z V  gene  62. P la s m id  p i l l  (E v e re tt,  19876) w as derived  
fro m  p l l 0 d e l 7  (P e rry  et al., 1986) by  filling  in  th e  E co R I s ite  in  the  
p o ly lin k e r sequences .
Cells. B aby  h a m s te r  k id n e y  cells (B H K -21  c lone  13; M acp h e rso n  & 
S to k er, 1962), w ere  g ro w n  in  G la sg o w  M o d ified  E a g le ’s m edium  
(G M E M , G ib c o ) s u p p lem e n te d  w ith  100 u n its /m l p en ic illin , 100 pg/m l 
s tre p to m y c in , 10%  try p to se  p h o s p h a te  a n d  10%  n e w b o rn  c a lf  serum . 
H u m a n  foe ta l lung  (H F L ) cells w ere  g ro w n  in  G M E M  supp lem en ted  
w ith  10%  fo e ta l c a lf  se ru m , p e n ic illin  a n d  s tre p to m y c in  as above.
Viruses. T h ro u g h o u t th is  p a p e r  w ild -ty p e  (w t) v iru s  re fe rs  to  HSV-1 
G lasg o w  s tra in  17 syn+ (B ro w n  et al., 1973). T h e  H SV -1 deriva tive  
D 3 0 E B A , w h ich  lack s  c o d o n s  84 to  1270 o f  th e  V m w l7 5  coding 
seq u en ce  (P a te rso n  & E v e re tt,  1990), w as  u sed  as  th e  p a re n t v irus for 
th e  c o n s tru c tio n  o f  H SV -140 . D 3 0 E B A  w as p ro p a g a te d  o n  M 64A  cells, 
a  tra n s fo rm e d  cell lin e  th a t  ex p re sse s  V m w l7 5  a n d  w h ic h  is equ iva len t 
to  M 65 cells as d e sc rib e d  by D a v id so n  &  S tow  (1985).
Construction of HSV-140. A  m ix tu re  c o n ta in in g  ap p ro x im a te ly  1 pg 
o f  p la sm id  p G D 1 4 0  lin e a riz ed  w ith  Pstl, 3 pg  o f  D 3 0 E B A  v ira l D N A  
a n d  5 pg  o f  c a lf  th y m u s  D N A  (as a  c a r r ie r )  w ere  tra n s fe c ted  in to  2 x 
106 B H K  cells by  th e  m e th o d  o f  S tow  &  W ilk ie  (1976). C ells w ere also 
tra n s fe c te d  w ith  v ira l o r  p la sm id  D N A  a lo n e  as a  con tro l. Follow ing 
tra n s fe c tio n , cells w ere  in c u b a te d  a t  37 °C  a n d  w h en  c .p .e. was 
a p p a re n t (a f te r  3 to  4  days), th e  cells a n d  m e d iu m  fro m  e ac h  p la te  were 
h a rv e ste d , s o n ic a te d  a n d  s to re d  as  a  v iru s  s to ck . T h e  p resen ce  o f  the 
d e sired  re c o m b in a n t v iru s  w as d e te c te d  by  slo t b lo t analy sis  o f  to ta l 
ce llu la r D N A  p re p a re d  fro m  B H K  cells in fe c te d  w ith  th e  in itia l virus 
s tocks. T h e  s tru c tu re  o f  th e  re c o m b in a n t v iru s  g e n o m e  w as analysed  by 
S o u th e rn  b lo ttin g . F in a lly , H S V -140  w as p u rif ied  fro m  these  initial 
iso la tes  by  lim itin g  d ilu tio n .
Preparation and analysis of viral DNA. V ira l D N A  w as p rep a red  as 
to ta l c e llu la r D N A  fro m  B H K  cell m o n o lay e rs  in fe c ted  w ith  HSV-140 
o r  w t v iru s  (as d e ta iled  in  th e  tex t)  by  th e  m e th o d  o f  S tow  et al. (1983) 
a n d  an a ly sed  a f te r  d ig e s tio n  w ith  Bamlll by  S o u th e rn  b lo tting  
(S o u th e rn , 1975) u s in g  n ic k - tra n s la te d  p l4 0  as a  p ro b e  (R igby  et al., 
1977).
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F ig . 1. T h e  s tru c tu re  o f  p la sm id  p G D 1 4 0  a n d  a  su m m a ry  o f  th e  s tru c tu re  o f  v iru s  H SV -140. (a) P la sm id  p G D 1 4 0  w ith  th e  V Z V  gene  62 
co d in g  reg io n  fla n k ed  by  th e  H SV -1 IE 3  tra n s c r ip tio n a l c o n tro l sequences . T h e  v e c to r seq u en ces  e x te n d  fro m  th e  Pvull s ite  o f  p B R 3 2 2  
(w h ich  h a d  b e en  a lte re d  to  a n  Sstl s ite ) th ro u g h  th e  a m p ic illin  re s is ta n c e  g en e  (w ith  its  Pstl site ) to  th e  Hindlll s ite . T h e  Hindlll s ite  is 
lo c a ted  a t  th e  ju n c tio n  o f  H SV -1 a n d  p A T l 53 seq u en ces  a n d  is jo in e d  to  th e  Smal s ite  a t  p o s itio n  — 331 o f  th e  IE 3  p ro m o te r . T h e  V Z V  
gene  62 seq u en ces  from  p o s itio n  + 5 7  to  a n  in tro d u c e d  E co R I s ite  ju s t  a f te r  th e  V Z V  140K  s to p  c o d o n  a re  sh o w n , w ith  th e  co d in g  
seq u en ce  in  a  s tip p led  box. S eq u en ces  d o w n stre am  o f  th is  in c lu d e  th e  3 ' p o rtio n  o f  IE 3 , th e  ‘a ’ seq u e n c e  a n d  p a r t  o f  T R L as fa r  as th e  Sstl 
site  as sh o w n  (n o t to  scale). T h e  p la sm id  w as c o n s tru c ted  by  lig a tio n  o f  th e  Pstl-BamHl f ra g m e n t o f  p G X 1 6 1 , th e  Bglll-EcoRl 
frag m e n t o f  p l4 0 B T E  a n d  th e  £coR I-<Ss/I f ra g m e n t o f  p I3 8  as  d e ta iled  in  M eth o d s . (6) T h e  lo c a tio n s  o f  th e  V m w l7 5  a n d  V Z V  gen e  62 
co d in g  reg io n s  (in d ica te d  by  a rro w s) in  th e  g en o m es o f  H SV -1 a n d  V Z V  resp ec tiv e ly . T h e  sh o rt u n iq u e  reg io n  (U s) a n d  f lan k in g  re p e a t 
seq u en ces  ( IR S a n d  T R S; o p e n  boxes) o f  th e  g en o m es  a re  sh o w n  (n o t to  scale).
Labelling and analysis of viral polypeptides. E x a m in a tio n  o f  p o ly p e p ­
tid e  sy n th esis  th ro u g h o u t th e  g ro w th  cycle  w as p e rfo rm ed  a t  37 °C 
u sing  a  2 h  lab e llin g  p e rio d . S ing le  w ells o f  24-w ell L in b ro  b locks  w ere 
in fe c ted  a t  v a rio u s  m u ltip lic i tie s  (as d e sc rib e d  in  th e  te x t)  a n d  a t 
v a rio u s  tim es  th e re a f te r , w a sh e d  w ith  p h o sp h a te -b u ffe re d  sa lin e  (PBS) 
a n d  in c u b a ted  w ith  15 jaCi [35S ]m eth io n in e  (A m e rsh a m , > 8 0 0  
C i/m m o l) in  200 p i o f  PB S. A fte r  lab e llin g , th e  cells w ere  w ash ed  a n d  
h a rv e s te d  an d  th e  lab e lled  p ro te in s  an a ly sed  o n  d isco n tin u o u s  7-5%  
S D S -p o ly a c ry lam id e  gels as d e sc rib e d  by M arsd e n  et al. (1978).
Assay of DNA replication. B H K  cells in  L in b ro  w ells w ere  in fec te d  
w ith  H SV -140 o r  w t v iru s  a n d  to ta l c e llu la r D N A  w as p re p a re d  a t 
v a rio u s  tim es  p o s t-in fe c tio n  (as d e sc rib e d  in  th e  tex t). D N A  sam p les  
w ere  tre a te d  w ith  R N a s e  (100 pg /m l, 65 °C  fo r 1 h) p r io r  to  a p p lic a tio n  
to  a  n itro ce llu lo se  m e m b ra n e  u s in g  a  slo t b lo t a p p a ra tu s  (S ch le ich e r 
a n d  S chuell, M in ifo ld  II). B lo ts w ere  p ro b e d  w ith  n ic k - tra n s la te d  p i l l  
(R ig b y  et al., 1977).
Results
Construction of a virus expressing VZV 140K in place of 
Vmwl75
Virus D30EBA lacks the majority of the Vm wl75 coding 
sequences and is unable to grow in normal cell lines 
(Paterson & Everett, 1990). Since VZV and plasmids 
expressing the VZV 140K polypeptide complement 
HSV-1 viruses with ts mutations in Vm wl75 (Felser et 
al., 1987, 1988), we expected to be able to rescue 
D30EBA by the introduction of gene 62 of VZV. Hence 
plasmid pGD140, which contains the VZV gene 62 
coding region inserted into an IE3 transcription unit 
(Fig. 1 a), was constructed. The IE3 sequences 5' and 3' of
the VZV 140K coding region allow recombinational 
insertion into the normal location of IE3 in the short 
region repeats.
D30EBA viral D N A  was cotransfected into BHK cells 
with linearized pGD140. We expected that any recom­
binants that contained ORF62 would be able to grow, 
whereas input viral D N A  alone would not lead to virus 
production. After 4 days c.p.e. was observed in cells 
cotransfected with viral and plasmid D N A , whereas no 
c.p.e. was observed in the control transfection with viral 
D N A  alone. Cells and medium combined from both the 
control and cotransfected plates were sonicated and 
retained as virus stocks. These stocks were used to infect 
further BHK cells and total infected cell D N A  was 
prepared. This was initially analysed by D N A  slot blots 
using nick-translated p i40 (McKee et al., 1990) as a 
probe, which showed that only D N A  prepared from the 
cotransfected cells hybridized to VZV sequences (results 
not shown).
The recombinant viral D N A  was further analysed by 
Southern blotting (Fig. 3). The controls show that neither 
mock- nor wt HSV-1-infected cell D N A  samples 
hybridize to the p i40 probe. The BamHl restriction map 
for the expected recombinant virus (Fig. 2) predicts that 
the probe will hybridize to the following fragments on the 
blot: BamHl [k'] (6-0 kb) and BamHl [y' +  n] (7-1 kb) 
derived from IRS; BamHl [x +  y'] (4-1 kb); BamHl [q'] 
(3-0 kb) derived from TR... Fragments corresponding in 
size to the three larger predicted BamHl restriction 
fragments are clearly observed on the blot. However, the
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F ig . 2. T h e  p re d ic te d  BamHl r e s tr ic tio n  m a p s  fo r  th e  s h o r t  reg io n s  o f  th e  w t H SV -1 a n d  H S V -140  g en o m es. V Z V  g en e  62 coding 
seq u en ces  re p la c e  b o th  co p ie s  o f  V m w l7 5  in  th e  sh o r t re g io n  re p e a ts  o f  th e  H SV -1 g en o m e  in  H S V -1 4 0 ; V Z V  seq u e n c es  a re  rep resen ted  
by  th e  s tip p le d  bo x  a n d  th e  lim its  o f  th e  O R F s  sh o w n  b y  a rro w s . T h e  V m w l7 5  c o d in g  seq u e n c es  in  H SV -1 a re  c o n ta in e d  w ith in  BamHl 
q  a n d  BamHl y ; th e ir  re p la c e m e n t b y  th e  c o rre s p o n d in g  g e n e  62  seq u e n c es  in  H S V -1 4 0  re su lts  in  re s tr ic t io n  f ra g m e n ts  d e sig n a ted  
BamHl q ' a n d  B a m H l y '. B a m H l k ' r e p re s e n ts  (q ' +  s) d e riv e d  fro m  th e  I R L/ I R S ju n c tio n . T h e  B a m H l s ite  a t  th e  c a p  s ite  o f  th e  IE 3  gene 
(p re s e n t a t  m a p  u n its  0-865 a n d  0-965 a p p ro x im a te ly  in  H S V -1) w as  d e s tro y ed  d u r in g  th e  c o n s tru c t io n  o f  p G D 1 4 0  (m a rk e d  * in  H SV - 
140, see  F ig . 1). T h e re fo re  B a m H l d ig e s tio n  o f  H S V -140  D N A  p ro d u c e s  fra g m e n ts  (y ' +  n ) a n d  (x +  y '). T h e  sizes (k b ) o f  th e se  fo u r novel 
frag m e n ts  c o n ta in in g  p o r tio n s  o f  th e  V Z V  g e n e  62 seq u e n c e  a re  sh o w n .
BamHl [q'] fragment, which represents sequences from 
the genome terminus, was not observed in this experi­
ment. A weakly hybridizing fragment of 3 kb was once 
observed during the isolation and purification of HSV- 
140, which probably indicates that viral D N A  prepared 
from infected cells is highly concatemerized with 
consequent under-representation o f the terminal frag­
ment. The simplest interpretation of these results is that 
an intact copy of VZV gene 62 is present in both IE 3 gene 
loci in the HSV-1 genome in our primary isolate o f the 
recombinant virus HSV-140.
The initial isolate was amplified and plaque-purifica- 
tion under agar was attempted, but despite several 
attempts no plaques were observed (see below). Virus 
HSV-140 was subsequently purified by limiting dilution 
in Linbro wells, such that c.p.e. was observed in 30% or 
less of wells. Medium was retained from wells that 
displayed c.p.e. and used to infect cells for total cellular 
D N A  preparation. Southern blot analysis o f the resulting 
D N A s showed all eight stocks of virus to be of the 
predicted structure with no evidence of contamination. 
Recombinant viruses carrying only one copy of gene 62 
were not detected at any stage, suggesting that HSV-140,
with two copies of gene 62, has a strong growth 
advantage. One of the small scale stocks was selected for 
a large scale virus preparation which was again checked 
by Southern blotting. The isolation of HSV-140 on 
normal BHK cells shows that VZV-140K can functional­
ly replace Vm wl75.
Growth properties of HSV-140
HSV-140 was compared to wt virus in a standard plaque 
assay in BHK cells to assess the extent to which VZV 
140K can complement for loss of Vm wl75 function. 
Cells were infected with increasing dilutions of each 
virus and fixed and stained after 2 days. At lower 
dilutions both viruses produced extensive c.p.e. although 
the appearance of c.p.e. during HSV-140 infections was 
delayed approximately 12 h compared to that during wt 
virus infections. A t increasing dilutions single plaques 
were obtained with wt virus as normal, but no clear 
plaques were produced by HSV-140. The assay was 
repeated several times with independent stocks of HSV- 
140 and in no case were distinct plaques formed. Similar 
results were obtained using HFL cells. The results 
suggest that although HSV-140 is able to grow in the
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1 2  3 4
—  Z tam H I ( y '+  n ) (7-1)
— BamHl k ' (6 0)
— BamHl (x +  y ')  (4 1 )
— BamHl q '?  (3 0)
F ig . 3. S o u th e rn  b lo t a n a ly s is  o f  D N A  p re p a re d  fro m  H S V -1 4 0 - 
in fe c te d  cells. D N A  w as p re p a re d  fro m  in fe c te d  cells  w h e n  e x te n s iv e  
c .p .e .  w as  a p p a r e n t .  T h e  D N A  w a s  d ig e s te d  w ith  BamHl a n d  s u b je c te d  
to  S o u th e rn  b lo t a n a ly s is  u s in g  a  n ic k - tr a n s la te d  p la sm id  p i 40  p ro b e  
w h ic h  c o n ta in s  V Z V  g e n e  62 b u t n o  H SV -1 se q u e n c e s . L a n e  1, m o c k - 
in fe c te d  cell D N A ; la n e s  2 a n d  3, H S V -1 4 0 - in fe c te d  cell D N A  u s in g  
tw o  d if fe re n t v iru s  s to c k s ;  la n e  4, H S V -l- in fe c te d  ( s tra in  17) cell D N A . 
T h e  p o s it io n s  o f  X Hindlll s ize  m a rk e rs  (k b )  a re  sh o w n  o n  th e  le ft. T h e  
id e n t i t ie s  o f  f r a g m e n ts  h y b r id iz in g  to  th e  p ro b e  a n d  th e i r  p re d ic te d  
s ize s  (k b )  a re  s h o w n  o n  th e  r ig h t. T h e y  w ere  a s s ig n e d  by  c o m p a r is o n  o f  
th e ir  e s t im a te d  s ize s  to  th o se  p re d ic te d  fro m  th e  m a p s  in  F ig . 2. T h e  
la rg e r  f r a g m e n ts  in  la n e  2 re p re s e n t p a r t ia l  d ig e s t io n  p ro d u c ts .
absence o f V m w l75 expression, plaque formation is 
impaired, at least in the cell types used in these studies.
The numbers o f virus particles in the large scale stocks 
o f cell-associated and supernatant HSV-140 virus were 
determined. HSV-140 cell-associated stocks were rou­
tinely around 3 x 1010 particles/ml, which was equiva­
lent to the corresponding particle counts o f stocks o f wt 
virus produced in parallel. The supernatant virus particle 
count o f HSV-140 was reduced by a factor o f 10 
compared to the cell-associated virus and the wt 
supernatant virus stocks. If this reflects a slower rate of  
virus assembly or release then it may in part explain the 
lack o f plaque formation by HSV-140.
The time course of HSV-140 viral polypeptide synthesis
As titres could not be determined by plaque assay for 
HSV-140 virus stocks, viral polypeptide synthesis in 
HSV-140- and wt virus-infected cells were compared 
using 10 p.f.u./cell o f wt virus and increasing dilutions o f  
HSV-140. Cells were labelled with [35S]methionine from 
3 to 6 h post-adsorption (p.a.) and proteins analysed by 
S D S-P A G E . Infection with dilutions o f HSV-140 
corresponding to m ultiplicities o f 2500, 500 and 100 
particles per cell (p.p.c.) resulted in levels o f viral gene 
expression that were equivalent to the wt virus infection  
(results not shown). Since an amount o f VZV inoculum  
corresponding to 100 p.p.c. gave viral polypeptide 
expression similar to lO p.f.u. wt o f virus/cell in this 
single experiment, this amount o f HSV-140 was used in a 
subsequent time course experiment.
>!
(a) 1 2 3 4 5 6 7 8 9
—  M C P
—  gB
—  V m w 6 5
 V Z V  140K
— M C P  
—  gB
— V m w 6 5
F ig . 4. T h e  tim e  c o u rse  o f  v ira l  p ro te in  e x p re s s io n  in  B H K  cells  
in fe c te d  w ith  H S V -1 4 0  a n d  w t v iru s . L in b ro  w e lls  c o n ta in in g  4 x  105 
cells  w ere  in fe c te d  w ith  (a ) 10 p .f .u ./c e ll  w t H S V -1  ( s t r a in  17) o r  (6) 100 
p .p .c .  H S V -1 4 0 . P ro te in s  w e re  la b e lle d  w ith  [35S ] m e th io n in e  a t :  la n e  2, 
0  to  2 h ;  la n e  3, 2 t o 4  h ;  la n e  4 ,4  t o 6  h ;  la n e  5, 6 to  8 h ;  la n e  6, 8 to  10 h ;  
la n e  7 ,1 0  to  12 h ;  la n e  8, 16 to  18 h ;  la n e  9 , 22  to  24  h  p .a .  a n d  a n a ly se d  
by  S D S - P A G E . T h e  s a m p le s  in  la n e  1 a re  f ro m  m o c k - in fe c te d  cells. 
S o m e o f  th e  m a jo r  v ira l p ro te in s  a re  in d i c a t e d : m a jo r  c a p s id  p ro te in ,  
M C P ;  g ly c o p ro te in  B, g B ; V m w 6 5  a n d  V Z V  140K  (H S V -1 4 0 - in fe c te d  
cells  on ly ). L ess  in te n s e  la b e llin g  in  th e  la te r  t im e  p o in t  s a m p le s  is d u e  
to  loss o f  te rm in a lly  in fe c te d  cells.
Cells were m ock-infected or infected with wt and 
HSV-140 viruses and labelled between 0 to 2, 2 to 4, 4 to 
6, 6 to 8, 8 to 10, 10 to 12, 16 to 18 and 22 to 24 p.a. These 
results are shown in Fig. 4. The protein expression  
profiles of the two viruses were similar, but a significant 
difference was the kinetics o f expression o f a high M r 
protein in HSV-140-infected cells. On the basis o f its 
mobility, expression by HSV-140 and W estern blotting 
using a polyclonal rabbit antiserum directed against a 
fusion protein including part o f VZV 140K (data not 
shown; D. Stephenson & A. Davison, personal com m un­
ication), the most likely interpretation is that this high 
M t band is the VZV 140K polypeptide. It is notable that 
the kinetics of expression o f VZV 140K in HSV-140- 
infected cells is very different compared to V m w l75 in 
wt virus-infected cells. Strikingly, VZV 140K was 
expressed as an early protein and was abundant late in 
infection. Thus VZV 140K is apparently not subject to 
autoregulation in HSV-140, which suggests that the
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S tra in  17
C o n tro l
H S V -1 4 0
F ig . 5. C o m p a r is o n  o f  v ira l D N A  re p lic a tio n  in  B H K  cells  in fe c te d  
w ith  H S V -140  a n d  w t v iru s . C ells  w e re  in fe c te d  as  d e s c r ib e d  in  F ig . 4 
a n d  h a rv e s te d  a t : la n e  2 ,4  h ; la n e  3 ,6  h ; la n e  4 , 8 h ; la n e  5 ,1 0  h ; la n e  6, 
16 h  p .a . fo r to ta l c e llu la r  D N A  p re p a ra tio n s .  D N A  w a s  a lso  iso la ted  
fro m  m o c k -in fe c te d  cells  (la n e  1). T h e  s am p le s  w e re  t re a te d  w ith  
R N a s e  p r io r  to  s lo t b lo t a n a ly s is  u s in g  a  n ic k - tr a n s la te d  p i l l  p ro b e  
w h ic h  c o n ta in s  IE  1 s e q u e n c e s  c o m m o n  to  H S V -1 40 a n d  w t H S V -1. T h e  
co n tro l c o n ta in s  10 ng  o f  p i l l .
normal repression o f IE gene expression may be 
defective in this virus. It is not possible to determine 
from these data whether V m wllO , Vmw68 or Vmw63 
are also overexpressed during HSV-140 infection.
Most other clearly visible viral proteins are expressed 
in HSV-140- and wt virus-infected cells in similar 
amounts and with similar kinetics. However, the 
expression of certain late gene products (for example, 
Vmw65 and the major capsid protein) appears to be 
lower in HSV-140-infected cells. This may be the result 
of less efficient replication of viral D N A  during HSV- 
140 infection (see below).
Comparison of viral DNA replication during strain 17 and 
HSV-140 infections
BHK cells were infected with HSV-140 and wt virus and 
total cellular D N A  was prepared at 4, 6, 8, 10 and 16 h 
p.a. The D N A  samples were treated with RN ase and 
analysed in a slot blot experiment to compare the 
amounts of viral D N A  present in the two infections. 
Nick-translated p i l l  (which contains HSV-1 IE gene 1 
sequences; Everett, 19876) was used as a probe as it 
contains sequences common to both viruses. In cells 
infected with wt virus, D N A  accumulation began prior 
to the earliest time point of 4 h p.a. and continued 
through to 16 hp.a. (Fig. 5). The onset o f HSV-140 D N A  
replication was delayed 2 to 4 h relative to that o f wt 
virus and the amounts of viral D N A  produced were
1 2 3 4 5 6
I I I I
I I I
(a) 1 2 3 4 5 6 7 8 9 10
V m w 65
(b) 1 2 3 4  5 6  7 8 9 10
(c) 1 2 3 4  5 6 7 8 9  10
F ig . 6. H S V -1 4 0  v ira l g e n e  e x p re ss io n  is im p a ire d  a t  lo w e r m u lt ip l ic ­
itie s  o f  in fe c tio n . B H K  o r  H F L  ce lls  in  L in b ro  w ells  w e re  in fe c te d  w ith  
( a ) w t  H SV -1 ( s t ra in  17) a n d  (6) a n d  (c), tw o  s e p a ra te  s to c k s  o f  H S V -1 4 0  
p re p a re d  in  p a ra lle l a t  m u ltip l ic i t ie s  c o r re s p o n d in g  to :  la n e s  2 a n d  7. 50 
p .p .c . ; la n e s  3 a n d  8, 30 p .p .c . ; la n e s  4 a n d  9 .1 0  p .p .c . ; la n e s  5 a n d  10, 3 
p .p .c .  C e lls  w e re  la b e lled  w ith  [3 iS ]m e th io n in e  fro m  10 to  12 h p .a .  a n d  
p ro te in s  a n a ly se d  by  S D S - P A G E . L a n e s  1 to  5 o f  e a c h  gel a re  s a m p le s  
p re p a re d  fro m  B H K  cells, la n e s  6 to  10 a re  s a m p le s  fro m  H F L  cells. 
L a n e s  1 a n d  6 o f  e a c h  gel sh o w  m o c k - in fe c te d  s a m p le s . S o m e  m a jo r  
v ira l p ro te in s  a re  in d ic a te d , a s  d e s c r ib e d  in  th e  le g e n d  to  F ig . 4.
generally reduced; no accumulation o f D N A  was seen at 
4 h p.a. and only very low levels were seen at 6 h p.a. 
(Fig. 5).
Viral gene expression during infection with HSV-140 is 
multiplicity-dependent
Several mutants o f HSV-1 containing mutations in 
regulatory functions have been shown to have defects in 
viral gene expression at low multiplicities in certain cell 
types (Stow & Stow, 1986; Sacks & Schaffer, 1987; Ace et 
al., 1989; Everett, 1989). We decided to investigate the
140K
M C P
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V m w 65
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V m w 6 5
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synthesis of viral polypeptides during high and low 
multiplicity infections of BHK and HFL cells by HSV- 
140. In an attempt to minimize experimental variation, 
the virus stocks used in this study were all prepared in 
parallel from the same batch of cells. BHK or HFL cells 
were infected at 50, 30, 10 and 3 p.p.c. with HSV-140 or 
wt virus and labelled with [35S]methionine at 10 to 12 h 
p.a. (Fig. 6). In agreement with the time-course 
experiment (Fig. 4) at higher multiplicities both viruses 
expressed similar levels of most viral polypeptides, 
although the expression of certain late proteins (for 
example Vmw65 and the major capsid protein) was again 
reduced in HSV-140 infections. At the lower multiplic­
ities of 10 and 3 p.p.c., HSV-140 expressed reduced 
amounts of all viral polypeptides compared to wt virus in 
both BHK and HFL cells. This finding was consistent 
with several different stocks of HSV-140. Therefore 
HSV-140 exhibits a multiplicity-dependent gene expres­
sion defect which, in the cases examined, is not cell type- 
dependent.
In addition, the results in Fig. 6 suggest that the ability 
of HSV-140 to shut off host protein synthesis is 
significantly impaired. These results cannot be consi­
dered conclusive because labelling at late times means 
that secondary infection by the faster growing wt virus 
could contribute to the observed shut off of host protein 
synthesis. However, an experiment in which cells were 
infected with equal particle numbers of the two viruses 
(1000 particles per cell) in the presence of actinomycin D  
showed that virion-associated shut off by HSV-140 was 
significantly reduced compared to that of wt virus 
(results not shown). This could be due to inefficient 
presentation by HSV-140 of the virion host shutoff 
function encoded by gene UL41 (Kwong et al., 1988; 
McGeoch et al., 1988), or slight alterations in the 
composition or structure of HSV-140 virus particles 
might reduce their efficiency of cellular adsorption or 
penetration.
Discussion
The predicted amino acid sequence of VZV gene 62, 
which encodes VZV 140K, shows strong homology to 
Vmwl75 of HSV-1 (McGeoch et al., 1986). Like 
Vmwl75, VZV 140K is a potent trans-activator of gene 
expression in transfection assays (Everett & Dunlop, 
1984; Everett, 1984; Inchauspe et al., 1989). Previous 
studies have shown that VZV 140K can complement the 
growth of HSV-1 viruses with ts and deletion mutations 
in Vmwl75 (Felser et al., 1987, 1988). By construction of 
a virus in which the VZV 140K coding sequences replace 
those of Vmwl75 we have confirmed and extended the 
previous observations on the relatedness of the two
proteins. The results graphically illustrate the functional 
similarities of Vmwl75 and VZV 140K since recombin­
ant virus HSV-140 propagates in normal cell lines. Its 
failure to form clearly defined plaques may be a 
consequence of slight alterations in the balance of viral 
gene expression which would be difficult to define. 
Similarly, if one of the proteins involved in viral D NA  
replication were aberrantly expressed during HSV-140 
infection it would not be easily detected by analysis of 
viral polypeptide expression, yet could account for the 
delayed and reduced levels of HSV-140 D N A  replica­
tion. It is likely that the reduced expression of certain late 
proteins is a consequence of less efficient D N A  
replication and this in turn may explain the slower 
appearance of c.p.e. in HSV-140-infected cells. These 
results show that the properties of VZV 140K and 
Vmwl75 are not indistinguishable but they are largely 
interchangeable.
The multiplicity dependence of HSV-140 gene expres­
sion is reminiscent of other HSV-1 variants with 
mutations in Vmw65 and Vmwl 10 (Stow & Stow, 1986; 
Sacks & Schaffer, 1987; Ace et al., 1989; Everett, 1989). 
Since one of the phenotypes of the Vmw65 virus mutant 
is synthesis of reduced amounts of Vmw 110 and since the 
synergistic activation of gene expression by the combina­
tion of Vmwl 10 and Vmwl75 observed in transfection 
assays (Everett, 1984; Quinlan & Knipe, 1985; Gelman 
& Silverstein, 1985) does not appear to occur with VZV 
140K and Vmwl 10 (our unpublished data), it is 
intriguing to speculate that the multiplicity dependence 
of HSV-140 gene expression might be a reflection of this 
lack of synergy.
The regulation of VZV 140K expression during HSV- 
140 infection is also of interest since it accumulates to 
high levels as infection proceeds, which is in contrast to 
the relatively low levels of accumulation of V m w l75 
during wt virus infection. Therefore, VZV 140K is 
apparently unable to effect the repression of IE3 gene 
expression which is normally a function of V m w l75. 
Repression of the IE3 promoter by V m w l75, which 
requires the presence of a specific Vmwl75 DNA- 
binding sequence at the cap site of the IE3 promoter 
(Muller, 1987; Roberts et al., 1988), can be reproduced in 
transfection assays (O’Hare & Hayward, 1985, 1987). 
Mutants of the Vmwl75 protein that fail to bind to an 
IE3 cap site probe are unable to repress the IE3 promoter 
(DeLuca & Schaffer, 1988; Paterson & Everett, 19886). 
The failure of VZV 140K to repress the IE3 promoter 
during HSV-140 infection is consistent with data which 
show that VZV 140K does not repress the IE3 promoter 
in transfection assays (Disney et al., 1990) and does not 
bind to the IE3 cap site region (our unpublished data). 
We do not yet know whether the other IE genes are also 
overexpressed in HSV-140 infections, but if not it
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suggests that the mechanism of their repression may 
differ from that of IE3. If this is the case, then HSV-140 
may be a useful tool with which to study the mechanism 
of IE gene repression.
In conclusion, our results demonstrate that VZV 140K 
is able to complement, to a great extent, for loss of 
V m w l75 function in HSV-1. The high levels o f expres­
sion of VZV 140K in HSV-140-infected cells should 
permit a more detailed analysis of the biochemical 
properties of the protein.
T h e  au th o rs  w ould  like  to  th a n k  P ro fesso r J. H . S u b ak -S h arp e  an d  
D r C. M . P res to n  fo r h e lp fu l c ritic ism  o f  th e  m a n u sc rip t. W e also  th a n k  
D r  J. M cL au ch la n  fo r syn thesis  o f  o ligonucleo tides  a n d  M r J . A itk en  
fo r p e rfo rm in g  p a rtic le  co u n ts  o n  v iru s  stocks. G .D . is su p p o rte d  by  an  
M R C  p o s tg rad u a te  s tu d en tsh ip .
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The product of varicella-zoster virus gene 62 autoregulates its own 
promoter
Graham H. Disney, Tom A. McKee,f Chris M. Preston and Roger D. Everett*
MRC Virology Unit, Church Street, Glasgow Gil 5JR, U.K.
Varicella-zoster virus (VZV) gene 62 encodes a protein 
with a predicted M r o f 140000 (140K) which has 
considerable amino acid identity with the major 
immediate early (IE) protein V m w l75 (ICP4) of  
herpes simplex virus type 1 (HSV-1). V m w l75 is an 
essential virus polypeptide with a pivotal role in the 
activation of early and late viral gene expression and 
also in the repression of IE gene expression. The VZV  
140K protein has been shown to function as a strong 
transcriptional activator in transfection assays and 
largely complements for the loss o f V m w l75 function 
in HSV-1. We report the results o f cotransfection 
experiments which demonstrate that the 140K protein 
strongly represses expression from its own promoter,
that o f gene 62, thus establishing further functional 
similarity between it and V m w l75. However, whereas 
V m w l75 can substitute for the 140K protein in 
repression of the gene 62 promoter, the 140K protein 
does not repress the HSV-1 IE3 promoter in the 
reciprocal experiment. The integrity o f a domain of 
V m w l75 (designated region 2), previously shown to be 
crucial for repression of the HSV-1 IE3 promoter, is 
also required for repression of the gene 62 promoter. 
Moreover, a similar requirement for the highly similar 
region 2 of the 140K protein for repression is 
demonstrated, suggesting that VZV 140K protein and 
HSV-1 V m w l75 autoregulate IE gene expression by a 
related mechanism.
Varicella-zoster virus (VZV), a member of the neurotro­
pic alphaherpesvirus subfamily, is the causative agent of 
two human diseases. Primary exposure to the virus 
results in chickenpox and reactivation following a period 
of latency gives rise to shingles. Despite being highly 
infectious in the human population, VZV grows poorly 
in the available tissue culture systems; the virus is 
predominantly cell-associated and does not readily yield 
stable, high titre stocks. Consequently, the identification 
and mapping of specific VZV functions has been 
limited. The determination of the complete VZV D NA  
sequence identified 71 major open reading frames 
(ORFs) (Davison & Scott, 1986). Furthermore, similarity 
comparisons between VZV and herpes simplex virus 
type 1 (HSV-1) sequences has allowed potential func­
tions to be assigned to some of the VZV ORFs. The 
products of these ORFs can now be studied in more 
detail using transfection and expression systems.
Gene expression following HSV-1 infection of tissue 
culture cells is well characterized (for reviews see 
Wagner, 1985; Everett, 1987). The first class of 
polypeptides to be expressed during infection has been 
designated immediate early (IE). Of the five IE
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polypeptides, four can function as transcriptional regula­
tors and have a key role in mediating control of viral gene 
expression. They each participate, to varying degrees, in 
the induction of early and late gene expression, while 
protein Vmwl75 (and possibly protein Vmw63) is also 
involved in the repression of IE gene expression. 
Analysis of viruses with temperature-sensitive lesions 
has demonstrated that two of the IE polypeptides, 
Vmwl75 and Vmw63, are essential for growth in tissue 
culture. VZV genes 4 and 62 encode products which 
share similarity with Vmw63 and Vmwl75, respectively 
(Davison & Scott, 1986; McGeoch et al., 1986), 
suggesting that they encode VZV regulatory polypep­
tides. This study is concerned with the product of VZV 
gene 62, which has a predicted M r of 140000 (140K). 
Considerable functional similarity between Vmwl75 
and the VZV 140K protein has previously been 
demonstrated. The 140K protein functions as a powerful 
transcriptional trans-activator in transfection assays 
(Everett & Dunlop, 1984; Everett, 1984; Inchauspecf a/., 
1989) and, furthermore, largely complements the growth 
defects that result from loss of Vmwl75 function in HSV- 
1 (Felser et al., 1987, 1988; Disney & Everett, 1990).
As noted above, during HSV-1 infection functional 
Vmwl75 significantly reduces the levels of IE gene 
expression from those observed in its absence (Honess &
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Fig. 1. (a) S tructu re  o f  p lasm id  pM O C A T  (M cK ee  et al., 1990). A 
Smal/BgBl frag m en t rep re sen tin g  V Z V  gene 62 sequences from  
— 1146 (Clal) to  + 5 7  (an d  co n ta in in g  th e  com ple te  p ro m o te r  o f  th e  
gene) w as iso la ted  from  p lasm id  p l4 0 B T  (M cK ee  et al., 1990) a n d  
in serted  b e tw een  th e  Smal an d  BamYll sites o f  th e  v ec to r p C A T , 
u p s tream  o f  th e  C A T  cod ing  sequences, to  g en era te  p  HO C A T . T h e  
tra n sc r ip tio n  s ta r t site  ( + 1 )  is in d ica ted . T h e  Smal s ite  is d e riv ed  from  
p U C 9  po ly linker sequences loca ted  5 ' to  th e  V Z V  in se rt in  pH O B T . 
T h e  BgBl site  is th e  resu lt o f  a  tw o-step  m u tag en esis  p ro toco l in  w h ich  
nuc leo tide  + 5 7  (o f gene 62) w as first m u ta ted , ch an g in g  th e  sequence  
from  A A A T T C  to  G  A A T T C ; th e  resu lting  iscoR I s ite  w as su b se q u e n t­
ly m odified  by lin k e r in sertio n  to  c rea te  th e  u n iq u e  Bglll s ite  in 
pH O B T . (b) S equence  a lig n m en t o f  th e  V Z V  140K  p ro te in  a n d  HSV-1 
V m w l7 5 . T h e  cod ing  sequences a re  d iv id ed  in to  five reg ions (1 to  5) on  
the  basis  o f  sequence  s im ila rity  (M cG eo ch  et al., 1986). P o rtio n s  o f  the  
cod ing  sequences a re  rep re sen ted  by b locks, th e  solid  lines be ing  
spacers  in tro d u ced  to  o p tim ize  th e  a lig n m en t. T h e  e x ten t o f  s im ila rity  
rep resen ted  by th e  d ifferen t sh ad in g s  is □ ,  low ; g |,  30 to  50%  
sim ila rity ; ■ ,  over 80%  sim ilarity . T h e  positions  o f  th e  in sertio n  
m u ta tio n s  in  pC 34  an d  p i  13 (used in  th is  s tudy) a re  show n.
Roizman, 1975; Preston et al., 1978; Preston, 1979; 
Watson & Clements, 1980). Since repression of the HSV- 
1 IE-3 promoter by Vmwl75 has been reproduced in 
transfection assays (O’Hare & Hayward, 1985), it was of 
interest to determine whether the VZV 140K protein
exhibited similar autoregulation of its own promoter. 
Therefore, plasmid pMOCAT was constructed in which 
the promoter-leader sequences of VZV gene 62 (which 
encodes the VZV 140K protein) drive expression of the 
chloramphenicol acetyltransferase (CAT) gene (Fig. 1 a). 
We have previously reported that gene 62 promoter 
activity is increased about 15-fold by cotransfection with 
a plasmid expressing Vmw65, the HSV-1 virion-associat­
ed IE promoter transactivator (McKee et al., 1990). The 
ability of the VZV 140K protein to repress the gene 62 
promoter was therefore determined both in the absence 
and in the presence of stimulation by Vmw65. Plasmid 
pl40SV, which contains the VZV gene 62 transcription 
unit (without its own promoter) linked to the simian virus 
40 (SV40) early promoter and enhancer region, was used 
to express VZV 140K protein. The use of pl40SV (rather 
than a plasmid which expresses VZV 140K protein from 
the gene 62 promoter) reduces difficulties in the 
interpretation of the results which would arise from 
promoter competition effects and through repression of 
the gene 62 promoter in the VZV 140K protein 
expression plasmid.
BHK cells, at a density of 106 cells per 50 mm dish, 
were transfected (by calcium phosphate precipitation; 
Corsalo & Pearson, 1981) with 4pg pMOCAT in the 
presence or absence of pM Cl (which expresses Vmw65) 
and increasing amounts of pl40SV. The total amount of 
plasmid D N A  in each transfection was equalized to 
14 jig by the addition of pUC9. CAT assay extracts were 
prepared after 48 h and CAT activities determined as 
described by Gorman et al. (1982). The protein concen­
trations of the extracts were determined by the method of 
Bradford (1976) and the percentage conversion from 
substrate to product per microgram protein was calculat­
ed. The CAT activities of extracts prepared from cells 
transfected with test plasmids were expressed as a 
percentage of the control value (no test plasmid). The 
results, depicted graphically in Fig. 2(a), are from a 
typical repression experiment. Transfection of pl40CAT  
alone into cells resulted in 4% conversion per microgram 
protein (representing a total conversion of 36% in the 
assay) and the inclusion of pM Cl in the transfection 
increased CAT activity 30-fold (determined using suit­
able extract dilutions). The results clearly show that both 
the basal and Vmw65-stimulated levels of CAT activity 
from pMOCAT were repressed up to 50-fold by the 
addition of increasing amounts of pl40SV. This repres­
sion is not due to promoter competition effects because 
transfection with equivalent molar amounts of pSVEB 
(which contains the SV40 promoter region present in 
pl40SV but lacks coding sequences) resulted in levels of 
repression which were insignificant compared to those 
induced by pl40SV (Fig. la). Similar results were 
obtained using Vero cells (data not shown).
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F ig . 2. G ra p h s  show ing  rep ressio n  o f  exp ression  from  V Z V  gene 62 p ro m o ter-le ad e r sequences (in  pM O C A T ) by V Z V  140K p ro te in  
an d  V m w l7 5  (an d  th e ir  m u ta n t de riva tives), a n d  a c tiv a tio n  (ra th e r  th a n  rep ression ) o f  th e  HSV-1 IE 3  p ro m o te r (in  p IE 3 C A T ) by the  
V Z V  140K p ro te in . B H K  cells w ere  tra n sfec ted  w ith  4 pg  o f  pM O C A T  (or p IE 3 C A T ) a n d  in c reasin g  am o u n ts  o f  te st p lasm ids in the  
p resen ce  o r ab sen ce  o f  p M C l (w h ich  expresses V m w 65). T h e  te s t p la sm id s  used  exp ress th e  follow ing p o ly p e p tid e s : V Z V  140K p ro te in  
(pM O SV ); V m w l7 5  (p l7 5 ) ; in sertio n  m u ta n t d e riv a tiv e s  o f  th e  140K p ro te in  a n d  V m w l7 5 , respec tive ly  (p C 3 4 a n d  p i  13). T h e  negative  
c o n tro l p lasm id , pS V E B , lacks  cod ing  sequences p re sen t in  th e  te s t p la sm id s  a n d  is c o nsequen tly  ap p ro x im a te ly  h a lf  th e  size. H en ce  the  
a c tu a l am o u n ts  used  in  tran sfec tio n s  w ere  0 -5 ,1 ,2  a n d  4  pg  to  m a in ta in  a  m o la r equ iva lence  o f  com m on  sequences, (a) R ep ress ion  o f  the  
gene 62 p ro m o te r by 140K  p ro te in  in  th e  ab sen ce  a n d  p resen ce  o f  p M C l ( ■ ,  pM O S V ; A , p S V E B ; □ ,  pM OSV +  p M C l ; pSV E B  +  
p M C l) .  (b) R ep ress io n  o f  th e  V m w 65 (p M C l)-s tim u la te d  gene 62 p ro m o te r by 140K p ro te in , V m w l7 5  a n d  th e ir  in sertio n  m u ta n t 
d e riv a tiv e s  ( □ ,  pM OSV ; O , p l7 5 ;  A , p S V E B ; ■ ,  p C 3 4 ; # ,  pI13). (c) A c tiv a tio n  o f  th e  V m w 65 (p M C l)-s tim u la te d  IE 3  p ro m o te r by 
140K p ro te in . P lasm id  p IE 3 C A T  (in  w h ich  th e  HSV-1 IE 3  p ro m o te r d rives  exp ression  o f  th e  C A T  gene) rep laced  pM O C A T  in  th is 
ex p erim en t ( □ ,  pM O; O , p l 7 5 ; A . SV EB). T h e  d a ta  show n  in  (a) a n d  (b) a re  d e riv ed  from  a  typ ica l t itr a tio n  ex p erim en t. T h e  degree o f  
rep ression  o b serv ed  in  t itr a tio n  ex p erim en ts  w as v a riab le  a n d  a lm ost cer ta in ly  reflects th e  v a ria tio n  in  levels o f  expression  from  the 
gene 62 p ro m o te r n o ted  in  th e  tex t. H ow ever, th ese  ex p erim e n ts  h av e  b een  rep e a ted  a  m in im u m  o f th ree  tim es [w ith  the  excep tion  o f  
t itr a t io n  in  th e  ab sence  o f  p M C l in  (a), w h ich  w as p e rfo rm ed  tw ice] an d  in  all cases th e  p a tte rn  o f  resu lts  w as co n sis ten t w ith  those 
above. T h e  d a ta  in  (c) a re  th e  re su lt o f  a  single t itr a tio n  ex p erim en t.
It should be noted that repression of the gene 62 
promoter by pl40SV was most clearly observed when the 
levels of CAT activity in control transfections were high 
(about 50 to 200-fold above background). If the cells 
transfected poorly then the degree of repression was 
correspondingly reduced (as might be expected). Since 
repression was always most clearly observed with high 
level expression from the gene 62 promoter, most 
experiments included pM Cl.
The results presented above clearly demonstrate that 
cotransfection of pl40SV represses the gene 62 pro­
moter. Given the functional similarities of VZV 140K 
protein and Vmwl75 in trans-activation transfection 
assays (Everett, 1984), it was of interest to determine 
whether the two proteins were functionally interchange­
able in repression transfection assays. Therefore, 
pMOCAT was con transfected with increasing amounts 
of p i75. The results show that Vmwl75 represses the 
gene 62 promoter with an efficiency similar to that of the 
VZV 140K protein (Fig. 2b). The converse experiment to 
determine whether the 140K protein is able to repress the 
HSV-1 IE-3 promoter was performed in Vero cells, the 
cell type in which repression of the IE3 promoter by 
Vmwl75 was first demonstrated (O’Hare & Hayward,
1985). (As noted above, the 140K protein efficiently 
represses the gene 62 promoter in Vero cells as well as 
BHK cells.) Plasmid pIE3CAT (in which the HSV-1 IE3 
promoter drives expression of the CAT gene) replaced 
pMOCAT as the reporter plasmid in these experiments. 
Fig. 2(c) shows the results of a single experiment in 
which pIE3CAT was contransfected into cells with 
pMCl and increasing amounts of test plasmids. The 
pMCl -stimulated level of expression from pIE3CAT 
was of the same order of magnitude as that from pM Cl- 
stimulated pMOCAT. IE3 promoter activity showed a 
small reduction in the presence of pSVEB, a maximum of 
twofold reduction being observed with the largest 
amount of plasmid. Titration of p i75 led to a greater 
reduction in activity, fourfold in the presence of 8 pg 
p i75. Although this was less efficient than in previous 
assays (Paterson & Everett, 1988), it does confirm 
repression of the IE3 promoter by Vmwl75. In marked 
contrast, titration of pMOSV resulted in an increase in 
IE3 promoter activity of two- to fourfold. In agreement 
with this, it was found that in BHK cells pMOSV strongly 
trans-activated the basal level of expression from the IE- 
3 promoter (in the absence of pM Cl) approximately 40- 
fold (data not shown). Therefore, although both VZV
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140K protein and Vmwl75 repress their respective 
promoters, the mechanisms by which this occurs are not 
entirely interchangeable. This failure of the VZV 140K 
protein to repress the IE-3 promoter is consistent with 
the properties of a recombinant virus (HSV140) in which 
the Vmwl75-encoding sequences have been replaced by 
those of the VZV 140K protein in a transcription unit 
with the IE-3 regulatory sequences; infection by HSV 140 
leads to high levels of VZV 140K protein expression 
(Disney & Everett, 1990).
The integrity of homology region 2 of Vmwl 75 (amino 
acid residues 315 to 484; Fig. 1 b) has been shown to be of 
crucial importance for repression of the IE-3 promoter 
(Paterson & Everett, 1988; DeLuca & Schaffer, 1988; 
Shepard et al., 1989). To determine whether region 2 of 
Vmwl75 was also involved in the repression of the gene 
62 promoter, plasmid pi 13 (Paterson & Everett, 1988) 
was cotransfected in increasing amounts with pMOCAT. 
Plasmid pi 13 contains an in-frame insertion of four 
amino acids in the proline codon at position 324 of 
Vmwl75 (region 2; see Fig. lb). The effect of the 
mutation is essentially to eliminate repression of the IE-3 
promoter by V m w l75 (Paterson & Everett, 1988). The 
same effect was observed in cotransfections of pMOCAT 
and pi 13 (Fig. 2 b). Therefore the same region of 
V m w l75 is involved in the repression of both the gene 62 
and IE-3 promoters.
Plasmid pC34 encodes a mutant form of the VZV 
140K protein which is analogous to the protein expressed 
by pi 13. It was derived from p 140 (McKee et al., 1990) by 
the method of Paterson & Everett (1988) and contains a 
mutation resulting in the insertion of four amino acids 
into the glycine codon at position 471 of the 140K 
protein, which lies within region 2 (amino acid residues 
467 to 641; see Fig. lb). Like p l l 3, pC34 was unable to 
repress pMOCAT (Fig. 2b). The interpretation of this 
result is potentially complicated because pC34 uses the 
gene 62 promoter instead of the SV40 early promoter in 
pMOSV. This raises the possibility that the lack of 
repression by pC34 is not due to the mutation in region 2 
of the VZV 140K protein but that autoregulation of C34 
polypeptide expression from pC34 results in insufficient 
protein to repress the gene 62 promoter in pMOCAT as 
well. However, it is difficult to envisage how the C34 
polypeptide might repress its own expression from pC34 
without also reducing gene 62 promoter activity in 
pMOCAT. In addition, in trans-activation transfection 
assays the C34 mutation, like that of pi 13 (Paterson & 
Everett, 1988), eliminates the ability of plasmid pC34 to 
trans-activate the HSV-1 glycoprotein D  (gD) promoter 
(whose activity is increased approximately 100-fold by 
the 140K protein; results not shown). Therefore it is most 
likely that, as with the mutations in region 2 of V m w l75 
(Paterson & Everett, 1988; DeLuca & Schaffer, 1988;
Shepard et al., 1989), the C34 mutation results in an 
inactive polypeptide. The experiment therefore demon­
strates that the same similar regions of Vm w l75 and 
the VZV 140K protein are involved in the repression of 
their respective promoters.
The mechanism of repression of the IE-3 promoter by 
Vmwl75 requires a functional Vmwl75 DNA-binding 
domain (Paterson & Everett, 1988; Shepard et al., 1989) 
and the presence of a cognate DNA-binding site at the 
cap site (Roberts et al., 1988). This binding site includes a 
consensus sequence (ATCGTC) common to many, but 
not all, sequences with which V m w l75 can associate 
(Muller, 1987; Faber & Wilcox, 1986; Michael et al., 
1988). We attempted to determine whether analogous 
sequences in the region of the gene 62 cap site were 
required for repression by the VZV 140K protein by 
constructing deletion variants of pMOCAT in which 
promoter sequences upstream of the TATA box re­
mained intact but leader or cap site-leader sequences 
were deleted. It was found, however, that the intrinsic 
activities of both deleted promoters were consistently 
reduced by at least 10-fold relative to pMOCAT, which 
implies that sequences in the gene 62 leader region 
contribute to the efficiency of its expression. The activity 
of both promoters was increased 15- to 30-fold when 
pM Cl was present in transfections (as with the intact 
promoter) but promoter activity was still at least 10-fold 
less than that of the pMCl-activated gene 62 promoter. 
As noted above, low levels of promoter activity result in 
relatively poor levels of repression and therefore it was 
not possible to draw unequivocal conclusions from the 
results obtained with these constructs.
In conclusion, we have shown that the functional 
similarity of Vmwl75 of HSV-1 and the VZV 140K 
protein extends to the repression of their respective 
promoters and that V m w l75 is also able to repress the 
VZV gene 62 promoter. Since the C34 mutation, which 
inactivates repression by the VZV 140K protein, is 
located within a region similar to that of the DN A - 
binding domain of V m w l75, we speculate that the 
mechanism of repression used by the VZV 140K protein 
might involve sequence-specific D N A  binding. How­
ever, our attempts to identify a 140K protein D N A  
recognition element by deletion of cap site or leader 
sequences from pMOCAT were inconclusive. We have 
also carried out preliminary studies to investigate the 
DNA-binding properties of the 140K protein by using 
nuclear extracts from cells infected with HSV 140 (which 
contain 140K protein in abundance) in gel retardation 
DNA-binding assays with probes encompassing the 
entire gene 62 promoter region in pMOCAT. Although 
we have been able to show that the VZV 140K protein 
binds to D N A , as yet we have been unable to define any 
specific VZV 140K protein recognition sequence in the
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gene 62 promoter region. Further elucidation of the 
properties of VZV 140K protein, and the comparison of 
its functions and mechanisms of action with those of 
V m w l75, will be facilitated by the availability of more 
purified preparations of the protein. These studies are in 
progress.
T h e  a u th o rs  w ish  to  th a n k  D r J. M cL au ch lan  fo r syn thesis  o f  
o ligonucleo tides. T .A .M . w as su p p o rte d  by a n  M R C  fellow ship  an d  
G .H .D . by an  M R C  p o s tg rad u ate  stu d en tsh ip .
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Control of expression of the varicella-zoster virus major immediate early 
gene
Tom A. McKee, Graham H. Disney, Roger D. Everett and Chris M. Preston*
Medical Research Council Virology Unit, Church Street, Glasgow, Gil 5JR, U.K.
The cis-acting D N A  sequences and trans-acting pro­
teins that control the expression of the major immedi­
ate early (IE) gene o f varicella-zoster virus (VZV) were 
investigated. The location o f the IE m RNA 5' terminus 
was determined by primer extension and SI nuclease 
analyses and the functional activities o f D N A  se­
quences upstream o f this site were analysed by a 
transfection assay. The VZV IE promoter exhibited 
low activity in BHK and HeLa cells, but was trans­
activated by the herpes simplex virus type 1 (HSV-1) 
virion protein Vmw65. D N A  sequences between 
positions -1 3 1  and +57 were responsible for promoter 
activity, whereas sequences between -4 1 0  and -1 3 1  
mediated the response to Vmw65. Two short elements
in the -4 1 0  to -1 3 1  region formed protein-D N A  
complexes with HeLa cell nuclear proteins and formed 
a ternary complex when Vmw65 was added. One o f the 
elements, ATGTAAATGAAAT, possessed a strong 
similarity to the HSV-1 TAATGARAT. The VZV  
homologue o f Vmw65, encoded by open reading frame 
(ORF) 10, failed to trans-activate expression from 
HSV-1 or VZV IE promoters and did not form a 
ternary complex with functional TAATGARAT ele­
ments and HeLa cell proteins. Therefore, stimulation 
o f  VZV IE transcription by Vmw65 can occur by a 
mechanism similar to that employed by HSV-1, but 
VZV ORF 10 does not function as a trans-activator of 
IE gene expression.
Introduction
Varicella-zoster virus (VZV), an alphaherpesvirus, is the 
causative agent of two human diseases, chicken pox and 
shingles. Primary exposure to VZV results in chicken 
pox and, after an initial infection, the virus becomes 
latent in the dorsal root ganglia. Reactivation of latent 
virus results in shingles, a painful vesicular rash which is 
usually confined to the distribution of a single sensory 
nerve root. Understanding of the biology of VZV has 
been hindered by difficulties in propagating viable cell- 
free virus at high titre in tissue culture. The determina­
tion of the complete VZV D N A  sequence (Davison & 
Scott, 1986) has enabled the structure and function of the 
products of the 71 major open reading frames (ORFs) to 
be investigated, thus bypassing, to some extent, the 
problem of virus isolation.
Regulation of herpesvirus gene expression has been 
most intensively studied in the case of herpes simplex 
virus type 1 (HSV-1), in which the genes can be classified 
as immediate early (IE), early or late, depending on their 
kinetics of expression and response to inhibitors of 
macromolecular synthesis (Honess & Roizman, 1974; 
Clements et al., 1977). The five IE genes of HSV-1 are 
transcribed when infection occurs in the absence of de 
novo protein synthesis and at least three of the IE proteins^.
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are important trans-activators that are required for 
maximal expression of early and late genes (Honess & 
Roizman, 1974; Clements et al., 1977; Preston, 1979; 
Everett, 1984; O’Hare & Hayward, 1985a; Sacks et al., 
1985). The HSV-1 IE genes possess one or more copies of 
the element TAATGARAT (where R is a purine), a cis- 
acting motif that mediates stimulation of IE transcrip­
tion by the virion protein Vmw65 (otherwise named 
VP 16 or a-TIF), between 100 and 600 base pairs (bp) 
upstream of the m RNA initiation sites (Post et al., 1981; 
Mackem & Roizman, 1982; Campbell et al., 1984; 
Preston et al., 1984). Vmw65 does not bind directly to 
D N A  (Marsden et al., 1987), but interacts with one or 
more cellular factors to form a ternary complex, IEC, 
that binds to TAATGARAT (McKnight et al., 1987; 
Preston et al., 1988; O’Hare et al., 1988). One of the 
cellular components of IEC appears to be a ubiquitous 
protein with various names, including NFIII (Pruijn et 
al., 1986), OBP100 (Baumruker et al., 1988; Sturm et al., 
1987), OTF-1 (Gerster & Roeder, 1988), TRF (O’Hare & 
Goding, 1988) and a-Hl (Kristie & Roizman, 1987), that 
recognizes an octamer element of consensus ATG- 
CAAAT as well as TAATGARAT. Although NFIII 
binds to a range of target sequences, complex IEC is 
formed efficiently only when a match to TAATGARAT  
iuM ^ en t (Gerster & Roeder, 1988; O’Hare et al., 1988;
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ApRhys et al., 1989). The formation of IEC upstream of 
IE m RNA initiation sites enables a strongly acidic 
activating domain, located within the C-terminal 80 
amino acids of Vmw65, to interact with a transcription 
complex and thereby augment transcription (Dalrymple 
et al., 1985; Triezenberg et al., 1988; Sadowski et al., 
1988; Cousens et al., 1989). At the biological level the 
stimulation of IE transcription by Vmw65 is important 
for virus replication after infection at low m.o.i. or in vivo 
(Ace et al., 1989).
Four VZV IE gene products have been detected in 
infected cells (Shiraki & Hyman, 1987), but little is 
known about the regulation of their expression. The 
product of VZV ORF 62 (and ORF 71, since this gene is 
diploid), a polypeptide of calculated Mr 139989, is 
thought to be equivalent to HSV-1 Vmwl 75, which is a 
major trans-activator of HSV-1 early and late gene 
transcription. This conclusion is based on their compar­
able locations in the short repeat region of the genome 
(Davison & Scott, 1985, 1986), sequence homology 
(Davison & Scott, 1986) and the ability to stimulate gene 
expression in transfection assays (Everett & Dunlop, 
1984; Everett, 1984). Furthermore, Vero cells that 
contain integrated copies of ORF 62 (FI 14 cells) 
complement the growth of HSV-1 temperature-sensitive 
mutants with mutations in the coding sequences of 
Vmwl75 (Felser etal., 1988). Interestingly, the transcrip­
tion of ORF 62 in FI 14 cells is stimulated by HSV-1 
infection and this effect occurs even in the absence of 
protein synthesis, suggesting that a component of the 
KSV-1 inoculum, possibly Vmw65, is responsible (Felser 
et al., 1988). A homologue of Vmw65, ORF 10, has been 
identified in the VZV genome (Dalrymple et al., 1985). 
The two proteins share homology over the N-terminal 
410 amino acids but, strikingly, ORF 10 is 81 amino 
acids shorter, lacking the acidic C-terminal activating 
region of Vmw65 (Dalrymple et al., 1985).
Studies with HSV-1 indicate that the efficiency of IE 
gene expression has important implications for the 
biological properties of the virus (Ace et al., 1989). We 
have therefore investigated the cis-acting sequences that 
control the expression of VZV ORF 62 and have clarified 
the functional relationship between Vmw65 and VZV 
ORF 10.
Methods
Plasmids. P la sm id  pM O C A T  c o n ta in s  th e  reg ion  from  — 1146 to  +  57 
o f  th e  V Z V  O R F  62 gene in serted  in to  th e  ch lo ram p h en ico l 
ace ty ltran sfe rase  (C A T ) v ec to r p C A T , w h ic h  w as d e riv ed  from  
pB L W 2 (G affney  et al., 1985) a n d  co n ta in s  re s tric tio n  sites  fo r Hindlll, 
Pstl, Smal a n d  BamHl u p s tre am  o f  th e  C A T  cod ing  region. T h e  O R F  
62 p ro m o te r reg ion  in  pM O C A T  w as d e riv e d  from  p V Z V S stf (k ind ly  
p ro v id ed  by D r A . D av ison ), w h ich  co n ta in s  th e  te rm in a l Sstl frag m en t 
from  th e  sh o rt re p ea t reg ion  o f  V Z V  cloned  in to  th e  Pstl s ite  o f  p A T  153
by G C  ta ilin g , th u s  effectively  c re a tin g  a  Pstl site  a t  th e  genom e 
te rm in u s . P la sm id  pM O c o n ta in s  th e  V Z V  O R F  62 gene  fro m  th e  Clal 
s ite  a t — 1146 to  th e  genom e te rm in u s  Pstl s ite  o f  p V Z V S s tf in se rted  
b e tw een  th e  Accl a n d  Pstl s ites o f  a  p U C 9  p la sm id  fro m  w h ich  th e  
£ c o R I s ite  h a d  b een  rem o v ed  by cu ttin g  a n d  filling in . P la sm id  pM O E T  
is a  d e riv a tiv e  o f  pM O, in  w h ich  a n  .EcoRI s ite  h ad  b een  c re a te d  a t 
p o sitio n  + 5 7  by  o ligonucleo tide  m u tag en es is  o f  n u c leo tid e  + 5 7 , 
ch an g in g  th e  sequence  A A A T T C  to  G A A T T C  (F ig . 1). T h e  new  
E eoR I site  in  pM O E T  w as co n v erted  to  a  BgHI s ite  (pM O BT) by 
c leav ing  w ith  EcoRl, filling in  a n d  in se rtio n  o f  a n  o ligonucleo tide  
lin k e r (G A G A T C T C ). U sin g  th is  novel BglI I  s ite  a n d  th e  Smal s ite  in  
v ecto r sequences im m ed ia te ly  5' o f  th e  V Z V  insert, th e  O R F  62 reg ion  
from  — 1146 to  + 5 7  o f  pM O B T w as c loned  b e tw een  th e  S m a l an d  
BamHl sites o f  p C A T  to  g ive pM O C A T . S eq u en tia l 5 ' d e le tions  o f  
pM O C A T  w ere p ro d u ced  by c leav ing  pM O C A T  a t th e  u n iq u e  Hindlll 
a n d  Sail ( —410) o r  Xhol ( — 131) sites, filling in  th e  5 ' overhangs^w ith  
T 4  D N A  po lym erase  a n d  all fou r deoxynucleoside  tr ip h o sp h a te s  an d  
re liga ting , to  y ie ld  p l4 0 A 4 1 0 C A T  a n d  p l40A 131C A T .
T h e  O R F  10 o f  V Z V  w as c loned  by in tro d u c in g  a n  8 b p  EcoRl l in k e r 
(G G A A T T C C ) in to  a  Dral site  25 b p  u p s tre am  o f  th e  O R F  10 
in itia tin g  A T G , th e n  subclon ing  a  1290 b p  EcoRl/Sphl f rag m en t 
c o n ta in in g  th e  e n tire  O R F  in to  p T Z 1 8 R  (P h arm ac ia ), to  y ie ld  tw o 
a p p aren tly  id en tic a l iso la tes, p T Z O R F lO A  a n d  p T Z O R F lO B . T h e  
1290 b p  EcoRl/Sphl frag m e n t from  p T Z O R F lO A  w as rec loned  
b e tw een  th e  EcoRV a n d  Sphl s ites  o f  p M C l . in l7  (A ce et al., 1988). 
P lasm id  p M C l c o n ta in s  th e  H SV-1 gene en co d in g  V m w 65 (C am p b e ll 
et al., 1984) a n d  p M C l . in  17 c o n ta in s  a  12 b p  in sertio n , very  n e a r  to  th e  
C  te rm in u s  o f  th e  c od ing  sequences, th a t  does n o t affect th e  a c tiv ity  o f  
V m w 65 (A ce et al., 1988). T h e  use o f  p M C l . in l7 ,  as o p p o sed  to  p M C l,  
is irre lev an t to  th e  w o rk  d e sc rib ed  here . T h e  re su lta n t p lasm id , 
p M C O R F lO , co n ta in s  th e  V Z V  O R F  10 cod ing  sequences  in  p lace  o f  
th e  V m w 65 cod ing  sequences.
P lasm id s  p G E M T IF  a n d  th e  in se rtio n  m u ta n t p G E M T I F .in l5 ,  
d esc rib ed  p rev iously  (A ce et al., 1988), w ere  used  fo r in vitro 
t ra n sc r ip tio n  a n d  tran s la tio n . P la sm id  p F J 3 , c o n ta in in g  th e  j3- 
g a lacto s idase  gene con tro lled  by  s im ian  v iru s  40 p ro m o te r  an d  
en h an c e r sequences w as k in d ly  p ro v id ed  by D r  F . J . R ixon . P lasm id  
p R R 5 5 , co n ta in in g  th e  C A T  gene  u n d e r th e  c o n tro l o f  h u m an  
cy tom egalov irus (H C M V ) s tra in  A D  169 IE  gene  p ro m o te r an d  
en h an c e r sequences (F ick en sch e r et al., 1989), w as k in d ly  p ro v id e d  by 
D r  R . R iiger. P la sm id  p IE 3 C A T , c o n ta in in g  th e  C A T  gene u n d er 
HSV-1 IE  gene 3 c on tro l (S tow  et al., 1986), w as k in d ly  su p p lied  by  D r 
T . P a te rso n .
Cells. B aby  h a m ste r  k id n ey  (B H K ) cells w ere  g row n  in  E ag le ’s 
m ed iu m  c o n ta in in g  10%  try p to se  p h o sp h a te  a n d  10%  n ew b o rn  ca lf  
serum . H u m a n  foe ta l lung (H F L ) cells w ere  g row n  in  E ag le ’s m ed ium  
c o n ta in in g  10%  foe ta l c a lf  serum  a n d  H eL a  cells w ere  g row n in  
D u lb ecco ’s m e d iu m  co n ta in in g  2-5%  n e w b o rn  a n d  2-5%  foe ta l calf 
serum . P en ic illin  (100 un its /m l) a n d  s trep to m y c in  (100 pg /m l) were 
a d d ed  to  all m ed ia .
Preparation ofVZV-infected cell RNA. H F L  cells w ere  in fec ted  by  the  
a d d itio n  o f  a  one -s ix th  q u a n tity  o fV Z V -in fe c ted  H F L  cells show ing 70 
to  80%  c.p .e. W h en  th e  cu ltu re  re a ch ed  70 to  80%  c .p .e . cy toplasm ic 
R N A  w as ex trac ted  as d e sc rib ed  by  P res to n  (1977).
Primer extension. A  29 base  o ligonucleo tide  (5 'G G G G T G T A - 
G A G C G C T G C A T C G G C G G C G T A 3 ') ,  co m p lem en ta ry  to  a  region 
close to  th e  N  te rm in u s  o f  V Z V  O R F  62 (F ig . 1), w as 5 ' end-labelled  
w ith  32P  using  T 4  po lynucleo tide  k in ase . T e n  pg o f  cy top lasm ic  R N A  
w as m ixed  w ith  rad io lab e lled  o ligonucleo tide  in  h y b rid iza tio n  buffer 
(40 m M -K Cl an d  50 m M -T ris-H C l p H  8-3) a n d  h e a ted  to  90 °C. T he 
te m p e ra tu re  w as d ecreased  to  45 °C o v e r 1 h , M g C l2 w as add ed  to  a 
final c o n c en tra tio n  o f  5 mM an d  th e  fo u r deoxynucleoside triphos­
p h a te s  w ere  ad d ed  a t  a  c o n ce n tra tio n  o f  0-5 mM. A M V  reverse
VZV  IE gene expression 899
Sal I
CACACCGTCGACGTGCATTTGATTAACTAGATGCCGGATGGGTGGAAACAACCCGTGTTA - 3 5 6
O ctam er
TATAAGATGTTTTG CA TGTGAGACAACCCCAATTGTGTTTATGTATATTATATATCGTCT - 2 9 6
AccI O c t/T G  AfllW
GTAGACACACGATGATTGGTTGTTATTTAAACATATGTAAATGAAATTCACATGTCTGGT - 2 3 6  
ATCCCTTGTTATGATGTTGTAAGGTATGCGGAAATAGACACCGGGCGTACATCGCCAACC -  1 7 6
Xhol
AGCGGTCTCTCCTTAAACGCATACTATGGTCCATGAACTTCCCGCCTCGAGTCTCGTCCA -  1 1 6  
ATCACTACATCGTCTTATCATTAAGAATATTTACACGGTGACGACACGGGGAGGAAATAT - 5 6
T A T A ’ m R N A ,— ►
GCGGTCGAGGGGGGGOCACAACACGTTTTAAGTACTGTTGGAACTCCCTCACCAACCGCA + 5
iscoR I
ATCGCAATCCTTTGAAGGCTGCGAGAGCGTTTGGAAAACTCGGGTACGTCTAAATTCACC + 6 5
M et (G )
CCAGTGCGATGGATACGCCGCCGATGCAGCGCTCTACACCCCAACGC + 1 1 2
Fig . 1. D N A  sequences in  th e  u p s tream  regu la to ry  reg ion  o f  V Z V  
O R F  62. R es tric tio n  en donuclease  c leavage  sites  re lev an t to  the  results 
a re  u n d erlin ed . T h e  m R N A  s ta r t s ite  is d e sig n a ted  + 1  by con v en tio n  
an d  a  T A T A  box hom ology T T T T A A  is found  a t  p o sitio n s  —25 to 
— 30. A  13 b p  sequence c en tred  a t  —255 co n ta in s  b o th  o c tam er an d  
T A A T G A R A T  m otifs  a n d  a  sim ple  o c ta m er m o tif  in  inverse  
o r ie n ta tio n  is p re sen t a t  n u c leo tides  —346 to  —339. Sequences from  
w h ic h  o ligonucleo tides fo r use in  p r im e r ex tension  a n d  SI nuclease  
analysis  w ere co n stru c ted  are  u n derlined . T h e  A  residue  a t  p o sition  
+  57 w as chan g ed  to  a  G  residue  d u rin g  th e  co n stru c tio n  o f  p l4 0 C A T .
tra n sc r ip ta se  (10 u n its) w as ad d ed  a n d  th e  reac tio n  co n tin u e d  a t 45 °C 
fo r 30 m in . R ea c tio n  m ix tu res  w ere  ex trac ted  w ith  p h en o l-c h lo ro fo rm  
an d  p re c ip ita te d  w ith  e th an o l. P rec ip ita te s  w ere d isso lved  in  90%  
fo rm am id e  in  90 m M -T ris-bo ra te  p H  8-3 a n d  2-5 m M -E D T A , an d  
h ea ted  a t 90 °C for 1 m in . Sam ples w ere  e lec tro p h o resed  on  a  12% 
sequencing  po lyacry lam ide  gel a n d  rad io lab e lled  b a n d s  d e tec ted  by 
au to rad io g rap h y .
Nuclease SI mapping. A  77 b ase  o ligonucleo tide  (5 'G A G T T T T C C - 
A A A C G C T C T C G C A C C T T C A A A G G A T T G C G A T T G C G T T G - 
G T G A G G G A G T T C C A A C A G T A C T T A A A A C G T 3 ')  w as sy n th e ­
sized  an d  5 ' end-labe lled  w ith  32P  using  T 4  p o lynucleo tide  k inase . T h e  
o ligonucleo tide  w as designed  to  ov erlap  th e  V Z V  m a jo r IE  R N A  5' 
te rm in u s  p red ic ted  by p rim er ex ten sio n  analysis  (F ig . 1). R ad io lab e lled  
o ligonucleo tide  w as hyb rid ized  w ith  10 pg  o f  V Z V -in fected  cell R N A  
a t 42 °C fo r 16 h , th e  re ac tio n  m ix tu re  tre a te d  w ith  nuclease  SI an d  the  
p ro d u c ts  w ere  e lectrophoresed  on  d e n a tu rin g  12%  po lyacry lam ide  
sequencing  gels, as d e sc rib ed  p rev iously  (R ixon  & C lem en ts , 1982; 
P res to n  et al., 1984).
Transfections. M onolayers o f  3 x  106 B H K  cells in  50 m m  d ia m e te r  
P e tr i d ishes w ere tran sfec ted  w ith  calc ium  p h o sp h a te -p rec ip ita ted  
D N A , as desc ribed  by C ord ing ley  et al. (1983). P rec ip ita te s  co n ta in ed  
5 pg  o f  C A T -co n ta in in g  p lasm id  a n d  0-5 pg  o f  p F J3 . T h ree  pg  o f  p M C l 
w as ad d ed , w here  ap p ro p ria te , an d  th e  to ta l am o u n t o f  D N A  w as 
ad justed  to  9 pg by th e  a d d itio n  o f  p U C 1 8  D N A . C ells w ere  ha rvested  
a f te r  18 h  a t 37 °C.
M onolayers o f  106 H eL a  cells in  50 m m  d ia m e te r  P e tri d ishes w ere 
tran sfec ted  w ith  calcium  p h o sp h a te -p rec ip ita te d  D N A , as desc ribed  
by C orsalo  & P earso n  (1981). P rec ip ita te s  co n ta in ed  8 pg  o f  C A T - 
co n ta in in g  p lasm id , 1 pg  o f  p F J3 , 5 pg  o f  p M C l,  w here  ap p ro p ria te , 
an d  p U C 1 8  D N A  to  g ive a  to ta l o f  16 pg. H eL a  cells w ere h a rv ested  
a fte r in cu b a tio n  a t 37 °C for 40 h.
CAT and fi-galactosidase assays. Cell e x trac ts  w ere p rep a red  and  
assayed fo r C A T  ac tiv ity  as d esc rib ed  by G o rm an  et al. (1982). /?- 
G a lac to s id a se  w as assayed  as desc ribed  by Spae te  & M ocarsk i (1985). 
B efore con d u ctin g  C A T  assays, ex trac ts  w ere ad ju sted  to co n ta in  equal
/?-galatosidase ac tiv itie s , to  co rrec t for v a ria tio n s  in  tran sfec tio n  
efficiencies. In  p rac tice  th is  resu lted  in d ilu tions  n ev er g rea te r th a n  
th reefo ld  for B H K  cell e x trac ts  an d  fivefold for H eL a  cell ex trac ts. T o 
q u an tify  C A T  assays rad io ac tiv e  spo ts w ere cu t ou t and  th e  p e rcen tage  
o f  su b stra te  ace ty la ted  w as calcu la ted  a fte r sc in tilla tio n  coun ting . T he  
am o u n t o f  ex trac t w as v a ried  to  ensure  th a t  the  lin ea r response  range  o f 
th e  assay  w as used.
In  v itro  transcription and translation. P la sm id s  w ere  c leaved  w ith  
ap p ro p ria te  re s tric tio n  enzym es an d  in vitro tra n sc r ip tio n  and  
tra n s la tio n  w as carried  o u t as desc rib ed  by A ce et al. (1988). D up lica te  
tran s la tio n s  w ere pe rfo rm ed  in  e ith e r th e  p resence  o r absence  o f  
[35S ]m ethionine. R ad io labe lled  sam ples w ere analy sed  by S D S -P A G E  
(P reston , 1979) a n d  n o n -rad io ac tiv e  sam ples w ere used  in  gel 
re ta rd a tio n  assays.
Gel retardation assays. H eL a  cell n u c lear ex tra c ts  an d  e x trac ts  o f 
HSV-1 p artic les  w ere p rep a red  as desc ribed  prev iously  (P resto n  et al., 
1988). D N A  fragm en ts  w ere rad io labe lled  by in cu b a tio n  w ith  T 4  D N A  
po lym erase  a n d  tw o n o n -rad io ac tiv e  an d  tw o 32P-labelled  deoxynu­
cleoside  tr ip h o sp h a te s  an d  purified  from  po lyacry lam ide  gels. B ind ing  
reac tio n s  co n ta in ed  10 m M -H EPES p H  7-9, 0-6 m M -dith io threito l, 2-3 
m M -M gCl2, 0-1 m g/m l bov ine  serum  a lb u m in , 4 pg po ly (d I).p o ly (d C ), 
ap p ro x im ate ly  0-2 ng  rad io lab e lled  D N A  frag m en t, 5 pg  H eL a  cell 
n u c lear ex tra c t and , w here  ap p ro p ria te , HSV-1 e x trac t (0-5 pg) o r a 
sam ple  co n ta in in g  V m w 65 or V Z V  O R F  10 syn thesized  in vitro. A fte r 
in cu b a tio n  a t 25 °C fo r 30 m in  reac tio n  m ix tu res  w ere  loaded  on to  a 
3-5%  po lyacry lam ide  gel, e lectrophoresis  w as ca rried  o u t for 3-5 h  a t 
160 V an d  the  gel w as d ried  a n d  exposed  for a u to rad io g rap h y . I f  assays 
invo lved  the  use o f  co m p e tito r o ligonucleo tides th e n  a  100-fold m o lar 
excess w as in cu b a ted  w ith  the  reaction  c o m p o n en ts  fo r 15 m in  p rio r to  
th e  ad d itio n  o f  a  rad io labe lled  D N A  frag m en t. C o m p e tito rs  used  were 
all 36 bp , one co n ta in in g  a C C A A T  sequence  (P resto n  etal., 1988), one 
th e  adenov iru s  m a jo r la te  p ro m o ter (M L P ) recogn ition  sequence 
(P resto n  et al., 1988) an d  th e  o th e r tw o co n ta in in g  A T G C A A A T - 
C A T G T  (oc tam er) o r G C G G T A A T G A G A T  (T A A T G A R A T ) in  an 
o therw ise  id en tica l sequence con tex t.
DNase I protection assays. D N A  fragm en ts  w ere un iquely  3 ' end- 
labelled  an d  used  fo r gel re ta rd a tio n  analysis. P ro te in -D N A  com plexes 
w ere  elu ted  from  po lyacry lam ide  gels, an d  D N ase  I p ro tec te d  regions 
w ere  identified  as desc ribed  by P res to n  et al. (1988).
Results
Mapping the 5' terminus of the VZV major IE RNA
To analyse the regulation of VZV IE transcription it was 
first necessary to determine the location of the mRNA 5' 
terminus. Two techniques were used for this analysis. 
First, the length of the 5' untranslated region was 
determined by primer extension analysis using a 5' 32P- 
labelled synthetic oligonucleotide complementary to 29 
bases of the N-terminal coding sequence of ORF 62. Fig. 
2 shows that an extension product of 105 bases was 
produced from VZV-infected cell RNA, but not mock- 
infected cell RNA, indicating that the length of the 5' 
non-coding region is 71 bases. No extension products 
longer than 105 bases were detected (results not shown). 
To confirm the primer extension result and to exclude the 
existence of an intron within the 5' non-coding region,
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Having ascertained the location of the m RNA 5' 
terminus a plasmid, pMOCAT, was constructed in which 
sequences from + 57  to —1146 were inserted 5' to the 
CAT gene. A comparison of the activity of this plasmid 
with pIE3CAT and pRR55, in which the HSV IE3 and 
the HCMV IE control sequences, respectively, direct 
expression of CAT, is shown in Fig. 3. The activities of
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Fig . 2. M ap p in g  the  5 ' end  o f  th e  m R N A . (a) P r im e r ex ten sio n  analysis  
w as p e rfo rm ed  on th ree  R N A  sam ples p re p a re d  from  d iffe ren t b a tch es  
o f  V Z V -in fected  H F L  cells (lanes 1, 2 an d  3) an d  from  m ock-in fec ted  
H F L  cells (lane 4). M ark ers  o f  th e  in d ica ted  sizes (bp) w ere  ru n  in 
pa ra lle l an d  th e  ex ten d ed  p ro d u c t is labe lled  ( # ) .  (b) N uc lease  SI 
analysis  w as pe rfo rm ed  on  R N A  p re p a re d  from  V Z V -in fected  H F L  
cells (lane 5) o r m ock-in fec ted  cells (lane  6). G  an d  G  +  A  lanes o f  the  
o ligonucleo tide  used  in th e  assay  w ere  inc luded  as size m a rk e rs  and  
ap p ro p ria te  exposures a re  show n (lanes 7 a n d  8). U n d ig ested  
o ligonucleo tide  ( □ )  an d  d igested  p ro d u c t ( ■ )  a re  labelled .
nuclease SI analysis was carried out using a radiolabelled 
probe that spanned the 5' terminus predicted by primer 
extension. As shown in Fig. 2(b) a cluster of protected 
DN A  bands of 45, 46 and 47 bases was observed when 
VZV-infected cell RNA, but not mock-infected cell 
RNA, was used, in agreement with the result of the 
primer extension analysis and excluding the possibility 
of splicing in the 5' untranslated region.
Inspection of the sequence (Fig. 1) reveals the element 
TTTTAA to be 25 to 30 bp upstream of the mRNA start 
site. This probably represents the TATA box, a cis- 
acting element known to be an important signal for the 
correct initiation of transcription by RNA polymerase 
II.
Fig . 3. C o m p ariso n  o f  th e  activ itie s  o f  IE  con tro l sequences  o f  V Z V  
(lanes 1 a n d  2), H C M V  (lanes 4 a n d  5) an d  HSV-1 (lanes 6 a n d  7) lin k ed  
to  th e  C A T  gene. L an e  3 rep re sen ts  m o ck -tran sfec tio n . In  lanes 
m a rk ed  +  (lanes 2, 5 an d  7) re p o rte r p lasm ids  w ere co tran sfec ted  w ith  
p M C l,  w hereas  in  lanes m a rk e d  — (lanes 1 ,4  an d  6) p U C  18 w as a d d ed  
in  o rd e r to  equalize  p lasm id  q u an titie s .
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Fig. 4. A c tiv ity  o f  pM O C A T  an d  d e le tio n  m u ta n ts  in  B H K  cells (lanes 
1 to  9) a n d  H eL a  cells (lanes 10 to  16). T o  d em o n stra te  the 
responsiveness  o f  th ese  sequences to  V m w 65, cells fo r lanes m ark ed  +  
w ere  co tran sfec ted  w ith  p M C l an d  those  fo r lanes m a rk e d  — w ith  
p U C 18 . Sam ples 10 to  16 w ere  excised  from  th e  sam e au to rad io g rap h  
a n d  rep re sen t eq u al exposures.
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the three plasmids were tested with and without 
cotransfected pM Cl, a plasmid that expresses HSV-1 
Vmw65. The VZV upstream sequences were much less 
active in directing CAT expression, since it was 
necessary to dilute extracts from cells transfected with 
pIE3CAT or pRR55 250-fold to obtain comparable 
enzyme levels. When pMCl was cotransfected with 
pIE3CAT a fivefold stimulation of CAT activity was 
observed, whereas a small stimulation (not greater than 
twofold) of CAT expression from pRR55 occurred. 
Cotransfection of pMCl with pMOCAT resulted in a 15- 
fold stimulation of activity, suggesting that the transcrip­
tion of the IE gene of VZV is stimulated by Vmw65. 
Therefore, the major VZV IE gene has a relatively weak 
promoter, but contains sequences that respond to 
activation by Vmw65.
To analyse in greater detail the D N A  sequences 
involved in the response to Vmw65, a set of 5' endpoint
deletions of pMOCAT was produced. Plasmids were 
transfected into BHK or HeLa cells, with or without 
pM Cl, and expression of CAT was assessed after 
correction for different transfection efficiencies by the 
use of pFJ3, an internal control plasmid that expresses /?- 
galactosidase (Fig. 4). Deletion to —410 or —131 did not 
affect the expression of CAT in either cell type. When 
pMCl was included in transfection mixtures, the 
expression of pl40A410CAT was stimulated on average 
21-fold in BHK cells and 15-fold in HeLa cells, whereas 
expression of p 140A131 CAT was not stimulated in either 
cell type. The apparent small stimulation of 
pl40A131CAT in HeLa cells was not reproducible. 
Therefore, sequences that respond to Vmw65 are located 
between —410 and — 131, but sequences that determine 
the basal expression of the VZV major IE gene are 
located within the 131 bp upstream of the mRNA 5' 
terminus.
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Fig . 5. G el re ta rd a tio n  analysis o f  th e  reg ion  b e tw een  — 410 an d  — 131. F rag m en ts  co n ta in in g  th e  o c tam er (O ct) m o tif  (114 bp) a n d  the  
o c ta m er /T A A T G A R A T  m o tif  (49 bp) w ere in c u b a ted  w ith  H eL a  cell n u c lea r ex trac t. HSV-1 v irion  e x trac t (V E ) w as p resen t in  lanes 
labelled  +  and  a b sen t from  lanes labelled  —. A 100-fold m o la r excess o f  o ligonucleo tides c o n ta in in g  o c tam er (lanes 3, 4, 9 a n d  10), 
T A A T G A R A T  (lanes 11 an d  12), C C A A T  box (lanes 5, 6, 13 an d  14) o r ad en o v iru s  M L P  b in d in g  site  (lanes 15 and  16) w ere  add ed  as 
com petito rs . C om plexes H C 3  a n d  IE C  are  labelled .
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Formation o f  protein-D N A complexes responsible for  
stimulation by Vmw65
Previous studies have shown that stimulation of tran­
scription by Vmw65 depends on the presence of 
TAATGARAT in the control sequences of the gene in 
question. Vmw65 does not bind directly to TAAT­
GARAT, but interacts with proteins that themselves 
recognize the octamer element ATGCAAAT as well as 
TAATGARAT. Analysis of the region upstream of the 
TATA box reveals two sites that match the octamer 
element closely. Site I (TTTTGCAT) is centred at — 345 
and matches the octamer element at seven out of eight 
positions in the opposite orientation. Site II (ATG- 
TAAATGAAAT) is centred at —256 and is a more 
complicated motif representing a combination of the 
octamer sequence (seven out of eight matches) and the 
TAATGARAT motif (eight out of nine matches). Both 
of these sites are within nucleotides —410 to —131, 
defined above as the region that determines the response 
to Vmw65.
Binding of cell proteins and Vmw65 to these sites was 
investigated by gel retardation assays (Fig. 5). Three 
radiolabelled fragments from the region —410 to — 131 
in the VZV IE promoter were tested in the assay. A 114 
bp S all/A ccl fragment, containing TTTTGCAT, gave a 
complex (lane 2) and, upon addition of virion extract, 
slightly more material that migrated slowly into the gel 
was observed (lane 1). Additional experiments con­
firmed that the major complexes comigrated with the 
previously described HC3 (Preston et al., 1988) (results 
not shown). Production of the radiolabelled complexes 
was competed for by the addition of oligonucleotide 
containing ATGCAAAT (lanes 3 and 4), but not by an 
oligonucleotide containing CCAAT (lanes 5 and 6). A 49 
bp A ccl/A fllll fragment containing ATGTAAAT- 
GAAAT readily formed the HC3 complex (lane 8) and 
upon addition of virion extract a major band represent­
ing IEC was formed (lane 7). Oligonucleotides contain­
ing TAATGAGAT or ATGCAAAT competed effi­
ciently (lanes 9 to 12), but oligonucleotides containing 
CCAAT or MLP recognition sites did not (lanes 13 to 
16). An A fllll/X h o l fragment making up the remainder 
of the —410 to — 131 region failed to form any protein- 
D N A  complexes (results not shown). Thus two subfrag­
ments of the —410 to —131 region bind proteins to form 
an HC3-like complex, and the IEC forms efficiently on 
the A ccl/A fllll fragment that contains an eight out of 
nine match to TAATGARAT.
The protein binding site on an A ccl/Xhol fragment 
(Fig. 1) was determined by DNase I protection analysis 
(Fig. 6). The only footprint detected in the HC3 complex 
was a disturbance to the digestion pattern at ATG- 
TAAATGAAAT (lane 2) with a slight extension of the
HS*
Fig . 6. D N ase  I fo o tp rin tin g  analysis  o f  a  165 bp  Accl/Xhol ( — 296 to  
— 131) frag m en t. L anes  4 a n d  5 a re  G  a n d  G  +  A  seq u en c in g  track s. 
P r io r to  D N a se  I tre a tm e n t, th e  fra g m e n t in  lane  1 w as in c u b a ted  w ith  
H e L a  cell e x trac t an d  v irion  ex tra c t, th e  frag m e n t in  lan e  2 w ith  H eL a  
e x trac t, w hereas lane  3 rep re sen ts  free  fra g m e n t a lone. D a rk  b a rs  
rep re sen t th e  sequences p ro tec ted  in  lanes  1 (left) a n d  2 (rig h t) and  
hypersensitive  sites  a re  labelled  HS.
region of protection in the presence of Vmw65 (lane 1).
By analogy with the well characterized HSV-1 system 
it is likely that the element ATGTAAATGAAAT is of 
major importance for the observed stimulation of 
expression from the VZV major IE promoter by Vmw65.
Activity o f  V Z V  O RF 10
It was of interest to determine whether the VZV 
homologue of Vmw65, the ORF 10 product, could also
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stim ulate transc rip tion  from  the VZV m ajor IE  gene. 
The coding sequences o f Vmw65 in the p lasm id p M C l 
were replaced by those o f O R F  10 to form  the plasm id 
pM C O R FlO . W hen pM C O R FlO  was used in short term  
transfection  assays it failed to stim ulate expression from 
either pM OCAT or p IE 3C A T  (results not shown). To 
determ ine w hether the protein  encoded by O R F  10 was 
able to  form  a com plex analogous to IEC , the coding 
sequences were inserted into the polylinker o f the 
plasm id pT Z 18R , w hich allows the transcrip tion  of 
O R F s in vitro. Two separate clones o f this construction, 
pT Z O R F lO A  and pTZ O R FlO B , were isolated and 
transcribed , together w ith the p lasm id p G E M T IF  (Ace 
et al., 1988), w hich encodes Vmw65, using T7 R N A  
polym erase. In  addition , p G E M T IF .in i5  cleaved w ith 
BamVU. was transcribed  to  provide a transc rip t lacking 
the sequences encoding the acidic C -term inal tail, but 
reta in ing  the N -term inal 411 am ino acids o f Vmw65 th a t 
are homologous to O R F  10. The transcrip ts were then 
translated  using rabb it reticulocyte lysate in the presence 
or absence o f [35S]m ethionine. Sam ples o f reactions in 
w hich [3SS]m ethionine was incorporated  revealed the 
presence o f translation  products o f the expected sizes 
upon S D S -P A G E  (Fig. 7); differences in the in tensities 
o f the bands produced by the VZV and  HSV polypep­
tides are largely due to  the occurrence o f threefold m ore 
m ethionine residues in HSV-1 Vmw65 than  in VZV
V E V E O R F O R F  C o n t.V m w  V m w  
-  +  10A 10B 65 65
de.15 wt
L ane 1 2 3 4 5 6 7
V E  V E O R F  VmwiVmw 
-  +  10A 65 65 
de.15  wt 
8 9 10 11 12
j —  IE C  —
— H C 3 — M
1 Jif
14 1 3
II
m r n m m
Fig. 8. G el re ta rd a tio n  assay  using  in vitro syn thesized  V m w 65 and  
O R F  10 p roducts . R ad io labe lled  p ro b es  used in b in d in g  reac tio n s  were 
a  49 bp  Accl/Afllll frag m en t from  th e  V Z V  m ajo r IE  gene contro l 
sequences (lanes 1 to  7) an d  a 74 bp  frag m en t from  HSV-1 IE  contro l 
sequences (lanes 8 to  12). F rag m en ts  w ere in cu b a ted  w ith  H eL a  cell 
n u c lear ex trac t a lone (lanes 1 an d  8) a n d  w ith  a d d itio n  o f  v irion  ex trac t 
(lanes 2 and  9), o r tra n s la ted  p roduc ts  o f  O R F  10 (lanes 3, 4 a n d  10), 
p G E M 2  (lane 5), p G E M T I F .in l5  (lanes 6 an d  11), o r p G E M T IF  
(lanes 7 an d  12). T h e  positions o f  com plexes IE C  an d  H C 3 are  
ind ica ted .
1 2 3 4 5
Fig . 7. In vitro tran s la tio n  o f  V m w 65 an d  O R F  10 po lypep tides. R N A  
tran sc rib ed  from  p G E M T I F .in  15 (lane 1), p G E M T IF  (lane 2), 
p G E M 2  (lane  3) an d  p G E M O R F lO A  a n d  -B (lanes 4 an d  5) w ere 
tra n s la ted  in vitro in  th e  p resence  o f  [35S]m eth ion ine. M r values o f  the  
p ro te in s  p red ic ted  from  the  D N A  sequence  a re  g iven. C o m p ariso n  
w ith  M r s tan d a rd s  g ives a p p a re n t M r o f  63000 (V m w 65) an d  54000 
(O R F  10).
O R F  10 protein. Sam ples o f reactions lacking [35S]meth- 
ionine were used for gel reta rda tion  assays w ith 
radiolabelled D N A  fragm ents contain ing the T A A T ­
G A R A T  elem ents o f VZV or HSV-1 (Fig. 8). As 
expected, Vmw65 produced in vitro from  p G E M T IF  
d irected  the form ation o f IE C  w hen tested w ith the 49 bp 
AccllAfllW  from  the VZV IE  gene or the 74 bp 
oligonucleotide derived from  HSV-1 IE  gene 4/5 (lanes 7 
and 12). T runcated  Vmw65 also form ed IE C  w ith each 
fragm ent (lanes 6 and 11), showing th a t the acidic C 
term inus does not partic ipa te  in the in teraction  of 
Vmw65 w ith cellular proteins to form  IEC . H owever, 
VZV O R F  10 did not direct the form ation o f a com plex 
analogous to IE C  w ith either VZV or HSV-1 fragm ents 
(lanes 3, 4 and 10). Therefore, although O R F  10 protein 
is a homologue o f Vmw65, it does not activate IE  
transcrip tion  or form  IEC .
Discussion
The VZV m ajor IE  gene possesses two classes o f control 
sequences, as m easured in the transfection  assays. A 
prom oter responsible for basal gene expression lies
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within the region —131 to + 55 , whereas sequences that 
mediate stimulation of expression by Vmw65 are located 
further upstream, between —410 and —131. The identity 
of the promoter is unknown, but the elements 
TTTTGCAT and, particularly, ATGTAAATGAAAT  
are strongly implicated in the response to Vmw65. The 
observation that expression of ORF 62 is stimulated by 
Vmw65 confirms and extends the work of Felser et al. 
(1988), in which the response of ORF 62 to infection by 
HSV-1 was first described. However, our candidate 
responding sequences differ from the predicted regula­
tory elements of the earlier study. Felser et al. (1988) 
assumed that the TATA box is located 374 bp from the 
first AUG of ORF 62 and consequently identified a 
number of potential signals upstream of this site. The 
primer extension and nuclease SI analyses presented 
here result in an assignment of the element TTTTAA, 97 
bp from the first AUG  of ORF 62, as the TATA box and 
hence a different set of regulatory sequences.
The VZV IE gene upstream region was considerably 
less effective at directing CAT production than were 
equivalent control sequences of HSV-1 or HCMV. Thus, 
VZV does not possess an efficient promoter or enhancer 
that operates in the systems tested here, in contrast to 
HSV-1 (Lang et al., 1984; Preston & Tannahill, 1984), 
HCMV (Boshart et al., 1985) and, presumably, pseudo­
rabies virus (PRV) (Campbell & Preston, 1987). This 
finding can be viewed in two ways. The alphaherpesvir­
uses HSV-1 and PRV produce only limited amounts of 
V m w l75 and 180K, the respective IE proteins homolo­
gous to the product of VZV ORF 62, during normal 
infection because autoregulation by the HSV-1 and PRV 
IE proteins results in a rapid reduction in transcription of 
their genes (Watson & Clements, 1980; Ihara etal., 1983; 
O’Hare & Hayward, 19856; Muller, 1987). This homeo­
static mechanism stabilizes the levels of V m w l75 and 
180K and thus the potential for high level synthesis, 
which occurs when autoregulation is prevented, is not 
realized. In the case of VZV, the ORF 62 product may 
accumulate more slowly, but reach intracellular levels 
comparable to those of Vmwl 75 or 180K. Alternatively, 
the low observed activity of pMOCAT may be related to 
the cell types used in this study. Even the most 
permissive tissue culture cells, such as HFL cells, human 
foreskin fibroblasts or Vero cells, give low virus yields 
and could be viewed as only semi-permissive. Although 
the activity of pMOCAT is low in Vero as well as BHK 
and HeLa cells (T. A. McKee, unpublished results), the 
possibility remains that the VZV major IE promoter 
would be stronger in a natural host cell type. Unfortu­
nately, the tissue culture systems currently available do 
not accurately reproduce the efficient growth of VZV 
that occurs during infection in vivo.
The failure of VZV ORF 10 protein to stimulate
expression from HSV-1 or VZV IE gene promoters was 
expected, since it lacks the C-terminal acidic region that 
is crucial for the activity of Vmw65 (Sadowski et al., 
1988; Triezenberg et al., 1988; Cousens et al., 1989). It 
was more surprising to find that ORF 10 did not form a 
ternary complex with cellular factors and either homolo­
gous or heterologous TAATGARAT elements. The 
possibility that the acidic C terminus is required for 
formation of IEC was eliminated by the demonstration 
that the N-terminal 411 amino acids of Vmw65 are fully 
active in the gel retardation assay, in agreement with the 
recent report of Greaves & O’Hare (1989). Thus, the 
observed homology between Vmw65 and VZV ORF 10 
protein reflects conservation of features required for 
assembly of virus particles rather than for structures 
involved in interaction with cellular factors that bind 
TAATGARAT. The HSV-1 protein Vmw65 therefore 
possesses two distinct functional characteristics that are 
absent from the latter, namely a binding site, as yet 
undefined, for cellular proteins and an acidic C-terminal 
activating region.
Functional analyses have now been performed on IE 
control regions from the alphaherpesviruses HSV-1 
(Mackem & Roizman, 1982; Preston et al., 1984; O’Hare 
& Hayward, 1987), herpes simplex virus type 2 (HSV-2) 
(Gaffney et al., 1985), PRV (Campbell & Preston, 1987) 
and VZV. The HSV-1 protein Vmw65 and its HSV-2 
homologue stimulate transcription from the IE promot­
ers of all these viruses, but PRV particles do not contain 
an active counterpart and VZV ORF 10 is inactive. With 
the reservation that stimulation of VZV IE transcription 
may be carried out by another virion protein, it appears 
that HSV-1 and HSV-2 differ fundamentally from PRV 
and VZV in this respect. All four viruses possess 
elements that respond to Vmw65 in their IE control 
regions, but the reason that the sequences are retained in 
the absence of the effector protein is unclear at present. 
One possibility is that binding of cellular factors to 
TAATGARAT per se is sufficient to confer IE speci­
ficity to a gene, perhaps by displacing other proteins and 
rendering the promoter accessible to transcription 
factors. This hypothesis is compatible with the observa­
tion that the HSV-1 mutant in 1814, which specifies a 
form of Vmw65 inactive for trans-induction, neverthe­
less transcribes IE genes during infection in the absence 
of protein synthesis (Ace et al., 1989). As previously 
suggested (Ace et al, 1989) TAATGARAT, rather than 
an active effector protein, may be the primary determi­
nant of an IE gene. It is also possible that functional 
TAATGARAT elements are retained by VZV and PRV 
because certain cell types contain homologues of Vmw65 
that replace its function. This explanation could account 
for the low activity of the VZV major IE gene promoter 
in  tissue culture cells and suggests that higher activity
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could be attained in the appropriate host cells. It is a 
challenging future prospect to determine whether the 
intriguing variations in strategies used for the expression 
of IE genes is related to the biological properties of 
different herpesviruses.
W e th a n k  P ro fesso r J . H . S ub ak -S h arp e  fo r h is  in te re s t a n d  D r  J. 
M cL au ch lan  fo r th e  syn thesis  o f  o ligonucleo tides. T .A .M . w as 
su p p o rted  by a  M ed ica l R esearch  C ouncil Fellow sh ip  an d  G . H . D . w as 
a re c ip ie n t o f  a  M ed ica l R esearch  C ouncil R esearch  T ra in in g  A w ard .
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